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ABSTRACT
The elms of this reseerch study are three-fold:
1 . to explore the relevance of recent developments In the 
methodology of cost-effectiveness analysis to disease control 
programmes In developing countries and specifically to malaria 
control in Nepal;
2 . to apply cost-effectiveness analysis to the malaria control 
programme in Nepal in terms both of (a) the cost-effectiveness 
of various malaria control strategies and (b) the cost- 
effectiveness of the malaria control programme as a whole, in 
order to refine a methodology capable of more general 
application to disease control programmes in developing 
countries;
3. to assess whether policy-relevant conclusions can be drawn from 
the application of cost-effectiveness analysis to the malaria 
control programme in Nepal.
The thesis is structured as follows. After the first introductory 
chapter. Chapter 2 reviews the literature on the cost-effectiveness 
analysis of disease control programmes, considering first the 
methodology of cost-effectiveness analysis, then its application to 
disease control programmes In first developed and then developing 
countries, and finally its application to malaria control. Chapter 3 
briefly describes the epidemiology of malaria and policies and 
strategies of control before considering the history of malaria 
control in Nepal, present malaria control strategies and economic 
characteristics of the control programme.
In Chapter 4, objectives and methods are presented for the study of 
malaria control in Nepal with a description of the theoretical 
framework of the analysis followed by a description of the various 
sub-studies, comprising a cost analysis, an effectiveness analysis and 
two surveys of malaria patients. The findings are presented in three 
chapters. The first (Chapter 5) presents the results of an analysis
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of the recurrent expenditure of NMEO (Nepal Malaria Eradication 
Organization) dlatrlcta. The aecond assesses the Internal efficiency 
of the Nepalese malaria control programme, considering first vector 
control strategies and second case detection and treatment strategies. 
The following chapter (Chapter 7) presents results relating to the 
desirability of malaria control (as opposed to other Investments).
These results are discussed in Chapter 8 in terms both of the 
application of the cost-effectiveness methodology and of the findings 
In Nepal. Chapter 9 then draws out the Implications of the findings 
for malaria control policies and strategies In Nepal. In Chapter 10, 
conclusions are drawn relating to the three alms of the research study 
Identified above and recommendations are given. Finally, Chapter 11 
draws out the Implications of this study for further research.
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1. INTRODUCTION: THE APPLICATION OP COST-EFFECTIVENESS ANALYSIS TO 
DISEASE CONTROL PROGRAMMES.
Disease control programmes have for long been a feature of the health 
sectors of developing countries. Indeed In some countries, of which a 
prime example Is Nepal, disease control programmes preceded the 
extension of general health services to the population and were the 
first health programmes to reach Into people's homes. Some early 
successes, for Instance yaws control In Africa and malaria control In 
South East Asia in the 1940's and 1950's, encouraged the emphasis on 
disease control programmes. As a result, a sizeable proportion of 
health sector expenditure was, and often continues to be, spent on 
disease-specific programmes, despite attempts to integrate these Into 
general health services.
There has also for long been an interest In the economic Impact of 
tropical diseases. A classic epidemiological study of malaria In the 
Punjab published In 1911 commented on Its economic effects:
"The autumn of 1908 in the Punjab was characterised by an epidemic 
of extraordinary severity. The effects of this epidemic were 
first prominently brought before the public by a sudden 
disorganisation of the train service due to "fever" among the
employees at the large railway centre, Lahore...... At Amritsar, a
city of 160,000 inhabitants. It Is stated that almost the entire 
population wee prostrated and the ordinary business of the city 
disrupted. For many weeks labour for any purpose was unprocurable 
and even food vendors ceased to carry on their trade" 
(Christophers 1911).
A review by Prescott (1979) of studies on the benefits of malaria 
control lists the earliest economic study as dating from 1916: it 
studied the effect of malaria on 74 tenants on a Louisiana plantation. 
The earliest developing country study published was by Slnton in 1935, 
which put together a mass of (largely anecdotal) evidence dating from 
the nineteen hundreds onwards on the economic consequences of malaria in 
India.
The motivations of such studies were mixed. Partly they were genuinely 
humanitarian and philanthropic, though often commercial Interests or the 
economic Interests of the colonial power were also involved. Behind 
publication often lay a motive of propaganda - to stimulate the
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authorities to take action - rather than of informing an academic or 
research community. There was therefore a clear tendency for evidence 
on the economic consequences of disease to be exaggerated and to be 
insufficiently based on empirical data.
This exaggeration was one reason for growing disillusionment with 
studies of the economic impact of disease. Other reasons were 
methodological difficulties. The main theme of these early studies was 
the impact of disease on production since diseases such as malaria, at 
times of epidemics, had an obvious Impact on the ability of a household 
to produce for its own survival and on the ability of a country to 
expand production and raise its level of economic development. The 
value of lost production was therefore seen as the main economic cost of 
disease, and a theoretical rationale was later provided by Mushkin and 
others in the form of human capital theory, where programmes such as 
health and education are viewed as Investment in people which enables 
them to be more productive and to Increase their material well-being 
(Mushkin 1962). Productive benefits (plus other benefits such as 
averted medical care costs) could therefore be set against control costs 
in order to assess the desirability of public health programmes.
Health economists are now retreating rapidly from this theoretical 
approach to benefit valuation. It has been severely criticised as 
ignoring the value of improved health per se (ie the consumption as 
opposed to the investment value of health); as not necessarily 
reflecting either individuals' or society's valuation of improved 
health; and as biasing choice towards programmes benefiting the most 
productive members of society. The application of the theory can also 
be criticised for its tendency to base estimates of production gains on 
the existing earnings of individuals, ignoring whether these reflect 
their social productivity or whether the productivity of additions to 
the labour force will be the same as that of existing members of the 
labour force.
However, the approach to benefit valuation that is proposed in the place 
of the human capital approach, namely the willingness - to-pay approach, 
also has both theoretical and practical difficulties. Usually the 
willingness-to-pay is defined to be that of the consumer, although in 
principle a willingness - to-pay approach does not automatically imply
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consumer sovereignty (Drummond 1981). Consumer valuations can be 
questioned on a number of grounds, including the ability and desire of 
consumers to make such Judgements (Mooney 1977), and the desirability of 
accepting valuations that will be based on a distribution of Income and 
wealth that may not be considered equitable.
There is the further difficulty of eliciting valuations in the frequent 
absence of prices for the output of the health sector. Valuations can 
be based either on observing behaviour or on questionnaires. Valuations 
based on behaviour - for instance the costs individuals are willing to 
incur in order to avoid a health hazard - will be affected by whether or 
not the individual accurately perceives the risks (though this does not 
undermine the approach for Mlshan: Mlshan 1971). Questionnaires are 
extremely difficult to phrase appropriately and simply, and respondents 
may deliberately overstate their valuations. Questionnaires in general 
are fraught with difficulties in developing countries (Campbell, 
Strestha and Stone 1979) though one attempt has been made to ask 
willingness-to-pay questions (Birdsall 1987).
Proponents of the application of economic evaluation techniques have now 
therefore largely retreated from the use of cost-benefit analysis to 
assess public sector health programmes, preferring Instead cost- 
effectiveness analysis. In its simplest form, cost-effectiveness 
involves the choice of either the strategy that achieves a given health 
objective at least cost, or that maximises the achievement of a health 
objective for a given fixed budget. In contrast to cost-benefit 
analysis, where the emphasis is usually placed on whether a health 
programme is worthwhile compared to other health programmes or 
completely different uses of the resources, cost-effectiveness analysis 
focuses attention on the particular health strategies chosen to reach 
health objectives. It has therefore introduced an emphasis on internal 
efficiency which is welcome given the evident inefficiencies of many 
parts of countries' health sectors. Health policies and strategies have 
tended to be technologically-driven, if constrained by absolute resource 
limitations, and in the past have largely neglected considerations of 
cost-effectiveness.
The increasing interest In cost-effectiveness analysis has been matched 
by theoretical developments which make It a more flexible and
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sophisticated technique. These theoretical developments are 
Increasingly being adopted in cost-effectiveness studies done in 
developed countries, but have been little employed in developing 
countries.
Most cost-effectiveness studies in developed countries have evaluated 
strategies for the care of chronic conditions and the desirability of 
new medical procedures or therapies. Not surprisingly, given the 
structure of developed country health systems, the emphasis has been on 
the medical care sector rather than the broader health sector.
In developing countries, perhaps surprisingly, most attention has been 
paid to the cost-effectiveness of immunization and family planning 
programmes. This emphasis probably results on the one hand from the 
Interest shown by international agencies responsible for supporting 
these programmes in the use of cost-effectiveness analysis as an aid to 
policy making and management, and on the other hand from the relative 
ease of applying cost-effectiveness analysis to programmes such as these 
where units of output are relatively easily defined.
In contrast, the cost-effectiveness of disease control programmes 
(excluding the strategy of immunization) is surprisingly little studied, 
with a few exceptions such as diarrhoeel diseases. Partly this reflects 
the continuing Influence of the past emphasis on cost-benefit analysis 
(studies are still being done, for example, to explore the effects of 
schistosomiasis on work output) . Partly it also reflects the decreasing 
international emphasis given in recent years to disease control 
programmes in favour of the promotion of primary health care, since 
international agencies are often the sponsors of economic evaluation 
studies.
Yet disease control programmes are a major consumer of resources in many 
developing countries. In terms of the criteria suggested by Williams 
(1974) for the selection of Issues worthy of economic evaluation, a 
disease control programme such as malaria control:
- involves decisions on sizeable amounts of resources;
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- Is the concern - or Is Influenced by - a variety of government 
departments, raising Issues of co-ordination of policy amongst 
them;
- has objectives which may not be shared by all these departments 
(for example the objectives of the malaria control department may 
not be of interest to the agriculture and Irrigation departments 
and may even clash with their own objectives) ;
- faces clear choices between control strategies or between 
different mixes of strategies;
- employs technology that Is reasonably well understood (In terms of 
the association between Inputs and outputs) If only In comparison 
with many other health technologies.
Disease control programmes, and malaria control programmes In 
particular, thus seem a suitable choice for the application of cost- 
effectiveness analysis. The volume of resources at stake means 
improvements In efficiency could lead to savings or the transfer of 
resources for other uses within the programme; and the choice of 
strategies Is not strictly determined by technological considerations, 
providing scope for other considerations to enter the decision-making 
process.
The alms of this research study are three-fold:
1 . to explore the relevance of recent developments In the methodology 
of cost-effectiveness analysis to disease control programmes in 
developing countries and specifically to malaria control in Nepal;
2. to apply cost-effectiveness analysis to the malaria control 
programme In Nepal In terms both of (a) the cost-effectiveness of 
various malaria control strategies and (b) the cost-effectiveness 
of the malaria control programme as a whole, in order to refine a 
methodology capable of more general application to disease control 
programmes in developing countries;
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3. to assess whether policy-relevant conclusions can be drawn from 
the application of cost-effectiveness analysis to the malaria 
control programme in Nepal.
The remainder of this thesis is structured as follows. Chapter 2 reviews 
the literature on the cost-effectiveness analysis of disease control 
programmes, considering first the methodology of cost-effectiveness 
analysis, then its application to disease control programmes in first 
developed and then developing countries, and finally its application to 
malaria control. Chapter 3 briefly describes the epidemiology of 
malaria and policies and strategies of control before considering the 
history of malaria control in Nepal, present malaria control strategies 
and economic characteristics of the control programme.
In Chapter 4, objectives and methods are presented for the study of 
malaria control in Nepal with a description of the theoretical framework 
of the analysis followed by a description of the various sub-studies of 
costs and of effectiveness and of two surveys of malaria cases. The 
findings are presented in three chapters. The first (Chapter 5) 
presents the results of an analysis of the recurrent expenditure of 
districts where malaria control is provided by the vertical programme, 
the National Malaria Eradication Programme (NMEO). The second assesses 
the Internal efficiency of the Nepalese malaria control programme, 
considering first vector control strategies and second case detection 
and treatment strategies. The following chapter (Chapter 7) presents 
results relating to the desirability of malaria control (as opposed to 
other investments which would also improve health).
These results are discussed in Chapter 8 in terms both of the 
application of the cost-effectiveness methodology and of the findings in 
Nepal. Chapter 9 then draws out the implications of the findings for 
malaria control policies and strategies in Nepal. In Chapter 10, 
conclusions ate drawn relating to the three alms of the research study 
identified above. Finally, Chapter 11 draws out the implications of 
this study for further research.
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2. REVIEW OF THE LITERATURE ON THE COST-EFFECTIVENESS OF DISEASE 
CONTROL PROGRAMMES
This review defines Its sphere of Interest as disease control 
programmes. By this Is meant a health sector activity, project or 
programme which has the objective of reducing the Incidence, prevalence 
or mortality of a disease. Often this will be a preventive programme, 
such as Immunization or vector control, but not always. For example in 
the case of schistosomiasis, mass treatment Is a serious alternative to 
preventive measures as a means of reducing prevalence and mortality. 
However, activities which provide curative treatment but do not have the 
ultimate aim of Influencing the level of disease are excluded from the 
scope of this review. So are programmes such as general primary or 
secondary care which are not targeted at specific diseases. This 
distinction Is relatively easy to make in the context of developing 
countries, where reducing disease levels Is usually of high priority in 
health planning. In developed countries, the health sector as a whole 
is more focused on personal health care and on meeting the needs of 
Individuals, and tends to pay relatively less attention to systematic 
disease control programmes. It Is therefore not always easy to draw a 
distinction between activities that primarily respond to the health 
needs of individuals and those that have broader objectives.
2.1 Theoretical developments In cost-effectiveness analysis
Cost-effectiveness analysis Is said to have originated in the US 
Department of Defense In the early 1960's, though the Initial use and 
author of the term have not been traced (Crosse 1967). The reason for 
Its development was the difficulty of applying the technique of cost- 
benefit analysis because of the problem of valuing military programme 
objectives In monetary terms. Since this problem Is encountered also in 
other fields of public expenditure, the use of cost-effectiveness 
analysis spread rapidly. For example the Overseas Development 
Administration of the UK Foreign and Commonwealth Office published in 
1972 a guide to project appraisal In developing countries and noted 
that:
"A major problem arises In relation to projects whose benefits
cannot be satisfactorily valued In monetary terms. Typical
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examples In the social field are public health projects and 
projects designed generally to Improve anenltlea. The role of 
social cost benefit analysis In relation to this type of "social" 
investment is as a tool In the Identification of the least cost 
method of achieving the desired objective. Moreover by enabling 
costs to be evaluated on a consistent basis social cost benefit 
analysis enables due consideration to be given to the implications 
for economic policy of particular objectives. A t  the margin 
choices have to be made and a consistent evaluation of the costs 
of alternative choices Is evidently of great assistance to 
rational decision making" (Overseas Development Administration 
1972).
As initially applied, cost-effectiveness analysis usually compared the 
cost -*f one or more interventions with Its health effects, producing a 
ratio s^ch as cost per life saved. In contrast, cost-benefit analysis 
placed a value on lives saved and on resource consequences of 
interventions, enabling costs and benefits to be compared in monetary 
terms.
Recently the distinction between cost-effectiveness and cost-benefit 
analysis has been blurred by development and categorization of various 
types of economic evaluation (see Figure 2.1). "Consequences" has been 
adopted as the generic term for the results of interventions, to avoid 
the confusion caused by the term "effects" and "benefits", and also to 
avoid using the term familiar to economists of "output" which clashes 
with epidemiologists' definitions. Where there is no evaluation of 
alternatives or of both costs and consequences, the evaluation can only 
be partial. Full economic evaluations are classified as:
cost-minimization analysis: where the alternatives produce Identical 
health outcomes and the analysis can focus on identifying the least-cost 
alternative;
cost-effectiveness analysis: where the costs of the alternatives are 
compared to a single, common measure of health effect, which the 
alternatives may produce to different degrees;
cost-utility analysis: where the health status change is weighted In 
terms of Its utility (to individuals or society) and the cost and 
utility of alternatives are compared;
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Figure 2.1: The distinguishing characteristics of economic evaluation of 
health programmes
Art both co iti (inputs) and consequences (outputs) 
of the a lternatives exaeined?
NO TES
Exaeines only 
consequences
Exaeines only 
costs
NO PARTIAL EVALUATION PARTIAL EVALUATION
I t  th trt 
cosparison 
of tHO
1A
Outcose
description
11
Cost
description
2
Cost-outcoee description
alternatives? YES PARTIAL EVALUATION FULL ECONOMIC EVALUATION
3A
Efficacy or
effectiveness
evaluation
31
Cost analysis
4
C ost-e in is i:a tio n  analysis 
Cost-effectiveness analysis 
C o s t- u t il ity  analysis 
Cost-benefit analysis
Sourcti Druttond, Stoddart and Torranct (1987)
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cost-benefit analysis: where both coats and consequent 
monetary units.
ilued In
Both costs and consequences can be subdivided Into various elements (see 
Figure 2.2), discussed in greater detail below. Vhlle cost- 
effectiveness analysis may end in a simple division of costs by units of 
health effect, it may also net out against costs those elements of 
benefits that can easily be valued In monetary terms. In this way, the 
previous clear distinction between cost-benefit analysis and cost- 
effectiveness analysis has been blurred.
Costs
Figure 2.3 describes in more detail the currently accepted 
classification of the cost of programmes. The generally recommended 
viewpoint of any economic evaluation is that of society as a whole 
(though analyses may explore the particular Implications for agency or 
household budgets). Thus the cost elements comprise those of operating 
the particular programme Incurred by the health sector; those borne by 
households (eg home care, time lost from work because of the treatment) 
and those borne externally to the health sector (eg possibly schools In 
the case of child health programmes).
The origins of economic evaluation are rooted In welfare economics 
theory. Cost-benefit analysis can be seen as a technique for 
identifying potential Pareto improvements, that is situations where the 
maximum total sum of money that the gainers from a project would be 
prepared to pay to ensure that the project is undertaken exceeds the 
minimum total sum of money that the losers from It would accept as 
compensation to allow It to be undertaken (Drummond 1981). Cost- 
effectiveness analysis does not permit this Judgement to be made since 
benefits are not valued, but is based on Paretian principles to the 
extent that the prices used to value the resources used by programmes 
are assumed to have welfare significance.
Resources used should therefore be valued using prices which reflect 
their social opportunity cost. If markets function efficiently (ie 
there Is perfect competition and no external effects) prices should 
reflect social opportunity cost. Although these conditions are not
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Figure 2.2: Components of mconoalc eve lume Ion
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Figura 2.3: Type* of coat relavant to the economic evaluation of health
programmes
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always met In developed countries, analysts generally make the 
assumption that the divergences are not great and use market prices when 
they are available. Thus shadow pricing Is only necessary for resources 
which are not purchased (eg the time of volunteers) .
In contrast, In developing countries analysts start from the assumption 
that market prices are unlikely to reflect social opportunity cost. 
Firstly, the domestic price structure may be distorted by measures such 
as tariffs, subsidies. Import licensing and excise taxes which shelter 
the domestic economy from International competition, and by an acute 
shortage of foreign exchange. These distortions may mean that goods 
produced domestically could have been purchased from abroad at lower 
real cost by using domestic resources to produce exports and exchanging 
them for the foreign products. The domestic price thus exaggerates the 
opportunity cost of the goods.
Secondly, the existence of a large pool of unemployed or underemployed 
labour, together with rigidities In the labour market which Influence 
wage levels, can mean that wage rates do not reflect the opportunity 
cost of employment. A health programme might be able to employ
unskilled labourers without a corresponding decrease In output from 
their previous occupations because they were unemployed. If they were 
previously subsistence farmers, their opportunity cost would be greater 
than zero but might still be less than the market wage.
The recommendation of economic evaluation methodologies concerned with 
the developing country context (Overseas Development Administration 
1972, Squire and Van der Tak 1975) Is therefore to use a system of 
shadow (efficiency) prices when valuing costs and consequences. For 
goods that are traded Internationally, the use of "border" or "world" 
prices (the price at which a good can be bought on the world market and 
transported to the border) Is suggested; labour Is valued at Its 
domestic opportunity cost; and the domestic value of non-traded goods 
and services (including labour) are translated by various procedures 
into world prices.
Non-traded goods can make up a large proportion of total costs and the 
translation into world prices may have to use short-cuts (such as the 
" s t a n d a r d  conversion factor": Squire and Van der Tak 1975).
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Alternatively, non-traded goods can be valued at their domestic price 
and the world price of traded goods translated to rough donestlc 
equivalent prices through the use of a shadow exchange rate (tfelss 
1978). The use of a shadow conversion factor and shadow exchange rate 
are essentially equivalent. Less approximate methods than the standard 
conversion factor are usually, however, recommended, such as roughly 
disaggregating the production costs of non-traded goods Into traded and 
non-traded components, and then applying a conversion factor to the non- 
traded residual.
More basic differences exist In economic evaluation methodology between 
developed and developing countries than arise In shadow (efficiency) 
pricing practices alone. Indeed, the practice of cost-benefit analysis 
In developed and developing countries has diverged to the extent that 
the "traditional" and "new" approaches are now distinguished (Irvin 
1978, Ray 1984). The traditional approach gives priority to efficiency 
- whether a project will lead to a net gain In social welfare - leaving 
to one side equity Issues on the grounds that these can be dealt with 
separately by the goverment. In effect, this assumes that Income gains 
are of equal value regardless of to whom they accrue (Ray 1984). In 
addition, the traditional approach Is not concerned to break down Income 
Into Its Investment and consumption components, because capital markets 
are assumed to be efficient and therefore Investment Is equally as 
valuable as present consumption at the margin. Even If there are 
distortions, again these should be the focus of separate government 
action.
The "new" approach, drawing on recent work on growth and development, 
recognizes the economic circumstances In developing countries where 
income disparities are likely to be very wide, markets poorly developed, 
and consumers poorly informed. It argues that the social valuation 
implicit In the traditional approach does not have to be followed; 
instead countries may choose different fundamental objectives. In 
particular, decision makers may wish to use cost-benefit analysis to 
place greater weight on Investment than implied by the traditional 
approach, or to Incorporate the objective of redressing poverty and 
economic inequality.
If so, the valuation of costs and benefits will differ, and will be
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based on shadow (social) prices which reflect a country's preference for 
savings versus consumption, and/or for benefiting some Income groups 
more than others. In the case of savings, developing countries facing a 
serious shortage of savings for public or private Investment may wish to 
bias project selection by using a "savings premium" that weights costs 
and consequences that produce savings more heavily than those that 
Increase consumption. In the case of Income distribution, the value of 
project costs and consequences accruing to different Income groups could 
be adjusted by use of a consumption weight which reflects the value 
decision-makers place on reducing Inequality.
Irvin (1978) summarized the features of the now-accepted approach to 
cost-benefit analysis In developing countries:
"1 ) productive efficiency for all traded goods Is taken as 
determined Independently of the domestic consumption 
pattern;
1 1 ) Interpersonal utility comparisons are firmly re-established 
via the principle of social valuation of consumption 
benefits to different groups;
ill) the present method, by articulating crucial macro-planning 
variables In micro-level selection criteria, lays claim to 
playing a central role In the overall planning process."
In theory at least, therefore, the approach to costing adopted when 
evaluating health programmes in developing countries should differ from 
that adopted In developed countries.
A further difference can arise from differences In the availability of 
expenditure Information, usually the starting point for cost analysis. 
In developing countries, Information systems vary considerably In their 
sophistication. Expenditure may not be disaggregated by geographical 
area let alone by health institution or programme (Kaewsonthi and 
Harding 1984)., Different budgets may fund the same institutions, making 
It difficult to calculate total expenditure. Communications and 
accounting difficulties may mean that expenditure records of local 
Institutions are not kept up to date and actual expenditure may not be 
known until many months after the end of the financial year. Hospital 
accounts are usually not disaggregated by individual department and It
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is usually necessary, for instance, to apply estimation procedures to 
separate inpatient from outpatient expenditure (Heller 197S).
However some problems In the collection of cost data are common to both 
developed and developing countries, particularly the problem of Joint 
costs. In the health sector, resources frequently serve more than one 
programme and may need to be divided up In order to distinguish the 
total cost of a particular programme. Alternative methods of cost 
allocation Include:
- if one of the programmes Is clearly pre-eminent, the whola cost of 
the shared resources could be attributed to that and any 
contribution the resources may make to another programme Ignored;
- if one of the programmes Is clearly dominant, but has been 
modified to permit other programmes to use the shared resources, 
the additional cost of the modlflcatlons could be attributed to 
the subsidiary programme;
- If the programmes cannot clearly be divided into main and 
subsidiary, total costs could be divided pro-rata with some 
measure of workload or throughput;
- the fixed cost element could be left unallocated and variable 
costs attributed to the programme which gives rise to them. This 
procedure will not produce an estimate of the total cost of 
programmes.
Consequences
Figure 2.4 indicates the main elements of consequences. Category 1, 
changes In physical, social or emotional functioning, is often referred 
to as health effects. Its specification here in rather broader terms 
reflects the frequent concern of developed country analysts with the 
evaluation of treatments for chronic conditions, where little may be 
done about the underlying condition but treatment may permit patients to 
lead more or less satisfactory lives. The measure used as an indicator 
of physical, social or emotional functioning may be specific to the 
disease in question (eg number of cases of malaria prevented) or broader
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Figure 2.4: Types of consequence relevant to the economic evaluation of 
health programmes
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(eg number of deaths prevented). The broader the measure, the more 
possible it is to use cost-effectiveness analysis to compare a variety 
of health programmes, but the greater the danger of distorting the 
comparison by ignoring other health outcomes or qualitative dimensions 
of the health outcome chosen. For Instance most diseases cause not only 
mortality but also morbidity, and the severity of morbidity will differ 
between diseases.
In developed countries, while information on health effects of 
Interventions may be less than would be desired, it is usually possible 
to piece together a picture, if only from a literature review (Drummond 
1987). In developing countries, evidence is much scarcer and 
epidemiological studies or clinical trials rare. Therefore measures of 
intermediate output are often used as proxies for health effects (eg 
"fully immunized children" in place of "cases averted" or "deaths 
averted") .
The misleading nature of a single measure of health effect has led some 
theorists to propose the use of multiple measures and others the 
development of a health index. Multiple measures simply list dimensions 
of quality of life or health. For example the Nottingham Health 
Profile, used recently to evaluate heart transplants in the UK (Buxton, 
Acheson, Caine, Gibson and O'Brian 1985), measures quality of life along 
six dimensions: physical mobility, pain, sleep, energy, social isolation 
and emotional reactions. In a study of a variety of mixea of 
Interventions aimed at improving maternal health in Narangwal, India, 
the health indicators used were deaths averted, days of illness averted, 
extra centimeters of growth at 36 months, and increase in psychomotor 
scores over the first 3 years of life (Klelmann and associates 1983) .
Such multiple measures are difficult to interpret when one intervention 
performs better on some dimensions and worse on others. A health index, 
by incorporating multiple measures in one index (Torrance 1976), 
resolves this problem at the expense of sometimes questionable 
Judgements on how to combine the measures. Chapalaln (1978), for 
example, simply added deaths and cases of handicap avoided by 
alternative interventions to reduce perinatal mortality, implicitly 
weighting them equally. A slightly more sophisticated type of health 
index is that proposed by the Ghana Health Assessment Project Team
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(1981). This uses estimates of Incidence, case fatality and duration 
and extent of disability to calculate the number of healthy days of life 
lost because of a particular disease. While Incidence, case fatality 
and duration of disability can, In principle at least, be measured, the 
extent of disability Is assessed subjectively by equating "total" 
disability with death, and the absence of disability with health, and 
then placing different degrees of disability between these points. For 
Instance one day of leprosy Is counted as 75% of a healthy day.
This procedure leaves plenty of scope for disagreement. In the 
application of the healthy days of life lost concept to an evaluation of 
the Onchocerciasis Control Programme In West Africa, Prost and Prescott 
(1984) assumed that blindness results In complete disability and thus Is 
equivalent to death, though they note It could be worse than death 
because the community has to support the consumption of a non-productive 
blind person. In reworking their figures, Evans and Murray (1987) 
pointed to evidence that blind people were active both socially and 
economically and considered that a year of blindness Is worth 0.5 of a 
healthy year.
The Ghana Health Assessment Project Team method values Individuals In 
direct proportion to their expectation of life at their current age. It 
therefore biases the selection of projects toward those that favour 
younger age groups since they have the greatest number of healthy days 
to lose (It Is interesting to note that one of the precursor indexes 
which confined itself to mortality only, took years of life lost between 
the ages of 1 and 70 to avoid over-estimating the value of an infant 
death which would often be replaced by another birth - Romeder and 
McWhinnle 1977). It has recently been argued that the concept of 
healthy days of life lost should incorporate a different weighting for 
age preference, and should also incorporate time preference (Barnun 
1987). Barnum points out that the timing of health effects over 
individuals' life-spans has implications for their economic 
contribution. He therefore weights healthy days of life lost by 
productivity weights for each age group. He also argues that the 
concept of time preference, normally applied In economic evaluations to 
both costs and consequences, should be Incorporated In the indicator by 
applying a discount rate to the time-stream of healthy days of life.
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Barnum ahowa that weighting for productivity and dlacountlng can 
potentially Influence the choice of prloritlea and progrannes.
If a measure of health effect or a health index la weighted by utility 
weighta which reflect the relative value of one health atate compared to 
another (consequence type 3 in Figure 2.4), this turns the analysis into 
a cost-utility analysis. Cost-utility analysis can be seen as a special 
case of cost-effectiveness analysis (and was at first treated as such) 
but is now considered a distinct technique (Torrance 1985) . It could be 
argued that the measure healthy days of life lost Incorporates utility 
weights in its assessment of disability relative to death, but little 
emphasis was placed on seeking public or individual values. Utility 
weights may be devised either from the general public (in which case it 
may be possible to use pre-existing surveys) or may need to be specific 
to the condition under consideration, in which case a special survey may 
be required. It can be argued that for planning decisions, the relevant 
values are those of the general public, though patients' valuation of 
the changes in quality of life may also be valuable if the general 
public lacks information on the condition in question and also as an aid 
in clinical decision-making (Drummond 1987). An extensive review of the 
determination and measurement of health state utilities is given in 
Torrance (1985) and a critical examination of the assumptions underlying 
them in Loomes and McKenzie (1989) .
The most commonly used measure in cost-utility analysis is the quality* 
adjusted life year (Drummond, Stoddart and Torrance 1987). Here the 
life extension gained is adjusted by utility weights which reflect the 
relative value of the quality of the life extension. While years of 
life gained are discounted, it is usually argued that a year of life 
gained is of equal value regardless of who receives it. The method 
therefore implicitly biases project selection against age groups who 
have the fewest years of healthy life to gain (le the elderly). As with 
any measure, however, a different weighting for age preference and 
Indeed for other preferences (eg sex, social class, occupation: Charny, 
Lewis and Farrow 1989) could be incorporated.
The quality-adjusted life year has not so far been employed in economic 
evaluations of developing country health programmes. One reason may be 
its greater relevance to chronic diseases than to many acute
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communicable conditions where Individuals, after a relatively brief 
spell of illness, either die or return to complete health. However 
there are sone communicable diseases that have long-lasting effects (eg 
schistosomiasis, onchocerciasis) and chronic diseases (eg cardiovascular 
disease, cancers) are of Increasing Importance in the health sector of 
those countries where the Incidence of communicable diseases is 
decreasing. Another reason for the neglect of the quality-adjusted life 
year in developing country economic evaluation studies Is likely to be 
the unavailability of information on the preferences of the general 
public for different health states and the difficulties of obtaining It. 
It would seem to be highly dangerous to transfer the utility weights of, 
say, a sample of the Canadian public to a developing country setting. A 
special survey would therefore be necessary, probably in each country, 
with extensive evaluation to check Its sensitivity to racial, socio­
economic and cultural differences.
Torrance (1985) has suggested the circumstances when cost-utility 
analysis is appropriate:
"when quality of life is the Important outcome, when quality of 
life is go important outcome, when the programme under evaluation 
• ffacts both morbidity and mortality and you wish to have a common 
unit of outcome that combines both effects, when the programmes 
being compared have a wide range of different kinds of outcomes, 
and when you wish to compare a programme to others that have 
already been evaluated using CUA. Cost-utility analysis is 
inappropriate or unnecessary when the effectiveness data for final 
health outcomes is not available, when the effectiveness data show 
that the programmes being compared are all equally effective, when 
quality of life is Important but it can be captured by a single 
variable measured In easily understood natural units, or when It 
is clear that the extra cost of obtaining and using utility values 
connot change the results".
The final type of consequence listed In Figure 2.4 is changes In 
resource use. A health programme (eg immunization) may produce savings 
for the health sector and for Individuals In terms of the savings In 
resources that would otherwise have been used to treat and care for the 
sick. This could clearly be a significant consequence of preventive 
programmes In developed countries where health services are universally 
accessible. In developing countries Its inclusion in an analysis is 
more controversial because it may bias the analysis in favour of areas 
already well served with health facilities. To avoid this, the
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importance of the equity objective may need to be explicitly 
acknowledged. by giving greater weight to health conaequencea 
experienced by more deprived population groupa (Mills 1985).
The inclusion of the final category listed under changes in resource 
use, savings in lost work time, is controversial. There are several 
arguments here. In a cost-benefit analysis (not the main focus of this 
review), if the willingness-to-pay approach is used to value health 
consequences, it may be that individuals would take time savings into 
account in their valuation; including them also as a separate category 
could thus involve double counting (Drummond 1981) though Torrance 
(1985) denies this. Even when health consequences are not being valued, 
the inclusion of savings in lost work time biases evaluations in favour 
of individuals or groups that participate in the work-force (Drummond 
and Stoddart 1985). There is clearly a dilemma: countries may be 
crucially dependent on the wealth created by those members of the 
population who work, and individuals may place a high value on their 
ability to earn their living and support their families, but it may not 
be considered ethically defensible to give such groups priority in 
access to health care.
A further problem relates to the measurement of time savings. In a 
subsistence economy, where many productive activities are undertaken 
collectively by the household, the effect of the Illness of a household 
member on productive time may be minimized by reallocation of 
responsibilities within the household. If there is spare time within 
the household at that period of the year, the actual time lost may be 
leisure time, or it may be time spent on childcare or housework 
(Rosenfield, Golladay and Davidson 1984) .
The scheme of consequences of Figure 2.4 is demanding in terms of 
Information. It requires information not only on the relationship 
between the activities of the health programme and health consequences 
but also on treatment patterns prior to the introduction of the health 
programme and the behaviour of individuals after its introduction. To 
obtain information on health consequences, randomized controlled trials 
are frequently recommended in both developed and developing country 
settings (Tugwell, Bennett, Sackett and Haynes 1985). Alternatives in 
decreasing order of preference are cohort studies and before and after
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studies, case-control studies, and descriptive studies. Tugwell et al 
suggest assessing "community effectiveness" (how well an Intervention 
with potential for reducing Illness will work when applied In the 
community) on the basis of efficacy (assessed by clinical trials), 
screening and diagnostic accuracy, health provider compliance, patient 
compliance, and coverage of the target population (dependent on 
availability and acceptability of effective health services). These 
would Ideally be combined to assess community effectiveness using a 
multiplicative conditional probabilities model but In the absence of the 
necessary Information, a simple multiplication formula Is used, which 
assumes that all the factors are Independent.
This approach Is clearly useful for assessing Interventions targetted at 
Individuals; its relevance Is less clear to, for instance, environmental 
health measures. However It provides a valuable emphasis on the 
Importance of the behaviour of providers and patients, In addition to 
clinical efficacy, as determinants of effectiveness. In some sample 
calculations, Tugwell et al found that patient and provider compliance 
appeared to be the major limiting constraints to community effectiveness 
for some interventions.
In the developing country setting, where relevant epidemiological data 
are often unavailable, analysts have recommended major data collection 
efforts. Barnum (1987), for example, calls for an international effort 
to collect consistent and accurate epidemiological information, stating 
that:
"the technology of cost-effectiveness analysis and sector 
evaluation, whether for single or multiple diseases, has outrun 
the epidemiological basis for analysis".
Rosenfield, Golladay and Davidson (1984) recommend focussing on the 
household when considering the social and economic consequences of 
disease. They suggest
"a number of methods for data collection and analysis ranging from 
small samples of Intensive case studies to subsequent larger-scale
representative surveys In a given region.... The survey ......
should capture Information on mortality, morbidity, acute and 
chronic disability (over as long a time period as possible) , 
functional disability and compensation In the household due to 
disease (how roles, time allocation and other resource
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expenditures change)....... A particularly Important task la to
develop methods for assessing the severity or functional effects 
of morbidity and Impairment related to the prevalent tropical 
diseases. These methods should be capable of being reliably 
applied In large-scale representative household surveys, both 
prospective and retrospective types. Multiple indicators of 
health outputs could be used to evaluate the effectiveness of 
interventions, methods and activities".
Needless-to-say, the funds necessary for such surveys are usually not 
available, and previous experience of large scale surveys has not always 
been happy (Barnum 1987).
In evaluating the effect of a health programme on communicable, 
especially vector-borne, diseases, a model of the mechanism by which the 
disease spreads can be valuable. Such models exist, for Instance, for 
schistosomiasis (Rosenfield, Smith and Uolman 1977) and malaria 
(Mollneaux and Gramiccia 1980).
Putting costs and consequences together
As indicated In Figure 2.2, cost analysis, cost-effectiveness analysis 
and cost-utility analysis may be more or less comprehensive In terms of 
the types of cost and consequence Included. The main options concern 
whether indirect costs and indirect benefits are added to direct costs 
and direct benefits, and whether In cost-effectiveness and cost-utility 
analysis, costs are simply divided by the chosen measure of health 
effect or utility, or whether those benefits that can be valued (le 
direct benefits and possibly Indirect benefits) are subtracted from 
costs.
However the calculations are formulated, certain procedures are 
recommended (Drummond, Stoddart and Torrance 1987):
Discounting: Individuals and society have a positive rate of time 
preference, therefore both costs and consequences should be discounted. 
How to determine the discount rate is controversial. In traditional 
analysis, the market interest rate is used for reference, but this Is 
likely to Indicate the discount rate appropriate for inter-generational 
comparisons only under very unrealistic assumptions (Ray 1984). 
Developing countries may select a discount rate (the accounting rate of
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interest) which reflects their preference for investment rather than 
consumption, end for consumption scruing to low rather then high income 
groups. Since ell economic evaluations in a particular country should 
use a common discount rate, in practice analysts are advised to first 
investigate whether an agreed rate exists before estimating their own 
(Overseas Development Administration 1972).
Incremental analysis: in comparing alternatives, one may be both
cheaper and more effective. More often, it will be cheaper but less 
effective. An Incremental analysis is then required (Drummond, Stoddart 
and Torrance 1987) to compare the incremental costs of the other 
alternative (costs of option 2 minus option 1) with its Incremental 
effects (effects of option 2 minus option 1). This provides evidence of 
the cost of seeking greater effectiveness and leads to the question: is 
it worth it?
Sensitivity analysis: The variables in economic evaluation studies are 
rarely estimated with absolute certainty or precision. Therefore it is 
desirable to test the sensitivity of the conclusions to plausible 
changes in the values of the main variables by re-working crucial 
elements of the analysis using different assumptions (Drummond, Stoddart 
and Torrance 1987).
In addition, distributional issues should be explored in quantitative or 
qualitative terms (Klarman 1982). They often cannot be explicitly 
Incorporated in the analysis (perhaps because they Involve transfer 
payments or because making a judgement on weighting for equity 
considerations may seem excessively arbitrary). However, most public 
programmes, whatever their objectives, have distributional consequences 
(Uelsbrod 1977).
While putting costs and consequences together m a y  be a simple 
arithmetical calculation, various forms of modelling have been 
suggested. For example, cost considerations can be Incorporated into a 
disease transmission model, to trace the cost and health consequences 
over time of particular interventions. Other possibilities Include 
linear programming which can be used, for instance, to Identify the 
allocation of resources that would maximise given objectives subject to 
various resource constraints, and simulation models whch can help to
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study Che effects of alternative policies on target variables (Carrln
1984).
International comparisons
In the developing country literature, there has been a recent trend 
toward Identifying optimal health strategies by putting together the 
results of economic evaluation studies from a wide range of countries 
and time periods. To evaluate such attempts later In this review. It Is 
useful here to Identify the main Influences on costs and consequences 
which will cause them to vary.
Barlow and Grobar (1985) give a useful summary of why the prices of 
Inputs In relation to the official exchange rate (and hence costs) can 
vary substantially from one country to another. The factors lncluda:
- differences between countries In the rates of taxation or subsidy;
- differences In the degree of competition In the national market 
(prices are likely to be higher where there Is a greater degree of
monopoly);
- differences In market demand (larger demand may mean a higher
price);
differences In supply conditions (labour Inputs or Inputs which 
are produced using labour-intensive technology are likely to be 
relatively cheap in economies with abundant labour relative to 
capital);
- differences in the ratio between the general price level and the 
official exchange rate (the degree of currency over-valuation).
In addition, if the studies being compared date from different years, 
price Indices need to be used to convert costs to a common year. This 
conversion is not straightforward because the price Indices commonly 
available are often not sensitive to the changing price levels of health 
service inputs.
Finally, there are a number of influences on both costs and consequences 
that are specific to the particular programme being evaluated (Mills and 
Drummond 1987, Berman 1982, Tugwell at al 1985). The effectiveness of a 
programme depends on factors such as delivering an efficacious drug or
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vaccine, patient and provider compliance and population coverage. These 
can vary considerably between different social, cultural and 
organisational settings, resulting In different levels of effectiveness 
for the same Intervention. The costs of a programme also depend on a 
number of local factors. Including the scale of the programme, 
population density and whether a new programme can be added to an 
existing Infrastructure and can take advantage of existing under­
utilised resources.
Standardised methodology
As Indicated In this review of methodology, a reasonably standard 
approach to cost-effectiveness and cost-utility analysis has now 
developed, though the literature demonstrates a considerable diversity 
of practice. Several analysts, concerned with the lack of uniformity, 
have suggested that economic evaluation methodology be standardised 
(Russell 1986, Barlow and Grobar 1985). Barlow and Grobar for Instance, 
propose that an International agency engaged In health activities should 
design a standardised form on the lines of that shown In Table A5.1 and 
promote Its use In disease-control projects.
2.2 Application of cost-effectiveness analysis to disease control 
programmes in developed countries
This section reviews the application of cost-ef fectlveneee analysis 
(Including cost-utility analysis) to disease control programmes In 
developed countries. Many studies do not adhere closely to the 
terminology and methodological approaches reviewed above (for instance 
Cretin (1977) calls his study "cost/benefIt analysis of treatment and 
prevention of myocardial Infarction" but calculates a cost-effectiveness 
ratio: dollars per added y e a r  of life). In particular, studies 
frequently term themselves "cost-benefit analysis" when only programme 
costs and the consequences In terms of saved treatment costs are 
considered. This review includes such studies but excludes those where 
an attempt Is made to place a value on health Itself, for instance by 
using the human capital or willingness-to-pay approach. This section 
reviews first the topics covered by studies, secondly their methods and 
finally their findings.
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Topica
A starting point for a review of tha topics chosen for analysis Is 
provided by Uarner and Hutton (1980) who reviewed cost-benefit and 
cost-effectiveness studies on health care topics (le personal health 
care) published between 1966 and 1978. They classified studies by the 
three broad categories of prevention, diagnosis (Including screening) 
and treatment. When they analysed the balance of studies between these
and over time , they found the following picture:
% of studies on: 1966-73 1974-78
prevention 44.7 22.0
diagnosis 18.8 30.9
treatment 36.5 47.2
total 100.0 100.0
They comment that the early CBA/CEA literature concentrated relatively 
more on health programmes with the characteristics of public goods - 
especially communicable disease control - than Individual patient care. 
They ascribe the Increased emphasis on diagnosis (primarily screening) 
and treatment to the expansion of technology and concerns of cost. 
Indeed in the treatment category, evaluation of medical procedures 
predominated, with a recent emphasis on equipment (mainly CT scanners). 
They noted that although the literature covered a vast array of disease 
problems, a few accounted for a large share of the literature: 
cardiovascular disease (especially hypertension), cancers (especially 
screening), mental illness, drug abuse and alcoholism, renal disease, 
communicable diseases (mainly prior to 1974) and birth defects (more 
recently).
A more recent review (Drummond 1986) confirms that the majority of 
economic evaluations of health programmes undertaken In industrialised 
countries are of alternatives in therapy. A large proportion of these 
concern "high technology* medicine In the fields of chronic renal 
failure, coronary care and neonatal intensive care.
Figure 2.5 sets out a framework for reviewing the topics and choices 
considered in the disease control field. It classifies broad strategies 
as prevention (aimed at the individual or at the environment), diagnosis
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Figure 5.1: Relationship between district-level expenditure and 
district population-at-risk
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and treatment. Tha alternatives that studies may evaluate are 
classified as choice of: sector, Intervention or technique, strategy for 
delivering that Intervention or technique, target group, place of 
Intervention and time of Intervention. Studies which illustrate this 
range of strategies and choices have been noted on the figure, in order 
to Indicate the nature of the choices evaluated by studies.
Since the focus of this review is on disease control, it is perhaps not 
surprising that prevention features large, though most studies are 
concerned with strategies aimed at Individuals rather than the 
environment. A few are concerned with strategies that are Implemented 
outside the health sector, such as motorcycle helmet laws (Muller 1980) 
and giving fluoride tablets to children at school (Stephen and Campbell 
1978). Many are concerned with the choice of Intervention or technique. 
For Instance Chapalaln (1978) reviewed the cost-effectiveness of seven 
programmes for reducing perinatal mortality and morbidity in France 
(including rubella vaccination, improved antenatal care, better 
supervision of labour, resuscitation In the labour room and the creation 
of neonatal resuscitation centres). Stason and Weinstein (1977) 
examined a number of Issues concerning the detection and treatment of 
hypertension. They defined four questions for analysis (identified in 
Drummond, Stoddart and Torrance 1987): the desirability of treatment of 
hypertension as opposed to treating the cardiovascular morbidity that 
would otherwise arise; the efficiency of treating hypertension as 
opposed to using the resources In any other way; the choice among 
programmes aimed at different age, sex and pre-treatment diastolic 
pressure groups; and the choice between screening programmes to detect 
hypertension and improved efforts to manage known hypertensives.
Clven agreement that a particular disease should be controlled by means 
of a particular intervention (or only one means may be available), 
choice of delivery strategy is of relevance. For example Berwick, 
Cretin and Keeler (1981) compared three approaches to providing dietary 
advice designed to control chloresterol levels in children. The 
approaches were universal screening plus dietary counselling in 10-year- 
olds, targeted screening with dietary counselling for those 10-year-olds 
with a family history of early coronary disease, and population-wide 
Intervention through a mass-media campaign or school education. Mulley, 
Sllversteln and Dienstag (1982) examined the cost-effectiveness of three
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strategies for the us« of Hepatitis B vaccin«: vaccinating everyone,
screening everyone and vaccinating those without evidence of Immunity, 
and neither vaccinating nor screening but passively Immunizing those 
with known exposure.
Compliance Is a problem with many screening programmes, either with the 
screening programme Itself or with subsequent treatment. It has been a 
particular concern of hypertension treatment programmes because of the 
side-effects of treatment. Using a delivery strategy that Improves 
compliance has been evaluated by Mitchell, Drummond, Haynes, Johnston 
and Gibson (1983).
Because of the cost of extending new technologies to everyone, the 
choice of target group has been of interest, either as a central concern 
or as a side issue, as in the studies cited above of hypertension 
treatment and screening, control of chloresterol levels and the use of 
Hepatitis B vaccine. Similar choices of target group selection (those 
at high risk versus widening the population covered) are evident in 
other studies of vaccination policy, for example for influenza 
(Helliwell and Drummond 1987) and pneumococcal pneumonia (Uillems, 
Sanders, Rlddiough and Bell 1980) and in studies of screening policy 
(Drummond and Mills 1987).
The place of Intervention has been Increasingly of concern since certain 
locations such as school and work offer captive populations and thus 
potentially high coverage at low cost. For example Shephard (1985) 
evaluated a fitness programme for company employees and Logan, Milne 
Achber, Campbell and Haynes (1981) compared the cost-effectiveness of 
screening and treatment of hypertension using nurses at the worksite or 
regular commun!ty-based care by physicians.
Finally, time of intervention is often a central Issue in disease 
control programmes since primary prevention (eg Immunisation) or 
secondary prevention (eg screening) can be compared to the alternative 
of later treatment. Timing has therefore entered Into many of the 
studies mentioned already. Other studies include Torrance and Zlpursky 
(1984) who considered the cost-effectiveness of antepartum prevention of 
Rh immunisation (an alternative to postpartum or post-abortion 
treatsrant).
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Very few published studies of preventive strategies aimed at modifying 
the environment were located. The greatest number concern the issue of 
water fluoridation, comparing dental care costs with and without 
fluoridation (for example Fidler 1977). Pollution control has also been 
an issue (Lave and Seskin 1978). Despite widespread public concern 
about cancer-inducing toxic substances and occupational hazards, there 
is relatively little analysis of the cost-effectiveness of control 
measures (Warner 1979). One interesting study (Weinstein 1983) assesses 
research priorities to identify preventable causes of cancer, proposing 
a quantitative approach to priority setting based on decision analysis 
and cost-effectiveness analysis, and illustrating the approach by 
comparing the value of research into dietary beta-carotene (thought to 
reduce the risk of cancer) with carcinogen bloassays of high-volume 
industrial chemicals such as p-dichlorobenzene. Another diet-related
study is that by Dichter and Weinstein (1984) on the cost-effectiveness 
of lowering the aflatoxin tolerance level.
Much of the literature in this field ia unpublished (in official 
documents) or semi-published. A very useful article (Graham and Vaupel 
1981) summarises the results of 57 lifesaving programmes falling under 
five US agencies concerned with the environment (eg traffic safety, 
environmental protection). Very few were the responsibility of the 
Department of Health and Human Services. Most analysed measures to 
improve transport safety and reduce pollution.
The strategy of diagnosis Is most clearly relevant to disease control 
when used in screening programmes. Drummond and Mills (1987) provide a 
useful review of issues that arise in screening programmes, covering 
many of the choices in Figure 2.5. For example, studies have evaluated 
which test or combination of tests is most cost-effective (Simpson, 
Chamberlain and Gravelle 1978 and Mooney 1982 in the case of breast- 
cancer screening)..
Delivery strategy is an Important consideration in encouraging take-up 
of a screening programme. For example Hagard, Carter and Milne (1976) 
proposed adding a publicity campaign to a screening programme for 
antenatal detection of neural tube defects. Perhaps the most famous 
example of delivery strategy Issues comes from an evaluation of
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screening for asymptomatic cancer of the colon (Newhauser and Levickl 
1975). Six sequential tests for each patient were advised to minimise 
the cases missed, and while the average cost per case detected over the 
six tests was $2500, the Incremental cost per case of the sixth test was 
$47m. Both delivery strategy and place were evaluated In a study of 
alternative methods of screening school children for asymptomatic 
bacteriurla (Rich, Glass and Salkon 1976). One method Involved 
supervised collection at schools of urine samples and the other the 
self-administered home use of dlpslldes.
As discussed above In relation to prevention, one of the most crucial 
Issues In screening Is whom to screen, for Instance for Down's Syndrome 
and neural tube defects. Drummond and Mills (1987) review this Issue. 
Time of Intervention Is relevant In terms of when and how frequently to 
screen. Eddy (1980) considered how frequently to carry out a variety of 
cancer screening tests.
Few studies considering the strategy of treatment are highly relevant to 
disease control, except In the sense that in the case of chronic 
diseases, treatment can slow down or prevent progression to more serious 
states of Ill-health. Innumerable studies of treatment for end-stage 
renal failure have been done, evaluating hospital dialysis, home 
dialysis and transplantation (for example Ludbrook 1981, Stange and 
Summer 1978). Choices In treatment for coronary care, especially 
surgical Interventions, have had similar attention (Weinstein, Pllskln 
and Stason 1977). Culyer and Maynard (1981) evaluated the choice of 
drug therapy or surgery for duodenal ulcer treatment.
Place of care Is a frequently evaluated choice because of the cost of 
Institutional care. Applications Include hospital or home renal 
dialysis (referred to above), community-oriented or hospital-based 
treatment for mental Illness (Welsbrod, Test and Stain 1980, Mangen, 
Paykel, Griffith, Burchall and Mancinl 1983) and the location of 
epilepsy clinics (Krledel 1980).
From this review of the subjects of economic evaluation studies relevant 
to disease control In developed countries, four conclusions can be 
drawn. Firstly, most attention has been paid to preventive strategies 
aimed at individuals and delivered via health care facilities.
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Secondly, immunisation and screening have been the prime approaches to 
disease control evaluated, with little attention paid, for instance, to 
health education, dietary change or manipulation or modification of the 
environment. Thirdly, choice of the appropriate target group, place of 
intervention and time of intervention have been seen to be of major 
importance. Finally, those diseases of greatest Interest have been non- 
communicable, chronic conditions such as renal failure, coronary 
disease, mental illness, neo-natal conditions and birth defects, which 
are often expensive to treat and/or prevent. Communicable diseases 
rarely feature in recent literature with a few exceptions such as 
hepatitis B, influenza, syphilis and (very recently) Aids.
Methods
Methodological Issues arising from the developed country literature are 
reviewed here under the headings type of study, cost assessment, 
assessment of consequences, and comparison of costs and consequences.
Type of study: Warner and Hutton (1980) note an increasing tendency 
towards cost-effectiveness analysis. Between 1966 and 1973, cost- 
effectiveness studies made up 42.1% of total cost-benefit and cost- 
effectiveness studies published, but in 1974 to 1978, 53.2%. More
recently, cost-utility analysis has increasingly been adopted. As 
notable, however, has been the number of so-called cost-benefit studies 
which compare the costs of a programme with Its consequences in terms of 
reduced need for treatment. This is particularly evident in the disease 
control literature, no doubt because the treatment costs averted by a 
preventive programme are considered an Important consequence when health 
budgets are under strain and new expenditure needs to be strongly 
justified.
Related to this point is the limited focus of many studies. While it is 
generally accepted that a true economic evaluation should take a 
societal perspective (Drummond and Mills 1987), many studies restrict 
themselves to costs and consequences that fall on the health sector's 
budget.
Cost assessment: where resources used in health programmes carry a 
price, the market price has been used unadjusted. Inputs of patient.
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family or volunteer time often have an opportunity coat, but this is 
rarely priced. One exception is the study by Logan et al (1981) where 
wages were used to value lost leisure-time (some of the treatment took 
place after work). Drummond, Stoddart and Torrance (1987) question this 
valuation on the grounds that leisure time in the early evening may 
actually be valued more highly than work-time.
Placing a value on resources used Jointly is a continual problem, 
especially since hospital accounting systems are rarely helpful in 
identifying the resources used in a particular activity. Culyer and 
Maynard (1981) cope with this problem by using a variety of methods to 
calculate the cost of surgery for duodenal ulcer.
Assessment of consequences: perhaps the most Important methodological 
issue in the assessment of consequences is the availability and 
reliability of medical evidence. Developed countries are relatively 
well supplied with published data on clinical aspects of health care 
interventions but this often does not provide the necessary Information 
for an economic evaluation. Culyer and Maynard (1981) point out, for 
example, that few clinical trials include broad assessments of the 
patient'8 (or his family's) functioning. Evaluations of public health 
measures particularly suffer from lack of good evidence on effectiveness 
since prospective controlled studies are hard to design and manage 
(Drummond 1985) .
Studies use a variety of measures of health effect, usually specific to 
the health intervention being evaluated (eg reduction in diastolic blood 
pressure for a hypertension treatment programme; number of cases of 
breast cancer detected for a breast cancer screening programme). 
Increasingly, however, they are using quality-adjusted life-years 
(sometimes in addition to more programme-specific measures) to permit 
comparison to be made with other, perhaps very different, health 
programmes. Sometimes the utility weights are obtained in an apparently 
arbitrary manner (for Instance Stason and Weinstein (1977) concluded one 
year on hypertension treatment was equivalent to 0.99 quality adjusted 
life years). Other studies have used published results of surveys of 
health state utilities (for Instance Willems et al (1980) used the 
results of Bush, Chen and Patrick (1973)). Yet others have done their 
own assessments of health state utilities: Boyle, Torrance, Sinclair and
51
One Issue that has arisen In the assessment of consequences concerns the 
boundaries of the analysis. If a programme permits people to live 
longer and to die of another disease, should the cost of treating that 
disease be Included In programme costs? Stason and Weinstein (1977) 
Included the cost of treating noncardlovascular disease In future years 
In the cost of the hypertension programme they evaluated. Willems et al 
(1980) allowed for a similar effect In their evaluation of vaccination 
against pneumococcal pneumonia. Drummond, Stoddart and Torrance (1987) 
argue that such consequences can be safely Ignored If they are not 
closely linked to the programme being evaluated and will occur some 
distance Into the future. They point out that a decision has always to 
be made on the boundaries of an economic evaluation.
As mentioned above many studies place particular emphasis on the 
consequence of health service costs averted. This leads to the problem 
of assessing the value. In their alternative use, of the resources 
saved. For example, fluoridation might lead to lower dental carles, but 
how would dentists use the time they would otherwise have spent treating 
dental carles and what would be the benefits of the extra services they 
performed?
Comparison of costs and consequences: cost-effectiveness studies. 
Instead of simply dividing programme costs by health effects (or quality 
adjusted life years In the case of cost-utility analysis) are 
Increasingly netting out savings In treatment costs and the value of 
Indirect benefits (savings In work time) from programme costs. 
Discounting Is generally employed, using discount rates ranging up to 
10% but commonly 5% or 7%. In some studies, the conclusions are shown 
to be sensitive to the choice of discount rate. Distributional issues 
are present In biost studies, but rarely drawn out clearly. An exception 
is the study by Rich et al (1976) where the cheaper test was found to be 
less effective than Its alternative for lower social class children.
Horvood (1983) used the preferences of a local random sample of parents
with school-aged children to value the life years gained by a neonatal
Intensive care programme.
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Findings
It is difficult to summarise the findings from a wide range of often 
very disparate studies. This section therefore summarises some of the 
evidence on immunisation and screening and draws on published reviews of 
findings for screening and for a variety of programmes which have been 
evaluated using cost-utility analysis.
Evaluations of the traditional childhood vaccines generally find that 
they are efficient uses of resources. For example, studies of measles 
vaccination in the US argue it has saved far more than it has cost 
(Warner 1979). As, however, the incidence of communicable diseases 
declines, vaccination can become more questionable. Stillwell (1976), 
for example, argued that BCG vaccination in schools would eventually 
become uneconomic when compared to the cost of treatment.
In the case of newer vaccines which tend to be more expensive, 
evaluations often find that their use is clearly Justified only in high 
risk groups. This was so in the case of Influenza vaccine (Helliwell 
and Drummond 1987), Hepatitis B vaccine (Mulley et al 1982) and 
vaccination against pneumococcal pneumonia (Willems et al 1980).
The results of a review of screening programmes in the Developed 
Commonwealth (Drummond and Mills 1987) Indicated that for some screening 
programmes (for instance screening for PKU, cervical cancer and 
syphilis), savings in health service costs alone were sufficient to 
offset the programme cost. For a few others (mass miniature radiography 
and screening for congenital toxoplasmosis) programme costs considerably 
exceeded health service savings. For yet others, especially screening 
for Down's syndrome, the balance of benefits and cost depended on the 
selection of the target group. In general, while targeting may be 
worthwhile, it can also be costly to identify and reach high risk 
groups.
As Mulley et al (1982) point out, new health programmes are rare that 
actually save resources, though it is notable that of the 57 options for 
environmental protection measures reviewed by Graham and Vaupel (1981), 
13 involved no net additional costs per life or life-year saved, of 
which only one fell within the health sector (genetic screening), the
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others involving transport safety measures, fire prevention or pollution 
reduction. However, creation of savings or zero net costs should not be 
the only criterion for programme choice from society's point of view 
because It ignores the value that society would place on the value of 
health Improvement per se. Table 2.1 presents the results of a North 
American review of cost-utility studies, which ranks them in terms of 
net health care costs per QALY gained, and Table 2.2 presents a similar, 
British summary. Such results enable policy makers to ask how much it 
is worth spending and to assess programme expansion in the light of 
these results. For example some well established programmes (for 
instance dialysis) are relatively expensive per quality-adjusted life 
year gained when compared to newer programmes which have yet to gain 
widespread acceptance as a routine health service activity. It had been 
argued that the antepartum antl-D programme was too expensive, but the 
evaluation showed it gave relatively good value for money compared with 
other programmes.
It remains to ask, however, what has been the influence of economic 
evaluation studies on policy makers. Recently analysts have became 
increasingly concerned about the weakness of the link between study 
results and their implementation (Drummond and Hutton 1986, Ludbrook and 
Mooney 1984) . Problems include the lack of interest of analysts in 
policy change, lack of awareness and interest of policy-makers in study 
results, the political framework of policy-making, the potential threat 
to professional expertise and the practical and methodological problems 
of the evaluations (Drummond and Mills 1987).
2.3 Application of cost-effectiveness analysis to disease control 
programmes in developing countries
This section reviews the application of cost-effectiveness analysis to 
disease control programmes in developing countries. As with the 
developed country literature, it can be difficult to draw the boundaries 
of the review in terms of the definition of both disease control and 
cost-effectiveness analysis. Studies have been classified as disease 
control if their prime focus is on reducing the incidence, prevalence or 
■ortality of one or more diseases rather than on the delivery system. 
They have also been included if they look both at programme (control) 
costs and health effects. Studies that look only at programme costs or
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Tabla 2.1: Comparative cost-utility results for salectad health care 
programmes
Prograaae Reported cost/QAlY(a) 
gained in  US 1 (year)
Adjusted(b) cost/QALV(c) 
gained in  US 9 1983
Hoapital heaodialysis 40,200
(1980)
34,000
Continuous tabulator y 
peritoneal d ia lys is
33,100
(1980)
47,100
School tubarculin tasting 
prograaae
13,000
(1988)
43,700
Coronary artary bypass surgery for single vassal 
disease a ith  aoderately severe angina
30,000
(1981)
38,300
Neonatal in tensive care, 
500-999ge
19,800
(1978)
31,800
Estrogen therapy for post-aenopausal syaptoas in 
aoaen uithout a p rior hysterectoay
18,180
(1979)
27,000
Treataent of a ild  hypertension (d iasto lic  
93-104 aa Hg) in aales age 40
9,880
(1978)
19,100
Treataent of severe hypertension (d iasto lic  
> 103 ao Hg) in aales age 40
4,830
(1978)
9,400
T4 (thyroid) screening 3,800
(1977)
8,300
Neonatal intensive care, 
1000-1499 ga
2,800
(1978)
4,300
Coronary artery bypass surgery for le ft  
aain exonary a r t x y  disease
3,300
(1981)
4,200
Antepartua anti-D 
Postpartua anti-D
1,220
(1983)
<0
(1977)
1,220
<0
PKU screening <0
(1970)
<0
(a) These studies use s ia ila r , but not id en tica l, aethods. 6enerally, c o a ts  a rt net health 
care costs; houever, discount rates and preference «eights are not co ap la te ly  consistent. 
Difference in  aethods should be considered «hen coaparing the relative c o s t - u t i l i t y .
(b) QAIY denotes quality-adjusted li f e - y e x .
<c) Adjusted to 1983 dollars accxding to the US Consuaer Price Indei f x  fled ica l Care for a l l  
urban consuaers. Source: US Durtau of Labx S ta t is t ic s , Monthly Labx R evie« .
Source: Txrance and Zipursky (1984)
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Table 2.2: Approximate NHS cost per 
activities
QALY gained for some selected
Activity Cost per quality adjusted life year gained 
(C 1985)
Hospital haemodialysis 15,000
Heart transplantation 8,000
Coronary artery bypass for double 
vessel disease and moderate angina
4,000
Kidney transplantation 3.000
Coronary artery bypass for left main 1.000
Total hip replacement 800
Pacemaker for heart block 700
CPs counselling patients 
to stop smoking
< 200
Source : Williams (personal communication)
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at disease consequences (la "cost of disease” studies) are therefore 
excluded, as are cost-benefit analyses. In the developing country 
context, unlike the developed country literature, cost-benefit analyses 
have been concerned primarily with benefits In the fora of productivity 
gains rather than averted health service costs. Studies on malaria are 
excluded here, since they are the subject of the following section.
Topics
Most developing country economic evaluations are directed at disease 
control rather than diagnosis and treatment (unless these are part of a 
curative strategy for disease control). This bias reflects both the 
origin of the studies (most are done by developed country economists and 
are commissioned by International agencies) and the more purposeful 
direction of national health policy in developing countries. It is 
also, of course, a reflection of the disease burden in developing 
countries and the availability of the technology (if not the resources 
or management skills) to reduce the burden.
There has been over time a change in the attention paid to different 
diseases. Early studies were prlmsrlly on malsrla, with other 
parasitic diseases, mainly schistosomiasis, later receiving attention. 
Most recently, lmmunisable diseases, and to a slightly lesser degree 
dlarrhoeal diseases, have received the greatest attention from analysts 
(or perhaps more accurately from their commissioning agencies).
Figure 2.6 presents a similar framework for reviewing the subjects of 
studies to that employed in Figure 2.5 for developed countries. An 
extra set of boxes has been added, to allow for studies that compare the 
alternatives of prevention and treatment for controlling a particular 
disease (while some developed country studies compare prevention with 
treatment, the latter aims merely to treat cases that come to the health 
service rather than to use treatment as a strategy for disease control).
It Is convenient to review the choices that the developing country 
literature considers by broad disease category. The review therefore 
commences with parasitic diseases and then considers in turn immunisable 
diseases, other communicable diseases, non communicable diseases and 
studies not specific to any single disease category.
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Figure 2.6: Framework for reviewing cost-effectiveness studies of
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The literature on parasitic diseases has been comprehensively reviewed 
by Barlow and Grobar (1985). The greatest number of studies relate to 
schistosomiasis control. Many of these examine only one option (for 
instance molluscldlng or chemotherapy) and thus can draw no firm policy 
conclusions on their own other than to ask: is the cost worthwhile? 
The more sophisticated studies evaluate a mix of control measures. For 
Instance Jordan (1977) compared the costs and effects (in terms of case* 
years prevented) in three areas, one receiving molluaclcldes, another 
water supplies and the third chemotherapy. A more elaborate study, by 
Rosenfleld, Smith and Wolman (1977) in Iran, developed a transmission 
model to predict the impact of control on schistosomiasis and used it to 
compare the costs and effects of four alternative approaches: 
mollusclcides, chemotherapy, physical destruction of snail habitats and 
a combination of measures. Bekele (1980) also used a transmission model 
and exploited it to consider in much greater detail the costs and 
effects of combinations of control measures (chemotherapy, molluscldlng, 
water supplies).
The technology of schistosomiasis control has been transformed in recent 
years by the development of new drugs that are safe to use for mass 
chemotherapy. Since available drugs bear different prices and Involve 
different treatment regimes, they are an obvious subject for economic 
evaluation. Several studies have looked at choice of drugs, for example 
Korte, Schmidt-Ehry, Kielmann and Brinkman (1986) and Saladin, Saladln, 
Holzer, Dennis, Hanson and Degremont (1983). Prescott (forthcoming) 
investigates the further issue of whether drugs should be given to 
everyone, to high risk groups only, or to those identified by screening 
to be infected.
In the case of schistosomiasis, therefore, control choices have Involved 
both measures directed at the environment (molluscidlng, water supplies, 
irrigation engineering) and at individuals (mass treatment). Choices 
have involved not only aector (the health sector versus other sectors in 
the case of water supplies and irrigation engineering) but also control 
technique and target group (mass or selective chemotherapy).
Choice of drug for mass chemotherapy has also been evaluated for 
ankylostomiasis and ascarlasls (Slnnlah and Slnnlah 1981 and Sturchler,
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Stahel, Saladin and Saladln 1980) and for Crichuriaals (Slnnlah and 
Sinnlah 1981) . The cost of mass chemotherapy has been considered for 
Bancroftian fllarlasls but with no comparison (except the Implicit "do 
nothing") .
Two final examples of cost-effectiveness analysis of parasitic disease 
control are worth mentioning. Rao, Chandrasekharan, Kaul, Naraslmhan 
and Sharma (1980) applied a number of control measures for Bruglan 
fllarlasls in different areas, including Imaglcldes, lmagicides plus 
selective or mass treatment, mass or selective treatment only, and 
larvlcldes. They evaluated their cost and Impact on prevalence rates. 
Prost and Prescott (1984) evaluated the cost-effectiveness of the 
Onchocerciasis Control Programme in West Africa, which employs 
larvlcldes and lmagicides. In order to be able to evaluate whether 
onchocerciasis control was worthwhile, they compared It with cost- 
effectiveness ratios from two measles Immunisation programmes.
Unlike parasitic diseases, which have more often been the subject of 
cost-benefit than cost-effectiveness enalysls, most analysts of 
lrnmunlsable diseases employ cost-effectiveness analysis. Immunisation 
lends itself more than do other health programmes to assessing 
effectiveness since the link between inputs (immunisation) and effects 
(prevention of disease) is reasonably well understood. In addition, the 
Idea of comparing alternatives. If only the costs of fully Immunising a 
child at different health centres, has been well established by the 
publications of the Expanded Programme on Immunisation (EPI) of WHO.
Immunisation cost-effectiveness studies can be divided into those that 
use a measure of intermediate output (uaually fully immunised child) and 
those that use a measure of health effect (usually case or death 
averted). The former group of studies usually concentrate on the 
Internal efficiency of immunisation programmes. One important Issue has 
been the relative merits of fixed and mobile immunisation strategies. 
For example Creese (1984) looked at the relative cost-effectiveness of 
fixed, outreach and mobile immunisation clinics in Brazil, and Creese 
and Dominguez-Uga (1987) at the cost-effectiveness of the routine 
vaccination services and national campaign in Colombia. Another issue 
has been the appropriate size of fixed clinics: a number of EPI -
commissioned studies have looked at how costs per fully-immunised child
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vary by health centra (Creese, Srlyabbaya, Casabal and Wlseso 1982, 
Robertson, Davis and Jobe 1984) . Choice of target group has also been 
considered (should a new Immunisation programme Immunise only newborns 
or also the backlog of older children: Barnum 1980).
Choice of place of Intervention Is Implicit In the debate over whether 
the delivery strategy should be fixed or mobile. It also emerges as an 
Issue In a cost-benefit analysis of measles Immunization in Zambia 
(Ponnighaus 1980) which Is of Interest here because one of the questions 
Investigated was whether measles Immunization should be confined to 
areas with a 24 hour electricity supply (because maintaining the cold 
chain was difficult and costly in the absence of electricity) .
Those Immunization studies that use a measure of health effect In the 
cost-effectiveness ratio usually seek to tackle the question: Is the
EPI programme (or vaccination against one or more diseases) worthwhile 
compared to other uses of the resources? Robertson, Foster, Hull and 
Williams (1985) calculated the cost per case and death prevented by the 
various vaccines In the Gambian EPI programme. They compared these with 
each other, with similar results from other countries and with other 
health Interventions. Barnum, Tarantola and Setlady (1980) similarly 
calculated cost per case and death prevented for each of the vaccines 
used In Indonesia but compared them with treatment costs, thus 
considering choice of time of Intervention. Shepard, Sanoh and Coffl 
(1986) analysed measles vaccination only In the Ivory Coast and like 
Robertson et al (1985) compared their results to those from other 
countries In order to consider the value of the programme.
Other communicable diseases that have been studied Include dlarrhoeal 
diseases, tuberculosis and hepatitis B. Of these, diarrhoeal diseases 
have been the most analysed. Choices considered have been of 
intervention, of place of Intervention and of sector. Phillips, Feachem 
and Mills (1987) reviewed the potential cost-effectiveness of six 
strategies for controlling diarrhoeal diseases - vaccination against 
rotavirus diarrhoea, measles and cholera, breast-feeding promotion, 
improved weaning practices and improved personal hygiene - as an input 
to international policies on diarrhoeal disease control strategies. 
Horton and Claquln (1983) compared the cost-effectiveness of the 
provision of treatment for diarrhoea at a large "Western-style"
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treatment centre and a smaller treatment centre staffed by paramedics. 
Lerman, Shepard and Cash (1985) analysed total expenditure on diarrhoea 
treatment for under fives (by health centre, hospital and families) 
noting the extensive use of Ineffective or marginally effective 
medications. Finally, a number of studies of the cost-effectiveness of 
oral rehydration therapy (ORT) have been done (reviewed In Shepard, 
Brenzel and Nemeth 1986). The approaches to delivering ORT studied 
Included health education via the mass media, care In health facilities 
and by outreach workers, home visits and making ORT available through 
commercial outlets. Unfortunately, most of the approaches have data 
from only one site, making It difficult to compare approaches.
Two studies on tuberculosis are of particular Interest. Feldstein, Plot 
and Sundaresan (1973) developed a resource allocation model to study 
the optimum allocation of resources among various tuberculosis control 
approaches, including treatment, vaccination and chemoprophylaxis. In 
the Republic of Korea. Barnum (1986) considered both choice of drug and 
place of treatment in a comparison of the cost-effectiveness of a short- 
course tuberculosis treatment regimen using rifampicin or ethambutol 
with long course regimens based on thlacetazone and isoniazld, and 
Involving different combinations of inpatient and outpatient care.
The final communicable disease considered here is Hepatitis B. McNeil, 
Dudley, Hoop, Metz, Thompson and Adelstein (1981) developed a 
quantitative model to assess the value of screeening for hepatitis B 
surface antigen as a means of reducing serum hepatitis amongst 
recipients of blood transfusions. The choice of either second- 
generation (counterimmunoelectrophoresis) or third-generation 
(radioimmunoassay) tests was considered and the model was applied to 
Indian data.
Few strategies for the control of non-communicable disease have been 
analysed. One study, similar to that on hepatitis B, reviewed the cost- 
effectiveness of several tests for screening for hypo- and 
hyperthyroidism in India, suggesting that the results should be compared 
with the cost-effectiveness of iodine supplementation in order to 
determine optimal policies towards subcllnical thyroid disease 
(Thompson, McNeil, Ganatra, Larson and Adelstein 1981). Another disease 
resulting from a nutritional deficiency, xeropthalmia, was the subject
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of a cost-benefit analysis In the Philippines (Popkln, Solon, Fernandez 
and Lathan 1980), though a subsequent correspondent In the Journal 
pointed out that a cost-effectiveness framework would have been more 
appropriate and re-calculated the figures (Fowler 1982). Three 
different strategies designed to eliminate vitamin A deficiency were 
analysed Involving choices of sector and Intervention: mass
distribution of vitamin A capsules, vitamin A fortification of 
monosodium glutamate and a primary health scheme.
Studies not specific to the disease groupings considered above fora a 
disparate set of analyses, their main common feature being their focus 
on infant and child diseases. Alaroth, Greiner and Latham (1979) 
compared the cost of breastfeeding a child with artificial feeding, 
commenting on the likely health consequences of each. Barnum (1980) 
examined the choice of intervention (immunisation, ORT, low technology 
water supplies) to combat communicable childhood diseases In Kenya. In 
a more elaborate study In Colombia, a non-linear resource allocation 
model was developed to provide a framework for deciding how to allocate 
resources amongst programmes aimed at reducing Infant and child 
mortality (Barnum, Barlow, Fajardo and Pradilla 1980). The programmes 
Included health promotion, latrines, well-baby clinics, antenatal Iron 
supplements, inpatient care and Institutional deliveries. Grosse (1980) 
presented a cost-effectiveness model which estimated deaths and days of 
incapacity for a number of interventions Including health centres, 
village health workers, nutritional programme. Immunisation, sanitation, 
malaria control and combinations of these, applied within a variety of 
budget constraints.
Finally, a major epidemiological study In Narangwal, India, which also 
had an economic component. Investigated amongst other questions whether 
a programme which combined nutrition and Infection control was more 
cost-effective (In terms of a variety of health Indicators) than 
nutrition and infection control programmes conducted separately 
(Kielmann and associates 1983). The services were targeted on mothers 
and children.
What conclusions can be drawn from this review of the subjects of 
developing country economic evaluation studies? Firstly, the majority 
are concerned with evaluating new policies and strategies either In the
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abstract (prior to their introduction) or as pilot projects. Several 
consequences follow from this, including lack of consideration of 
alternative strategies, lack of investigation of the routine operations 
of the health sector and lack of accurate cost and effectiveness data (a 
problem considered further below). Secondly, because many of the 
studies were commissioned by International agencies, they address the 
concerns of those agencies and thus tend to follow international health 
policy fashions rather than national needs. This is exemplified by the 
recent emphasis on evaluating diarrhoeal disease control and measures to 
increase child survival. Thirdly, the range of diseases which have been 
the subject of a reasonable number of cost-effectiveness analyses is 
extremely limited, being confined to schistosomiasis, immunlsable 
diseases and possibly diarrhoeal diseases. Even with these diseases, 
conclusions on the cost-effectiveness of the programme in question 
relative to other programmes can only be made on the basis of cross­
country comparisons: in no country have a sufficient number of different 
studies been done to assist choices between different diseases or health 
programmes. Choices within programmes have been rigorously analysed by 
relatively few studies which are scattered in terms of both 
disease/programme and country. The only country where a number of 
studies have been done on one disease is St Lucia (population 140,000) 
and schistomlasis.
Methods
Type of study: cost-effectiveness studies have appeared only in the
last 10 years, and have been the preferred analytical technique only for 
the last few years. No study has adopted the Drummond and Stoddart 
framework, netting out either or both direct and indirect benefits 
against programme costs. Two recent studies mention the possibility of 
so doing (Shepard, Sanoh and Coffl 1986, and Shepard, Brenzel and Nemeth 
1986). Difficulties Include those of projecting the likely use of 
curative facilities in the absence of the preventive programme (in 
countries where health services are not universally accessible) and the 
need to retain consistency of practice with other studies when policy 
conclusions are drawn on the basis of comparison of results from a 
number of studies.
The study by Barnum, Tarantola and Setiady (1980) of Immunisation in
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Indonesia does Juxtapose the cost per death and per caae prevented with 
the cost of treating one case. However the calculation assumes all 
cases would receive treatment: an implausible assumption, not
reflecting the likely actual Impact of the immunisation programme on 
health sector expenditure. Other studies which consider treatment costs 
averted do so as part of a cost-benefit analysis, where health effects 
are not retained In physical units but converted to a monetary value 
through the human capital approach.
Although cost-effectiveness analysis is a technique for the comparison 
of alternatives, remarkably few studlea do so, often because a cost 
analysis is attached to an epidemiological trial of the efficacy of a 
drug, insecticide or mollusclclde, or because only one strategy was 
employed in the programme under study and analysts felt unable to 
project the costs and consequences of alternative strategies. There Is 
therefore an implicit comparison with doing nothing or an explicit 
comparison with results from other studies in other countries. Rarely 
is there a discussion of the problems of International comparisons 
(Barlow and Grobar (1985) Is an exception) except occasionally to note 
the problems of using exchange rates to convert overvalued currencies.
As in the case of the developed country literature, few studies take a 
social perspective, most considering only those costs and savings that 
fall on the government. For instance the Narangwal study (Klelman and 
associates 1983) notes that the project appears to have caused a 
reduction In household expenditure on private practitioners but does not 
include this as a resource-saving consequence. Nor does It, In common 
with many other studies, draw out any distributional Implications from 
this effect.
Cost assessment: programme costs calculated in studies are frequently
Incomplete. A review by the Population, Health and Nutrition Department 
of the World Bank (World Bank 1983) summarises the principal problems as 
omissions and under-estlmatlon, mishandling of capltal/recurrent costs, 
absence of shadow pricing, Inadequate treatment of Joint cost allocation 
and lack of cost models. Inputs not paid for are frequently not costed, 
although they are likely to have an opportunity cost (eg airtime on the 
government-owned radio station In The Gambia, not costed In Shepard, 
Brenzel and Nemeth 1986). Some studiea of the effectlvenesa of drugs or
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Certain costing problems frequently arise. One is whether or not to 
allow for the full cost of expatriates in programme costs. If fully 
costed, they can take up a sizeable share of total costs and some 
studies calculate Instead or in addition the local cost if technical 
assistance were to be withdrawn.
Another is the problem of Joint costs. This frequently arises in the 
analysis of immunisation programmes and different approaches have been 
adopted. Robertson et al (1985), for example, allocated EPI costs 
(excluding vaccines which were directly allocated) to the various 
diseases in proportion to actual vaccination contacts. This provides no 
idea of the cost implications of adding or subtracting a vaccine from 
the programme. In contrast, Bam u m  et al (1980), in evaluating the 
expansion of a programme of smallpox and BCG immunisation to include 
DPT, calculated the costs of operating the BCG and DPT programmes 
separately and also calculated the cost of adding DPT to an existing BCG 
programme and vice versa. Similarly, Phillips et al (1987), in 
considering the costs of introducing new rotavirus diarrhoea and cholera 
vaccinations, undertook an incremental analysis. It was assumed the 
vaccines would be added to existing immunisation programmes and the 
calculation allowed for the nature of the new vaccine (injectable or 
oral), whether it must be delivered on its own or in a dose with other 
vaccines, and whether or not it would be administered at an age when 
children attended for other vaccinations.
An alternative approach was adopted by Shepard, Sanoh and Coffi (1986) 
in focusing on measles alone of the EPI diseases, on the grounds that it 
was the leading cause of reported morbidity. For this reason and others 
(for instance the more stringent cold chain requirements of measles 
vaccine and the greater difficulty of recruitment of children at the age 
the vaccine is given), 75% of EPI costs were allocated to measles. This 
contrasts with the Robertson et al (1985) approach which would have 
produced a figure of 17%.
No cost-effectiveness study located employed the full Squire and Van der 
Tak methodology for shadow pricing (one cost-benefit analysis has done
chemicals calculate only a drug or material cost, excluding the delivery
cost.
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Certain costing problems frequently arise. One Is whether or not to 
allow for the full cost of expatriates In programme costs. If fully 
costed, they can take up a sizeable share of total costs and some 
studies calculate Instead or In addition the local cost If technical 
assistance were to be withdrawn.
Another Is the problem of joint costs. This frequently arises In the 
analysis of Immunisation programmes and different approaches have been 
adopted. Robertson et al (1985), for example, allocated EPI costs 
(excluding vaccines which were directly allocated) to the various 
diseases in proportion to actual vaccination contacts. This provides no 
idea of the cost implications of adding or subtracting a vaccine from 
the programme. In contrast, Barnum et al (1980), In evaluating the 
expansion of a programme of smallpox and BCG Immunisation to Include 
DPT, calculated the costs of operating the BCG and DPT programmes 
separately and also calculated the cost of adding DPT to an existing BCG 
programme and vice versa. Similarly, Phillips et al (1987), in 
considering the costs of introducing new rotavirus diarrhoea and cholera 
vaccinations, undertook an incremental analysis. It was assumed the 
vaccines would be added to existing immunisation programmes and the 
calculation allowed for the nature of the new vaccine (injectable or 
oral), whether it must be delivered on Its own or In a dose with other 
vaccines, and whether or not it would be administered at an age when 
children attended for other vaccinations.
An alternative approach was adopted by Shepard, Sanoh and Coffi (1986) 
In focusing on measles alone of the EPI diseases, on the grounds that it 
was the leading cause of reported morbidity. For this reason and others 
(for instance the more stringent cold chain requirements of measles 
vaccine and the greater difficulty of recruitment of children at the age 
the vaccine is given), 75% of EPI costs were allocated to measles. This 
contrasts with the Robertson et al (1985) approach which would have 
produced a figure of 17%.
No cost-effectiveness study located employed the full Squire and Van der 
Tak methodology for shadow pricing (one cost-benefit analysis has done
chemicals calculate only a drug or material cost, excluding the delivery
cost.
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so (Knudsen 1981) and a case-study of domestic water supply (Porter and 
Walsh 1978) was employed to demonstrate the application of the ODA- 
recommended methodology to cost-effectiveness analysis, though without 
using any Indicators of health effects). Indeed virtually all studies 
employ market prices and actual foreign exchange rates. A  very few 
mention the possibility of a shadow wage and foreign exchange rate and 
Horton and Claquln (1983) used a shadow exchange rate but not a shadow 
wage rate. No study discusses or uses world prices and conversion 
factors. In this sense, practice In the health sector can be seen to be 
considerably out of step with economic evaluation practices in other 
sectors.
Assessment of consequences: assessment of health effects is a major 
problem in all studies. Those that can rely on an epidemiological study 
are very rare. The Narangwal study (Klelman and associates 1983) was 
based on prospective longitudinal field experiments yet because of its 
cost and complexity, such a study Is unlikely to be repeated. More 
limited studies are more common (for example of the effectiveness of a 
drug or insecticide) but may not provide the Information required for an 
economic evaluation. For example indicators of effectiveness used are 
often parasite prevalence In the case of a drug, or vector densities in 
the case of an insecticide, not the cases of clinical disease or deaths 
prevented required for the economic evaluation.
In the absence of good epidemiological data on health indicators, 
economic evaluation studies have had recourse to a number of different 
approaches. Household surveys of programme take-up (for instance of ORT 
use or immunisation status) may provide the basis for projecting health 
impact. A few countries - for instance The Gambia and Bangladesh - have 
areas where disease patterns have been Intensively studied by 
epidemiologists, providing at least base-line information. Many studies 
match utilisation data with International estimates of efficacy (of a 
drug or vaccine) and case fatality rates. Others use Intermediate 
measures of outcome such as "fully immunised child".
A final strategy used has been a survey of expert opinion. For Instance 
Crosse (1980) relied on a literature review to Identify the link between 
a variety of health programmes and delivery system components and 
changes In disease -specif 1c morbidity and mortality. Barnui et al
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(1980) used the Delphi technique, surveying the views of International 
experts, to Identify the effects of alternative combinations of maternal 
and child health services on child survival.
The difficulties and dangers of extrapolating from limited data are 
Indicated by two studies of the Onchocerciasis Control Programme In West 
Africa. Evans and Murray (1987) reworked the figures of Prost and 
Prescott (1984) and produced cost-effectiveness ratios that were 8 to 22 
times as costly per unit of health effect. The main reasons for these 
differences were different values for the population at risk, the 
Incidence and prevalence of onchocercal blindness and the years of 
healthy life lost due to blindness.
In terms of the measures of health effect used, a few recent studies 
have used "healthy days of life lost" (for example Prost and Prescott 
1984 and Shepard, Sanoh and Coffl 1986) . A  few others have used 
multiple measures (Crosse 1980, Klelman and associates 1983). Most use 
either one Indicator relevant to the disease under study (eg case years 
of schistosomiasis prevented) or one or two indicators relevant to a 
number of diseases (deaths prevented, cases prevented). The 
deficiencies of this approach are e x e m p l i f i e d  by studies of 
immunisation. For exasq>le the following cost-effectiveness ratios for 
the immunisation programme In Brazil can be calculated from Creese 
(1984):
Cost-effectiveness Immunisation against:
ratio measles polio
cost per death averted $ 108 $2128
cost per disability averted $6667 $ 286
cost per case averted $2.14 $ 212
Choice between these programmes requires a trade-off between large 
reductions In mortality and small reductions In disability from measles 
vaccination, and the opposite for polio vaccination. A further problem 
of many studies and exemplified in this one Is that the relevance of 
these ratios to policy makers is unclear: numbers of deaths,
disabilities and cases are presented as the consequences of spending $lm 
on either polio measles vaccination but Is this a realistic choice 
for policy makers?
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Other difficulties result f r o m  the use of a single measure of 
effectiveness to evaluate very different strategies. For example, cost- 
effectiveness studies of schistosomiasis control have frequently used 
cost per case year prevented to compare the strategies of chemotherapy, 
molluscicldlng and water supplies. Yet water supplies have far broader 
benefits than schistosomiasis control alone. Numerous studies use 
reduction In infant or child mortality to compare very disparate 
interventions (eg Welsh and Warren 1979) .
No study has used "quality adjusted life years". Interestingly, 
Feldsteln, Plot and Sundaresan In 1973 recognised that relative social 
values needed to be placed on the different effects of health programmes 
and reviewed alternative approaches to establishing relative social 
value weights, Including the literature that led later to the 
development of quality of life measures. No analyst concerned with 
developing countries seems to have taken this further In the succeeding 
15 years.
Concern amongst developed country analysts with the subsequent health 
experiences of survivors Is of relevance to developing countries: Is a 
child saved from one Illness more likely to die from another illness? 
Only Shepard, Sanoh and Coffl (1986) have allowed for this, arguing that 
children who would have died from measles but are saved by vaccination 
face higher mortality than oth e r  children of the same age . They 
therefore adjusted their calculation of healthy days of life saved to 
allow for this.
As mentioned earlier, no cost-mffectlveness study has concerned Itself 
with Indirect benefits (the value of productivity gains). While cost- 
benefit analyses are not the subject of this review. It Is relevant to 
note here that the methods used in these studies to measure and value 
productivity gains are usually extremely weak. In principle gains In 
productive time should be carefully measured and valued at their 
marginal product (Mills 1985). In practice, arbitrary and often 
exaggerated assessments are made of days of work lost due to Illness and 
these are multiplied by the average or minimum wage regardless of the 
relationship between wages and marginal product and the likely change In 
marginal product as available labour time Increases. Indeed, the 
discredit that has been attached to the human capital approach partly
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stems from the crude way In which It has been applied and may help to 
explain why Indirect benefits are not discussed In cost-effectiveness 
studies.
Studies which adopt a more sophisticated approach are very rare. A 
model study Is that by Conly (1975) which explored the economic 
consequences on households of malaria. Instead of assessing days of 
work lost and their value, it looked directly at Indicators of 
production, comparing households with much malaria and those with little 
malaria. It did not look, however, at the cost of control.
Comparison of costs and consequences: neither discounting nor
sensitivity analysis have been consistently employed In studies. The 
Importance of discounting when comparing alternatives with very 
different time horizons was shown by Cohn (1972) In a comparison of 
malaria eradication and control strategies. Variations In the discount 
rate affected the choice of strategy because the higher the discount 
rate, the less weight Is given to the future continuing costs of 
control.
Incremental analysis Is largely absent, even when studies appear to 
offer a good opportunity. Barnum (1986) for example, when estimating 
the costs and effects of alternative regimes for tuberculosis treatment, 
presented only average costs per unit of effect for the seven 
alternatives. Yet It seems from the text that some options had lower 
costs and lower effectiveness and others higher costs and higher 
effectiveness, providing the Ideal opportunity for Incremental analysis. 
Another example where Incremental concepts are relevant but not used Is 
the Immunisation study by Robertson et al (1985) which divided costs 
between all diseases (Including dlptherla, pertussis and tetanus 
although these are prevented by one combined vaccine) . A more relevant 
approach would have been to regard some vaccines as the main 
Justification for the vaccination programme and others as optional add­
ons, thus analysing their Incremental costs and affects. McNeil et al 
(1981) and Thompson et al (1981) are unusual In calculating Incremental 
cost-effectiveness ratios. In both cases for one diagnostic test over 
another.
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Finding*
As in the case of the developed country literature, it is difficult to 
summarise findings from a wide range of studies. This section therefore 
relies for quantitative results on those studies which have tackled the 
lengthy and time consuming task of analysing and presenting results in 
as consistent a fashion as possible, by selecting similar ratios and 
translating them to a common currency and year. This has been done for 
parasitic diseases by Barlow and Grobar (1986), for oral rehydration 
therapy for dlarrhoeal diseases by Shepard, Brenzel and Nemeth (1986), 
for immunization b y  Phillips, Feachem and Mills (1985) and for a variety 
of health interventions by Cochrane and Zacharlah (1983). These results 
are reproduced in Annex 5 and summarized here in order to provide a 
basis for later comparisons with similar ratios for malaria control.
Summaries of the findings of cost-effectiveness studies on parasitic 
diseases (excluding malaria) are presented in Table A5.2 for annual cost 
per person protected and Table A 5 .3 for cost per case year prevented. 
Only two studies of parasitic disease control projects produced a cost 
per death averted. Since they were both of malaria, they are considered 
later.
The measure "cost per person” shows an enormous range, even for the same 
disease (for example schistosomiasis). However, while it gives some 
indication of the level of resources required, especially if compared to 
annual health expenditure, it is not particularly helpful given the 
vagueness of the term 'protection' .
"Cost per case-year prevented" is more useful and suggests there are big 
differences b etween different control measures - for instance 
chemotherapy and vector control in the case of schistosomiasis. Bekele 
(1980), on the basis of looking at combinations of control measures for 
schistosomiasis, concluded that the gains from simultaneously operating 
several control measures rather than chemotherapy alone did not Justify 
the additional cost. Unfortunately most studies do not study 
combinations of methods and so cannot provide further evidence on this 
conclusion.
Table A S . 3 demonstrates the enormous differences in the cost-
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effectiveness of similar techniques in different locations. For 
Instance costs (1984 prices) of vector control (molluscicidlng) to 
reduce schistosomiasis prevalence varied between $9.29 per case-year 
prevented (Iran) and $84.23 (St Lucia).
A variety of reasons could account for these differences, including on 
the cost side differences In Input prices, different combinations of 
Inputs a n d  different environmental circumstances and on the 
effectiveness side, differences In vectors or vector behaviour, 
differences In the compliance of the population or the efficacy of 
control measures. Differences in cost, appropriately standardised, have 
been little investigated. An exception la Jobin (1979), who has 
compared the cost of molluscicidlng per 100m^ treated and per km^ in a 
number of schistosomiasis control projects (see Table AS.4). He 
concluded that costs were generally related to simple geographical 
parameters such as volume of snail habitat and distance between 
habitats. Rainfall patterns and the cost of chemicals (which take up 
very different shares of programme costs) can also be important.
Data on variation in effectiveness is available from the second set of 
results discussed here, from oral rehydration therapy projects (see 
Table A5.S). Cost per child per year varied by a factor of 20, deaths 
averted per 1000 children also by a factor of 20 and cost per death 
averted by a factor of about 65. These differences are accounted for by 
the very different approaches employed by different projects (for 
instance repeated home visiting by nurses in Egypt as opposed to 
primarily mass media in The Gambia) and very different use rates 
achieved for oral rehydratlon therapy. In contrast, comparison of costs 
per fully immunised child from immunisation programmes (Table A5.6) 
shows only a four-fold difference, probably because the technology is 
reasonably standard, known to be effective if properly administered, and 
not dependent on patient compliance once a child is contacted (Mills and 
Drummond 1987) .
Further evidence on the importance of delivery strategy is available, 
particularly from immunisation programmes. Evidence is accumulating 
that mobile campaign-type strategies appear to offer a cheap way of 
achieving high levels of coverage in the short term, though they do not 
necessarily offer a comparable range of services to that of fixed
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services. Moreover, campaigns are difficult to sustain in the long term 
and may become increasingly costly as coverage from fixed centres 
Improves (Creese and Dominguez-Uga 1987).
In terms of service Integration, there Is now considerable evidence that 
bringing the provision of different services together can produce 
benefits both In Increased effectiveness and reduced costs, providing 
that the efficiency of the newly Integrated services can be maintained. 
However, there Is less evidence on whether Integration Is more 
appropriate for some services (eg for general child care) than others 
(eg for vector-borne diseases).
There has recently been Interest In ranking health Interventions In 
terms of cost per death averted, which provides an Indication of best- 
buy programmes, assuming that reduction in mortality Is an adequate 
proxy for national health objectives. Table 2.3 reproduces one such 
comparison, shown in common 1984 dollars, adapted from Cochrane and 
Zachariah (1983). The general impression from this and other, similar 
tables Is that "primary health care" Interventions, for Instance 
Immunisation and oral rehydratlon, represent good buys and that control 
of vector-borne diseases and especially water supplies are not such good 
investments In terms of mortality reduction. However, while the 
reliability of estimates for immunisation Is reasonably good, there are 
very few estimates of deaths averted by parasitic disease control 
programmes. Barlow and Grobar (1986) list only two, both for malaria, 
and only one of these has much foundation in reality. There is 
therefore a large gap In the literature regarding the cost-effectiveness 
of vector control projects In terms of reducing mortality.
To summarize: sufficient evidence has been collected from developing 
country economic evaluation studies to indicate that certain 
interventions, particularly those falling under primary health care, are 
highly cost-effective. However they also indicate that costs, 
effectiveness, and cost-effectiveness vary widely, between countries, 
diseases and programmes, for reasons that are not well understood. 
Moreover, the evidence on the cost-effectiveness of parasitic disease 
control projects is particularly poor.
What has been the Impact of economic evaluation studies on policy
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Table 2.3: Cost per death prevented through different health Interventions
Author Intervention Country Cost per death
prevented($1984)
Shepard Measles Immunization (Includes Ivory Coast $529
(1982) all joint costs of a programme
of polio, DPT, BCG and tetanus)
Barnun et Total Immunization programme Indonesia $163
al (1980) BCG programme only $558
DPTT programme only $169
BCG added to existing programme $127
DPTT added to existing programme $97
Barlow Mass vaccination Morocco, 1971
(1976) BCG $41
DPTT $64
Polio $1,859
Barnun Immunization Total Kenya $107
(1980) DPT, TT, BCG only $344
Measles only $63
Polio only $7.972
DPT, TT. BCG $87
Measles added to existing progran $33
Polio added to existing programme $712
New births only $88
Barnun & Nepal $695
Yaukey Integrated with family planning $371
(1979)
Faruquee Nutrition programme prenatal Narangwal, $9
& Johnson Health care - Infant India $27
(1982) • child $33
Barlow Hospital Morocco, 1971
(1976) Large $4,460
Medium $4.770
Small $3,990
Horton & Hospital treatment of diarrhoea Bangladesh
Claquln Sotaki $202
(1982) Matlab $1,362 -
$1.459
Prescott Malaria eradication Bangladesh $1,014 -
(1980) (spraying and drugs) $31,463
Walsh & Mosquito control - malaria Cross-country $820
Warren (Infant & child) analysis
(1979) Community water supply. $4,930 -
sanitation $5,890
Selective primary health care $275 -
$340
Adapted from Cochrane and Zacharlah (1983). Costa of original sources 
converted to US$ 1984 by multiplying by ratio between US GNP deflators 
for year of study and 1984 (ratios from Barlow and Grobar 1985).
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making? This question Is clearly not easy to answer. In terms of 
Impact on national decision-makers, the answer Is likely to be very 
little because few studies have been oriented to their concerns. In 
terms of international health policy, there Is some evidence that 
economic evaluation results (for instance on primary health care, 
immunisation and dlarrhoeal diseases) have had some Influence. An 
unfortunate consequence of the interest of policy-makers In such studies 
has, however, been the simplistic application of cost-effectiveness 
analysis to Justify policies formulated on other grounds rather than to 
assist In making policies.
2.4 Application of cost-effectiveness analysis to malaria control 
programmes
In order to review a reasonable number of studies, the criteria for 
Inclusion of studies In this section are rather more lax than In 
previous sections. In particular, cost analyses (producing, for 
instance, a cost per person protected) are Included. In addition, the 
method of measurement and valuation of direct and indirect benefits 
(averted treatment costs and productivity gains) used In cost-benefit 
studies is reviewed, since It is of relevance to the subsequent case- 
study.
Topics
Figure 2.7 provides a framework for reviewing the subjects analysed by 
malaria control studies. Table 2.4 lists, in alphabetical order by 
author, those studies reporting a cost-effectiveness ratio. It briefly 
indicates the group or area studied, the purpose of the study and the 
control methods Involved.
Most studies are concerned with choices of strategies for prevention. 
Although case detection and treatment are, together with vector control 
measures, an important part of the preventive activities of national 
malaria control programmes, economists have paid little attention to 
them. Griffith (1961) reviewed the costs of a number of national 
malaria eradication campaigns, his main aim being to estimate the 
financial implications of moving from the attack phase, where spraying 
was the main strategy, to surveillance including case detection and
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Tabla 2.4: Description of studies of malaria control reporting a 
cost-effectiveness ratio
Author (dits) 6roup or arta 
studied
Purpose of 
study
Control sethods 
involved
la r i  ou (1966) Sri Lanka: actual 
data 1947-66; 
projected data 
1976-77
Assess econoaic 
inpact of
sa la ria  eradication
Insecticides, case 
detection and treateent, 
surveillance
•ruce-Chuatt 
1 Archibald 
(1939)
Nestern Sokoto, 
Nigeria, 130,000 
people
Coapare coaparative 
value of 3 
insecticides to 
control aalaria
DDT, PNC, dieldrint 
alternative dosages 
and spray cycles
Irucs-Chsatt
(1967)
Non-specific Assess cost of 
cheaotherapy
Chesotherapy
Cohn (1973) India, 1930-71 Revieu costs and 
benefits of so laria  
control prograaae
Insecticides, case 
detection and treatoont, 
surveillance
6andahusada 
•t al (1984)
3 areas, each c . 
30,000 pop., in  
Central Java, 
Indonesia, 1980-2
Evaluate fu ll and 
selective coverage 
of residual 
fenitrothion
Insecticides: a lternative 
dosages and coverage
G r if f ith  (1961) Greece, 1938, 
national prograsse
Assess cost of 
sa la ria  eradication
Surveillance
Thailand, I960, 
fie ld  t r ia ls
• Surveillance,
spraying
Indonesia, 1961, 
national progranse
* Spraying) spraying 
and surveillance
Ceylon, 1960, 
national prograsse
• * Spraying and 
surveillance
Taman, 1936 and 
1960, national 
prograese
Spraying; spraying 
and surveillance) 
surveillance
India, 1961, 
national progranae
Spraying) spraying 
and surveillance, 
surveillance.
Hsdaan at al
(1979)
Nining toen in 
L ibe ria , pop. 16,000, 
1976/7
Evaluate
prograsae
DDT spraying, larvic ide  
eeasures, chenotherapy
continued
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Tabi« 2. A: Continued
Author (date) Group or arca 
studiod
Purpose of 
study
Control aethods 
involved
Jeffrey (1984) Non specific , 1984 Assess cost of 
eheaotherapy ia 
PNC
Chloroquine
Kaeasonthi and 
Harding (1984)
Thailand, 2 zona«, 
pop. 1.3a and O.Sa, 
1900-1
Assess cost and 
perforaance of 
su rve illance
Case detection and 
treataent a c t iv it ie s
Holineaux and
6raaiccia
(1980)
Gorki d is t r ic t , 
Kano Stata,
Ni garia , 1949-79
Assess effectiveness 
of control aeasures
Various coabinations 
of insectic ide , aass drug 
adainistration , 
larvtciding
Ortiz (1968) Paraguay, 1965-72, 
national prograaaa
Projection of cost 
of eradication 
prograaae
Insecticides, case 
detection and 
treataent
Sitaraa (1986) Khada d is t r ic t , 
Gujarat, India, 
1985
Coapare cheaical 
and environaental 
control aethods
Spraying uith DDT 
and aalathion; 
environaental 
aanageaent
Nalsh and 
Narren (1979)
Non-specific Id en tify  p r io r ity  
priaary health care 
interventions
Vector control
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The main concern of this analysis was to ensure adequate financial 
resources were made available for the crucial phase of surveillance. 
The analysis was also Intended to promote the usefulness of cost 
analysis of programmes - though this seems to have fallen on deaf ears. 
While several subsequent studies have costed an entire package of 
malaria control measures in order to proceed to a cost-benefit analysis 
(eg Barlow 1968, Cohn 1973, Ortiz 1968) no other study was located that 
attempted a comparative cost analysis until Kaewsonthi and Harding 
(1984).
The Kaewsonthi and Harding study had a number of objectives. Including 
to develop a methodology for assessing the cost-effectiveness of malaria 
surveillance and monitoring processes, to produce results of use to 
programme managers and to strengthen research capabilities in health 
economics. Although the aim of the research was to compare the cost- 
effectiveness of surveillance processes within an area and between 
areas, this aim was rejected because It was argued that it was 
impossible to achieve unless the processes were real alternatives and 
not complements; had the same target and achieved the same level of 
effectiveness; and operated in the same environmental conditions. It 
was considered that these conditions were not met. The research 
therefore concentrated on assessing the unit cost and performance of 
surveillance processes. Comparisons involved different delivery 
strategies for surveillance activities (active case detection, malaria 
clinics, volunteers etc), different places for making contact with 
potential cases (patient's home, malaria clinic, volunteer's home, 
hospital etc) and different target populations (the whole population for 
routine activities, mass drug administration for selected groups).
No other study has gone into preventive measures aimed at individuals in 
such detail. A few other strategies have been evaluated, but with only 
Partial cost or effectiveness information. For example there is now 
considerable interest in the potential of bed nets impregrated with 
insecticide and partial costing (Schreck and Self 1985). Historical 
data from the Tennessee Valley Authority Indicates that parasltaemia
treatment, epidemiological investigation, protective measures against
malaria importation and transmission, and entomological vigilance and
focal vector control.
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rates in the late 1930s were far lower in houses that had been screened 
against mosquitos as opposed to unscreened houses (Cooney and Brooks
1986).
Most of the attention of analysts has been directed to preventive 
measures aimed at the environment. The use of residual insecticides has 
been extensively evaluated in terms of their insecticidal properties, 
safety, and required dosages and frequency of application. Rarely do 
such studies consider their Impact on the Incidence of malaria or their 
cost over and above that of the insecticide alone. A rare study which 
included cost considerations is that by Gandahusada, Fleming, Sukanto, 
Damar, Suwarto, Sustrlayu, Bang, Arvati and Arif (1984), which compared 
alternative dosages and coverage of fenitrothion, incorporating 
parasitological, entomological and cost studies.
Comparisons of insecticides usually consider insecticide cost alone. An 
exception is Phillips and Mills (1986) who compared the operational 
(delivery) costs of three insecticides in Nepal (DDT, malathlon, 
bendiocarb), concentrating on costs associated with transporting the 
Insecticides and delivering them to the walls of houses.
Because of vector resistance to insecticides and their foreign exchange 
cost, there has been renewed Interest in environmental management and 
modification. This was the subject of a meeting of the WHO/FAO/UNEP 
Panel of Experts on Environmental Management for Vector Control (PEEM) 
in 1986 which reviewed a number of case studies (PEEM 1986). Most 
compared environmental management approaches with chemical control. Few 
had data on the effectiveness of the alternative approaches, Instead 
comparing the cost of achieving control (the level of control usually 
being unspecified) using different methods. For example Sharma (1986) 
projected the costs of achieving control by chemical or environmental 
management methods in Kheda District, Gujerat, basing his calculations 
on estimated chemical control costs and a pilot project of environmental 
management.
Extensive comparisons were made from the experience of the Tennessee 
Valley Authority, covering a wide range of environmental management 
techniques (Cooney and Brooks 1986). Some approaches had been built 
into the engineering design, others involved later modifications to that
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design, and yet others required annual activities. Further comparisons 
were quoted at the PEEM meeting from mosquito control In coastal salt 
marshes In the US. For example the Public Health Study Team report 
(1976) compared Impounding and dike maintenance with larvlcldlng. 
Finally, the cost of the use of fish as part of an Integrated approach 
to control was compared to the savings from reduction In larvlcldlng It 
made possible in a study in California (Lichtenberg and Getz 1985). All 
these studies took vector control (at an unspecified level) as their 
objective and compared alternative means of achieving It. Reduction in 
the nuisance of mosquitos was as much the purpose of vector control as 
reduction In disease transmission.
Although diagnosis Is a central activity of malaria control programmes, 
little attention has been paid to the costs of alternative patterns of 
organisation, though this was one of the issues implicitly included In 
the study by Kaewsonthi and Harding (1984) since they compared malaria 
clinics (where parasitology Is carried out Immediately) with other 
methods of case detection where parasitology Is centralised.
Similar comments apply to treatment. While choices certainly exist with 
respect to choice of drugs and place of treatment, these have not been 
evaluated except by Kaewsonthi and Harding (1984). Two studies have, 
however, documented the cost consequences of poor prescribing practices: 
Guyer and Candy (1979) In a comment on the widespread and unnecessary 
use of Injectable antlmalarial therapy in the Cameroon and Barnett and 
Creese (1980) In a study of the treatment provided for common diseases, 
including malaria, in a sample of clinics in Ghana. Several studies 
have estimated the cost of Including chemotherapy for malaria In primary 
health care (eg Jeffery 1984).
Two conclusions can be drawn from this review of the subjects of cost 
and cost-effectiveness studies of malaria control. Firstly, no study 
has compared the value of malaria control with the value of other health 
programmes In terms of preventing morbidity and mortality. A cost per 
infant and child death averted by malaria control was shown in Table 2.3 
but the empirical basis of that estimate is very speculative. Secondly, 
very few studies have adequately explored the innumerable choices 
concerning the strategies and organisation of malaria control.
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Methods
Type of study: no study has attempted a full cost-effectiveness 
analysis, Incorporating complete costing and effectiveness measures. 
Gandahusada et al (1984) come closest although the costs appear 
Incomplete, and Kaewsonthi and Harding (1984), while employing a cost- 
effectiveness framework, concentrated on cost analysis and unit cost 
measures. Other studies focus on either costs or effectiveness, or are 
primarily concerned with vector rather than disease control. Several 
cost-benefit analyses have produced a single cost-effectiveness ratio 
(Cohn 1973, Barlow 1968) but Its policy Implications are not drawn out.
Costs: Many of the comments in the review of the developing country 
literature apply also here. Costs are often Incomplete and shadow 
pricing Is not employed. The only example of a careful dissection of 
programme costs is Kaewsonthi and Harding (1984). Their task of 
Identifying the costs of operational activities was much hampered by an 
accounting system that was not disaggregated by type of activity 
(spraying, case detection etc). Much time and effort was therefore 
spent developing means of allocating expenditure to activities and 
Investigating the sensitivity of the results to the various formulae 
used. This study is the only one which investigated time and financial 
costs of patients and their relatives and friends.
Consequences: a variety of means have been used to obtain information on 
health effects. Historical (retrospective) studies such as those by 
Barlow (1968), Cohn (1973) and Kuhner (1971) project cases and deaths 
with and without control. Most studies of this type estimate cases and 
deaths without control on the assumption that levels prior to control 
would have remained the same In the absence of control. Barlow (1968) 
was able to draw on much more sophisticated analyses of the effect of 
malaria control on mortality rates In Sri Lanka.
Studies based on epidemiological trials (for Instance Gandahusada et al 
1984, Molineaux and Gramiccla 1980) use the Indicators of the trials. 
Gandahusada et al (1984) had to use the slide positivity rate rather 
than malaria incidence because the blood examination rate varied by time 
and place. Molineaux and Gramlccla (1984) monitored malaria incidence. 
The US studies of vector control used various measures of the vector
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population (for instance mean number of mosquitos per light trap night: 
DeBord, Carlson and Axtell 1975 and Sarhan, Howitt, Moore and Mitchell 
1981).
Two non-field-based studies looked only at health effects, not at other 
consequences or programme costs, and are considered here because effects 
are measured in ways that would adapt well to economic evaluation 
studies. The Ghana Health Assessment Project Team (1981) used census 
data, death certificates, inpatient and outpatient statistics and 
special surveys to estimate the number of healthy days of life lost from 
various diseases. Malaria was assumed for analytical convenience to be 
a single life-time disease, with high mortality in late infancy and 
early childhood followed by recurring disability from clinical attacks 
throughout the rest of life. OJo (undated) applied the Tugwell, Bennet 
and Sackett (1985) approach to estimating the community effectiveness of 
vector control, chemoprophylaxis and treatment, deriving the weights for 
the various components of community effectiveness from a literature 
review.
Kaewsonthi and Harding (1984) used Indicators of performance: for 
example effectiveness (the extent to which a target - eg speed of 
treatment - is met), time taken, performance (degree to which a task is 
successfully completed) and relative contribution to surveillance. In 
order to relate performance to costs, they calculated unit costs based 
on measures of intermediate output (slides taken, positive cases 
detected etc).
Although no cost-effectiveness study Includes consideration of direct 
and indirect benefits as categories of consequence, their use in cost- 
benefit studies of malaria is reviewed here since it is of relevance to 
the later case study. Table 2.5 summarises the main approaches to the 
measurement and valuation of direct (treatment costs saved) and Indirect 
(production gains) benefits adopted in cost-benefit studies. A few 
other relevant studies are also Included; those which measure days of 
disability lost and those which attempt to assess the "cost"of malaria, 
without considering control. A more extensive theoretical and empirical 
review of the effect of malaria control on the supply of labour has been 
included in Section 3 of Annex 1.
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Table 2.5: Measurement and valuation of direct (ti int costs
saved) and Indirect (production gains) benefits from 
malaria control
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By no means all studies attempt an assessment of the cost of treatment 
without control and of the likely savings with control. A few studies, 
for Instance Bhombore, Brooke-Worth and Nanjundlah (1952) compare actual 
expenditure before and after and with and without malaria control 
(though they appear to derive their Information from a single survey, 
requiring a period of recall of up to 2 years) . Most studies estimate 
treatment costs on the basis of assumptions on the proportion of cases 
treated and the unit cost of treatment. Common shortcomings are to 
exaggerate the likely proportion of cases receiving treatment, and to 
assume that eradication Is Instantaneous and completely effective, thus 
implying zero treatment costs with control.
A notable point from Table 2.5 Is the enormous variation in days of 
disability per malaria episode assumed (or measured) in the various 
studies. Since days of disability lost will depend on such factors as 
the parasite species, immune status of the population, frequency of 
attacks per individual and whether or not the episode is treated, 
comparison between the studies must be undertaken cautiously. However, 
it is notable that those studies which measure days of disability from 
their own surveys (eg Conly 1975, Mason and Hobbs 1977, Miller 1958) 
tend to find lower values than the other studies which rely on 
estimates, suggesting a tendency of the latter studies to exaggerate.
Most studies assume that days of disability equal days of productive 
labour lost. Van Dine (1916), however, converts days of disability into 
equivalent labour days, taking account of important factors such as 
varying labour force participation rates, seasonality of labour demand, 
debilitating effects of disease and the time spent by family members in 
caring for the sick.
Most of the methods of valuation of days of work lost due to morbidity 
and debility are based on some estimate of the average wage, adjusted or 
unadjusted. For example Bhombore et al (1952) multiplied the disability 
days reported in their survey by the prevailing wage rate for hired 
labour; Sinton (1935) multiplied days of work lost by the average 
monthly wage rate (weighted to allow for differing male and female 
earnings); Quo (1959) used the minimum weekly wage; San Pedro (1967-8) 
the legal minimum wage for agricultural workers; Nlazl (1969) a "daily 
wage"; Khan (1966) the "average product of labour"; and Ortiz (1968) the
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assumed output per man day In various agricultural sub-sectors. The 
only substantially different approach was adopted by Kuhner (1971) who 
used the marginal product of a labour year, estimated from an assumed 
Cobb-Douglas production function for the agricultural sector. With this 
specification, the marginal product of labour is equal to a constant 
fraction (the labour elasticity of output) of its average product. A 
time series of the average product was used to derive the marginal 
product, using two plausible values for labour elasticity (0.4 and 0.5).
Most of these studies value years of life lost due to mortality in a 
similar fashion, basing the estimate on the average or minimum wage, or 
annual per capita Income. The main exception is Quo (1959) who 
multiplied the number of deaths by $1,500, the value placed on death by 
the Philippines Civil Code.
A notable exception to the above methodology which bases estimates of 
loss on the product of the number of days of work lost and their value 
is the study by Conly (1976) which looked directly at the economic 
consequences of malaria in terms of, for Instance, land area cultivated, 
crop selection and harvest quantities. Households were studied for a 
two year period and differences in malaria incidence between groups of 
households and between years one and two permitted a comparison of 
indicators of household production between groups of households 
experiencing different levels of malaria. The value of the loss due to 
malaria was not, however, compared with the cost of control, as in the 
cost-benefit analyses.
No cost-benefit study is entirely convincing in its estimate of the 
output loss due to morbidity, debility and mortality caused by malaria, 
and most estimates are implausible. The main problems are:
indirect benefits are not completely specified or explored: some 
analysts Include all three causes of loss (morbidity, debility, 
mortality), others only one or two;
the empirical basis for estimating length of illness, degree of 
disability and debility, and mortality rates is extremely weak: 
most estimates are guesses;
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- Che empirical basis for quantifying time lost from work Is also
extremely weak: most studies assume that days of Illness are
equivalent to productive days lost, ignoring issues of the 
seasonality of labour demand, sex and occupational differences In 
work patterns, substitution for the labour of the sick person by 
other household members;
- virtually all studies assume that the value of the lost output Is 
equivalent to some measure of the average wage, ignoring issues 
such as whether the wage reflects productivity, whether an average 
measure Is appropriate when sizeable increments of labour may 
result from control programmes and in labour surplus economies, 
and the variations of productivity by sex and occupation.
Indirect benefits discussed so far are those relating to the labour 
supply of Individuals. The relationship between malaria and economic 
development is much broader than that stemming from the effects of 
malaria on individuals. Some of these broader effects can be taken into 
account within the micro-analytical framework of cost-benefit and cost- 
effectiveness analysis. For example if malaria control permits
migration to land previously unoccupied because of malaria and which is 
more fertile than land presently occupied, then estimates can be made of 
the increased marginal product of labour resulting from migration. More 
often, however, the effects of malaria control are likely to be so far- 
reaching that the partial equilibrium framework of cost-benefit analysis 
is inappropriate and a macro-framework required.
Within the constraints of cost-effectiveness analysis, while it is 
possible to take account of Indirect benefits affecting individuals, it 
is impossible to take account of the interaction of the variety of 
other economic variables that will affect overall national income. 
Nonetheless, it is important for a cost-effectiveness analysis to 
acknowledge these broader interactions even if they cannot be neatly 
quantified. Annex 1 therefore summarises the likely relationship 
between malaria, malaria control and economic development, reviewing 
both theoretical Issues and empirical evidence.
Comparison of costs and consequences: studies permit a number of
comparisons to be made of the annual cost per person protected of single
88
or combined control measures, but very few produce ratios of cost per 
case or death prevented. The US studies of vector control alternatives 
usually present estimates of cost per acre or per unit reduction in 
vector populations rather than per person. Only Kaewsonthi and Harding 
(1984) employ sensitivity analysis and no study attempts incremental 
analysis. A resource allocation model to help identify most effective 
intervention strategies has been proposed (Parker 1983) but not tested 
with real data.
Findings
Table 2.6 summarises the results of those studies that have produced 
cost-effectiveness ratios expressed in the form annual cost per person 
protected, cost per case prevented, or cost per death averted, in US $ 
of 1984. These results should be treated with some caution because the 
source documents often provide Inadequate information for Judging the 
quality of the cost and effectiveness estimates. In particular, cost 
estimates are liable to be Incomplete, for instance omitting capital 
costs, administrative overheads and private costs. In addition some 
estimates come from particular small-scale trials (eg Gandahusada et al 
1984, who compare full and selective coverage of residual fenitrothion 
spraying) and some from national malaria control programmes using a 
combination of strategies (eg Kaewsonthi and Harding 1984, who analyse 
data for Thailand). A final reason for cautious interpretation relates 
to the malaria situation at the time of the study. Some estimates are 
based on the cost of a research programme assessing the feasibility of 
establishing control in a previously uncontrolled situation (eg 
Molineaux and Gramiccla for the Garkl area in Nigeria), some on the 
costs of maintaining control in areas where control has been established 
for some time (eg Kaewsonthi and Harding for Thailand) and some on the 
costs of the entire control programme over a considerable period of 
time, including both the attack and maintenance phases (eg Cohn for 
India and Barlow for Sri Lanka) .
Griffith (1961) concludes from his review of national programme costs 
that these range from $0.01 to $0.48 ($0.03 to $1.56 in $ 1984). It is 
interesting to note that these are not very different from more recent 
estimates for national programmes using combined strategies (eg 
Thailand). As might be expected, however, recent vector control costs,
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Tabla 2.6: Coat-affactlvenosa ratios of malaria control projacta
Country Control
aethod
Annual cost 
per person 
protected
Cost per case 
prevented
(a)
Cost per 
death
averted
Reference
IDCs Drugs 0.07(b)
Iruce-Chaatt (1017)
UC* Drugi 0.07(b) Je ffre y  (1084)
Tai mm Surveillance 0.10 t r i f f i t h  (1041)
Thailand Drug*, vector 
control
0.14 Kaessonthi and 
Harding (1084)
India Surveillance 0.10 G r if f i th  (1041)
Thailand Surveillance 0.20 G r if f i th  (1041)
Thailand 0.20 G r if f i th  (1041)
Tai Man Coabined
eethod*
0.24 G r if f i th  (1041)
India
(Kheda)
Environaental
aanageaent
0.27 Sharaa (1084)
India
(national
Spraying and 
surveillance
0.20 G r if f i th  (1041)
prograaae)
Spraying 0.J0 G r if f i th  (1041)
Greece Surveillance 0.41 G r if f i t h  (1041)
lndoneiia Spraying 0.42 G r if f i th  (1041)
Ceylon Spraying and 
surveillance
0.43 G r if f i th  (1041)
Talnan Sprtyifl, 0.43 G r if f i th  (1041)
lndoneiia Spraying and 
surveillance
0.40 G r if f i th  (1041)
Thailand Drugs, vector 
control
0.41 - Kaeusonthi and 
Harding (1084)
India
(Kheda)
Spraying 0.43 Sharaa (1084)
continued
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Table 2.6: Continued
Country Control
aethod
Annual cost 
per person 
protected
Cost per case 
prevented
(a)
Cost per
death
averted
Reference
Taiuan Spraying and 
surveillance
1.29 - • G riff ith  (1961)
LDCs Surveillance, 
vector control
1.47 ’ - Saith (1985)
Indonesia Vector control 1.97 73.00 - Gandahusada 
et al (1984)
Nigeria
(Sokoto)
Spraying 1.43 - - Bruce-Chuatt 6 
Archibald (1959)
LDCs Vector control 2.97 - 892.20 Malsh 6 Barren (1979
Indonesia Vector control 4.83 92.10 -
ct al (1984)
Liberia Drugs, vector 
control
6.64 12.30 - Hedaan et al
(1979)
India Vector control - I .B I - Cohn (1973)
Paraguay Vector control - 53.77 - O rti: (1968)
Nigeria
(6arki)
Drugs, vector 
control
- 233.19 * Nolineaux and 
6raaiccia (1980)
S ri Lanka Vector control 69.93 Barlou (1968)
Sourcts Barlo* and brobir (1983); references cited in table.
U ) Annuel cost« divided by annual nuaber of c a m  (deaths) prevented, or total cost 
during project l i f e  divided by nuaber of case-years (deaths) prevented during 
pro ject l i f e .
(b) Drug costs only
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The range of Influences on the ratio 'cost per case prevented' makes It 
difficult to draw conclusions from the figures In Table 2.6. The higher 
the Initial Incidence, the greater will be the potential reduction In 
Incidence on application of a control measure. This helps to account, 
for Instance, for the very low cost per case prevented In India and per 
death prevented In Sri Lanka. Other Influences will be the 
characteristics of the vector and environment as expressed In the basic 
case reproduction rate (helping to account for the high cost In the 
Garkl project, Nigeria where control measures had to be applied 
Intensively to be effective) and population density (helping to account 
for the relatively cheap control In the Liberian project where a mining 
town was the location of control efforts).
The results of cost-effectiveness studies of vector control through 
environmental management were reviewed by the meeting of the Panel of 
Experts on Environmental Management for Vector Control (PEEM 1986). 
Conclusions were difficult to draw because of the lack of consistency 
of the expressions of cost and effectiveness. However It appeared that 
environmental management has been proved to be cost-effective for vector 
control In many circumstances In the US. Whether this conclusion 
applies widely elsewhere Is uncertain: In the US, objectives of level 
of control are as much Influenced by mosquitos as pests than as disease 
vectors; environmental management has other virtues besides vector 
control, notably Its value for recreational purposes and environmental 
safety; and studies Indicate Its value Is site - specif1c, depending on 
the vector, nature of the environment and size and location of breeding 
sites, and on the degree of malarial endemlclty.
2.5 ConclusIons
What conclusions can be drawn from the review In this chapter that are 
relevant to the design of a study on the coat-effectiveness of malaria 
control? In terms of topic, there Is great need for a study of routine 
control operations, to Investigate the costs and effectiveness of 
alternative control measures and alternative ways of delivering them.
expressed per capita of the population protected, are considerably
higher than their 1960s counterparts, reflecting both the Increased cost
of Insecticides and a switch to more expensive Insecticides.
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The value of malaria control per se la an Important question but given 
the difficulty of answering It (even If reasonable estimates could be 
produced for malaria control, there Is a lack of similar studies on 
other health programmes to which malaria control could be compared), It 
should probably remain a subsidiary question.
Such a study of routine malaria control operations needs to be tied 
closely to the Issues and choices facing policy-makers. Only one study 
of malaria control so far, that by Kaewsonthl and Harding (1984), has 
attempted this. It also needs to evaluate not only existing strategies 
but also the costs and consequences of Incremental changes to them, 
since Incremental change Is the reality of decision-making.
In terms of methodology, there is now a well developed approach to cost- 
effectiveness analysis of health programmes in the developed country 
literature which has yet to be fully applied in the developing country 
context. Similarly, the practices of economic evaluation In other 
sectors In developing countries have yet to be fully applied in the 
health sector. In detail, a study should incorporate the following 
methodological features:
- attempt to apply the Drummond and Stoddart (1985) approach to the
assessment of costs and consequences;
analyse the total costa of control measures, accounting for all 
resources used and including consideration of the resources of 
private households;
consider the relevance of the three categories of consequence 
(health effects, direct and Indirect benefits, changes In utility) 
quantifying them where possible and If not possible, developing 
proxy measures;
Include consideration of the extent to which the time costs of 
illness are compensated for by reallocation of tasks within the 
household;
shadow price those costs and consequences expressed in monetary 
terms;
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apply discounting, sensitivity analysis and Incremental analysis 
where relevant.
2.5 Summary
This chapter has reviewed the literature on the cost-effectiveness of 
disease control programmes. It first examined theoretical developments 
In cost-effectiveness analysis and defined the various types of economic 
evaluation. It then considered costs, categorising them as those borne 
by the health sector, by households and by agencies external to the 
health sector. Resources used should be valued using prices which 
reflect social opportunity cost, which may require shadow pricing. The 
differences between the evaluation methodology in developed and 
developing countries were reviewed with comments on the derivation of 
efficiency and social prices In developing country methodology. 
Practical costing problems reviewed Included lack of Information and 
analysis of Joint costs.
Consequences were categorized as changes in physical, social or 
emotional functioning, changes In resource use and changes In quality of 
life. The definition and measurement of the first category, health 
effects, were discussed, including the use of health Indices such as 
'healthy days of life lost' . The indicator 'quality-adjusted life 
years' was briefly discussed, with comments on why It had not yet been 
used In developing country studies. The pros and cons of including 
changes In resource use as a category of consequence were reviewed, 
Including the danger of biasing programme selection In favour of areas 
already well-served with health facilities, and the difficulties of 
measuring and valuing productive time lost In a subsistence economy 
where production is organized within the household.
Finally, the review of methodology commented on the procedure to be used 
In putting costs and consequences together, notably the use of 
discounting, incremental analysis, sensitivity analysis and examination 
of distributional issues. The section ended with a comment on the 
reasons why costs and consequences of a particular programme may vary 
between areas and countries.
The second main section of the review examined the application of cost-
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effectiveness analysis to disease control programmes in developed 
countries. In terms of topics studied, It was concluded that most 
attention had been paid to preventive strategies aimed at individuals 
and delivered via health care facilities; that immunisation and 
screening had been the prime approaches to disease control evaluated and 
that those diseases of greatest current interest to evaluators were non- 
communicable, chronic conditions. In terms of methods used, cost- 
effectiveness analysis was increasingly popular but few studies took a 
societal perspective; few studies considered or used shadow pricing; 
health indices and the 'quality-adjusted life year* were increasingly 
popular as indicators of health consequence; and many studies placed 
particular emphasis on the consequence "health service costs averted". 
In terms of findings, there was good evidence that the traditional 
vaccines were well worth while, though the use of the newer, more 
expensive vaccines might only be clearly Justified in high risk groups. 
Some screening programmes produced net savings; for others, the balance 
of benefits and costs depended on the selection of the target group. 
Ranking of programmes in terms of cost per quality adjusted life year 
indicated that some well-established programmes were relatively 
expensive compared to newer programmes yet to achieve widespread 
acceptance. The section concluded with a comment on the influence of 
economic evaluation studies on policy-makers.
The third main section of the review examined the application of cost- 
effectiveness analysis to disease control programmes in developing 
countries. From a review of the topics evaluated, it was concluded that 
the majority of studies were concerned with evaluating new policies or 
strategies rather than routine activities; that they responded to 
international health policy fashions rather than to national needs; and 
that the range of diseases evaluated was extremely limited. In terms of 
methodology, virtually no cost-effectiveness study had included 
consideration of direct or indirect benefits; few compared alternative 
strategies other than an implicit 'do nothing'; few took a social 
perspective; costs were frequently incomplete and shadow pricing rarely 
used; assessment of health effects was often inadequate, with most 
studies using indicators of intermediate output; and neither 
discounting, sensitivity analysis or incremental analysis had been 
consistently employed. In terms of findings, it was concluded from a 
review of parasitic diseases control projects that there were large
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differences In cost-effectiveness between different control measures and 
that the cost-effectiveness of similar techniques In different locations 
could vary enormously. Similar variations had been found In other 
programmes, for example oral rehydratlon therapy. Comparisons of cost 
per death prevented by different programmes suggested that primary 
health care Interventions represented good value for money, but 
Information was too scanty to draw conclusions on the cost-effectiveness 
of parasitic disease control programmes.
The final section of the review examined the application of cost- 
effectiveness analysis to malaria control programmes. In terms of 
topics, it was concluded that no study had compared the value of malaria 
control with the value of other heal t h  programmes In preventing 
morbidity and mortality, and that virtually no study had adequately 
explored the Innumerable choices concerning the strategies and 
organisation of malaria control. In terms of methods, no study had 
attempted a full cost-effectiveness analysis; only one had examined 
costs carefully; Indicators of health effects were frequently 
unsatisfactory; and no cost-effectiveness study had included 
consideration of direct and Indirect benefits.
Since cost-benefit analyses of malaria control had assessed direct and 
indirect benefits, those studies were reviewed. It was concluded that 
indirect benefits were rarely completely specified or explored; that the 
empirical basis for estimates was extremely weak; and that virtually all 
studies assumed that the value of the lost output was equivalent to some 
measure of the average wage, ignoring Issues such as whether the wage 
reflected productivity and whether an average measure was appropriate 
when sizeable increments of labour might result from control programmes 
in labour surplus economies. A br i e f  comment was made on the 
relationship between malaria, malaria control and economic development, 
and further discussion included in Annex 1.
The findings of all studies that produced a cost per capita, per case 
prevented or per death prevented were presented and reasons for the 
variations discussed.
The review in this chapter was used to draw conclusions relevant to the 
design of a study on the cost-effectiveness of malaria control. In
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particular, it was concluded that a study should focus on routine 
operations and alternative strategies; should attempt to answer 
questions of relevance to policy-makers; should undertake a complete 
cost analysis; should Include consideration of the extent to which time 
costs were reduced by reallocation of tasks within the household; and 
should use shadow pricing, discounting, sensitivity analysis and 
Incremental analysis where relevant.
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3. THE EPIDEMIOLOGY OF MALARIA AND MALARIA CONTROL POLICIES AND 
STRATEGIES
3.1 The characteristics of sialarla
From th® point of view of an economic evaluation, malaria has a number 
of Important characteristics. Malaria Is the result of Infection with 
parasitic protozoa of the genus Plasmodium transmitted by female 
mosquitos of the genus Anopheles. Infections In man are caused by four 
species of the parasite: f .falclpfliua. P .VlVRX. P.malarias and
P . ovale. The life cycle of all species of human malaria parasites is 
essentially the same, comprising an exogenous sexual phase with 
multiplication In certain Anopheles mosquitos and an endogenous asexual 
phase with multiplication in the human host.
The clinical course of malaria consists of bouts of fever accompanied by 
other symptoms such as headache, nausea and vomiting and alternating 
with periods that are symptom-free. Other consequences of infection 
include anaemia, splenomegaly and complications resulting from 
involvement of the brain, liver and kidney. The clinical severity of 
malaria varies considerably depending on the species and strain of the 
parasite and the immune status of the human host. The severest form is 
due to P. falciparum which is associated with a high fatality rate in 
non-immunes. Malaria due to P . vlvax and P . ovale is less severe and 
rarely fatal. However vlvax malaria, if untreated, can often result in 
relapses, causing anaemia and debility. P ,malaria produces the least
severe form of infection.
Only certain species of anopheline mosquito are important vectors of 
malaria under natural conditions. The inherent susceptibility of 
Anopheles to infection with human plasmodia varies somewhat in relation 
to the species and strain of malaria parasite. In addition, numerous 
external factors such as temperature and humidity Influence the 
development of the mosquito and malaria parasite within it. The various 
species of Anophellnes have well defined behaviour characteristics, 
including favoured breeding places, feeding habits (source of blood, 
time of feeding) and resting habits.
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Natural transmission of malaria infection occurs through exposure to the 
bites of infective female Anophellne mosquitos. It depends on the 
presence of and relationship between the vertebrate host (man), agent 
(parasite), vector (mosquito) and the environment. Sex and age are not 
Important Influences on infection in themselves except that the 
dangerous first infections are more likely to be in the young and sex 
and age may be related to behavioural practices that affect the risk of 
infection. Certain genetic characteristics appear to affect human 
response to infection (for example sickle cell trait). In addition, 
populations exposed continually to intense malaria in highly endemic 
areas develop a degree of immunity to infection.
In any geographical area, there are usually only a few anopheline 
species that are Important vectors. Conditions that determine 
Importance Include vector density, feeding habits, and length of life, 
which varies according to temperature and humidity. In particular, 
development of plasmodla in Anopheles does not occur below a certain 
minimum temperature. Temperature, however, is only one environmental 
Influence on transmission. Humidity affects mosquito survival and 
rainfall influences breeding places (both creating and destroying them). 
Sanitation, housing and occupation can affect vector/man contact. 
Migration can transfer malaria from one location to another.
Malaria is described as epidemic when there are periodic or occasional 
sharp Increases in the amount of malaria in a given Indigenous community 
and endemic when there is a constant incidence of cases over a number of 
successive years. Endemic areas can be classified as hypoendemic. where 
there is little transmission, mesoendemlc, with varying intensity of 
transmission depending on local circumstances, hyperendemic, where 
transmission is Intense but seasonal, and holoendemlc where there is an 
even higher perennial transmission resulting in a considerable degree of 
immune response in all age groups, particularly adults. The levels of 
endemlcity are formally described by the prevalence of parasites in 
children aged 5 - 9  years.
3.2 Malaria control policies and strategies
Russell (1952) classified the measures for prevention of malaria in
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Individuals and for larger scale control of the disease as follows:
measures to prevent mosquitos from feeding on man;
• measures to prevent or reduce the breeding of mosquitos by
eliminating collections of water or altering the environment;
- measures to destroy the larvae of mosquitos;
- measures to destroy adult mosquitos;
- measures to eliminate malaria parasites in the human host.
In general, the relevance of these methods depends on the various 
epidemiological types of malaria and the specific locations in which 
they are to be applied. In addition, combinations of measures, rather 
than a single measure alone, are often necessary for control.
Protection against bites
Measures that protect against the bites of mosquitos include bed-nets 
(which may be impregnated with insecticide); protective clothing; 
repellents applied to the skin, clothing or bed-nets or released into 
the air; screening of houses; and siting of houses.
Reduction and elimination of breeding sites
These measures can be permanent or temporary. Permanent measures 
Include filling waterlogged areas, drainage and the construction of deep 
ponds to retain water. Temporary measures Include water management, for 
Instance keeping the shore-line of reservoirs clear of vegetation and 
varying the water level to destroy larvae, sluicing and flushing streams 
using sluice gates in dams, intermittent drying of irrigated fields, 
ponds and water containers, and clearing vegetation round and in 
breeding places where vector species dislike breeding places exposed to 
sunlight, or growing trees if they dislike shade.
Anti-larval measures
Some of the above measures will destroy mosquito larvae (eg flushing). 
In addition there are measures which act directly on the larvae. These 
Include petroleum oils which are applied to the surface of water and 
kill larvae by suffocation or poisoning and other larvicides such as
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Paris green which are poisonous to larvae. Larvivorous fish have also 
been used where conditions are favourable.
Control of adult mosquitos
Residual insecticides are the most commonly used means to control adult 
mosquitos. They are sprayed on the preferred resting places of 
mosquitos, normally the inside walls of houses. The most commonly used 
insecticides are DDT, malathion and fenitrothion. They may be 
formulated in various ways, including solutions, emulsions, water- 
dispersible powders, and granules. An alternative or complement to 
residual spraying is space spraying of fast-acting compounds.
Genetic control, which reduces the reproductive potential of insects, 
has been explored but is still primarily the subject of research rather 
than practical application.
Chemotherapy and chemoprophylaxis
Drugs may be used to prevent transmission or to prevent parasites 
growing once they are inoculated. They may be used by individuals to 
protect themselves or as part of a community-wide control programme. 
While mass chemoprophylaxis has been tried (eg mass distribution of 
chloroquine to school children), the most widespread use of drugs is to 
treat diagnosed cases and thus prevent further transmission. 
Chemotherapy then forms part of a system of case detection and 
treatment, often involving an active search for Infected people, 
presumptive treatment of suspected cases, and radical treatment of 
confirmed cases. An alternative or complement to this process is mass 
drug administration.
3.3 The history of malaria and malaria control In Nepal
The history of malaria and malaria control in Nepal can be divided into 
three periods, the first up to the late 1950s before the introduction of 
residual spraying, the second between the late 1950s and early 1970s 
when eradication was attempted and the third, from the early 1970s to 
the present, when the aim was control.
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Period I
During the first period, the country could be divided Into the following 
areas on the basis of their malaria characteristics (see Map 3.1):
- the southern edge of the outer Terai which was flat, cultivated 
and with relatively limited malaria, though it was liable to more 
severe outbreaks from time to time. A.culcifacies was the 
suspected vector, and A.annularis later implicated. This area was 
classified as hypoendemlc.
- the northern forested edge of the Outer Teral, the lower forested 
slopes of the Churia and Slwalik hills (below 2000 feet), the 
Inner Teral and lower forested slopes of the Mahabarat range. 
This area was Intensely malarious, the main vector being 
A.minimus . It was classified as hyperendemic.
the area north of the Mahabarat range. In the cultivated valleys 
between 2000 and 4000 feet, there was some transmission of malaria 
at a low level, mainly by A.fluvlatllls. These areas were 
classified as hypoendemic.
- parts of the country above 4000 feet where there was little or no 
transmission of malaria. A.maculatus was later found to be a 
possible vector here.
Since malaria was known to be prevalent and eradication was initially 
the objective, there was probably seen to be little point in obtaining 
accurate and representative parasite rates for the pre-control
situation. It is therefore not surprising that the only country-wide
Information located was as shown below. No population base was available 
for these rates, and incidence could therefore not be calculated. In
the hyperendemic areas P. falciparum was found to be the most common
parasite and in hypoendemic areas, P .vlvax.
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Paraalt« rataa pre-spray
Area (Year 
of survey)
Hyperendemic areas(a) 
IPR (%)(b) CPR(%)(c)
Hypoendemic 
IPR (%)
areas(a)
CPR(%)
North central 
(1959)
29.0-34.6 23.2-40.0 0.0-0.8 0.7-2.2
South central 
(1959)
9.4-34.4 21.8-50.7 0.5-1.1 0.5-1.1
East zone 
(1962-4)
20.5-41.6 20.9-50.1 0.2-3.9 0.2-4.3
West zone
(1963-5)
11.0-85.1 11.7-70.4 0.0-4.6 1.3-7.8
(a) Classified on the basis of spleen rates
(b) Infant parasite rate
(c) Child parasite rate 
Source: NMEO 1970
An earlier survey done In the Raptl Valley (Central Inner Teral) 
during 1956-7 found that the Infant parasite rate was 63%, child 
parasite rate 57-77%, and child spleen rate 92%. Transmission was 
perennial, with a peak in the second quarter of the year (NMEO 1966). 
Supplementary information on this area is provided by a much earlier 
survey done in Makwanpur and Chltwan by Major Phillips of the Indian 
Military Services (Phillips 1925). The people in the area were made 
up of different tribal groups: Tharus, an indigenous race, Ral 
Dhanwars, of hill origin but who had been settled in the area for some 
time, and Kumalaya, who were recent migrants. Phillips found 
differing levels of morbidity and mortality amongst these groups, the 
Tharus being the least susceptible to malaria and the Kumalaya the 
most.
A survey of 436 Tharu children showed that 85% had enlarged spleens. 
Phillips commented that these disappeared with adolescence. Amongst 
the Ral Dhanwar, former migrants, 65% of 105 children had enlarged 
spleens, but spleens were not palpable in the majority of children 
after the age of 12 years. The recent migrants from the Hills seemed 
to be most susceptible to malaria, suffering both child and adult 
deaths. For example Phillips estimated a general mortality rate in 
children of around 43% in migrants and 17% in Tharus. One group of 
settlers he described as 'doomed to extinction'.
This information suggests that in this particular part of the Inner
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Terai, malaria may have had the characteristics of holoendemlclty: 
high spleen rates In children but low In adults for the Indigenous 
population.
Unfortunately this Is the only evidence that could be located on the 
morbidity and mortality caused by malaria before control began. It is 
not known to what extent it is representative of the Inner Terai as a 
whole, nor is there similar information available for hypoendemic 
areas. In the hyperendemlc areas, it is likely that immunity in 
adults gave some considerable degree of protection to indigenous 
farmers, though at the expense of infant and child mortality. New 
settlers, both adults and children, seem to have been at high risk of 
Illness and death. In hypoendemic areas, the relatively low infant 
and child parasite rates and predominant species (P.vivax) suggest 
that malaria prevalence in adults was relatively low and symptoms 
milder. Repeated relapses may have caused severe debility in a small 
proportion of the population. Occasional epidemics, causing morbidity 
and mortality, are likely to have occurred.
Period II
The second period started when it was shown that residual spraying of 
DDT inside houses stopped the transmission of malaria in a pilot 
project in the Raptl Valley in 1956-8. Similar success was obtained 
by pilot projects in other parts of Nepal. This suggested that 
malaria eradication was feasible and a nationwide campaign was 
started, with cooperation from USAID and WHO, based on DDT spraying 
followed by surveillance. Spray coverage was achieved in 1960-62 in 
the Central and West zones, in 1964 in the East, and 1965-6 in the Far 
West.
The campaign had rapid results. Transmission in the A.IPinlniVg area 
fell to a very low level. The combination of DDT spraying and 
clearing of the forest by settlers which destroyed breeding places 
resulted in the virtual elimination of A.minimus (none have been found 
in recent years). In other areas malaria transmission was much 
reduced but not completely interrupted. In the cultivated areas of 
the Terai an unexpected vector A.annularis was identified. It is now
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reslstanC to DDT; malathlon may reduce transmission but does not stop 
it. Over a wide area. Including the A.minimus area, scattered 
transmission continued at a low level due to A. fluvlatllls. which was 
susceptible but not completely controlled by DDT due to its exophilic 
habits.
Data on annual parasite incidence was only collected once surveillance 
systems had been set up. The earliest data for the whole country is 
for 1968. By then only a few thousand cases were being detected and 
this level was maintained for several years. However, there seemed 
little prospect of a complete interruption of transmission and in the 
early 1970s USAID support was withdrawn as part of a global policy 
since malaria eradication no longer appeared feasible. The objectives 
of the programme were changed, with control becoming the immediate 
objective. Programme activities were withdrawn from hills in the West 
where there was little malaria and because of operational difficulties 
and staff shortages.
Period III
The reduction in funding for the programme, together with large scale 
movements of population, often settling in temporary houses which were 
difficult to spray (Shrestha undated), contributed to an increase in 
cases to nearly 15,000 in 1974. Further contributory factors were 
problems encountered by malaria control in India, leading to a 
considerable number of imported cases. Extra funds and insecticide 
were obtained for the Nepal programme and the increase in cases was 
contained, the level remaining at around 12,000 until the early 1980s 
when it rose slightly, and markedly in 1984 and 1985 to around 42,000 
cases in 1985. The main cause was an epidemic in the Far West. 
Subsequently, the level dropped to around 37,000 cases in 1986 and 
27,000 in 1987. The majority of cases are now concentrated in the 
West and Mid/Far West Terai (HMC/WHO/USAID/ODA 1986).
A combination of malaria control and economic development has produced 
wide ranging changes in the ecology of the Terai, affecting vector 
habitats. A.minimus breeds in partially shaded, slow flowing water 
with marginal vegetation. Its disappearance in the very similar, 
adjacent Nalnital Terai has been attributed to deforestation and
107
cultivation (Chakrabartl and Singh 1957) and it is likely that similar 
influences were at work in the Nepal Teral. In Nepal it has been 
noted that the density of A. fluvlatills is reduced as trees are cut 
and its breeding places (similar to those of A.minimus) exposed to 
sunlight, though recently A .fluviatllis has been recorded breeding in 
clear ponds with vegetation in the plain cultivated Terai (Shrestha 
undated). In contrast, the density of A.annularis appears to have 
increased, possibly because of the expansion of irrigation and perhaps 
because DDT spraying has reduced its natural predators and competitors 
(White 1982).
3.4. Present malaria control strategies in Nepal
The aims, objectives and strategies of malaria control at the time of 
this research were summarized in the Nepal Malaria Eradication 
Organisation (NMEO) Plan of Action (NMEO 1984/5). The objectives were 
as follows:
Immediate : to prevent mortality and further reduce
morbidity due to malaria;
: to maintain the achievements made so far.
Intermediate to reduce malaria incidence to such a low
level that the Primary Health Care System 
would be able to take over the maintenance of 
the achievements in confirmation to the HMG's 
strategies of HFA 2000.
Long Term to control malaria effectively so that it may
not hinder socio-economic development and 
ultimately eradicate it from the country; 
to integrate all anti-malaria field operations 
with the PHC system as soon as the latter 
becomes ready to absorb such activities.
Malaria control operational strategies
Malaria control operational strategies consist of case detection 
through various mechanisms, slide examination, treatment of confirmed 
positive cases, and spraying with residual insecticides. These 
activities are common to both unintegrated districts, where malaria 
control is carried out by the National Malaria Eradication 
Organization (NMEO) and integrated districts, where malaria control is 
one of a number of services provided by the Integrated Community
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Health Services Development Project (ICHSDP). The activities of each 
strategy are described briefly below. They represent the approaches 
In general use at the time of the study (1983-5): experiments were and 
are being made with alternative approaches and these are described in 
Chapter 9.
(a) Case detection
Active Case Detection (ACD). At the time of this study, throughout the 
whole malarious area of Nepal with the exception of the hill districts 
of the mid-western and western regions where anti-malaria operations 
were withdrawn in 1971 due to their high cost, house to house visits 
took place monthly to collect blood smears from all people with a 
present or past history of fever and from those who had recently 
returned from areas In India where malaria prevalence was high. In the 
NMEO districts, house to house visits are carried out by malaria field 
workers (MFW) supervised by unit office staff. In the ICHSDP 
districts, village health workers (VHW) do the house-visiting, 
supervised by health post staff.
Activated Passive Case Detection (APCD). Cases detected by MFWs and 
VHWs outside their normal schedule of visits are termed APCD.
Passive Case Detection (PCD). There are four PCD mechanisms:
PCD (H): All health institutions (hospitals and health posts)
are encouraged to collect slides which are then sent to a 
malaria laboratory.
PCD (V): In NMEO districts, volunteers have been recruited
and supplied with the means to take blood smears and give 
presumptive treatment.
PCD (M): Cases detected by malaria offices at any level
(unit, district, region, headquarters), are termed PCD (M).
PCD (MC): At some main hospitals, malaria clinics have been
set up to receive any attender to the hospital complaining of
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fever. Blood slides are taken and examined on the spot, and 
radical treatment provided Immediately to positive cases.
Mass Blood Survey (MBS): Case detection through MBS takes two 
forms. In contact surveys, a number of blood slides are 
collected from the immediate family and close neighbours of a 
positive case. A mass blood survey Is conducted If a sudden 
outbreak of malaria occurs or If active malaria transmission Is 
suspected.
Follow-up: Slides are taken monthly for 12 months f rom all 
diagnosed cases, to screen for relapses.
(b) Parasitology
All slides are examined In malarla-speclflc laboratories, usually at 
district level, the exceptions being the malaria clinics which have 
their own microscopists and some temporary laboratories that are 
•■tabllshed In unit offices during the peak of the transmission 
season. Positive slides are notified to unit offIcee/health posts.
(c) Treatment
Presumptive treatment Is given to all people from whom blood slides 
are collected except those attending malaria clinics. Presumptive 
treatment consists of 600mg chloroquine for adults and appropriate 
dosages for younger age groups.
Radical treatment is given to confirmed cases. P.vlvax and Indigenous 
P. falciparum cases receive 1500 mg chloroquine (900 mg If presumptive 
treatment was given within the previous 7 days) , and 75 mg primaquine 
(adult dose) on 5 consecutive days. The only exception Is radical 
treatment for cases detected at malaria clinics where a two day 
treatment Is given of 1200 mg chloroquine and 60 mg primaquine. 
P. ffllçiparua cases that are classified as Imported A (la Imported from 
India) receive 1000 mg sulphadoxine, 50 mg pyrimethamine and 45 mg
primaquine (adult dose) in a single dose.
110
Mass drug administration is occasionally done, consisting of 600 mg 
chloroquine and 45 ng primaquine (adult dose).
(d) Spraying with residual insecticides
In general, spraying is considered to be required whenever the 
village-level Annual Parasite Index (API) minus Imported A cases 
exceeds 0.5 in the Terai and 1.0 in Hill areas. Focal spraying should 
be carried out during the transmission season in un-sprayed villages 
where two or more indigenous cases are detected. Due to financial and 
supply constraints, these rules have often not b e e n  followed 
precisely.
Malathion, at a dosage of 2 gm of active ingredient (a.l.) per sq 
metre, is the insecticide of choice in the outer Terai where 
A.annwlgrls is considered the main vector, since this vector has been 
shown to be resistant to DDT.
DDT, when available, is used in the moderate receptive areas of the 
forest and forest fringe in the Terai, Inner Terai and hill valleys 
where A. fIvvlfltlll» and A.maculatus are the vectors, and in some areas 
of the outer Terai where A.annularis has not yet been implicated as a
vector.
Spraying practices are modified in the light of the quantity and type 
of insecticide available at any particular time. In 1984, two rounds 
of malathion were sprayed but only one round of D D T  (1.5 gm 
a.i./sq m.) due to shortage of DDT. In 1985, Fleam took the place of 
DDT in the East, Central and West Regions.
Support programmes
The above operational strategies are backed up by support programmes 
for health education, entomology, training and research.
Health education. The aim of the health education programme is to 
inform communities of the objectives, methods and benefits of malaria 
control. The programme also supports the activities of the 
volunteers.
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Entomology. The entomology programme Investigates the ecology, 
density and behaviour of vectors In different ecological strata In 
order to provide guidance to control operations.
Training. The Research and Training Centre, Hetauda organizes basic 
and refresher courses for malaria control staff. In addition, regular 
seminars and workshops on specific topics are held.
Research. A number of field research projects are under way, 
supervised and carried out by staff from the Research and Training 
Section of the NHEO headquarters (NHQ) and from the Research and 
Training Centre, Hetauda.
Organizational structure
In 1984, the NMEO conducted malaria control activities In 26 districts 
(made up of 40 political districts), containing 6.2m people. The 
districts are divided into four Regions: the East, Central, Vest and 
Mid-West (including the Far-West). Within each district, unit 
officers are responsible for the malaria control activities within the 
unit boundary (approximately 50,000 population). Each unit Is divided 
Into localities (approximately 8000 population) each containing one 
malaria field worker. The organizational structure of the NMEO is 
shown In Figure 3.1.
For some time, Integration of malaria control activities with other 
Ministry of Health activities has been a policy objective of the 
Ministry of Health. In 1974, 6 districts were integrated and In 1983, 
a further 8 districts. Malaria control in these 14 districts, 
population approximately 3m, is now the responsibility of the ICHSDP. 
At district level, malaria control is the responsibility of the 
district health officer, assisted by a malaria assistant. Health 
posts carry out malaria control activities within their area. Each 
health post area is divided into a number of veks, with one village 
health worker per vek. Very recently (1988), integration has been 
pursued on a much larger scale.
Unit officers and health post staff carry out case detection and
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treatment activities, sending slides to the laboratories in the 
district malaria offices and district health offices. When spraying 
is required, temporary staff are recruited to work as sprayers, but 
the staff for direct supervision are drawn from the health posts and 
unit offices, and the training is done by these staff at their place 
of work. District and regional officers also supervise spraying 
activities. Figure 3.2 shows the operational activities carried out 
by the field units and staff of the NMEO and ICHSDP.
3.5 Economic characteristics of the Nepalese programme 
The cost of malaria control
Malaria control has traditionally represented about 20-25% of Ministry 
of Health recurrent expenditure (WHO 1982). It is thus a major 
consumer of health sector resources. Table 3.1 shows the annual cost 
of the malaria programme from its inception in the mid 1950s to 
1985/6, including funds from both internal and external sources. 
External sources have funded and continue to fund insecticides, drugs, 
equipment and vehicles, while the government finances local costs 
(mainly salaries). Between 1955 and 1985, around 56% of costs have 
been locally financed, and the rest externally financed. This balance 
is heavily dependent on the usage of insecticide, which takes up the 
great majority of external assistance.
Table 3.1 suggests that the total annual cost of control in 1980 
prices has varied surprisingly little between 1965/6, when total 
coverage was achieved, and the present. Expenditure declined to a low 
point in the early 1970s but had to be rapidly increased to keep a 
resurgence of malaria in check. A similar pattern can be seen in the 
early to mid 1980s though it is slightly distorted by the two-yearly 
consignments of USAID commodities. Given the current mix of malaria 
control strategies, an annual cost (1980 prices) of Rs 40m-50m seems 
to be the consequence.
In order to investigate further the economic characteristics of the 
control programme, a summary is presented here of 1984 costs by budget 
code and programme (taken from Mills 1987). While information is
114
Figure 3.2: 
Operational 
activities 
carried 
out 
by 
field 
units 
and
T a b i «  3.1; Expandltur« on «alarla control 1955 to 1985
Taar IK  USAI! (BAIO 
Bipeaditare P im e la !  i id  Ceaaoditie i
n o
t ip e a d i tv a  1
O tta
b  penditi™
(*)
ICI3DP
( I )
Tetal CDP 
l ip e id i te re  Defleter
( 0
Ceit IN O 
y r ìc e i
1955-8 100,000 1.947.200 i / o 2.055.200 23.0 0,935,452
1*51/9 «.310 124,929 120.412 37,210 l/A 334.061 21.0 1.455.917
1959/60 3*4.453 1.093,359 1,106,130 320,525 i / o 2.004,467 24.0 12,010,614
1960/1 3*7.703 1.193.110 1.207.047 344.767 •/A 3.147,627 25.2 12.4U.301
1961/2 377. m 1.732,194 1.752.42* 507.003 •/A 4.5*4.023 25.5 17,920.074
1962/3 •20.114 2.404,441 2,515,4*5 720.916 «/A 6.334.656 26.4 24,105.137
1943/4 1.132.49* 3.397,47* 3.417,156 995,9*9 l/A 0,961.105 20.7 31.210.110
1964/5 1.602,474 4.007.422 4,063,577 1.409,325 i / o 12.U2.79* 10.4 41,447,054
1965/6 2.506.¡54 6,034,340 6,104,147 2.274,441 •/A 16,949,002 31.3 51.030.456
19*6/7 4.573.494 6.007.59* 6.150,707 4,022,420 l/A 20,042,410 10.4 54,277.131
1967/1 5.4*9,43* 6.905,117 6,905,775 1.603.212 l/A 20.901,741 30.2 57.9U.114
1966/9 5.451.001 6.6*1.111 6.741,147 1.541.424 l/A 20,447,390 U .2 50.064.154
1969/70 *.*41.605 6.441,405 3.040,000 1.001.252 l/A 17.004.422 42.9 41.502.614
1970/1 *.*•6 .130 6.406.110 1,908,296 1.070.071 l/A 16.471,443 45.4 36.121.226
1971/2 *.199.352 6.119,274 2.902.449 1.430.024 l/A 15,431,901 47.1 12.623.501
1972/3 5.9*1.252 4.703.000 2.100,000 1.746,706 196.141 14.927,079 33.3 20.007.277
1973/4 12.323.317 3.576.704 2.197.124 407,159 10.504,304 31.4 36,000,592
1974/5 20.210.126 349.9*0 4,435,200 417.745 23.413,051 42.2 40.05*.994
1975/6 54.040.141 2,546,250 1.509,907 30.1*4.124 79.7 73,004.174
1976/7 37.923,750 11.375,000 2.4*4.375 1,671.637 53.450,702 U . l U , 740,033
1*77/1 27.075.044 20,000.000 1.624,000 2.472,000 1.717,172 52.000.216 77.1 U , 419,424
1971/9 27.739.401 20,000,000 2.000.000 1,743,984 1.761.019 51.245,20* •4.5 63,012.075
1979/00 20.905,400 20.000,000 2.000.000 1.007.426 52,713,106 92.4 5*.741.772
1910/1 23.771.2*1 31.500.000 2.030.000 1.054,624 41.164.705 1U.0 61.1U.703
1901/2 23.627.904 19.124,440 1,990,442 1,902,045 44,045,631 1*7.4 43.415.704
19*2/3 35.203,734 773,720 11,007.11* 1,952.318 49,010.909 110.0 41,541,441
1913/4 30.111.7*4 25.631,650 1.900.230 5,223.079 62.006,745 132.3 47.U1.694
1904/5 40.500.000 3.752.000 2.5*7.512 5,350.879 52.199,271 139.1 37.526.415
1905/6 *0.500.000 23.761.500 2.941,900 22.530.750 5.490,210 9 5 .2 U .3 U 147.7 64.U2.102
Tata 1 l> 440.71I.J4* 67.774,116 229.250,644 56.519.029 31,184,934 31,561,002 *65.014.145 1.191.910.7M
li«« 99.494.229
• /* ■ * •  t  « W lfo k le
(<) I  «elodee UlDf 1«) ODA e ipca d ita re .
(k ) b t ia e te d  t i  f e t i *  e f per cap ita cast ef l i  1.12 ( t a iw d  frea I t i l i  | « 7  *W  K /A ID / I IO  l i t i ) .  
CO P r ia  S k rc iU i (1974) ( i r  1955-9 « a l I iU r a t t i iM l  I t i t i i t i c i  Tt«rW«k ( i r  reaeiader.
116
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Itupandahl (NMKO, Weat ragtan. Out or Tarai){
1laa (NMKO. Kaat ragtan. Mill);
• Sapear1 (ICNSDP, Baat ragtan. (Matar Tarai);
• Paraa (ICMSDP, Control ragtan. (Matar Tarat)
Tha ahora af raglanal and nottanaI eaata that can ba at tributad ta 
thaaa dietrteta woo aatlaatad according ta tha aothod do acribad In 
Anna« 2.
Dlatrlbutton of «oato by budget coda
Tabla 2.2 ahowo tha dlatrlbutlan af eaata by budgot coda In 1%S4 far 
all ft vo dlatr teta, two NMKO ragiona. and NMKO haodquartare Perhapa
tha aoat atrIking factura of Tabla 2.2 La tha oaoll ahora of capital 
In total coata. In tha 5 dlotrlcto. tha ranga la from laaa than 1% to 
around 4%. Rant, although ahown aa a recurrent ltea, ahould b# added 
to thla aa ropraaontlng tha value of tha aervleea of building« Even 
ao. tha ahara of capital la laaa than 4t except In Saptarl vhara rant 
alone takea up St. Tha flguree reflect tha abaance of capital lteaa 
at dlatrlet level, aapeclally vahlclaa. In NNEO dlatrlota, vehlclea 
era kept at Regional loval, and thla la reflected In tha capital ahara 
at tha two ragiona (12-18%, or 22% Including rant). Tha capital ahara 
la alao a relatively low proportion of NHQ coato «van If axtarnal 
aaalatanca la ««ciudad froa total coata.
Within racurrant coata (excluding WHO aupport), virtually all ara 
Incurred by the government axcapt In aprayad dlatrlcta. Labour takaa
up the largaat ahara of racurrant coata axcapt In Paraa whara 
lnaectlclde takaa tha lion*a ahara. Indaad all dlatrlct aharaa ara 
heavily affactad by the amount of apraylng: lnaactlclda takao up 10% 
of total coata In Norang, 36% In Rupandahl and 70% In Paraa. Aftar 
labour coata and lnaactlclda, tha next largaat ahara of racurrant 
coata goea to DA/TA (par dies and travel allowance*). Other Items ara 
very low or lnalgnlfleant, Including druga. Externally donated druga, 
Fanaldar and prlnaqulne, taka up leaa than 0.05%. The low proportion
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Surv- 
ol1 lanca
•
Paraalt*
ology
«
Haalth SprayIng 
•ducatlon
• «
Adaln- Ente- Raaaarch 
stratlonaology and 
training
« « «
Norang «2.3 3.4 11.3 14.« 6.2 0.0 0.0
Rupandah1 39.1 7.0 4.7 43.4 3.8 0.0 0.0
I laa 68.0 3.7 13.3 0.0 10.9 0.0 0.0
Saptarl 78.2 11.1 0.0 0.0 10.7 0.0 0.0
Paraa 10.4 2.1 0.0 86.2 1.4 0.0 0.0
Eaat Ragion 12.3 14.0 4.0 7.8 41.9 20.1 0.0
Waat Ragion 10.9 14.3 4.2 9.3 42.3 19.0 0.0
NMEO NHQ+RTC 4.2 2.4 3.6 2.8 34.2 3.1 29.7
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malaria control In Nopal was than outllnad. From tha aarly 1970'a to 
tha aarly 1980'a, around 12,000 caaaa occurred a year. This figure 
lncraaaed to a peak of 42,000 casaa In 1985 a nd aubaaquantly fall to 
27.000 In 1987.
Preaent malaria control atrataglea In Nepal were described In some 
detail. Casa detection was carried out by active case detection 
(house-to-house visits by aalarla field workers and village health 
workers) and by a variety of passive methods. These Included PCD (H) 
(case detection by health Institutions), PCD (V) (case detection by 
aalarla volunteers), PCD (M) (case detection b y  aalarla offices), and 
PCD (MC) (case detection by malaria clinics) . In all case detection 
strategies except PCD (MC), a blood slide was taken and presumptive 
treatment given. Slides were examined In malaria laboratories and 
positive cases traced and given radical treatment. In malaria clinics, 
the blood slide was examined and radical treatment given Immediately. 
Chloroqulne was used for presumptive treatment; chloroqulne and 
primaquine for radical treatment for P . v l v a x  and indigenous 
P. falciparum: and sulphadoxlne, pyrimethamine and primaquine for 
imported P. falclnanui
Spraying of radical Insecticides was used wherever the API minus 
Imported A exceeded a given level. Malathlon was used where 
A . annularis was considered the main vector, and DDT elsewhere. 
Shortage of insecticide severely limited the amount of spraying.
Operational strategies were backed up by support programmes for health 
education, entomology, training and research.
The Nepal Malaria Eradication Organization (NMEO) was responsible for 
control activities In 26 districts c overing 6.2m people. The 
Integrated Health Services Development Programme (ICHSDP) was 
responsible for malaria control in 14 districts covering 3m people. 
Malaria control strategies used by the two organizations were similar, 
though the NMEO employed single-purpose workers and the ICHSDP mainly 
multi-purpose workers.
The economic characteristics of the malaria control programme were 
briefly described. Malaria control absorbed 20-25% of Ministry of
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Health recurrent expenditure. Capital took up a very small ahare of 
total costs and labour a very large share of recurrent costs except In 
sprayed districts. In unsprayed districts, the administration 
programme absorbed approximately 11« of total costs, parasitology 6- 
11% and surveillance the balance. In sprayed districts, the spraying 
programme was the largest.
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4. A STUDY OF THE COST-EFFECTIVENESS OF MALARIA CONTROL IN NEPAL
4.1 Objectives of the study
As stated earlier, the objectives of this research study ere to:
explore the relevance of recent developments In the methodology of 
cost-effectiveness analysis to disease control programmes in 
developing countries and specifically to malaria control In Nepal;
apply cost-effectiveness analysis to the malaria control programme 
In Nepal in terms both of
(a) the cost-effectiveness of various malaria control strategies 
and
(b) the cost-effectiveness of the malaria control programme as a 
whole
in order to refine a methodology capable of more general 
application to disease control programmes in developing countries;
assess whether policy-relevant conclusions can be drawn from the 
application of cost-effectiveness analysis to the malaria control 
programme in Nepal.
The review in Chapter 2 has identified the current state of cost- 
effectiveness methodology and current good practice. This chapter 
considers how this can be applied to malaria control in Nepal, the data 
requirements and how the data can be and was obtained. In developing an 
appropriate methodology, three major areas must be tackled: the
conceptual framework for the analysis; the methodology of the cost 
analysis; and the approach to the assessment of effectiveness. These 
three areas are considered in turn below, and are followed by a 
description of the methods used to obtain information relevant to the 
cost-effectiveness study from malaria patients.
4.2 Framework for the analysis
The conceptual framework for the analysis, based on ideas presented in 
Drummond and Stoddart (1985), is shown in Figure 4.1. It sets out those
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Figure 4.1: Framework for the cost-effectlvenesa analysis of malaria 
control
Costs
I Costs to the government of malaria control (le costs of the 
NMEO and costs of malaria control borne by the ICHSDP and 
other Ministry of Health services).
II Costs borne b y  patients, their households and community 
members :
-payments for treatment and transport to obtain 
treatment ;
- loss of time for the patient during the Illness prior 
to cure and for relatives who look after the patient 
(time may be diverted from household activities, work 
outside the home and leisure);
- time and money costs of preventive actions taken by 
households and communities.
Cppseqvencgg
I Cases of Illness and death averted (through preventive 
strategies); reduction in length of illness and secondary 
transmission prevented (through curative strategies).
II Savings In resource use:
- savings In government resources that In the absence of 
curative or preventive malaria control strategies 
would be spent on treatment of cases ;
- similar savings in individual or household expenditure 
on treatment and travel;
-savings In lost work time.
III Changes In the quality of life to patients and their 
households and to the whole community as a result of malaria 
control.
Source: adapted from Drummond and Stoddart (1985)
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costs and consequences relevant to a cost-effectiveness analysis of 
malaria control. The costs of malaria control are made up of two main 
categories: those falling on the government and those falling on the 
patient, his/her family and the community. Consequences are of two main 
types. The first is the immediate health effect of prevention or cure 
of malaria, namely cases prevented, illness curtailed and any secondary 
cases prevented through prompt treatment. The second is any savings in 
resource use to the government or individuals and households: for 
instance savings in government and household expenditure on treatment as 
a result of preventive strategies for malaria. The Inclusion of savings 
in lost work time as a category of this type of consequence is 
controversial as discussed earlier, not least because it may bias 
evaluation in favour of individuals or groups that participate in 
economic activity. Moreover, in a country such as Nepal, obtaining a 
value for lost work time is both conceptually and methodologically 
difficult. However, since the surveys described later in this chapter 
throw some light on the magnitude of lost work time and its implications 
for households, this category of consequence is retained.
The third type of consequence listed is change in the quality of life 
for patients, households and the community. This consequence adjusts 
the health consequence by some measure of its value to Individuals. For 
example, 10 days of illness resulting from Infection with P. falciparum 
might not be considered as equivalent to 10 days of illness resulting 
from infection with P .vlvax, because of differences in both the severity 
of the illness and the risk of serious complications. Adjustment to 
health consequences to allow for the severity of the illness or quality 
of life are most commonly made for health programmes which treat chronic 
conditions where the quality of life following treatment is an important 
consideration. In the case of a malaria control programme, where the 
health consequence, cases averted or reduction in days of illness, 
consists of change in an acute Illness of relatively short duration, 
quality of life is a much less important consideration. Two features 
do, however, deserve mention, though they are difficult to quantify. 
Firstly, prompt treatment of P.vlvax malaria prevents relapses and 
consequent anaemia and debility which affects the quality of life. 
Secondly, there may be a reduction in the fear of malaria amongst the 
whole community as a consequence of the malaria control programme. In 
Nepal, it is frequently said that the severely malarious areas of the
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Teral were much feared by Hill dwellers and travellers prior to malaria 
control; thus malaria control has given rise to a community-wide benefit 
affecting not merely the Inhabitants of malarious areas but also those 
who travel through them.
Integral to a cost-effectlveneas analysis Is the comparison of 
alternative ways of achieving an objective. In the case of malaria 
control, this comparison Is particularly complicated, for two main 
reasons. Firstly, malaria control Is usually conducted through a mix of 
strategies some of which are primarily preventive (vector control), some 
curative (various treatment regimes) and some both preventive and 
curative (case detection and treatment). The health consequences are 
thus heterogeneous: both cases prevented and cases cured. Secondly, 
because of the process of malaria transmission, one case cured or 
prevented may prevent also further cases. Thus a dynamic view should 
Ideally be taken of health consequences.
Cost-effectiveness analysis Investigates alternative ways of achieving 
an objective, and objectlvea and choices can be specified at different 
levels. In the case of malaria control, the following different levels 
can be distinguished, Involving objectives and choices of Increasing 
specificity:
(1) the objective of Improving health (choice of malaria control 
versus other means of health Improvement) ;
(2) the objective of malaria control (choice of vector control versus 
case detection and treatment and various mixes of both);
(3) the objectives of (i) vector control and (11) case detection and 
treatment (choice of strategies for each);
(4) the objective of delivering a pre-determined strategy (choice of 
means of blood slide examination, choices of different mixes of 
staff for various activities, choice of organizational pattern 
etc) .
The Importance of these levels Is at the same time conceptual, relevant 
to policy and practical. If decision-makers want to choose between 
Investing a given sum of money in malaria control rather than another 
health programme, then the objective Is at the first level, that of 
Improving health, and the measure of health consequence used must be one
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that is common to many different health programmes, for instance 
increasing years of healthy life.
If decision-makers are more concerned with how to maintain malaria 
control, then the objective is at the second level, and the measure of 
health consequence used must be relevant to comparisons between, for 
example, case detection and treatment on the one hand and vector control 
on the other.
Practical considerations, however, affect the extent to which these two 
types of analysis can be done, for the nature of the association between 
resources invested and Improvement in health or prevention of malaria is 
difficult to specify. This is particularly true in Nepal, where malaria 
control has contributed to population redistribution and consequent 
environmental changes which mean that the consequences of removing 
preventive measures are difficult to determine. Because of the 
difficulties of assessing effectiveness in terms of change in health, 
analysis often concentrates on evaluating alternatives to achieve the 
third and fourth levels of objective. At the third level, the 
objectives are stated separately, not requiring choice between them. 
For instance, if the objective is that of detecting and treating cases, 
the measure of health consequence used would be cases detected and 
treated. At the fourth level, the desirability of malaria control and 
of existing control strategies is taken for granted, and emphasis placed 
on discovering the least cost way of delivering the components of a 
control strategy, for instance examining a blood slide or spraying a 
house.
Assessing cost-effectiveness in terms of health impact is, however, 
extremely important. For instance, there is little point in minimizing 
the cost of an ineffective control strategy. Thus in the cost- 
effectiveness analysis here, an attempt is made to produce information 
relevant to all four levels of objective. The choices to be evaluated 
are therefore :
Level 1: choice of malaria control versus other health programmes;
Level 2: choice of vector control versus case-detection and treatment
as means of malaria control;
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Level 3: choice of means of case-detection and treatment, including 
case detection by active and passive methods and use of 
anti-malarial drugs);
choice of means of vector control, including alternative 
insecticides and environmental management;
Level 4: choice of ways of organizing an activity, for instance
district versus peripheral laboratories, integrated versus 
unintegrated patterns of organization.
While these choices have been specified in terms of 'either/or', it is 
also important to look at a mix of strategies, and particularly at 
choices 'at the margin': for instance, given an existing mix of 
strategies, at where additional resources might be put.
The cost-effectiveness analysis required the collection of data firstly 
on financial and economic aspects of malaria control activities (both 
government and non-government) and secondly on the effectiveness of 
malaria activities in controlling malaria. The methodology adopted for 
these components of the analysis is described below.
4.3 Sub-study no.l: cost analysis
Cost information was required on the costs of malaria control falling 
both on the government and on households and individuals. Household 
cost information was obtained as part of the surveys of malaria patients 
and households described later. This section therefore deals with the 
analysis of costs to the government.
The aims of the cost analysis were:
(i) to identify the resources used with the objectives they served;
(ii) within each main objective, to allocate resources used to 
operational activities.
The cost analysis of government malaria control activities was divided 
into two parts. In the first part, the geographical distribution of 
NMEO expenditure on malaria control was analysed, in order to look at 
the proportion of expenditure absorbed by different geographical areas 
and the relationship of expenditure to population covered and cases
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Created. This analysis was limited by the availability of financial 
information to NMEO districts only, and to recurrent not capital 
expenditure. The more detailed information required for the cost- 
effectiveness analysis was produced by undertaking in depth cost 
analyses in five districts. Cost analysis was done with the aid of a 
micro-computer and spreadsheet programme (Lotus 123). The methodology 
of the cost analysis is described in detail in Annex 2. The approach 
adopted is summarized here, firstly for the analysis of the geographical 
distribution of NMEO resources, and secondly for the detailed analysis 
in five districts.
Analysis of the geographical distribution of NMEO resources
The aim of this analysis was to compare the resources used in malaria 
control between NMEO districts. All resource use, therefore, needed to 
be allocated to districts. Total resource use (excluding capital) was 
calculated by adding together for each district:
- actual district expenditure;
- an estimate of the cost of the drugs used;
- an estimate of the cost of insecticide used;
- a share of regional expenditure;
a share of National Headquarters (NHQ) and Regional Training 
Centre (RTC) expenditure.
Malaria statistics are reported for years of the Gregorian calendar not 
financial years. In order to use comparable financial information, 
expenditure in 2039/40, 2040/1 and 2041/2 (July to December) was 
converted to equivalent expenditure for 1983 and 1984 by analysing the 
proportion of financial year expenditure disbursed in the first 6 months 
(July to December) and adding it to the last 6 months' expenditure of 
the previous financial year.
Drugs and insecticide purchases and donations are reflected in NHQ 
accounts, but their supply date may bear little relationship to when 
they are used. Expenditure on drugs and insecticides was therefore 
subtracted from NHQ expenditure and added in at district level by 
multiplying quantities used (kilos of insecticide and quantities of 
drugs obtained by multiplying numbers of cases by drug dosages) by the
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Different districts are likely to make different claims on regional and 
NHQ resources depending on their size and the severity of their malaria 
situation. It is thus necessary to share out the costs of NHQ and 
regional offices to districts. This was done by taking NHQ and Regional 
expenditure by programme (surveillance, parasitology, health education, 
spraying, administration, entomology, research and training) and 
apportioning each programme to districts according to various criteria 
(see Table A2.4 in Annex 2). For instance spraying expenditure was 
distributed in proportion to the population sprayed, and surveillance 
expenditure in proportion to an index giving equal weight to population 
and number of cases.
Analysis of government malaria control costs in five districts
The second part of the cost analysis involved the following sequence of 
steps:
five districts were selected for the analysis;
a comprehensive listing was made of all government resources used 
for malaria control in the five districts, their appropriate 
regions, the RTC and NHQ, including both capital and recurrent 
inputs and externally donated items;
resource use was analysed by the purposes it served. In NMEO 
districts, regions and NHQ, this analysis was based on the 
programme budget structure;
a share of regional, NHQ and RTC costs by programme was allocated 
to the district programmes;
within each programme, resources were allocated to operational 
activities;
resources valued in financial prices were converted to economic 
prices to obtain a true measure of the opportunity cost of the 
resources used;
the cost of each operational activity was divided by measures of 
output, to produce unit costs.
Choice of districts. The choice of districts was governed by the need
estimated price paid (see Annex 2 for details of how prices were
calculated).
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to obtain a representative selection of districts but also tempered by 
practical considerations. In order to match government with private 
expenditure, it was convenient to select districts where the patient 
survey (described below) had investigated private expenditure. Thus 
Morang in the East, and Rupandehl in the West were selected. A hill 
district, Ilam, was then added. Two ICHSDP districts were selected, 
Saptari and Parsa, on the basis of availability of financial and malaria 
data and accessibility. The location of the districts are shown in Map 
4.1. They cover the main characteristics considered to Influence the 
costs of malaria control, namely:
terrain (Terai and Hill; East and West Teral);
receptivity (low and moderate);
vector (A. an n u l a r i s  and A, f l u y l f l t l l l s ) ;
species (differing proportions of P. vlvax and P. falciparum);
- malaria incidence (relatively low API to relatively high API);
classification of cases (high proportion of imported cases to low 
proportion);
organizational pattern (integrated and non-integrated).
Listing of resources used. In order to obtain Information on resource 
use, information available at NMEO and ICHSDP headquarters was 
collected, and visits were made to all five districts and to the two 
NMEO regional offices (East and West). The cost of drugs and 
insecticide was estimated on the basis of quantities used and 
replacement prices. The main capital assets were valued at replacement 
cost and converted to an annual cost.
Since the NMEO is a single-purpose organization, all resource use serves 
the purposes of malaria control. In the ICHSDP districts, however, 
malaria control is only one of a number of activities carried out. A 
malaria budget does exist, but this funds only supplies for treatment 
and spraying, and the regular budget funds staff costs and other 
development budgets fund some supervision costs. Resources used by 
malaria control were thus estimated by identifying actual resources used 
where possible (for instance drugs and insecticides, salaries of malaria 
assistants and mlcroscoplsts) and elsewhere estimating the proportion of 
staff time, or building space etc, used by malaria control. In this 
way, ICHSDP district malaria costs were identified. It did not prove
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¡•Clon of th« districts for ths cost-offsetlvsnsss study
possible, however, to estimate the share of ICHSDP headquarters' 
resources consumed by malaria control.
Resource use by purpose. Within the overall objective of malaria 
control, a number of sub-objectives can be specified, for instance 
surveillance, spraying etc. Such sub-objectives can be identified with 
programmes. Indeed, the NMEO has implemented a programme budget system 
whereby the budgets and financial accounts for malaria control are sub­
divided into a series of programmes, each of which has a different 
purpose, although each serves the main purpose of malaria control. Such 
a programme budget structure much facilitated the cost analysis.
Figure 4.2 shows the programme budget structure at different management 
levels, and more details on the activities funded by each programme are 
given in Annex 2, Table A 2 .1. Some adjustments needed to be made to the 
allocation of expenditure between programmes. For Instance, the salary 
of the district malaria officer was paid from the surveillance programme 
although he was responsible for all programmes. Such misallocatlons 
were adjusted, based on discussions with the districts. ICHSDP 
districts did not use the programme budget structure, and resource use 
by programme was estimated.
Distribution of NHQ, RTC and regional costs to districts. NHQ, RTC and 
regional costs by programme were allocated to districts according to the 
criteria shown in Table A2.4 in Annex 2. Programme costs thus comprise 
three elements: district level costs, regional overheads and NHQ and RTC 
overheads.
Allocation of resources to operational activities. A number of 
operational activities were defined, which are carried out under the 
umbrella of various programmes (see Figure 4.3). Operational activities 
are the basic elements of malaria control, such as case detection and 
slide examination. They are provided by the surveillance, parasitology, 
health education and spraying programmes. The two other programmes, 
research and training, and administration, provide support but are not 
themselves responsible for operational activities. (Entomology is also 
a support programme but its prime purpose is to support the spraying 
programme and so was subsumed within that at district level) . Research 
and training was kept in the analysis as a support programme, but the
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Figur« 4.2: Th« programa« budget structur« of NHQ, 
Ragion and district
Figur« 4.3: Operation«! activities funded by programme«
Programme Operational activities
Surveillance Active case detection 
Activated passive case detection 
Passive case detection (hospital) 
Passive case detection (malaria office) 
Passive case detection (malaria clinic) 
Mass blood survey
Radical treatment and investigation
Parasitology Slide examination, district and unit 
laboratories
Slide examination, malaria clinic
Health education Passive case detection (volunteers) 
Community education
Spraying Spraying
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administration programme was distributed to the other programmes in 
proportion to their total cost. The spraying programme finances only 
one operational activity (spraying). The health education programme 
finances primarily PCD (V), but also community education activities. 
The cost of the latter could not be separated out so is included in the 
cost of PCD (V). The surveillance and parasitology programmes finance 
several activities, so the costs of the surveillance programme were 
distributed between the various forms of case-detection and radical 
treatment, and the costs of the parasitology programme between the 
district laboratory and malaria clinic. The costs of case detection and 
radical treatment cannot easily be distinguished from each other, since 
certain costs are joint. A particular problem arises from the use of 
MFWs for radical treatment in some districts. The views of district and 
unit officers were relied on to estimate the proportion of time spent on 
different operational activities within the same programme.
Conversion of financial prices to economic prices. The appropriate 
concept for valuing resources in an economic analysis is that of social 
opportunity cost - the value to society of a particular resource in its 
next best alternative use, or what has to be given up by using the 
resource in its current activity. Financial prices (prices actually 
paid) may not accurately reflect social opportunity cost and where 
necessary are adjusted to produce 'shadow' or 'accounting* prices. The 
method adopted is described in Section 6.4 of Annex 2. In brief, traded 
goods and services are valued at world (border) prices, that is the 
price prevailing on the world market, and the prices of non-traded goods 
and services are adjusted by use of conversion factors so that all goods 
and services are valued in terms of a common yardstick.
Calculation of unit costs. The costs of the operational activities were 
divided by appropriate measures of output to produce unit costs. 
Measures of output were specific to each programme, and included cases 
treated in the surveillance programme, slides examined in the 
Parasitology programme, and houses sprayed in the spraying programme.
Accuracy of the cost analysis. The method of cost analysis described 
here may produce certain inaccuracies:
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programme budgeting has only recently been Introduced Into the 
NMEO, and until 2041/2 (1984/85) there was no requirement to 
report expenditure by programme. Malaria staff accepted that a 
particular bill might be charged against a programme that had 
funds remaining rather than against the correct programme; 
when Joint costs have to be divided between activities, there is 
inevitably some uncertainty over the precise division;
- drugs and insecticides have been costed on the basis of numbers of 
cases and kilos of insecticides used. To the extent that wastage 
or losses of supplies occur, this is likely to be an underestimate 
of actual costs.
The great majority of costs, however, are salary costs. These are the 
easiest to account for accurately by programme, and thus serious 
mlsallocatlon between programmes is unlikely. Distribution of staff 
time between operational activities in the surveillance programme is 
more speculative, but if this has been done correctly, misallocatlon of 
other inputs will have little effect on unit costs.
4.4. Sub-study no.2: effectiveness analysis
The information on effectiveness required for the cost-effectiveness 
analysis is defined by the measures of effectiveness needed to answer 
the questions posed. The measures of effectiveness required differs, as 
discussed above, depending on the level of the choice being considered. 
A distinction is commonly made between two types of measure:
measures of activities (or intermediate output); 
measures of final output.
Choices at the first and second levels discussed above require measures 
of final output, whereas choices at the third and fourth levels require 
measures of intermediate output.
Measures of final output relevant to malaria control are:
number of days of healthy life gained;
- change in annual parasite index (API);
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cases cured; 
cases prevented.
Measures of Intermediate output are specific to particular strategies, 
and include:
Case detection - population covered;
- number of slides collected;
- annual blood examination rate (AfiER);
- number of houses visited;
- number of cases detected.
Treatment - number of cases given presumptive treatment;
- number of cases given radical treatment.
Spraying
Environmental
management
- number of houses protected;
- number of people protected;
- reduction in vector densities.
- number of ponds cleared;
- number of people protected;
- reduction in vector densities.
Information on final output measures: the majority of final output 
measures are not readily available from the routine information systems 
of the NMEO and ICHSDP. Indeed the only measure readily available and 
likely to be accurate is that of 'cases cured' . Even in the case of 
this measure, however, there Is some scope for inaccuracy since records 
report the number of cases given radical treatment and the number that 
relapsed (in the case of P.vlvax) or recrudesced (in the case of 
P ■falciparum) . The head-count of numbers treated is likely to be 
accurate since a record Is kept of every patient, but individuals not 
successfully treated, who relapse or recrudesce, are likely to be 
underestimated since this statistic relies firstly on identifying the 
case and secondly linking it to the earlier episode.
The API Is routinely reported, but its accuracy depends on whether it is 
representative by time and place. Annual blood examination rates are 
relatively high in NMEO districts, for example averaging 16.2% in the
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Annual blood examination rates are much lower in ICHSDP districts, 
ranging in 1984 between 0.5% and 15.7%, with an average for all 14 
integrated districts of 6.7%. Malaria staff of both the NMEO and ICHSDP 
felt that coverage was poor and cases missed. Therefore the API is 
likely to be a poorer indicator of malaria incidence, and of changes in 
incidence from one year to the next, in ICHSDP than in NMEO districts.
The two other measures of final output, number of days of healthy life 
gained and cases prevented, are far more difficult to estimate since 
quantifying them requires an answer to the question of how malaria would 
respond to a cessation of a particular strategy or of the control 
programme as a whole, or to the replacement of one strategy by another.
Estimates of the likely malaria incidence in the absence of a control 
programme are difficult to base on an empirical study. Even if control 
measures were stopped in one area of Nepal as an experiment, any results 
would not necessarily be applicable to the rest of Nepal given the 
varying epidemiology of malaria over Nepal. Most economic studies of 
malaria attempt to quantify cases prevented by reference to the 
situation before the control programme was introduced. However in Nepal 
there are good reasons for arguing that the pre-control situation is not 
likely to re-appear:
the original, extremely efficient vector in hyperendemic areas, 
A .minimus. appears to have been virtually eliminated;
- significant environmental changes have occurred, most notably a
reduction in the area under forest and an increase in the 
cultivated area;
substantial population movements have Increased population density 
in the Teral;
the population now has much greater access to private treatment 
facilities. Including drug stores.
East, 19.6% In th® Centre, 16.9% in the West and 14% in the Far-West in
1984. However, whether they are representative is unknown.
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Overall, Chase points suggest that Incidence is now likely to be less in 
the absence of control that it was pre-control. However, two factors 
complicate the assessment. Firstly, the Nepal malaria situation is 
highly dependent on the Indian malaria situation, itself unpredictable. 
Epidemics in the Indian Terai could spread to Nepal (and have done so in 
the past but intensification of control efforts in Nepal have contained 
the epidemic).
Secondly, the spread of chloroquine - resistant strains of malaria 
parasite from India to Nepal has implications for the case fatality 
rate. Without resistance, cases are likely to rise but the risk of 
deaths will continue to be relatively small. With resistance, deaths 
are likely to increase in the absence of proper treatment. Even if the 
government reaction is to expand treatment facilities, resistance to 
fansldar (the drug of choice with chloroquine resistance) is likely to 
develop, resulting in the use of much more expensive and complicated-to- 
admlnlster drugs, and again in Increased deaths.
Assessing the relative effectiveness, in terms of cases prevented, of 
one strategy over another is in principle more susceptible to empirical 
Investigation. Comparative data is collected by the NMEO on malaria 
incidence in sprayed and unsprayed areas, but given that areas selected 
to be sprayed are those anticipated to present control problems, most 
assessments of the NHEO's spraying programme have felt that few 
conclusions on the effectiveness of spraying can be drawn from this 
data. Moreover, while assessment of the effectiveness of one control 
measure over another is always difficult, it is particularly difficult 
in Nepal because the Incidence of malaria is relatively low. Control 
strategies are aimed primarily at maintaining this low level rather than 
producing a significant reduction in cases. The number of cases 
prevented is thus somewhat hypothetical, and no strategy is likely to 
produce a large decrease in cases, making detection of its actual effect 
difficult.
Complementing the cost-effectiveness study by a field survey of the 
effectiveness of various malaria control strategies would have been 
prohibitively expensive and time consuming, and possible trials were in 
any case being discussed and planned by the NMEO. It was decided in 
this study, therefore, to rely on the existing information system of
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the NMEO and ICHSDP, on various existing reports and on Informed 
speculation for evidence on the effectiveness of malaria control in 
terms of final output measures.
Information on intermediate output measures: the routine information
system produces relatively promptly virtually all of the measures of 
intermediate output listed earlier. In general, standards of data 
collection for specific activities seemed relatively high, and the 
activities of field staff were regularly checked by their supervisors. 
There are therefore good grounds for believing that the information is 
reasonably accurate.
Major problems arise with respect to only one indicator, namely 
reduction in vector densities. While routine entomological work is 
carried out, much of the field data is not easy to interpret. For 
example White (1982) reports that:
"Although three-fourths of the people living in the NMEO programme area 
are not protected by house - spraying, nearly all the entomological 
studies have been conducted in sprayed villages. The available data 
from sprayed villages are insufficient for computation of vectorial 
capacities and receptivity to malaria for the years since 1974, and 
there is virtually no information on which to base estimates of the 
malariogenic potential in unsprayed situations".
Finally, this research encounters problems of data availability that are 
common to any study of a routine programme, namely that empirical data 
is available for only those control strategies that are actually 
employed. This is a particular problem in the case of assessing the 
cost-effectiveness of environmental management, a control strategy that 
the NMEO has only recently begun to consider seriously, but also applies 
to possible variants of existing control strategies. Thus assessment of 
the effectiveness of various control strategies has to be based not only 
on empirical data from Nepal but also on published evidence from 
elsewhere and consideration of its relevance to Nepal.
4.5 Sub-study no.3: patient survey
The cost-effectiveness analysis framework adopted in the research 
required information on the number of days of illness and incapacity 
caused by malaria, on the use made of sources of treatment other than
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Chose offered by Che NMEO/ICHSDP, and on Che expendlCure of malaria 
paClenCs on CreaCmenC. This Información is noC rouClnely produced by 
Che NMEO información syscem. Chough some relevanc información is 
collecCed buC noC analysed via Che SFS form which is filled In for each 
malaria case ldenClfled and reporCs Che resulc of Che lnvesClgaClon of 
Che clrcumsCances surrounding each case as wall as brief personal 
characCerlsClcs of Che paClenC.
Since every case idenClfled Is vlslced and InvesCigaCed, an economical 
means of collecCing che addiclonal daCa required for Che cost- 
effecClveness analysis was Co add on a brief, excra form Co Che SF5 
enquiry. This form (che ESM1 form) inquired abouC number of days of 
work and school lose as a resulc of malaria, abouC use made of various 
sources of CreaCmenC, and abouC prlvaCe expenditure on CreaCmenC. NMEO 
discriecs were sCraClfled by geographical region and one disCrlcC chosen 
at random from Che Ease, CenCral, UesC and Mld-UesC Terai, and from Che 
Hills. To chese five districCs was added one ICHSDP disCrlcC. In order 
Co minimise Che efforC required Co obCaln Che información, che ESM1 form 
was filled in aC Che same time and by Che same malaria worker as Che SF5 
form.
The ESM1 form was used in Che dlsCrlcCs for beCween 4 and 12 monChs, 
depending on Che disCrlcC. Información on 3253 malaria cases was 
obeained and analysed cogecher wleh selected items from Che SFS form. 
The data was coded and entered into dBase II by NMEO staff, and cleaned 
and edited by Che author. The cleaned data set was Chen transferred Co 
SPSS/PC and analysed by Che author. The ESMl forms (in Nepali and in an 
English translation), together with a list of items of information on 
the SF5 form, are reproduced in Annex 3.
4.6 Sub-study no.4: household survey
The main virtues of the above study were its geographical spread and 
number of cases included. Both Chese virtues were possible because Che 
survey was tagged on to an existing data collection system. However, 
precisely for this reason, Che number of addiclonal questions Chat could 
be asked was limited, and questions had Co be very simple. Moreover, 
the use of malaria workers to collect the data introduced the 
possibility of biasing Che responses.
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Therefore a second, in depth survey in two small geographical areas 
using specially trained interviewers was also set up. The objectives of 
this survey were much broader than to provide information for the cost- 
effectiveness analysis alone. However, detailed questions were asked 
about time and income losses resulting from malaria and about the use of 
curative services and this information is used later in this thesis. 
The methodology of the study is therefore reported briefly here.
The aim of the survey was to find out the economic implications of 
malaria at the level of the household in terms of the present Impact of 
malaria on household activities; the implications for households of any 
future increase in the incidence of malaria, and patients' behaviour 
with respect to treatment. The main topics on which information was 
collected were:
the amount and type of sickness caused by an episode of malaria; 
the number of days of disability and debility per case of malaria; 
the socio-economic and personal characteristics of malaria 
patients;
what household activities were not done because of malaria, and 
whether they were postponed, done by other people, or not done at
a l l ;
any financial and economic losses arising from the effect of 
malaria on household activities;
the patient's choice and use of public and private treatment 
facilities;
private expenditure on curative and preventive care for malaria.
Because the Incidence of malaria at the time of the survey was 
relatively low (maximum API of 5 per 1000) , it was not feasible to study 
all or a random sample of households in an area and expect to obtain a 
sufficient number of households with a malaria case. Therefore the 
following approach was adopted:
two districts, and one malaria unit in each of the districts, were 
selected in order to ensure a sufficient number of accessible 
cases, a mix of both P. vivax and P. falciparum infections, a mix of
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imported end Indigenous cases, and a range of economic 
circumstances (household Income, predominant crops, etc); 
all malaria cases diagnosed by the NMEO in these two units were to 
be interviewed, as soon as possible after diagnosis and also a 
fortnight later, when a household questionnaire was also 
administered;
- for each malaria case, a neighbourhood control was identified, 
matched for age-group and sex but free from malaria for the 
previous month;
- the survey was carried out for 12 months, in order to pick up 
seasonal variations in malaria transmission and economic activity.
Survey activities were organised and implemented by a Nepali survey 
organisation (New Era), supervised by the author. Specially trained 
interviewers were used, who lived in the malaria units where the survey 
was located. Data was coded and entered into dBase III by New Era, and 
subsequently edited and cleaned in London and transferred to a mainframe 
computer. Statistical analysis was done using SPSS. Information on 867 
malaria cases and 867 controls was analysed. The questionnaires used 
are reproduced in Annex 4.
4.7 Summary
This chapter has outlined the methodology of the study of the cost- 
effectiveness of malaria control in Nepal. It considered the conceptual 
framework for the analysis, the data requirements and how to obtain the 
data.
The conceptual framework was based on Drummond and Stoddart (1985), 
classifying costs as those falling on the government and on patients and 
households, and consequences as health effects, savings in resource use 
(both expenditure and time), and changes in quality of life. Four 
levels of objective and choice were distinguished: objective of 
Improving health (choice of malaria control versus other means of health 
improvement); objective of malaria control (choice of vector control 
versus case detection and treatment and various mixes of both); 
objectives of (1) vector control and (ii) case detection and treatment 
(choice of strategies for each); objective of delivering a p re­
determined strategy.
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Data collection activities could be grouped into four sub-studies. 
These were the cost analysis, the effectiveness analysis, the patient 
survey and the household survey.
The alms of the cost analysis were to identify resources used with the 
objectives they served and to allocate resources used to operational 
activities. The cost analysis was divided into two parts. In the first 
part, NMEO recurrent expenditure by district was analysed and related to 
population covered and cases treated. In the second part, an in-depth 
study was done of malaria control costs in three NMEO districts and two 
ICHSDP districts. Resources valued in financial prices were converted 
to economic prices and costs analysed by programme and activity.
In the effectiveness analysis, measures of output required were defined 
and how to obtain them discussed. The 'number of cases cured' could be 
obtained from programme data but it was not known what proportion of 
total cases were being detected. The difficulties of estimating 'cases 
prevented' were discussed, together with the difficulties of mounting a 
field study. Information on Intermediate measures of output were 
available from programme data.
The patient survey was set up to collect information on the number of 
days of work and school lost as a result of malaria, the use made of 
various sources of treatment and private expenditure on treatment. 
Information on 3253 malaria cases in six districts was collected by 
malaria workers. This Information was analysed with information from 
the SF5 form, a routine form which described the epidemiological 
characteristics of each case.
The household survey was set up to obtain more detailed and accurate 
data than could be obtained through the patient survey. Its aim was to 
investigate the economic implications of malaria at the level of the 
household in terms of the Impact of malaria on household activities and 
patients' behaviour with respect to treatment. All malaria patients in 
two geographical areas were to be interviewed together with a 
neighbourhood control for each patient. Data on both the individual and 
their household were obtained. Information on 867 cases and 867 
controls was analysed.
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5. RESULTS OF THE STUDY I: THE RECURRENT EXPENDITURE OF NMEO 
DISTRICTS
In this chapter, the results of the sub-study on the recurrent 
expenditure of NMEO districts is reported. Particular attention is paid 
to the relative costliness of different districts, to the distribution 
of resources between districts and to the determinants of district 
expenditure.
5.1 Per capita expenditure
The recurrent expenditure of NMEO districts, regions, NHQ and RTC was 
analysed for 1983 and 1984 (Tables A5.7 and A5.8). Districts integrated 
in 1983 were excluded from the calculations. Table 5.1 shows total 
district expenditure per capita in 1983 and 1984 (columns 1 and 2) . 
Total district expenditure is made up of district-level expenditure, the 
value of insecticides sprayed, the value of drugs used, a share of NHQ 
and RTC expenditure, and a share of regional expenditure, and has been 
divided by district population-at-risk.
The column on per capita expenditure for 1983 shows a three-fold 
difference between the lowest cost district (Morang) and the highest 
(Udaipur). In 1984, although district-level expenditure increased, 
insecticide expenditure decreased especially in the East and mid West 
and the range between the lowest and highest cost districts increased. 
In general, Hill districts have higher expenditure for a given level of 
activity than other districts. This relationship is obscured in columns 
1 and 2 of Table 5.1 because Hill districts have fewer cases and a less 
severe malaria situation, and therefore receive fewer funds for 
treatment (drugs) or spraying. In order to look In more detail at cost 
variations between districts, it is therefore useful to analyse 
expenditure on the malaria control infrastructure alone, by 
distinguishing between fixed expenditure (district-level expenditure) 
and variable expenditure (drugs and insecticide). This division is 
approximate since included in district-level expenditure are some items 
that vary in the short-term in response to changes in the level of 
activity (e.g. minor supplies and DA/TA for radical treatment, wages of 
spraymen and DA/TA for spraying). However the great majority of 
district-level expenditures are consumed by salaries, and these do not
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Table 5.1: Analysis of NMEO district recurrent expenditure per capita 
In 1983 and 1984
D is tr ic t
Por capita Per cap ita  <.................1913.................><---------------1M4-------------- )
expenditure expenditure Per cap ita Per capita Per cap ita Per capita 
( Is ) 1983 ( Is )  198b fixed  variable fixed variable 
costs (a) casts (b) costs (a) costs (b)
( I )  (2 ) 0 )  («) 0 )  (»)
Geographical
locatios
(7)
Roring 4.05 3.76 2.40 0.81 2.51 0.40 Outer Terai
Suntari 4.51 4.23 2.74 0.88 2.86 0.48 Outer Terai
Jbapa 4.95 4.72 2.91 1.14 3.08 0.71 Outer Terai
H u 11.32 10.65 8.35 1.28 8.74 0.19 ( i l l
P ia ch tir 9.95 13.32 7.80 0.19 10.81 0.19 l i l i
Bbojpar 10.99 11.86 8.67 0.24 9.49 0.18 l i l i
Udaipur 11.87 11.50 7.95 2.20 8.95 0.57 Inner Terai
(hotaig 11.55 10.35 9.48 0.12 8.51 0.10 l i l i
Bsstern region i.15 6.06 4.09 0.95 4.43 0.47
laaechaap 8.94 12.12 7.36 0.12 10.10 0.13 l i l i
Sindhuli 11.04 10.74 0.21 1.11 8.36 0.46 laser Terai
l ik a t t a r i 6.61 8.37 3.18 2.35 3.11 4.12 Outer Terai
D iiatba 11.08 11.36 3.14 6.64 3.39 6.71 Outer Terai
S ir l ib i 5.87 6.30 2.98 1.92 3.13 2.17 Outer Terai
Cbit.en 5.57 5.68 3.55 1.02 3.90 0.65 lsaer Terai
l i t r e 6.68 7.89 5.20 0.15 6.27 0.16 l i l i
Ceatral region 7.86 8.58 3.90 2.78 4.11 3.14
lupndebi 4.57 7.45 3.34 2.01 3.64 2.46 Outer Terai
Gorkha 6.36 7.00 4.85 0.17 5.43 0.11 l i l i
Palpo 7.00 7.63 5.43 0.12 5.90 0.14 l i l i
Kapi1vasts 6.43 6.43 3.54 1.67 3.58 1.56 Outer Terai
la ia lp a ra s i 6.53 6.64 3.39 2.01 3.55 1.91 Outer Terai
(este ra regios 6.54 6.97 3.85 1.45 4.11 1.52
Surkie t 10.75 8.68 7.27 1.66 6.84 0.13 lin e r  Terai
Da.g 6.80 6.60 4.52 1.07 5.11 0.10 Inner Terai
Banker 6.29 5.40 3.56 1.71 3.60 0.53 Outer Terai
Bardiya 5.16 4.90 3.30 0.95 3.45 0.33 Outer Terai
la i  la 1 i 7.03 5.90 3.65 2.12 3.77 0.78 Outer Terai
laseh isp ir 10.07 8.01 5.13 3.43 5.13 0.95 Outer Terai
Rid vest regios 7.42 6.44 4.38 1.80 4.52 0.48
UTIOML RIM 6.99 7.05 4.04 1.7« 4.31 1.46
REM OF DISTIICTS 7.85 7.98 5.07 1.43 5.51 1.11
IAJKI 4.04-11.87 3.76-13.32 2.40-9.48 0.12-6.64 2.51-10.81 0.10-6.71
3D 2.46 2.66 2.20 1.34 2.55 1.47
(a) Ixpenditure financed f r u í  d i s t r i c t  budget
(b) Expenditure on drags <ad i  nsec t ic  ides
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change In the short-term in response to an increased level of spraying 
or of cases.
Columns 3 to 6 of Table 5.1 therefore show per capita expenditure for 
1983 and 1984 divided into fixed and variable components, and the 
geographical location of each district is Indicated. Per capita fixed 
expenditure at district level varies more than four-fold between the 
lowest and the highest cost districts. Per capita fixed expenditure is 
highest in Hill districts, partly because staff allowances are higher 
but also presumably because unit offices have to cover a scattered 
population and long distances. However it is not clear why per capita 
fixed expenditure in the Hills of the East Region should be almost 
double the expenditure of the two hill districts of the West region, 
Gorkha and Palpa, and Kavre in the Central region.
Of the Inner Terai districts, two (Udaipur and Sindhuli) have costs 
close to those of Hill districts, while Chltwan has costs close to those 
of Outer Terai districts, with Dang and Surkhet falling somewhere in- 
between. In the Outer Terai districts, per capita fixed expenditure 
increases from East to West.
Per capita variable expenditure tends to show a reverse pattern. It is 
low in Hill districts, where no spraying takes place and cases are 
relatively few, and high in the Outer Terai districts, especially where 
spraying with malathlon is concentrated, for instance Mahottarl, Danusha 
and Rupandehi.
On average around 70% of district-level expenditure is fixed - a 
relatively high proportion. This figure is as high as 98% in a district 
such as Panchtar where no spraying takes place, and as low as 32% in a 
district such as Danusha with extensive spraying of malathlon.
Geographical location, number of cases and presence or absence of 
spraying are therefore the main influences on expenditure. Figure 5.1 
plots district-level expenditure against district population-at-risk. 
Although there is a certain minimum level of expenditure associated with 
a district regardless of population size, the rate of increase of 
expenditure as the district population increases appears to be 
essentially constant.

5.2 Distribution of expenditure by geographical area, management level 
and type of expenditure
It is of Interest to look at the distribution of expenditure, to assess 
which geographical areas absorb the b u l k  of expenditure and the 
proportion of expenditure absorbed by management levels above the 
district. Districts cannot simply be classified by level of receptivity, 
since many districts contain areas of both low and moderate receptivity. 
A crude geographical classification has thus been used, categorizing 
districts as mainly Outer Terai (low receptivity), mainly Inner Terai 
(moderate receptivity) and mainly Hill (low receptivity). Around 65% of 
expenditure was absorbed by 13 Outer Terai districts, 17% by 5 Inner 
Terai districts, and 18% by 8 Hill districts (Table A5.9).
Since expenditure on insecticide can make up such a large proportion of 
total expenditure, it is useful to analyse it further. Spraying records 
distinguish quantities sprayed in terms of the receptivity of the area. 
In 1983, 56% of expenditure on insecticides went on low receptive areas, 
and 44% on moderate receptive areas. In 1984 the figures were 80% and 
20%. This pattern may appear paradoxical, since the bulk of expenditure 
is going on areas where there is relatively less risk of malaria 
resurgence. There are two explanations: firstly, malathlon is sprayed 
in low receptivity areas only due to resistance of the vector (A . 
annularis) to DDT and is considerably more expensive than DDT per head 
of the population sprayed; secondly stocks of DDT were very short in 
1984 and thus only one third of the 1983 quantity was sprayed.
Another analysis of interest is the distribution of expenditure by 
management level and type of expenditure (Table A5.10). On average, NHQ 
and RTC expenditure amounted to 11-12% of total expenditure (range 8- 
16%) and Regional expenditure 6% (range 4-8%). Drugs were a very 
insignificant proportion of total expenditure, amounting to 1-3% only. 
As might be expected, insecticide expenditure varied enormously, from 0% 
of expenditure to 59%. A reduction in insecticide expenditure between 
1983 and 1984 is evident: from an average of 23% of total expenditure in 
1983 to 19% in 1984. The reduction occurred only in the East and mid­
west Regions and was particularly marked in the latter.
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5.3 Expenditure per unit of output
It is desirable to express district expenditure In terns of some 
sppropriete treasure of output. Unfortunately, as discussed In Chapter 
4, there is no simple measure that encompasses both the curative and 
preventive objectives of the malaria control programme. Two simple unit 
costs are calculated here and shown In Table 5.2: district* level 
expenditure per slide and total district expenditure per case.
District-level expenditure per slide provides evidence of the cost of 
maintaining the case detection and treatment network in different 
districts. All district-level expenditure Is averaged out over the 
number of slides, so Included in expenditure Is any district-level 
expenditure on spraying (spraymen and supplies). This, however, Is a 
relatively small proportion of total district-level expenditure and 
should not therefore unduly distort the comparison of unit costs across 
districts. Insecticide and drugs have been excluded.
Columns 1 to 4 of Table 5.2 show district-level expenditure per slide 
and slides per 1000 population (to give an indication of the level of 
activity) for 1983 and 1984. As Indicated In earlier analyses, Hill 
districts tend to have the highest unit costs. It might be expected 
that the greater the number of slides per 1000 people the lower would be 
the cost per slide because a large proportion of expenditure Is likely 
to be fixed In relation to the level of activity. However Figure 5.2, 
which plots district-level expenditure per slide against slides per 1000 
population for 1983, does not show a clear relationship, probably 
because other factors (such as geographical location) obscure the 
pattern.
Columns 5 to 8 of Table 5.2 show total expenditure per case detected and 
treated (total district expenditure divided by total district cases). 
This unit cost is slightly misleading. In that the more cases that are 
detected, the better (l.e. lower) appears cost per case. This result is 
paradoxical from the perspective of malaria prevention since a district 
that Is falling to control malaria may reduce its costs per case. This 
problem arises because malaria control has dual objectives - both 
prevention and treatment - but these elements cannot be separated and in 
this unit cost all expenditure, rather than expenditure on treatment
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Table 5.2: Recurrent expenditure per slide end per esse, 1983 end 
1984.
<----------1N3--------- > <----------1904--------- > <----------190)--------- > <----------1904--------->
D ict. - leve 1 S lid c s  per D is t.- le re l SI ides per B ip ea d itire  Ceses per Eipeeditere Ceses per
D is tr ic t  eipeeditere 1000 pop eipeeditnre 1000 pep per cese 1000 pep per cese 1000 pop
per • l id *  ( le )  per s liée  ( Is )  (b ) ( b )
( I )  (2 ) O )  « )  (S) (4) (T) ( • )
Roresg 13.90 173 15.13 159 2.761 1.47 2,494 1.51
Sniseri 13.31 in 17.51 163 3.1)3 1.44 2,9)4 1.44
Jkepe 9.99 292 11.36 267 3,115 1.30 3,111 1.40
Ileo 24.12 346 21.11 311 9,554 1.19 7,957 1.34
fie c k te r 2 3 .•• 301 34.04 317 2,204 4.31 2,878 4.63
Bkojpur 33.30 260 33.33 269 2,437 4.47 2,234 3.31
Udii per 24.99 311 24.15 360 7,118 1.30 3,229 3.36
Ihoteog 39.00 243 35.37 134 5,226 2.21 5,043 2.03
Sestero re fio o 17.31 236 20.15 221 3,560 1.7) 3,069 1.91
leoeckeep 30.09 193 44.93 225 1,066 1.11 9,212 1.31
1 ta b a l  i 33.42 246 30.49 274 5,221 2.11 1.915 5.61
Reketteri 13.43 236 14.31 216 2,161 3.86 1,963 4.26
Deoeske 12.9« 242 13.11 224 2,209 5.02 2,109 5.39
Serleki 9.97 299 12.37 233 2,54) 2,)1 2,057 3.06
Ckitoeo 14.69 242 16.31 239 3,408 1.64 1,693 3.33
leere 22.10 233 26.76 234 2,220 ).01 2,299 3.4)
Centri 1 regies 13.63 249 17.79 235 2,623 3.00 2,093 4.10
tipeedeki 19.37 171 17.02 214 2,209 2.97 1,261 5.41
Cerkke 29.30 165 32.00 ITO 2,142 2.97 1,621 4.32
fe lpe 21.11 193 26.41 223 2,190 3.20 1,546 4.94
to p i I r e s t i 14.30 215 15.07 231 2,321 2.n 1,204 3.34
leve l porosi 17.11 197 17.07 20« 2,724 2.40 1,720 3.04
(estero region 20.43 111 19.44 212 2,326 2.11 1,413 4.93
Surkhet 30.49 239 34.34 199 3,995 2.69 1,346 6.45
Deog 33.45 135 32.07 159 5,071 1.34 1,320 4.97
Seokey 20.99 170 11.12 199 7,530 0 .8 ) 921 5.16
lerd iye 22.39 147 22.46 133 9,514 0.54 1,202 4.0«
le i  l e l i 25.89 141 23.46 161 3,288 2.14 951 6.16
leockeopnr 34.34 149 32.29 159 4,632 2.11 659 12.17
( id  te s t regieo 27.97 156 26.76 169 4,757 1.36 990 6.31-
UTIOlÀ l. (EU (e) 19.03 212 20.33 212 3,019 2.32 1,672 4.22
(S U  OF Dim iCTS 23.45 220 23.1) 221 4,173 2.32 2,502 4.30
IUGE 9.97-39.00 141-346 11.56-55.37 153-360 2142-9514 0.34-3.02 659-9212 1.34-12.17
SD 1.37 57 10.45 55 2,355 1.12 1,995 2.23
(e) loe Indes e ip ee d itire  oe tre e ta e e t of ceses et IRQ
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Figure 5.2: Relationship between district-level expenditure per slide
and slides per 1000 population, 1983
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only. Is distributed to cases. However, the cost per case Is useful If 
interpreted as showing the magnitude of malaria control expenditure in 
relation to the number of cases occurring. As demonstrated in Figure
5.3 which plots expenditure per case against cases per 1000 population 
for 1983 and 1984, there is a very strong relationship between these two 
variables, indicating how expensive a case detection and treatment 
system can become when malaria incidence falls to very low levels. For 
example Bardlya in 1983 had the lowest number of cases per 1000 
population (0.54) and one of the highest costs per case (Rs 9,514).
A comparison of the 1983 and 1984 figures for the mid West region 
emphasizes the responsiveness of unit costs to a change in the level of 
activity, for the rise in cases in 1984 dramatically reduced the cost 
per case. It is clearly Important to distinguish those areas where the 
high cost of a case detection and treatment system may be worthwhile 
because of the risk of resurgence, from those where a rapid and sizeable 
increase in cases is not likely and the malaria control infrastructure 
imposes continuing high fixed costs with little return in terms of cases 
detected.
5.4 The effect of expenditure on malaria incidence
It would be desirable to use the information presented in this chapter 
to examine the relationship between levels of expenditure and levels of 
malaria. However, it is clear from the analysis that any relationship 
is likely to be extremely complex and affected by factors that cannot 
easily be included in the analysis such as climatic conditions and the 
malaria situation across the border with India. Moreover malaria 
incidence in any one year is Influenced not merely by the expenditure of 
that year but also of preceding years. Thus not merely cross-sectional 
but also time series data is required to examine the relationship.
However, information has been presented here for two years and between 
those two years there was a marked change both in expenditure patterns 
and in malaria incidence. It is thus worth doing a simple comparison, 
shown in Table 5.3, of changes in total expenditure and insecticide 
expenditure and changes in indigenous cases.
Between 1983 and 1984, malaria incidence rose slightly in the East.
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Figure 5.3: Relationship between expenditure per case and cases per
1983 (upper): The line represents the empirically fitted equation
EPC - 6369 x CASES'07786 
r2 - 0.65
1984 (lower): The line represents the empirically fitted equation
EPC - 6508 x CASES -°-8882 
r2 - 0.69
1000 population for 1983 and 1984.
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Table 5.3: Relationship between change In expenditure and change In
number of cases, 1983 to 1984
ANfaiaus API (sinus Change Change i i  Total Total C h ip  i i  Ckaage is
¡■ported A) ¡sported A) is  AN indigenous Expenditure Expeaditare expenditure insec tic id e
D is tr ic t 1903 1916 1913-6 cases 1913-6 1913 1916 1913-6 exp. 1903-6
Unreal 0.A2 0.6) 0.01 11 1,960,021 1,195,617 (66,5)6) (189,582)
Suasari 0.51 0.61 (0.03) (21) 1,619,636 1,355,620 (66,016) (121,657)
Jhapa 0.22 0.25 0.03 25 2,226,081 2,116,803 (37.285) (176,256)
Mas 0.71 0.66 (0.16) (15) 716,556 700,116 (16,372) (68,129)
Paacktar 2.60 2.10 0.20 19 771,1)6 1,027,657 269,322 0
Bkojpar 0.97 1.16 0.17 9 882,078 965,163 83,066 (6.183)
Udo i par 0.62 2.21 1.66 106 1,627,706 1,623,959 (3,766) (198,928)
Kkotaaf 0.12 0.12 0.00 2 799,611 112,521 82,903 0
Eastern region 0.51 0.66 S.13 1)6 10,207,635 10,636,97) 229,331 (760,535)
lasecbaap 0.19 0.16 (0.05) (0) 751,232 166,652 86,620 0
Siadkul i 1.96 5.31 3.35 656 1,606,211 1,613,306 7,093 (86,706)
Rehottari 1.B2 2.67 0.65 251 2,368,051 3,072,566 706,515 672,826
Daauska 3.30 3.51 0.28 156 6,693,176 6,969,666 255,770 113,213
Sarlahi 1.26 1.72 0.68 177 1,196,166 2,100,666 206,682 112,199
C kitiaa 0.56 1.91 1.37 377 1,511,100 1,655,562 76,662 (102,853)
lavre 1.27 1.61 0.16 17 652,622 786,250 133,628 0
Ccatral region 1.76 2.57 0.11 1,626 13,356,256 16,122,626 1,661.370 710,678
lapaodehi 2.07 6.67 2.60 955 2,655,921 2,909,666 653,766 198,501
Gorkka 0.B5 1.57 0.72 161 1,398,610 1,560,956 162,566 (15,393)
ta lp a 0.51 1.07 0.56 67 972.662 1.076,265 101.103 0
lap ¡leasta 1.77 3.9! 2.21 639 1,963,803 2,023,563 59,760 (25,156)
Baoalperasi 1.11 2.61 1.30 610 2,151,117 2,263,806 111,989 (16,775)
les te ra  region 1.62 3.06 1.66 2,212 1,962,613 9,132,236 889,821 163,180
Sarkket 2.26 5.17 3.61 670 1,362,601 1,171,191 (183,510) (192,601)
Daa| 1.06 6.67 3.6) 906 1,881,882 1,117,661 (1,261) (275,3)8)
Baakey 0.66 5.67 6.13 926 1,262,692 1,111,660 (131.0)3) (235,086)
Bardiya 0.6B 3.95 3.67 603 1,037,016 1,027,195 (9,121) (126,036)
K a i la li 1.65 5.50 6.05 996 1,769.613 1,531,636 (210,978) (328,7)9)
laackanpar 1.90 11.96 10.06 2,071 2,010,113 1,673,362 (3)6,751) (691,891)
Rid w s t  region 1.2) 6.09 6.16 5,972 9,290,318 1,617,616 (872,6)6) (1,667,689)
TOTAL (a) 9,766 61,795,029 63,509,927 1,716,898 (1,556,368)
(a) lac lades eipeaditsre on treataeat of cases at IRQ
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* lightly higher in the Central Region, doubled in the West, and rose 
very sharply in the nid West. Insecticide use decreased markedly in the 
East and mid West and Increased slightly in the Centre and West. 
Expenditure excluding insecticide Increased slightly.
A marked reduction in insecticide use was thus accompanied by very 
Httla change in malaria incidence in the East (except in Udaipur) and 
by a very marked Increase in the mid West, suggesting that spraying has 
more Importance in the West than the East. Other factors, however, such 
as the Indian situation, were undoubtably Important, and more detailed 
studies would be required for any firm conclusions to be drawn.
In the Centre, where insecticide expenditure slightly Increased and 
incidence rose over the Region as a whole, there was a more varied 
pattern at district level. In the three districts where insecticide 
expenditure Increased, there was only a slight increase in the API. In 
two where It fell, there was a more marked Increase. In the West, 
however, no such clear pattern emerges. Very slight decreases in 
insecticide expenditure in three districts were accompanied by an 
approximate doubling of incidence, and in Rupandehl, incidence doubled 
despite a 25% increase in spraying.
5-5 Analysis of the main Influences on district cost per capita
It Is clear that from the analysis In this chapter that a variety of 
factors affect the cost of malaria control. The following variables 
seem to be the most important Influences:
- population size of districts
- terrain (Outer Teral, Inner Terai, Hill)
* region (East, Central, West, mld-West)
* number of cases per 1000 population 
number of slides per 1000 population
- insecticide type (DDT, Malathlon)
* proportion of the district population sprayed.
In order to attempt to disentangle the influence of these variables, a 
multiple regression analysis was carried out with district cost per 
capita as the dependent variable and the above variables as Independent
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variables. Approximately three quarters of the variation In cost per 
capita could be explained by these variables. However, the extent of 
the correlation between the independent variables was such that it would 
be unwise to attempt to quantify the contribution of any particular 
Independent variable. The multiple regression therefore added little to 
the findings already presented.
5.6 Conclusions
A number of conclusions can be drawn that are relevant to considerations 
of efficiency and of alternative malaria control strategies.
The cost of malaria control varies widely across the country, for 
reasons often not associated with the vulnerability or receptivity 
of the district to malaria. The case detection and treatment 
network is particularly expensive in Hill districts which are 
classified as low receptive.
Considerable resources are being absorbed by areas of low 
receptivity In the Outer Teral because the resistance of 
A. annularis to DDT requires the use of malathion where spraying 
is considered necessary.
Regional and national levels absorb around 17-18% of total NMEO 
recurrent expenditure: a relatively high proportion, though 
technical skills and back-up are concentrated at these levels and 
the NMEO headquarters provides support also to the ICHSDP.
External assistance (drugs, insecticides and WHO technical 
assistance) makes up approximately 25% of total recurrent 
expenditure.
Residual spraying adds significantly to malaria control costs even 
In terms of Insecticide alone (excluding operational costs of 
spraying).
Further investigation is required of the relationship between 
levels of spraying and levels of malaria, to see whether more 
economical use can be made of insecticide.
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A relatively high proportion of district-level expenditure Is 
fixed, resulting In high costs per unit of activity In districts 
with relatively few cases.
5.7 Summary
This chapter has examined the recurrent expenditure of NMEO districts In 
terms of per capita expenditure; expenditure by geographical area, 
management level and type of expenditure; and expenditure per unit of 
output.
1983 per capita expenditure showed a three-fold difference between the 
lowest ¿nd highest cost districts. When expenditure was disaggregated 
into fixed and variable components, per capita fixed expenditure varied 
more than four-fold between the lowest and highest cost districts and 
was highest in Hill districts, lowest in Outer Teral districts and in 
between for Inner Teral districts. In Outer Teral districts, per capita 
fixed expenditure Increased from East to West. Per capita variable 
expenditure showed a reverse pattern, being highest In Outer Terai 
districts especially those where malathion was sprayed. On average 
around 70% of district-level expenditure was fixed.
The 13 Outer Terai districts absorbed around 65% of expenditure compared 
to 17% for Inner Teral districts and 18% for Hill districts. A high 56% 
of insecticide expenditure in 1983 and 80% in 1984 went on low receptive 
areas, primarily because vector resistance to DDT in these areas 
required malathion to be sprayed rather than the cheaper DDT. On 
average, NHQ and RTC expenditure absorbed 11-12% of total expenditure, 
drugs only 1-3%, and insecticide 0-59%.
An analysis of district-level expenditure per slide confirmed that Hill 
districts tended to have the highest unit costs. District-level 
expenditure per case was highly correlated with the number of cases. 
For example, the rise in cases in 1984 sharply reduced the cost per 
case. It was concluded that it was important to distinguish those areas 
where the high fixed costs of a case detection and treatment system were 
worthwhile from those where it was not.
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An attempt to compare change between 1983 and 1984 In the number of 
cases, total expenditure and Insecticide expenditure was Inconclusive. 
In some areas a marked reduction in insecticide use was accompanied by 
very little change in malaria incidence and in others by a marked 
increase in cases. It was concluded that a variety of factors affected 
malaria control costs, some of which could be examined (e.g. population 
size, terrain, region, cases and slides per 1000 population, insecticide 
type, proportion of the population sprayed) but others which were less 
amenable to analysis over a short time period (climatic conditions, 
malaria prevalence in adjoining areas of India).
A variety of conclusions were drawn from the analysis in the chapter, 
notably that the cost of malaria control varied widely across the 
country, for reasons often not associated with malaria risk;.that the 
case detection and treatment network had high fixed costs and thus was 
very expensive if malaria incidence was low; and that spraying and 
particularly the use of malathion considerably increased district costs.
161

6. RESULTS OF THE STUDY II: THE COST-EFFECTIVENESS OF MALARIA CONTROL 
STRATEGIES
In this chapter, the results are presented of a detailed analysis of the 
costs and cost-effectiveness of malaria control strategies in the 
following districts:
Morang (NMEO, East region, Outer Teral) ;
Rupandehi (NMEO, West region. Outer Terai);
H a m  (NMEO, East region. Hill);
Saptari (ICHSDP, Eastern region, Outer Terai);
Parsa (ICHSDP, Central region. Outer Terai).
In order to be able to include the overhead costs of regional and 
national management levels, NMEO expenditure at the national level (NHQ 
and Regional Training Centre) , and East and West regions has also been 
analysed. A similar analysis of ICHSDP overhead costs was not possible.
The results are presented first for vector control strategies and second 
for case detection and treatment strategies. Within each section, costs 
to the government are considered first and then costs to individuals. 
Analysis of case detection and treatment mechanisms is done first for 
all case detection mechanisms taken together (but excluding volunteers) 
since this permits a comparison between non-integrated and Integrated 
districts. Subsequently the costs of the various NMEO case detection 
mechanisms are disaggregated and compared.
6.1. Vector control strategies
Costs to the government and cost-effectiveness estimates
In 1984, the only routine vector control method used was residual 
spraying. This was therefore the only method that could be rigorously 
costed, though the potential costs of alternative vector control methods 
are considered below in Chapter 9.
In looking at the costs of spraying per unit of output, it is Important 
firstly to distinguish between fixed and variable costs, and secondly to
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distinguish between the costs of spreylng different Insecticides since 
both chemical and operational costs are likely to be different.
The division of costs between fixed and variable components gives a feel 
for how costs are likely to change as the level of spraying increases or 
decreases. What Is considered fixed depends on the time-frame: In the 
long run (over several years) all costs. Including those of vehicles and 
spraying supervisors, could adjust to a changed level of output. Here, 
however, It seems sensible to take a time-span of about one year, and to 
regard the costs of the spraying programme at NHQ and Regional levels to 
be fixed, except for the fuel used for dumping Insecticide. At district 
level, some costs would not be Incurred in the absence of spraying 
(salaries of spraymen, Insecticides, sprayers etc.) and some costs 
represent time diverted from case detection and treatment (supervision 
by unit and district officers) . Thus all costs at district level can be 
regarded as variable, except for spraying's share of administrative 
overheads.
Table 6.1 shows 1984 spraying costs In NMEO districts. These represent 
the cost of delivering one cycle of DDT (In Morang and Rupandehl) and 2 
cycles of malathion. The table distinguishes between fixed and variable 
cost components and DDT and malathion areas. In Rupandehi, In order to 
divide costs (excluding Insecticide) between malathion and DDT areas, it 
has been assumed that the costs of delivering these Insecticides to the 
wall of a house are proportional to the distribution of sprayman days 
between insecticides. Thus non-Insecticide expenditure has been 
distributed to malathlon and DDT spraying In proportion to the number of 
sprayman days (22% to DDT, 78% to malathion).
Table 6.1 shows that In DDT areas, fixed costs make up around 25% of 
total costs, and In the one malathion area, 17%. The majority of fixed 
costs are Incurred at regional level, though NHQ fixed costs are also 
sizeable. Overall, fixed costs are relatively low.
The most immediately accessible Indicators of the level of output of the 
spraying programme are population covered and houses sprayed. The 
figures in Table 6.1, together with information from Parsa, have 
therefore been used to calculate spraying costs per house and per capita 
(see Table 6.2). The DDT unit costs refer to one cycle of spraying, and
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Table 6.1: Cost* of spraying in NMEO districts distinguished by fixed
and variable components.
Morang < .... Rupandehi
DDT
(R«>
DDT
(R*>
Malathion
(R»)
Fixed
district
- spraying 0 0 0
- administration 15.294 8,575 30,404
- total (% of fixed) 15,294(14») 8,575(13») 30.404(13»)
region
- spraying 56.928 22,142 78,503
- administration 10,037 10,135 35,931
- total (% of fixed) 66,965(61«) 32,277(50») 1 1 4 ,434(49«)
NHQ
- spraying 5,744 3,628 12,864
- administration 22.463 20,269 71,862
- total (% of fixed) 28.207(25%) 23,897(37») 84,726(37»)
Total fixed (% fixed) 110.466(100») 64,749(100») 229,564(100»)
(% of total) (25*) (21*) <17»)
Variable
- wages 30,876 36,245 128,506
- insecticide 259,096 194,140 922,766
- sprayers 27,433 6,035 21,398
- other district 13,550 6,123 21,709
- fuel for dumping 3,093 1.412 5,005
Total variable 334,048 243,955 1,099,384
(% of total) (75») (79*) (83%)
Total 444,514 308,704 1,328,948
(100«) (100*) (100%)
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Tabla 6.2: Spraying coata per houae and par capita par cycle
Coat
component
Morang
DDT(a)
(Ra)
<--Rupandehl----->
DDT(b) Malathlon(c) 
(Ra) (Ra)
Parsa
Malathlon(d)
(Ra)
(Number of houses) (7.329) (5,112) (12,684) (17,698)
Per house fixed
- district 2.09 1.68 2.40 1.50
- region 9.14 6.31 9.02 N/A
- NHQ 3.85 4.67 6.68 N/A
- total 15.08 12.66 18.10 N/A
Per house variable 45.58 47.72 86.67 123.70
Total district fixed
plus variable 47.67 49.40 89.07 125.21
Total per house cost 60.66 60.38 104.77 N/A
(Population) (40,221) (30,819) (84,663) (130,195)
Per capita fixed
- district 0.38 0.28 0.36 0.20
- region 1.66 1.05 1.35 N/A
- NHQ 0.70 0.78 1.00 N/A
- total 2.74 2.11 2.71 N/A
Per capita variable 8.31 7.92 12.99 16.82
Total district fixed
plus variable 8.69 8.20 13.35 17.02
Total per capita coat 11.05 10.03 15.70 N/A
(a) 1.5 gm of a.l. per sq.m. 1984; one cycle only
(b) 1.5 gm of a.l. per sq.m. 1984; one cycle only
(c) 50% at 1 gm of a.l. per sq.m.; 50% at 2 gm; two cycles
(d) 2 gm of a.l. per sq.m.; two cycles
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the malathion coats have been averaged over the output of both cycles. 
The unit costs therefore represent a cost per cycle and would need to be 
multiplied by two to give an annual cost. 'Houses' rather than total 
buildings (houses plus structures) has been used as the unit of output 
in order to approximate costs per household. The table has been laid 
out so that comparison can be made both for district-level costs between 
NMEO and ICHSDP districts, and for total costs between NMEO districts 
alone. In Parsa, the spraying programme 's share of administration costs 
has been treated as fixed, and all other costa as variable.
DDT costs per house and per capita are very similar in Morang and 
Rupandehl, at around Rs 8 per capita per cycle taking district costs 
only. Malathlon costs in Rupandehi are 60% higher, and in Parsa, more 
than double. The reasons for the difference between the Rupandehi and 
Parsa malathion unit costs can best be explored by disaggregating the 
unit cost:
Cost component Rupandehi
(Rs per capita)
Parsa
(Rs per capita)
District ■- fixed 0.36 0.20
Variable - malathlon 10.90 14.14
- other 2.09 2.68
Total 13.35 17.02
As explained in the footnotes to Table 6.2, Rupandehi used an average 
dose of 1.5 gm ai per sq.m. (50% at 1 gm and 50% at 2 gm) and Parsa, 2 
gm. However, Parse's insecticide cost is slightly less than would be 
expected from the dosage, suggesting either that there was less wastage 
or less strict adherence to dosage in Parsa. Parse's district overhead 
costs were less, but non insecticide variable costs more.
When comparing DDT and malathion, this analysis shows how important it 
is to take into account all aspects of the insecticides including the 
dosage required and their persistence. The border prices used in this 
analysis to value insecticide are quite similar for DDT (Rs 34.96/kg) 
and malathion (Rs 35.24/kg). Malathlon, however, is double the cost of 
DDT when the quantity used per house or per capita per cycle is 
considered. For example, the insecticide cost per capita was Rs 6.44
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for DDT in Morang, Rs 6.30 for DDT in Rupandehi, Rs 10.90 for malathlon 
in Rupandehi, and Rs 14.14 for malathlon in Parsa.
Moreover, the length of tine for which the insecticide reaains effective 
should be taken into account. This can be done by calculating a cost 
'per month of protection' . If we assume that DDT confers protection for 
6 months, malathion at 1 gm a.i. per sq.m, for 2 months and malathion at
2 gm for 3 months (based on Fontaine 1978), then total unit costs are:
DDT: Rs 1.76 per person per month of protection
(average of Morang and Rupandehi costs)
Malathion: Rs 6.28 per person per month of protection
(Rupandehi costs, protection estimated at 
average for 1 gm and 2 gm, le 2.5 months).
In order to Include consideration of Parsa where malathlon at 2 gm of 
a.l. per sq.m, was sprayed, costs at district level can be calculated:
DDT: Rs 1.41 per person per month of protection
Malathlon: Rs 5.34 per person per month of protection
(Rupandehi)
Rs 5.67 per person per month of protection
(Parsa)
These costs can be used to explore the trade-off between the Increased 
period of protection resulting from a higher dosage and the Increased 
cost. If Rs 13.35 (Rupandehi) protects for 2.5 months and Rs 17.02 
(Parsa) protects for 3 months, then the extra half month's protection is 
gained at an Incremental cost of Rs 3.67. Whether this cost Is 
worthwhile can only be judged In terms of the additional cases 
prevented, which will be Influenced by the length of the transmission 
season, and whether protection Is required beyond 3 months. In which 
case It may be more economical to repeat the spray cycle rather than 
extend the duration of its effect.
Fleam (bendiocarb) was sprayed In place of DDT in 1985. Information was 
therefore not available for this study on the actual costs of spraying
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Fleam (other then the purchase and freight costs), but a comparison can 
be made with DDT and malathlon on the basis of plausible assumptions.
A recent study (Phillips and Mills 1987) compared the operational costs 
for DDT, malathlon and Fleam. Only those costs likely to differ between 
the Insecticides were calculated. The operational costs per structure 
of Fleam (excluding Insecticide) were very close to those of DDT. Here, 
therefore, the cost of spraying Fleam Is taken to be the difference 
between the total variable cost per house and per capita and the 
Insecticide cost for DDT. Information on quantities sprayed and houses 
and population covered for Fleam Is taken from 1985 statistics for 
Morang (1 cycle) and Rupandehl (2 cycles). Only variable costs have
been calculated since fixed costs for Fleam were not known. They would 
not change the ranking of Insecticides.
Table 6.3 shows the resulting unit costs. The higher cost of the first 
cycle of Fleam In Rupandehl Is explained by greater quantities of 
Insecticide used per house. Fleam Is over twice as expensive per house 
or per capita per cycle as DDT, and 23% per house and 31% per capita 
more expensive than malathlon. The difference between the per house and 
per capita comparisons stems from differing average household sizes In 
the Fleam and malathlon areas.
The next step In this analysis should be to move from Indicators of 
level of activity as units of output to indicators of change In health 
status. If there are grounds for believing that the interventions being 
compared are similarly efficacious (as, for example. In the case of the 
different Insecticides compared above which have been field-tested In 
Nepal and found to be effective in killing mosquitoes), then indicators 
of activity, adjusted for the period of residual action of each 
insecticide, are adequate measures of output.
However, these units of output do not permit comparisons to be made 
between alternative vector control methods or between vector control and 
other control methods such as case detection and treatment. For these 
comparisons, an Indicator of output such as cases prevented is required.
Unfortunately, there Is very little evidence In Nepal on the 
effectiveness of spraying In terms of cases prevented. On the whole,
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Tsble 6.3: Comparison of the variable 
Malathlon and Fleam
costs per cycle of DDT,
Insecticide
DDT (a) Malathlon (a) Fleam b)
Cost per house per cycle (Ra)
Morang 45.58 - 97.23
Rupandeh1 47.72 86.67 132.56 (c)
106.97 <d>
CoMi sex c a p i t a  pgr cycl* (R»3
Morang 8.31 - 17.22
Rupandeh1 7.92 12.99 22.09 (c)
16.97 <d)
(a) Variable costs only (taken from Table 6.1).
(b) Assuming non-Insecticide variable costs per house and per capita 
are the same as DDT. Quantities and coverage taken from 1985 
spraying cycles.
(c) First cycle
(d) Second cycle
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spraying has continued on the assumption that it must be effective, as 
it was initially in controlling malaria in the 1950s and 1960s, rather 
than on the basis of good evidence about continuing effectiveness. 
Successive reviews of the control programme have compared the timing and 
level of cases between sprayed and unsprayed areas but have been unable 
to draw conclusions because the comparison has not formed part of a 
carefully designed study: for example those areas sprayed are those 
where transmission is expected to be more intense and thus they are not 
necessarily comparable to unsprayed areas, and the normal case detection 
system has been relied on to indicate number of cases.
Reviews have also looked at the trend of malaria incidence over the 
transmission season in relation to the timing of spray cycles, a 
frequent comment being that insecticide was applied too late to stop 
transmission (HMG/WHO/USAID/ODA 1984) . Perhaps the most detailed review, 
though still relying on programme data, was done by the 1988 external 
review team (HMG/WHO/USAID/ODA/JICA 1988). It comments that:
"On a village by village assessment of spraying, it is apparent 
that certain insecticides, applied in a timely manner, impact on 
malaria transmission whereas in the same districts others appear 
to have little effect on transmission. Any one of several factors 
can be responsible for failure of an applied Insecticide (vector
resistance or behaviour, timing of application etc.). From....
Unit data in the Far Western Region two trends can be observed. 
First, summer application of DDT had some dampening effect on 
malaria case incidence in the early summer but a sharp build up is 
noted starting in mid June. Second, insecticide application for 
the Autumn is just before or right at peak transmission. Upon 
comparison of data from sprayed and unsprayed areas of Kailali 
district similar trends are observed. The effect of DDT in the 
summer cycle, however, is somewhat limited, if at all. Fleam 
application in the autumn cycle has a more pronounced effect on 
the reduction of malaria transmission relative to the unsprayed 
areas where transmission continues at a fairly high level for an 
additional 2 months. Nevertheless, Ficam application was somewhat 
after the main peak of malaria transmission. Application of 
effective insecticides 4 to 6 weeks earlier is Indicated in most 
of the Far West Region to prevent the build up in transmission. 
Similar trends are observed in other regions but in depth analysis 
was not possible due to time limitations."
In 1987, because of concern that the effectiveness of spraying was not 
known, two small scale studies were set up in the Central and Western 
Regions, one locality being sprayed and another unsprayed in each region 
(Webber 1987). Parasitological results from a mass blood survey and 
serological profiles were used to check the localities were comparable.
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A comparison of cases In tha 2 localities in the Central Region showed 
no marked difference between the sprayed and unsprayed areas, suggesting 
that surveillance alone might have been sufficiently effective. In the 
Western Region study, the trend of cases from one small area which was 
sprayed in August showed that by September residual spraying was having 
no effect, possibly because the vector was exophillc and exophaglc.
Another reason for a lack of impact of spraying can be local customs, 
especially those of replastering houses twice a year and sleeping 
outside. In the patient survey, 65% of households whose house had 
recently been sprayed said tbey had replastered since then. In 5 out of 
the 6 districts in the survey, the majority of male malaria patients 
slept outside, and only a slightly lower proportion of women.
It Is clearly difficult to generalize about the effectiveness of 
residual spraying. If properly applied, in some areas It can be highly 
effective, In others not effective due to vector or human behaviour or 
unnecessary because of local Influences on transmission (for example 
transmission occurring in forest areas not In the sprayed, settled 
villages). Not Infrequently, factors to do with the application of 
insecticide (especially timing of spray cycles) have reduced any 
potential effectiveness. It Is clearly very Important to distinguish 
between the effectiveness of residual Insecticide spraying under ideal 
conditions and under normal programme and field conditions.
Because no clear-cut conclusions are possible on the effectiveness of 
spraying, no further calculatlona of cost-effectiveness are made here, 
discussion on the relative cost-effectiveness of alternative vector 
control and alternative malaria control methods being delayed to Chapter 
8 .
Costs to individuals
Unlike case detection and treatment strategies, residual spraying 
requires little action by Individuals and thus imposes few costs on 
them. Those costs that may arise stem less from the active participation 
of householders than from the unwanted side-effects of spraying. The 
main activity required of households is to vacate their houses and
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remove foodstuff* and utensils for 3 hours. The time (and hence cost) 
Implications of this are likely to be Insignificant.
Potential side-effects differ between Insecticides. DDT and Malathlon 
seem not to have caused 111-effects amongst the population at large, 
though In 1985 there were a few reports that children were occasionally 
affected to a minor extent by Fleam, but only If they returned to their 
houses too early or Instructions to sweep up and burn residues were not 
followed (Phillips and Mills 1987). Domestic birds and animals are 
occasionally affected by Insecticides.
A more serious problem from the perspective of malaria control Is the 
smell and residue left by the spraying of Insecticides which may lead 
households to refuse to allow their houses to be sprayed or to replaster 
soon after spraying. This appears to be mainly a problem with Malathlon. 
In contrast, Fleam lacks both smell and residue.
Finally, spraying confers some benefits to householders, in reducing the 
nuisance effect of insects and killing bed bugs (until they develop 
resistance).
None of these costs or benefits are readily quantified or valued. Since 
they are likely on the whole to be Insignificant, no attempt at 
quantification or valuation is made. However, they may be of some 
Importance in influencing compliance and thus coverage rates.
6.2 Case detection and treatment strategies: costs to the government
Costs per capita
Case detection and treatment strategies financed by the NMEO 
surveillance programme (le excluding malaria volunteers) are considered 
here as a whole, and in the following section are analysed individually. 
Case detection and treatment strategies provide protection to the whole 
population, so It Is appropriate to express the cost as a cost per head 
of the population covered. Table 6.4 shows the per capita cost of case 
detection and treatment, listing the share of administration separately. 
Since the cost of management levels is not available for ICHSDP
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Tabi« 6.A: Cost per capita of casa dataction and treatment at district 
laval
<R»)
Rupandehi
<R«>
H a m
<R«>
Saptari
(R»)
Parsa
(Rs)
Case detection and 
treatment :
- case detection and 
treatment costs 2.26 2.99 7.47 0.67 0.91
- administration costs 0.14 0.11 0.88 0.08 0.01
Total cost 2.40 3.10 8.35 0.75 0.92
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districts. Table 6.5 shows psr capita costs by management level for NMEO 
districts only.
In Table 6.4, there Is a striking difference between the per capita cost 
of case detection and treatment In NMEO and ICHSDP districts. NMEO costs 
In Morang are more than double and In Rupandehl, more than triple the 
costs In Saptarl and Parsa. Administration allocated to case detection 
and treatment takes up a relatively small share In the four districts, 
and the difference between them lies In the cost of the case detection 
and treatment network.
In ICHSDP districts, case detection Is only one of 8 tasks of a VHW, and 
so the cost Is likely to be significantly less than In an NMEO district 
where the MFW spends all his time on case detection. Moreover, In 
ICHSDP districts, treatment is carried out when required, using staff 
time diverted from other activities. Thus the nature of the costs In 
the two patterns are different: in ICHSDP districts, costs per capita 
will respond to changes in the number of cases, whereas In NMEO 
districts, they will largely remain fixed due to the high proportion of 
labour costs in total costs. This issue is Investigated further below 
In relation to the cost of case detection and treatment per unit of 
Intermediate and final output (costs per slide and per case).
In Ilam, an NMEO hill district, per capita costs are around three to 
four times as great as the NMEO Terai districts. This partly reflects 
higher rates of pay and allowances for staff in Hill districts, and 
partly the costs of maintaining a case detection and treatment network 
In a difficult terrain, with a scattered population. Ham's share of 
regional and NHQ costs is relatively high on a per capita basis because 
administration is the largest programme at regional and national levels, 
and this is allocated to Ilam on the basis of its share of expenditure 
and thus reflects its high costs.
Case detection and treatment costs per slide and per case (excluding 
parasitology)
Since case detection and treatment strategies are directed towards the 
taking of blood slides and detection of malaria cases, the most 
appropriate indicators of activity are slides taken and cases detected
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Tabi« 6. S: Cost par capita by management level of casa detection and
treatment In 3 NMEO districts
Norang
<R«>
Rupandehi
( R * )
H a m
( R e )
Case detection, treatment 
(Including administration) 
- district 2.40 3.10 8.35
- regional share 0.21 OO 0.45
- NHQ share 0.27 0.36 0.70
Total 2.88 3.76 9.51
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and treated. Table 6.6 therefore shows the cost of case detection and 
treatment, expressed as per slide and per case, for the five districts. 
This cost excludes parasitology and In NMEO districts, health education. 
It thus represents the cost of district, unit office and health post 
staff and supplies required for detection and treatment. The costs of 
parasitology, of health education and of the various case detection 
methods used by the NMEO surveillance programme are analysed in 
subsequent sections.
To look first at the three NMEO districts, cost per slide Is very 
similar between Morang and Rupandehi, but almost double In Ham. 
Because I lam has very few cases, Morang not many, and Rupandehi a lot, 
costs per case detected show a very different pattern. Morang cost per 
case is almost triple that of Rupandehi, and Ilam more than ten times 
higher. Virtually all costs can be regarded as fixed: the variable 
items such as drugs and forms take up only 5% of total costs. Therefore 
unit costs at different output levels show a direct (inverse) 
relationship with output. The high cost of a surveillance system when 
incidence is low Is evident.
As discussed earlier, the integrated districts, Saptari and Parsa, do 
not have the same high fixed costs because time is diverted from other 
activities when necessary. Cost per slide in Saptari is very similar to 
that in Morang and Rupandehi, and in Parsa it is lower. However, the 
slide positivity rate is much higher as might be expected when 
surveillance staff have other responsibilities and are less inclined to 
probe for fever episodes. Whether a slide is taken or not will then 
depend more on the patient, and a higher proportion of slides are likely 
to be positive. Thus the costs per case in Saptari and Parsa are higher 
than that of Rupandehi, though below that of Morang.
It is interesting to contrast the cost per capita in the two ICHSDP 
districts shown in Table 6.4 with the costs per slide and per case shown 
here. Costs per capita were two to three times higher in the two NMEO 
Terai districts than in the two ICHSDP Teral districts. However 
relatively fewer slides are taken and cases detected in the ICHSDP 
districts, so despite their relatively low proportion of fixed costs, 
their costs per slide are very close to Morang and Rupandehi, and per 
case lower than Morang but higher than Rupandehi.
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Table 6.6: Casa detection and treatment (CD 6 T) costs par slide and
per case
(•) (•) (s) (b) (b)
Cost Morang ! * y H a m Saptari Parsa
component (Rs) (Rs) (Rs) (Rs) (Rs)
(Number of
slides) (76,192) (74,340) (17,596) (19,345) (24,094)
District:
- CD & T 11.78 12.09 21.28 11.55 8.91
- administration 0.69 0.42 2.49 1.43 0.11
- total 12.47 12.51 23.77 12.98 9.02
Region:
- CD & T 0.33 0.34 0.16 N/A N/A
- administration 0.45 0.50 0.97 N/A N/A
- total 0.78 0.84 1.13 N/A N/A
NHQ :
- CD & T 0.17 0.24 0.12 N/A N/A
- administration 1.01 1.00 1.63 N/A N/A
- total 1.18 1.24 1.75 N/A N/A
Total cost per
slide 14.43 14.59 26.65 N/A N/A
(Number of cases) (615) (1556) (67) (297) (296)
District :
- CD & T 1460 578 5588 752 725
- administration 85 20 654 93 9
- total 1545 598 6242 845 734
Region:
- CD & T 41 16 43 N/A N/A
- administration 56 24 253 N/A N/A
- total 97 40 296 N/A N/A
NHQ:
- CD & T 21 11 33 N/A N/A
- administration 125 48 427 N/A N/A
- total 146 59 460 N/A N/A
Total cost per
case 1788 697 6998 N/A N/A
(a) Cost of the surveillance programme which covers ACD and PCD except 
volunteers. Health education and parasitology excluded.
(b) Cost of case detection and treatment, excluding parasitology.
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A most important consideration is the efficiency of the case detection 
system in terms of the proportion of total cases detected. 
Unfortunately, total cases are not known, and could not be investigated 
within the scope of this study. Further investigation of this issue 
would be well worth while, since it might change the relative cost- 
effectiveness of NMEO and ICHSDP districts.
Parasitology
Table 6.7 shows the cost of parasitology expressed as a cost per slide. 
This represents the cost of slide examination, excluding the cost of 
transporting the slide to the laboratory which is included within the 
case detection and treatment cost. In the two NMEO districts with a 
malaria clinic, Morang and Rupandehi, the cost of both clinic and 
district laboratories are included. This is disaggregated in Table 6.9.
Costs per slide are similar in all districts, being Rs 1.74 to Rs 2.03 
except in Morang which is significantly cheaper. In NMEO districts, 
regional and NHQ costs make up 20-37% of total costs per slide. This 
high overhead cost probably reflects the emphasis given to cross­
checking the performance of district laboratories. Calculation of the 
regional and national costs of cross-checking and expressing them per 
positive slide erroneously classified at district level as negative 
would help to establish the optimum level of quality control. If the 
unit cost exceeded the cost per case detected through case detection 
activities, it could be argued that the level of cross-checking should 
be decreased, and vice versa if the opposite were found.
Health education
In NMEO districts, the health education programme finances the support 
to volunteers and community education on malaria. In the cost analysis 
(see Annex 2) costs paid by other programmes but belonging to health 
education were transferred, so the cost of the programme shown here is 
higher than that shown in the NMEO accounts. The cost of community 
education could not be separated out, so all programme costs are 
attributed to PCD (V).
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Tabi* 6.7: Parasitology costs par allda
Cost
component
Morang
(Rs)
Rupandehl
(R«)
H am
(R*)
Saptarl
(R«)
Parsa
(R«>
(Number of
slides) (80,071) (83,450) (20,606) (19,345) (24,094)
District:
- parasitology 0.97 1.95 1.54 1.63 1.78
- administration 0.08 0.08 0.20 0.20 0.02
- total 1.05 2.03 1.74 1.84 1.80
Region:
- parasitology 0.35 0.40 0.16 N/A N/A
- administration 0.05 0.10 0.08 N/A N/A
- total 0.40 0.50 0.24 N/A N/A
NHQ:
• parasitology 0.10 0.12 0.06 N/A N/A
- administration 0.12 0.20 0.13 N/A N/A
- total 0.22 0.32 0.19 N/A N/A
Total cost per
slide 1.67 2.85 2.17 N/A N/A
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Table 6.8 shove the cost per slide and per case of case detection 
through PCD (V). The figures show large variation, with Rupandehl being 
particularly low in terms both of cost per slide and per case. The I lam 
cost per slide is mid-way between Rupandehl and Morang, but is very high 
when expressed per case because of the low number of cases in Ham. 
Around 80% of programme costs are incurred at district level, a slightly 
lower proportion than in the surveillance programme (Table 6.6).
These unit costs cannot be directly compared with the costs of case 
detection in the surveillance programme because the latter programme 
provides radical treatment for cases detected through PCD (V). In the 
section below, therefore, an attempt is made to separate the costs of 
the various case detection mechanisms and of radical treatment, in order 
to be able to make an appropriate comparison between case-detection 
mechanisms.
6.3 Comparison of case detection and treatment mechanisms
Costs to the government and cost-effectiveness estimates
The discussion above of the cost of case detection and treatment 
mechanisms lumped all mechanisms (except volunteers) together. It is 
important, although difficult, to look separately at each mechanism. 
Two important points, however, must be made.
Firstly, of the case detection mechanisms only PCD (V) has its own 
accounts. Thus the costs of the surveillance programme have to be 
broken down by case detection method. Many of the costs are joint 
between the methods, so the allocation of costs is to some extent 
arbitrary. The method used is described in Annex 2. The costs can only 
be approximations, representing the right order of magnitude but not 
necessarily the exact cost.
Secondly, comparison between each other and between districts of the 
unit costs of different case detection methods is complicated by the 
fact that they do not operate independently of each other. The yield of 
AC D  for example, will be affected by whether a PCD volunteer is 
available in the neighbourhood. In recent years, the PCD network in 
NMEO districts has been much expanded and this is reflected in an
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PCD (V).
Table 6.8: Costs per slide and per case of case detection through
Cost
component
Morang
(R*>
Rupandehi
(Rs)
H a m
(Rs)
(Number of
slides) (3879) (9110) (3010)
District:
- health educ. 42.24 11.77 28.26
- administration 2.73 0.47 3.46
- total 44.97 12.24 31.72
Region:
- health educ. 2.33 0.98 0.39
administration 1.79 0.56 1.34
- total 4.12 1.54 1.73
NHQ:
- health educ. 3.94 1.30 1.31
- administration 4.00 1.11 2.26
- total 7.94 2.41 3.57
Total cost per
slide 57.03 16.19 37.02
(Number of cases) (145) (752) (21)
District:
- health educ. 1130 143 4050
- administration 73 6 496
- total 1203 149 4546
Region:
- health educ. 62 12 56
- administration 48 7 192
- total 110 19 248
NHQ:
- health educ. 105 16 188
- administration 107 13 324
- total 212 29 512
Total cost
per case 1525 197 5306
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Increasing proportion of cases being detected through PCD rather than 
ACD mechanisms. Information from the patient survey suggests that there 
can be very little difference in the number of days between the start of 
the fever and slide collection for the different slide collection 
mechanisms. In Rupandehl, for instance, the mean time-lag for ACD was 
8.0 days (SD 7.5) and for all PCD 7.1 days (SD 6.7), with PCD (MC) 
having the shortest delay (mean of 6.6 days, SD 6.3) and PCD (H) the 
longest (mean of 9.1 days, SD 7.4). The distribution of the time-lag 
between start of the fever and slide collection was positively skewed. 
A logarithmic transformation was therefore applied and a geometric mean 
calculated. For Rupandehl, the geometric mean time-lag for ACD was 6.2 
days, for all PCD 5.5 days, for PCD (MC) 5.2 days and for PCD (H) 7.2 
days (these differences were not significant at the .05 level).
Data from the household survey gives a more mixed picture. In Nawal 
Parasl, as In Rupandehl, the time-lag between the start of the fever and 
slide collection was only slightly longer for ACD (nean of 8 days, SD 
9.3) than for all PCD mechanisms (7.3 days, SD 7.8), and the time-lag 
for PCD (V) was shorter (6.5 days, SD 6.4) and for PCD (M) longer (10.5 
days, SD 10.7). However in Dhanusa, PCD mechanisms consistently showed 
a significantly (P < .05) shorter time-lag (mean of 4.1 days, SD 6.9) 
than ACD (6.0 days, SD 6.6).
In summary, it appears that there Is a tendency for the delay between 
the start of the fever and slide collection to be least for PCD 
mechanisms, notably for PCD (MC) and PCD (V). However, the differences 
are relatively small, suggesting that the population cannot be 
distinguished clearly into two groups, one which waited for an ACD 
worker and the other which used PCD mechanisms. Thus there is likely to 
be Interdependence between ACD and PCD mechanisms, the one being 
affected by the other. In particular, the better the PCD network, the 
lower is likely to be the yield of ACD.
In the household survey, all patients who did not visit a PCD mechanism 
were asked whether they knew where they could get free treatment. In the 
area studied in Dhanusa district, 73% did know, their main reasons for 
not attending a PCD mechanism being that the malaria field worker 
visited (34%), and that they waited for the malaria field worker (37%). 
A related reason was that a malaria volunteer visited the patient (4%).
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In the area studied In Naval Parasl, 59% of non-attenders at PCD places 
of treatment knew where to get free treatment, their reasons for not 
attending being similar (MFW visited 32%, waited for MFW 29%, malaria 
volunteer visited 8%). Only 11% of all cases surveyed in Dhanusa and 15% 
in Nawal Parasi did not know where to get free treatment for fever.
Information about sources of treatment for malaria thus seems to be 
relatively well disseminated in these areas. It seems likely that the 
ACD mechanism is used if an MFW happens to arrive at the house in the 
first few days of the illness, if he is known to be due to come, or if 
the patient's symptoms are particularly mild. Otherwise a PCD mechanism 
is used. Only 5% of patients in Dhanusa and Nawal Parasi said PCD 
mechanisms were too far to visit.
Despite this lnterdependance between the various types of case detection 
mechanism, it is nonetheless still useful to look at their unit costs, 
to assess their order of magnitude and potential for expansion. The 
costs of surveillance in the two ICHSDP districts are already 
approximations because of the problem discussed earlier of identifying 
malaria control costs. It was therefore felt not to be worthwhile to 
attempt to break down the ICHSPD cost data further, to distinguish the 
costs of ACD and PCD (H) and radical treatment. This section therefore 
considers the cost of case detection mechanisms in NMEO districts only.
Table 6.9 compares the cost to the NMEO of ACD/APCD and Follow-up, PCD 
(V) , PCD (MC), PCD (M) and PCD (H) . Since the claim these methods make 
on administration at all levels is assumed to be proportional to their 
costs, administration costs can safely be ignored in this analysis. 
Programme expenditure at Regional and NHQ levels does differ between PCD 
(V) and all other mechanisms, but these costs were explored in the 
previous section, are a relatively small proportion of total costs and 
f or simplicity are ignored here. Moreover, the relatively higher 
regional and national costs of the health education programme can partly 
be attributed to community education activities rather than to the PCD 
(V) network per se.
T he costs included under each heading in Table 6.9 need some 
explanation. Radical treatment costs are for the moment omitted. 
ACD/APCD/Follow-up includes the cost of MFWs, supplies and laboratory
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Table 6.9: Comparison of cost to the NMEO of case detection methods
Case detection 
method <R«)*
Rupandehi
(R*)
H am
(R»>
ACD/APCD/follow-UC
% of total slides 87» 85» 84«
Cost/sllde:
- case detection 9.41 6.72 15.22
- parasitology 0.91 1.72 1.54
- total 10.32 8.44 16.76
% of total cases 56% 42« 65»
Cost/case 
- case detection 1546 493 4598
- parasitology 149 126 465
- total 1695 619 5063
PCD (V)
% of total slides 5* 11» 15«
Cost/sllde:
- case detection 42.24 11.77 28.26
- parasitology 0.91 1.72 1.54
- total 43.15 13.49 29.80
% of total cases 19» 33» 24«
Cost/case:
- case detection 1130 143 4050
- parasitology 24 21 220
- total 1154 164 4270
PCD (MC)
% of total slides 4% 2«
Cost/alide:
- case detection 2.13 9.82
- parasitology 2.54 11.63
- total 4.67 21.45
% of total cases 2« 19«
Cost/case:
- case detection 477 44
- parasitology 569 52
- total 1046 96
(continued)
Table 6.9: Continued
Case detection 
method
Morang 
(R*)
Rupandeh1
(R«>
I lam
<R*>
PCD (M) (a)
% of total slides 2« 12« 2«Cost/slide:
- case detection 0.90 0.83 1.96
- parasitology 0.91 1.72 1.54
- total 1.81 2.55 3.50
% of total cases 15* 4«
Coit/case:
- case detection 13 9 89- parasitology 13 19 70- total 26 28 159
PCD (H) (b)
% of total slides 1« 1« <1*Cost/sllde:
- case detection 14.76 9.90 80.65- parasitology 0.91 1.72 1.54- total 15.67 11.62 82.19
% of total cases 7* 3«
Cost/case:
- case detection 312 106 686- parasitology 19 18 13- total 331 124 699
(a) Only drugs and supplies costed
(b) Costs to the NMEO only.
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examination. PCD (V) Includes the cost of the health education 
programme as described earlier, plus laboratory examination. PCD (MC) 
includes the cost of the malaria clinic in terms of staff, supplies and 
equipment. Unlike the others, PCD (M) and PCD (H) are not fully costed. 
PCD (M) is assumed to be a virtually cost-less addition to the work of 
the unit staff, requiring only drugs and supplies. For PCD (H) no 
attempt was made to assess the hospital's costs: the cost shown is 
purely that Incurred by the NMEO in supporting PCD (H).
MFWs (through ACD, APCD and Follow-up) account for 85% of slides, but 
42-65« of cases. PCD mechanisms, In contrast, pick up relatively more 
cases than slides. The main Impression from the unit cost data is that 
the same mechanism can have widely differing costs depending on the 
level of use. For Instance both PCD (V) and PCD (MC) In Rupandehi 
appear as very low cost ways of detecting cases. Yet the cost per case 
in Morang Is roughly ten times higher. Rupandehi had on average 0.4 
volunteers per 1000 population and Morang 0.2, and Rupandehi volunteers 
on average took more slides than Morang volunteers. Thus accessibility 
and use of volunteers was clearly less in Morang. In addition, support 
costs were greater because the whole of the cost of the MFW for health 
education was allocated to PCD (V), whereas in Rupandehi, half of the 
time of this worker was said to be used for radical treatment. In Ham, 
volunteers were clearly working as an Important supplement to the ACD 
system, with a cost per case detected that was significantly lower than 
ACD.
Malaria clinics appear to be a cheap way of obtaining and examining 
slides, the relatively high cost of slide examination as compared to 
district laboratory costs being offset by the low case detection cost. 
In terms of cost per case detected, malaria clinics performed well. The 
performance of the malaria clinics in Rupandehi owe much to their 
location: in two urban centres adjacent to areas with many cases.
PCD (M) is clearly well worthwhile. PCD (H) also is relatively cheap 
from the NMEO's point of view, though relatively few cases are detected.
Radical treatment and investigation of cases detected through ACD/APCD 
and Follow-up, PCD (V), PCD (M) and PCD (H) is done by unit offices, and 
in malaria clinics by their staff at the time of case detection. The
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total costa of case detection and treatment are shown in Table 6.10. 
For the malaria clinic, the cost of radical treatment la purely the cost 
of drugs, since all other malaria clinic costs have been attributed to 
case detection. For all other mechanisms, however, the cost represents 
the activities of the unit offices In radical treatment and 
Investigation. This analysis accentuates the difference between the 
cost per case of malaria clinics and all other mechanisms.
A fair comparison must take account of costs other than those falling on 
the government, namely the opportunity cost to volunteers of spending 
time on malaria case detection, and any difference In costs to 
Individuals arising from different mechanisms. These differences may 
stem from a propensity to pay for private sources of treatment and 
losses due to Inability to work through Illness that differ between the 
case detection mechanisms. Inclusion of these costs In the cost of case 
detection mechanisms Is Important not only in the comparison of case 
detection mechanisms but also In the comparison of this strategy of 
malaria control with that of vector control, since more cases of malaria 
are likely to occur with the former than the latter strategy, thus 
imposing greater costs on Individuals.
Costs to Individuals
(a) Costs to volunteers
The costs to volunteers of slide collection and giving presumptive 
treatment will depend primarily on the extent to which these activities 
are compatible with their main occupations and the amount of time 
required. Little information is available on the occupations of 
volunteers. In a hill district, Bhojpur, the following information was 
available In the 1984 Annual Report:
Teacher 36 
Farmer 11 
Official 19 
Merchant 5
From visits to volunteers In the Teral, It appeared that quite a large 
proportion were merchants, often drug sellers. Acting as a volunteer
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Tabi* (.10: Coat par caaa of caaa datactlon and radical treatment
Caae detection 
method (Rs)
Rupandehl
<R«>
H a m
<R*>
ACD/APCD/Fo 1 low • up 
Coat per case:
- detection 1695 619 5063
- radical treatment 364 172 1253
- total 2059 791 6316
PCD (V)
Cost per case: 
- detection 1154 164 4270
- radical treatment 364 172 1253
- total 1518 336 5523
PCD (MC)
Cost per case: 
- detection 1046 96
- radical treatment 2 2
- total 1048 98
PCD (M)
Cost per case : 
- detection 26 28 159
- radical treatment 364 172 1253
- total 390 200 1412
PCD (H)
Cost per case: 
- detection 331 124 699
- radical treatment 364 172 1253
- total 695 296 1952
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may well bring them a commercial advantage. In addition, the volunteers 
visited seemed not to find the duties required onerous. The number of 
slides per volunteer per year Is low (35 In Morang, 57 In Rupandehl, 50 
In H a m  In 1984), so little time Is required. For all these reasons, no 
opportunity cost Is attributed here to volunteers' time. Even If It 
were, the effect would be Insignificant. For example, 50 slides a year, 
at 10 minutes per slide, gives a total of 8 1/2 hours per year, or one 
day's work.
(b) Costs to individuals: private expenditure associated with 
treatment
Expenditure by individuals which Is associated with treatment for the 
malaria episode may have a number of causes:
• purchase of drugs, special foods etc;
- consultations with private practitioners;
travel costs of visiting a PCD mechanism or private practitioners.
In addition, Individuals detected through a particular method may be 
more or less likely to spend money on drugs, medical advice etc. For 
Instance malaria patients may have to spend money on transport In order 
to reach a PCD post. Travel to PCD (H) or PCD (MC) will make other 
forms of care (drug sellers, private practitioners) more accessible and 
thus may encourage private expenditure on medical fees and drugs.
Information on expenditure on fees, drugs and laboratory examinations, 
special food, sacrifice and worship, and travel by malaria cases 
detected through different case detection mechanisms was collected In 
both the patient and the household survey. Their findings are rather 
different and so both are discussed here.
The results of the patient survey were reported in detail in Mills and 
Colbourne (1985) and are summarized here. Two districts are common to 
that analysis and this one, namely Morang and Rupandehl. Table 6.11 
thus shows mean expenditure by type of expense and case detection method 
for these two districts.
There are a number of problems with using this data in this analysis.
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Table 6.11: Private expenditure (Ra) per malaria case In Morang and 
Rupandehl, as Identified by the patient survey
Morang Rupandehl
Mean SD n Mean SD n
Fees : ACD 5.73 15.56 120 0.49 3.16 566
APCD 5.94 16.46 48 0.56 4.87 171
PCD(V) 5.00 16.92 30 0.27 2.61 434
PCD(MC) - - 0 5.71 9.10 404
PCD(M) 5.57 13.27 60 0.52 3.01 100
PCD(H) 2.86 10.69 14 0.54 3.69 46
MBS 33.33 57.74 3 0.50 2.74 30
Follow-up 0.56 2.32 36 0.00 0.00 54
ALL (a) 4.95 14.60 359 1.50 5.49 2022
Drugs : ACD 81.18 136.02 148 19.13 52.68 566
lab APCD 44.94 73.34 62 22.02 58.02 171
exams PCD(V) 65.20 173.21 35 24.10 72.51 434
PCD(MC) - ■ 0 34.12 51.25 404
PCD(M) 58.33 111.02 72 30.23 98.33 100
PCD(H) 48.84 62.99 19 8.20 13.01 46
MBS 170.00 286.85 4 13.37 37.29 30
Follow-up 9.32 17.35 38 4.15 10.21 54
ALL (a) 60.31 117.55 443 22.25 57.58 2022
Special:
foods ACD 8.48 25.93 120 4.36 21.06 566
APCD 2.76 10.95 49 6.56 46.93 171
PCD(V) 2.90 7.67 30 2.03 9.65 434
PCD(MC) . - 0 7.62 24.02 404
PCD(M) 12.50 38.35 59 5.62 17.17 100
PCD(H) 12.50 46.77 14 6.28 14.44 46
MBS 0.00 0.00 3 4.77 13.99 30
Follow-up 3.83 12.54 36 1.50 6.53 54
ALL (a) 7.10 25.12 359 4.38 22.01 2022
Sacrifice:
& ACD 9.99 34.07 121 0.60 4.78 566
worship APCD 5.29 16.90 49 0.20 2.05 171
PCD(V) 0.00 0.00 30 1.06 8.04 434
PCD(MC) - - 0 0.75 6.85 404
PCD(M) 8.61 30.98 59 0.63 4.04 100
PCD(H) 0.71 2.67 14 0.41 2.52 46
MBS 0.00 0.00 3 0.00 0.00 30
Follow-up 1.11 6.67 36 0.19 1.36 54
ALL (a) 5.88 24.84 360 0.61 5.57 2022
(continued)
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Table 6.11: continued
Morang Rupandehi
Mean SD n Mean SD n
Travel: ACD 5.53 26.86 148 1.17 7.71 566
APCD 2.42 6.82 62 1.19 6.31 171PCD(V) 0.77 2.86 35 2.03 24.65 434PCD(MC) - - 0 4.91 7.54 404
PCD(M) 10.03 31.05 73 0.99 3.55 100PCD(H) 1.42 4.78 19 0.13 0.88 46MBS 0.00 0.00 4 0.00 0.00 30Follow-up 0.79 3.59 38 0.20 1.37 54ALL (a) 5.63 31.37 444 1.98 19.92 2022
Total
expend- ACD 113.86 177.48 120 26.97 62.15 566iture: APCD 64.79 88.71 48 30.57 96.53 171(b) PCD(V) 80.63 202.07 30 30.93 93.88 434PCD(MC) - • 0 53.23 67.85 404PCD(M) 84.95 133.04 59 39.19 99.03 100PCD(H) 58.07 76.63 14 18.39 25.12 46MBS 261.67 380.60 3 18.63 39.66 30Follow-up 16.17 29.69 36 6.04 11.82 54ALL (a) 82.65 146.08 358 31.59 73.60 2022
(a) Includes PCD (unspecified) not shown separately
(b) Includes 'other' expenditure not shown separately
Source: Mills and Colboume (1985)
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Firstly its reliability la unclear, especially for Morang where reported 
expenditures seem extremely high (though one reason for this la that the 
survey found that higher levels of expenditure were In general 
associated with Imported cases, which made up a high proportion, 64%, of 
the Morang cases In contrast to 18% In Rupandehl) . Secondly, It Is
not possible to distinguish travel expenditure to a PCD mechanism from 
travel expenditure to other places of help, and thus to Include In the 
PCD cost an allowance for transport. Thirdly, the mean disguises a very 
wide range, as Indicated by the standard deviation.
The distribution of the data is highly positively skewed, with some very 
high values which Inflate the arithmetic mean. For example the 
arithmetic mean for all case detection mechanisms in Rupandehl was Rs 
31.59 and the geometric mean, Rs 7.44. Since the Morang data has some 
particularly extreme values, logarithmic transformation and calculation 
of the geometric mean reduces the differences between Morang and 
Rupandehl. For example the geometric mean for all case detection 
mechanisms In Morang was Rs 14.34, only double Rupandehl's geometric 
mean as compared to the more - than-four - fold difference between the 
arithmetic means.
Despite these problems with the data, some interesting impressions can 
be gained from Table 6.11. In Morang, the arithmetic mean expenditure of 
individuals detected through ACD Is more than if they are detected 
through PCD, especially on drugs. The geometric mean shows a less 
marked pattern Indicating that the ACD arithmetic mean Is influenced by 
some particularly high spenders. This may reflect a preference for 
self-treatment as opposed to seeking advice from the malaria service. 
Not surprisingly, the reverse Is true for travel expenses: Individuals 
attending PCD (M) spent double those d e t e c t e d  through ACD. 
Unfortunately no Information is available on PCD (MC) attenders.
In Rupandehi, the picture appears very different from Morang. 
Individuals attending PCD mechanisms, especially those attending PCD 
(MC), spend higher sums than those detected through ACD. PCD (MC) 
attenders stand out as spending significantly more (P < .05) than all 
other types of case. In particular they spent more o n  fees, drugs and 
laboratory examinations, special foods and travel, perhaps because of 
the close geographical proximity of malaria clinics to commercial
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sources of treatment. Total expenditure by PCD (MC) cases Is double 
that of ACD cases. Cases detected through other PCD mechanisms show a 
less clear pattern, total expenditure falling somewhere between ACD and 
PCD (MC) except PCD (H). In both districts PCD (H) attenders spend 
relatively low sums. As might be expected since some may be symptom­
less, follow-up cases spend least.
The data from the household survey shows a very different picture. In 
the survey area In Dhanusa, only 4% of patients Incurred expenditure on 
treatment but In Nawal Parasl, 45%. These compare with 70% of patients 
found to have Incurred expenditure by the patient survey In Rupandehl 
and Morang, and 76% In Bara, 60% In Sarlahl and Bhojpur and 47% In Dang, 
the other districts covered by the survey. Part of the explanation for 
the low proportion incurring expenditure on treatment In Dhanusa is 
likely to lie In the relative Isolation of the area (far from private 
sources of treatment) and In Intensive malaria control activities 
(because of persistent and relatively high levels of transmission) which 
made the Inhabitants more aware of and thus more likely to use the free 
malaria treatment services.
The amounts spent found by the surveys are also rather different. Of 
those patients who paid for treatment, the mean (standard deviation) was 
Rs 56 (Rs 126) in Dhanusa and Rs 35 (Rs 78) in Nawal Paras 1. These 
compare with figures from the patient survey of Rs 46 (Rs 85) in 
Rupandehl, Rs 123 (Rs 164) in Morang, Rs 49 (Rs 119) in Sarlahi, Rs 91 
(Rs 157) in Dang, Rs 91 (Rs 118) in Bara and Rs 119 (Rs 193) in Bhojpur.
Although these amounts seem on the face of it to differ considerably, 
they are reasonably consistent for similar districts such as Dhanusa, 
Nawal Parasi, Rupandehi and Sarlahi, all NMEO districts in relatively 
we 11-developed areas of the Outer Terai. Morang is the only Outer Terai 
NMEO district which has very different figures, and during the survey 
malaria staff in Morang did warn that in their opinion expenditure was 
being exaggerated.
An analysis by case detection mechanism of the data on expenditure from 
the household survey is shown in Table 6.12. In the survey area in Nawal 
Parasl, patients detected through PCD mechanisms spent more than ACD 
cases, and those detected by malaria volunteers the most. The data from
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Tabi« 6.12 Privata expenditure par salarla caaa by casa datactlon 
mechanism in tha survey areas in Dhanusa and Naval Parasi, 
as idantlfled by the household survey
Case detection 
mechanism
Dhanusa (Rs) Naval Parasi (Rs)
Mean SD n Mean SD n
ACD 1.3 7.9 59 12.5 27.3 58
APCD 1.4 6.8 34 18.8 34.6 23
PCD (V) 0.0 0.0 3 22.8 80.9 116
PCD (M) 0.0 0.0 5 15.3 24.3 42
PCD (H) - - 0 1.0 1.7 3
PCD(all) (a) 2.9 33.3 235 19.7 68.1 170
(a) Includes PCD (Unclassified)
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Dhanusa suggests a similar pattern, though is unhelpful for the various 
PCD mechanisms because the great majority of PCD cases were not 
classified by case detection mechanism. The difference in magnitude in 
the figures between Tables 6.11 (patient survey) and 6.12 (household 
survey) stems more from the differing proportions of patients who spent 
nothing than from the differing expenditures of those who spent 
something.
How can this information be used in the cost-effectiveness analysis? 
Both surveys suggest that the extent to which patients seek sources of 
treatment other than those offered by the NMEO and ICHSDP differs 
considerably between districts, and also, though to a lesser extent, the 
sums paid. It therefore seems best to use data relating to the two 
districts studied for the cost-effectiveness analysis, even though there 
are grounds for supposing that the way in which this data was collected 
may have biased the sums reported upwards.
Mean private expenditure per case for each case detection method, as 
identified by the patient survey for Rupandehl and Morang, is therefore 
added to the government cost per case of case detection and treatment. 
The resulting sums are shown in Table 6.13.
The inclusion of private costs associated with treatment does not alter 
the ranking of methods by cost per case, though in Rupandehl the 
distance between PCD(MC) and other mechanisms is narrowed.
(b) Costs to individuals: days of work lost
A cost is incurred by individuals if malaria prevents them from carrying 
out their normal activities and loss of earnings or production results. 
However there may be no, or a lesser loss to the household if other, 
underemployed household members replace the ill person; or no, or a 
lesser loss to society if the work that would have been done by the 
patient outside the household is done instead by a previously under­
occupied worker. This loss, if it exists, affects the choice of case 
detection method if use of one case detection method rather than another 
leads to a longer period of illness.
The information collected on likely production losses by the patient and
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Tabi* 6.13 Government end private coati of ceca detection and 
treatment
Cost per case <R«> <•>
Case detection method Mo rang Rupandehi
ACD/APCD/Fo 1 low - up
- government cost/case 2059 791
- private cost/case (b) 81 25
- total 2140 816
PCD (V)
- government cost/case 1518 336
- private cost/case 77 29
- total 1595 365
PCD (MC)
- government cost/case 1048 98
- private cost/case N/A 51
- total N/A 149
PCD (M)
- government cost/case 390 200
- private cost/case 81 37
- total 471 237
PCD (H)
- government cost/case 695 296
- private cost/case 55 17
- total 730 313
(a) Private expenditure has been roughly converted to economic 
prices by applying a conversion factor of 0.95.
(b) Weighted mean for ACD, APCD and Follow-up.
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household surveys was rather different. Since Information for the 
patient survey was collected by malaria workers as part of their routine 
activities, it was not possible to enquire In detail about the Impact of 
Illness on household economic activities. Instead, Information was 
simply sought on whether the patient regarded himself or herself as 
'normally working* , and how many days of work were lost as a result of 
the episode of malaria. Similar Information was sought about school 
attendance. In contrast, the household survey enquired In detail about 
both total and partial Incapacity caused by malaria, about whether the 
Illness Imposed an extra burden of work on household members and If so, 
who did this work and whether any problems resulted. Households were 
also asked directly whether they experienced any loss of cash Income as 
a result of the Illness, and whether they thought It likely that 
household production would be affected. The results are reported here In 
turn from the patient and household surveys.
Information from the patient survey of mean days of work lost and mean 
days of school lost by case detection method for those who declared 
themselves to work or attend school In Rupandehl and Horang Is shown In 
Table 6.14. On average, 8.3 days of work were declared to have been 
lost In Rupandehl and 14.5 In Morang as a result of the malaria episode. 
This period In Rupandehl matches reasonably well the time-lag between 
start of the fever and presusq>tlve treatment, which averaged 6.3 days. 
The same la not true, however, for Morang, where the mean time-lag 
between start of the fever and presumptive treatment was 6.6 days.
Differences In days of work lost between case detection methods are 
relatively small In Rupandehl, but cases attending malaria clinics seem 
to have a particularly short period of Incapacity. Conclusions are 
difficult to draw for Morang because the figures span a very wide range 
and the sample size la small for several of the mechanisms. However, 
there Is little difference In days of work lost between ACD and all PCD 
mechanisms.
Because of the skewed distribution of days of work lost, a logarithmic 
transformation was done and geometric means calculated. This procedure 
produces slightly lower means for Rupandehl but does not change the 
conclusion that there are no significant differences In days of work 
lost between case detection methods. For Morang, because there are some
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Tabi* 6.14: Mean days of work and school lost by casa datsctlon 
method, Morsng and Rupandehl
Case detection 
method
Rupandehl Morang
Mean SD n Mean SD n
Davs of work lost 
- ACD
per worker 
8.8 6.8 407 15.3 22.6 88
- APCD 8.9 6.3 138 12.3 17.2 42
- PCD(V) 9.1 7.5 368 24.6 44.2 20
- PCD(MC) 7.3 6.8 279 - - -
- PCD(M) 9.3 5.0 85 16.4 23.5 45
- PCD(H) 9.6 5.5 34 9.4 9.4 12
- MBS 9.9 7.7 23 90.0 0.0 1
- Follow-up 5.6 «0«n 44 5.5 8.2 27
- All PCD (a) 8.2 6.5 1090 15.1 23.8 155
- All 8.3 6.6 1564 14.5 22.9 271
Pay s  gf school lggt per school attender
- ACD 9.2 5.7 45 22.9 37.1 16
- APCD 8.3 5.6 16 4.0 4.4 5
- PCD(V) 11.0 7.1 26 6.0 1.4 2
- PCD(HC) 7.1 6.8 97 - - -
- PCD(M) 8.0 6.9 9 10.7 10.0 9
- PCD(H) 6.3 1.5 4 4.7 4.6 3
- MBS 14.0 10.8 4 - - -
- Follow-up 4.8 3.3 4 12.5 17.7 2
- All PCD (a) 8.0 6.8 164 9.1 9.1 24
- All 8.3 6.7 217 14.5 24.5 42
(a) Includes PCD (Unclassified)
Source: Mills and Colboume (1985)
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particularly extreme valuaa. tha geometric mean of days of work loat for 
all case detection mechanisms (5.9 days) is lower than that of Rupandehl 
(6.7 days). The conclusion stands, however, that there is no
significant difference In days of work lost between ACD and all PCD 
mechanisms in Morang.
As was apparent from the review In Chapter 2 of previous studies of 
■*l»rla which have estimated the likely economic loss resulting from 
malaria, the traditional, crude approach Is to estimate a total cost by 
multiplying days of work lost (or merely days of Illness) by some 
measure of the minimum or average wage. If this approach were to be 
adopted using the data from the patient survey, estimates could be made 
in the following way.
The survey form did not specifically enquire about lost wages, but In 
Rupandehl this Information was recorded for 1228 of the 1579 cases
'normally working'. It Is highly unlikely that such a high proportion 
of patients were wage labourers, and the majority of sums implied a wage 
P*r day of Rs 15. It appears that this wage may have been used as a 
means of valuing days of work lost; It Is also a reasonable reflection 
of local wage levels. Therefore Rs 15 per day could be used as a basis 
for valuing days of work lost. Since the main period of malaria
transmission occurs during and Immediately after the monsoon, when
farmers are busy planting and caring for crops, it can be argued that 
this figure need not be adjusted for seasonal under-employment. Although 
the age and sex pattern of malaria cases was analysed in the patient 
survey (see Mills and Colboume 1985), It would seem to be placing 
excessive emphasis on crude figures to make further adjustment to the 
value of days lost for age or sex. Therefore Rs 15 per day could be 
taken as the average cost (financial prices) per day lost by workers due 
to malaria, resulting In a total loss per episode of malaria of Rs 125. 
82% of patients declared themselves to work In Rupandehl, therefore this 
sum could alternatively be expressed as Rs 103 per malaria case.
The patient survey of malaria cases also provides Information on the 
proportion of malaria patients attending school. In total In the 6 
districts studied, 24.5% of patients were aged 5-14 years, and 38% of 
these normally attended school. This average conceals a large 
difference between males and females (49% of males and 23% of females
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attending school) and districts (from 7% attending school in Saptarl to 
36% in Morang and 43% in Rupandehl). Table 6.14 showed the mean days of 
school lost per school attender in Rupandehi and Morang, the figures 
reflecting fairly closely the pattern for each district shown by days of 
work lost. While illness can have an effect on school performance, it 
is not clear how to value that effect. Therefore the existence of a 
cost arising from school absence is noted here, but no attempt at 
valuation is made.
The household survey provides the data required to consider both the 
reliability of the above data on days of work lost and the 
appropriateness of the assumption that all days of work lost result in a 
cost. Mean days unable to work per worker infected were 3.8 (SD 3.2) in 
Dhanusa and 9.3 (SD 7.2) in Nawal Parasi. Per person unable to work (ie 
excluding those who lost no days) these figures were 4.7 (SD 3.0) days 
and 10.3 (SD 6.9) days. The mean days partially disabled per worker 
Infected were 0.99 (SD 2.1) in Dhanusa and 2.5 (SD 4.6) in Nawal Parasi. 
On these days, those partially disabled worked on average 280 (SD 104) 
minutes as opposed to a normal day of around 470 minutes in Dhanusa, and 
in Nawal Parasi, 205 (SD 111) minutes in contrast to a normal day of 
around 540 minutes.
This information from the household survey provides further evidence 
that the information on days of work lost from the patient survey is the 
correct order of magnitude. The difference in mean days unable to work 
between Dhanusa and Nawal Parasi is quite large, but this variability is 
repeated in the 6 districts covered by the patient survey. While mean 
days of work lost in Rupandehl were 8 days as reported above, the other 
districts surveyed had figures of 6 days (Sarlahi), 8 days (Bhojpur), 12 
days (Dang) , 13 days (Bara) and 15 days (Morang) .
Patients who were economically active were asked in the household survey 
whether anyone did extra work because of the malaria episode, only 38.5% 
responding yes in Dhanusa and 88.1% in Nawal Parasi. The great majority 
of episodes of malaria required assistance from only one person (83% in 
Dhanusa and 73% in Nawal Parasi), and the source of help was primarily 
the household (82% of helpers in Dhanusa and 88% in Nawal Parasi). Only 
10% of helpers in Dhanusa and 5% in Nawal Parasi were hired labourers. 
In Dhanusa, males and females were represented amongst the helpers in
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roughly equal nuibara, though In Nawal Parasl, 80* vara female. In both 
districts, the majority of female helpera were aged between 25 and 44 
years, though male helpers In Dhanusa were mainly in the age range 15 to 
54 and In Nawal Parasi, 35 upwarda. On average, total hours of help 
provided per episode of Illness where help was required was 33 hours 
(SD 31) in Dhanusa and 38 (SD 46) In Nawal Parasi (approximately 4 days 
in both districts) .
Where the malaria patient was a small child, the parents were asked 
whether any household member had to spend extra time In child care 
because of the illness. 80% of parents in Dhanusa and 94* in Nawal 
Parasi said yes. The carer was primarily the mother (89* of carers in 
Dhanusa and 83* in Nawal Parasi), and a mean of 4.9 (SD 3.3) days of 
extra care per child requiring extra care were provided in Dhanusa and
11.7 (SD 10) days in Nawal Parasl. Per child Infected, these means are 
3.9 (SD 3.5) and 10.9 (SD 10.1) days. The majority of carers spent from 
1 to 6 hours per day looking after the child. In both districts, 69* of 
carers were able to do their normal activities as well. Of those who 
could not, 36* in Dhanusa and 56* in Nawal Parasi received help, 
predominantly from other household members.
All households where help was required, whether this was because of a 
child's or adult's illness, were asked whether providing the help 
caused any problems. 75* of households in Dhanusa and 50* in Nawal 
Paraai said no. Of those families which had encountered problems, 
economic activities which suffered were suilnly agriculture in Dhanusa 
and to a lesser extent domestic work, and agriculture, domestic work, 
and animal husbandry in Nawal Parasl.
Those patients in households where no help was provided during the 
episode of malaria were asked why not. In Dhanusa, the main responses 
were no-one available (39*), help not needed (36*), availability of many 
household members/servants (24*), others could not do the patient's work 
(17*), and night fever (6*). In Nawal Parasl, 50* said that help was not 
needed, 27* that no-one was available, and between 7* and 10* gave each 
of the other reasons.
For the few households who hired labour to provide help, the mean cost 
was Rs 73 (SD Rs 47) in Dhanusa and Rs 74 (SD Rs 63) in Nawal Parasl.
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Per person Infected, this trensletes to means of Rs 1.6 and Rs 3.1.
All households were asked whether the Illness had caused any loss of 
cash Income other than payments for hired labour and medical care. 9% in 
Dhanusa and 20% in Nawal Parasl said yes, the main reasons being that 
the patient could not work as a wage labourer (92% in Dhanusa and 63% in 
Nawal Parasi) and that the patient could not do other types of work (25% 
in Nawal Parasl). Mean cash lost per household losing was Rs 169 (SD Rs 
156) in Dhanusa and Rs 138 (SD Rs 162) in Nawal Parasl. Translated into 
a mean per person infected, these figures convert to Rs 14 (SD Rs 65) 
and Rs 27 (SD Rs 90).
Patients were also asked whether they thought the malaria episode would 
affect production. 72% in Dhanusa and 71% in Nawal Parasi said no. 23% 
in Nawal Parasl said production would be affected because they could not 
cultivate their crops. This reason was also given by 7% in Dhanusa, 
further reasons being that agricultural implements were not made (5%) 
and that vegetables and wood were not sold (7%).
In summary, the great majority of households coped with the consequences 
of the malaria episode by drawing on household reserves of labour, 
primarily of adults rather than children. For 75% of households in 
Dhanusa the illness of a working household member caused no problems. 
This proportion was 50% in Nawal Parasl, perhaps because of the longer 
mean period of Illness. In Dhanusa, 91% of households experienced no 
cash loss (excluding hired labour and medical care costs) because of the 
Illness and in Nawal Parasl, 80%. Over 70% of households in both 
districts did not think household production would suffer. If the 
financial losses that were reported are expressed per case of malaria, 
they represent a mean of Rs 16 in Dhanusa and Rs 30 in Nawal Parasi. 
This contrasts with a figure of Rs 103 if the crude approach to 
valuation is taken of multiplying days of work lost by the local wage 
rate.
The first estimate is likely to be an underestimate because the value of 
the non-financlal production losses of the minority of households 
experiencing them are excluded; the second an over-estimate since it 
takes no account of the availability of spare capacity with the 
household.
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The sample size of the household survey is too small to permit a 
detailed analysis of losses by case detection mechanism. Moreover, as 
discussed later, the period of work lost Is Influenced by factors such 
as the species mix of cases, the delay between start of the fever and 
presumptive treatment and whether or not the patient has had previous 
episodes of malaria, all of which vary by district. Since the data In 
the household survey are not from Rupandehl or Morang, the districts 
being analysed here In the cost-effectiveness study, the data on days of 
work lost per worker by case detection mechanism from the patient survey 
are taken, but multiplied by the loss found by the household survey, 
expressed as a mean per worker per day of complete disability. This 
approach makes the assumption, probably realistic, that the factors 
mentioned above as affecting the Illness episode affect the length of 
disability (le number of days) rather than the severity of each day of 
Illness.
The result of this calculation Is a mean loss per worker per day of 
complete disability from the household survey of Rs 4.6 (Dhanusa) and Rs
3.7 (Nawal Parasl), rounded to Rs 4. This needs to be converted to a 
loss per person with malaria. In Rupandehl, 82» of malaria patients 
stated that they worked and In Morang, 79«. This gives a loss per 
malaria patient per day of Rs 3.3 In Rupandehl and Rs 3.2 In Morang. 
This loss, multiplied by the days of work lost by case detection 
mechanism, Is added to the coat per case of various case-detection 
methods In Table 6.15.
As with the Inclusion of expenditure by Individuals, Inclusion of losses 
due to inability to work does not change the ranking of methods and, 
indeed, increases the cost per case of malaria clinics by less than for 
other methods.
Speed of treatment
A final consideration In comparing case detection methods is the speed 
with which confirmed cases receive radical treatment. The longer the 
delay, the more likely that the initial case will lead to the Infection 
of others. Table 6.16 shows mean days from start of fever to radical
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Table 6.15: Costa of csss detection and treatment including value of 
losses due to inability to work (a)
Case detection 
method
Morang
<R*>
Rupandehi
(R*)
ACD/APCD/Foil ow - up
- total cost per case of treatment 2140 816
- value of days of work lost (weighted mean) 37 26
- total cost per case 2177 842
PCD (V)
- total cost per case of treatment 1595 365
- value of days of work lost 71 27
- total cost per case 1666 392
PCD (MC)
- total cost per case of treatment N/A 149
- value of days of work lost N/A 22
- total cost per case N/A 171
PCD (M)
- total cost per case of treatment 471 237
- value of days of work lost 47 28
- total cost per case 518 265
PCD (H)
- total cost per case of treatment 750 313
- value of days of work lost 27 29
- total cost per case 777 342
(a) Value of days of work lost has been converted to economic prices 
by multiplying by the conversion factor for unskilled labour of 
0.9.
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Tabl* 6.16: Number of days from start of currant favar to radical 
treatment, and from elide collection to radical treatment, 
by case detection mechanism.
....- -Rupandehl
Mean SD n Mean SD
(days) (days)
Start of fever to 
radical treatment:
ACD 30.3 18.9 147 19.4 14.4 570
APCD 30.1 19.4 62 17.3 11.1 173
PCD(V) 28.5 12.9 35 16.4 8.6 435
PCD(MC) - - 0 6.8 6.7 402
PCD(M) 19.8 15.0 70 15.8 8.1 100
PCD(H) 30.2 11.6 18 22.7 12.3 47
MBS 24.0 11.3 2 21.4 21.8 30
Follow-up 29.7 20.8 34 15.7 12.0 55
Slide collection to 
radical treatment:
ACD 23.4 16.4 147 11.4 12.4 570
APCD 23.2 16.8 63 9.5 7.4 173
PCD(V) 21.6 11.0 35 8.9 5.7 435
PCD(MC) - - 0 0.3 2.6 393
PCD(M) 12.9 12.3 71 8.4 6.0 100
PCD(H) 25.3 10.7 18 13.6 9.3 47
MBS 11.7 5.5 3 13.6 19.6 30
Follow-up 21.9 16.2 38 12.1 12.7 58
Source: Mills and Colbourne (1985)
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treatment, and from elide collection to radical treatment, by slide 
source, for Morang and Rupandehi.
The two districts differ in the speed with which cases receive radical 
treatment, but both display similar patterns. PCD cases in general are 
treated more quickly. Mean days for PCD (V) reflects well on the 
support provided to the volunteer system. PCD (M) may be relatively 
fast because cases live near the malaria unit office. PCD (MC) is very 
fast because immediate radical treatment is usually given. Why PCD (H) 
is relatively long is not clear, unless couriers collect slides less 
frequently than from other PCD mechanisms.
In general, therefore, the PCD mechanisms perform well in terms of the 
speed with which cases are detected and treated.
6.4 Summary
This chapter has analysed the cost and cost-effectiveness of malaria 
control strategies, facilitating a comparison of alternatives both 
within and between strategies. It has analysed costs both to the 
government and to malaria patients and their households.
With respect to the strategy of spraying, fixed costs made up 25% of 
total costs for DDT, and 17% for malathion. The district cost per 
capita per cycle was around Rs 8 for DDT and Rs 13 to Rs 17 (depending 
on the dosage) for malathion. Total costs per capita per cycle were Rs 
10-11 for DDT and a minimum of Rs 16 for malathion. Because of the 
differing persistence of DDT and malathion, the difference between them 
was Increased when a cost per person per month of protection was 
calculated: Rs 1.41 for DDT and Rs 5.34 to Rs 5.67 for malathion 
(district costs).
A rough estimate of the cost of spraying Fleam indicated that it was 
over twice as expensive per capita as DDT, and a third more than 
malathion.
No cost of spraying per case prevented could be calculated bectiuse of 
the absence of reliable data on the effectiveness of spraying. However, 
what data existed was reviewed and it was concluded that if insecticides
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were properly applied, spraying could be highly effective In some areas 
and Ineffective In others because of human or vector behaviour or 
unnecessary because of local Influences on transnlsslon. Not 
Infrequently, poor application practices had reduced any potential 
effectiveness.
The cost and effectiveness of case detection and treatment strategies 
were analysed first for all case detection strategies taken together 
(excluding volunteers) In Integrated and non-Integrated districts, and 
subsequently for each case detection strategy In non-Integrated 
districts.
The district cost per capita of case detection and treatment was Rs 0.75 
and Rs 0.92 In the two Integrated districts (Saptarl and Parsa), and Rs 
2.40, Rs 3.10 and Rs 8.35 In the three non-Integrated districts (Morang, 
Rupandehl and Ilam). Costs were low In Integrated districts at least 
partly because manpower was diverted to malaria control when required; 
total costs thus changed as the number of cases changed whereas In non- 
Integrated districts virtually all costs were fixed.
District costs per slide taken (excluding parasitology) were Rs 9.02 
(Parsa), Rs 12.98 (Saptarl), Rs 12.47 (Morang), Rs 12.51 (Rupandehl) and 
Rs 23.77 (Ilam). District parasitology costs per slide were around Rs 
1.80 In Integrated districts and Rs 1.05 to Rs 2.03 In non-Integrated 
districts.
District costs per case (excluding parasitology) were Rs 734 In Parsa, 
Rs 845 In Saptari, Rs 598 In Rupandehl, Rs 1545 In Morang and Rs 6242 In 
Ilam. Since virtually all costs In non-Integrated districts were fixed, 
unit costs at different levels of output showed a direct (inverse) 
relationship with output. In Integrated districts In contrast, unit 
costs remained more stable as cases increased. Thus In terms of cost 
per case, the Integrated districts fell within the range of costs of the 
non-Integrated districts, rather than outside It as with the cost per 
capita indicator. The question of whether there was any difference 
between Integrated and non-Integrated districts In the proportion of all 
cases detected could not be answered.
Before costs in non-integrated districts were disaggregated by case
208
detection mechanism, the Interdependence of the yields of the mechanisms 
was discussed. Based on survey data. It was concluded that the ACD 
mechanism was used If an MFW happened to arrive at a house In the first 
few days of the Illness, If he was known to be due to come, or If the 
patient's symptoms were particularly mild. Otherwise a PCD mechanism 
was used.
PCD (H) and PCD (M) represented relatively low cost additions to the 
work of units whose prime function was not case detection. Therefore 
only ACD/APCD/Follow up (all done by MFWs) , PCD (V) and PCD (MC) were 
discussed In detail. District costs of case detection through 
ACD/APCD/Follow up were Rs 1695 (Morang), Rs 619 (Ilam) and Rs 5063 
(Ham); of PCD (V) were Rs 1154 (Morang), Rs 164 (Rupandehi) and Rs 4270 
(Ilam) and of PCD (MC) Rs 1046 (Morang) and Rs 96 (Rupandehi). The same 
mechanism could therefore have widely differing costs, depending on the 
level of use, but In each district malaria clinics were consistently the 
cheapest followed by volunteers, and ACD etc consistently the most 
expensive. Adding the cost of radical treatment accentuated the 
difference between the cost per case of malaria clinics and all other 
mechanisms.
Costs to individuals were explored in terms of costs to volunteers, 
costs of private expenditure associated with treatment and costs of days 
of work lost.
Costs to volunteers appeared to be insignificant and so were not 
quantified.
Costs of private expenditure were available from both the patient and 
household surveys. They suggested that the extent to which patients 
sought sources of treatment other than those offered by the NMEO and 
ICHSDP differed considerably between districts and, though to a lesser 
extent, the sums paid. Mean expenditure per patient paying for 
treatment was Rs 46 in Rupandehi and Rs 123 in Morang, with 70% of 
patients in both districts incurring some level of expenditure. In 
Rupandehi, individuals attending PCD mechanisms, especially PCD (MC), 
spent more than those detected through ACD. The reverse was true in 
Morang except for PCD (M) . The addition of mean private expenditure per 
case for each case detection method to the government cost did not alter
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Che ranking of methods by coat per caae.
The coaC of daya of work loat la conventionally calculated by 
Multiplying daya loat by some measure of the average or Minimum wage. 
The patient survey found that on average 8.3 days of work were loat in 
Rupandehi and 14.5 in Morang per worker, with little difference between 
caae detection mechanisms. Multiplying days of work lost by the 
unskilled wage would result in a loss of approximately Rs 103 per 
malaria case in Rupandehi.
The validity of this approach was checked by using data from the 
household survey on changes In time allocation patterns of households in 
response to the illness of a household member. The great majority of 
households coped with the consequences of the malaria episode by drawing 
on household reserves of labour, primarily of adults rather than 
children. For 75« of households in Dhanusa the illness of a working 
household member caused no problems. This proportion was 50% in Nawal 
Parasl, perhaps because of the longer mean period of Illness. In 
Dhanusa, 91* of households experienced no cash loss (excluding hired 
labour and medical care costs) because of the illness and in Nawal 
Parasl, 80*. Over 70* of households in both districts did not think 
household production would suffer. If the financial losses reported 
were expressed per case of malaria, they represented a mean of Rs 16 in 
Dhanusa and Rs 30 in Nawal Parasl, contrasting with the figure of Rs 103 
If the crude approach to valuation, was taken.
Because the crude approach seemed likely to produce a gross over - 
estimate of loss, the loss found by the household survey was used to 
value the days of work lost found by the patient survey In Rupandehi and 
Morang. This was added to the cost per case of the case detection 
mechanisms. The complete (government and private) cost per case 
detected was therefore estimated to be In Rupandehi, Rs 171 for PCD 
(MC) . Rs 265 for PCD (M), Rs 342 for PCD (H), Rs 392 for PCD (V) end Rs 
842 for ACD/APD/Follow-up. In Morang, the estimates were PCD (M) Rs 
518, PCD (H) Rs 777, PCD (V) Rs 1666 and ACD/APCD/Follow up Rs 2177. 
The attractiveness of PCD mechanisms over ACD was emphasized by their 
shorter time-lags between start of fever and radical treatment and 
slide-collection and radical treatment, producing a not easily 
quantified benefit in terms of a reduced probability of secondary cases.
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7. RESULTS OF THE STUDY III: THE DESIRABILITY OF MALARIA CONTROL
Figure 4.1 in Chapter 4 set out a framework for the cost-effectiveness 
analysis of malaria control. The preceding chapter (Chapter 6) has 
analysed the cost of the malaria control strategies in use in Nepal in 
1984 and quantified their cost-effectiveness in terms of intermediate 
outputs such as houses sprayed, slides taken and cases detected. In 
this chapter, the consequences of malaria control activities as laid out 
in Figure 4.1 are estimated and matched against the control costs in 
order to produce cost-effectiveness ratios that can help in determining 
whether malaria control is worthwhile per se (rather than which 
activities are the most efficient means of malaria control, which was 
the theme of the previous chapter).
In Figure 4.1, consequences were listed as: 
cases of Illness and death averted; 
savings in resource use:
savings in government resources that in the absence of 
purposeful curative or preventive malaria control strategies 
would be spent on treatment of cases;
similar savings in Individual or household expenditure;
- savings in lost work time;
changes in the quality of life.
These are considered in turn below. The discussion is conducted in 
terms of the three districts, Morang, Rupandehi and Ilam, for which most 
data are available.
7.1 Cases and deaths prevented
It is most accurate to regard the entire malaria control programme as 
directed towards the prevention rather than treatment of malaria, and 
thus to use 'cases prevented' as the output measure. Quantifying this 
measure requires an answer to the question of how malaria incidence 
would respond to a cessation of the programme. Most commonly this 
question is answered by reference to the situation before the control 
programme was Introduced. As discussed in Chapter 4 section 4.4, there 
are good reasons for arguing in Nepal that the pre-control situation is 
not likely to re-appear because of changes in vector species, the
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environment, population distribution and access to private sources of 
treatment. However, in the absence of any experimental withdrawal of 
control activities, it is extremely difficult to estimate the cases 
currently being prevented by the control programme.
Since the likely course of events if the control programme is withdrawn 
is so unclear, the figures presented here on likely cases and deaths 
must be considered as highly speculative. They do, however, give an 
idea of the orders of magnitude Involved. The approach adopted is to
assume that present malaria control activities are adequate to maintain 
incidence at current levels. Cases (deaths) prevented are then cases 
(deaths) without the programme minus cases (deaths) with the programme.
Estimates of cases without the programme need to acknowledge the 
different vulnerability of different geographical areas to the 
resurgence of malaria. Table 7.1 defines five topographical and 
malariologlcal belts in Nepal, based on their malaria vulnerability, 
receptivity and risk. Of the three districts considered here, all 
contain a mix of low receptive and moderately receptive areas. In 
Morang and Rupandehi these are cultivated plain Teral and Inner Terai; 
in Ilam, Upper Valleys and Inner Teral. Cost-effectiveness 
estimates have been made separately for areas of low and moderate 
receptivity. In addition, low and high estimates have been made. The 
low estimate is baaed on the API In districts (distinguished by level of 
endemicity) with the highest incidence in 1985 and 1986, when there was 
a considerable Increase in transmission, and assumes that these 
represent a level that other districts of similar receptivity might 
reach without control. The high estimate for areas of moderate 
receptivity is based on information from other countries in South-East 
Asia on levels of malaria where control is ineffective. For low 
receptivity areas the high estimate has been set at a level that gives 
the same ratio between the high and low estimate as that of moderate 
receptivity areas. These assumptions produce estimates of APIs of 10 
and 40 in areas of low receptivity and 60 and 250 in areas of moderate 
receptivity. Since a certain level of malaria exists even with the 
control programme, the actual 1984 cases are subtracted from the 
estimates of cases obtained from these APIs to produce the numbers of 
cases prevented.
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Table 7.1: Provisional stratification of malaria vulnerability, 
receptivity and r i s k  in five topographical and 
malariologlcal belts of Nepal.
Area Type and endeaicity Transaission Vulnar- Rictp- Malaria r is k l
of original « a la n i smon a b i l i t y  t iv it y  <ainiaal<lou<aediua<high<aaxiaal) 
(eonths)
Cultivated
plain
terai
Stable
hypoendeaic
1-II1
Forested
plain
terai
Stable
hyperendeaic
1>II1
Inner
terai
(including 
fo o th ills  
up to 
1000a)
Stable 
hyperendeaic
1-111
Mountains Unstable Variable,
l  upper 
valleys 
(1000- 
2000a)
hypoendeaic froa
Vl-Vttt to 
IV-I
High Malaria-free Nona
Hiaalayas
♦ ♦ Loa aithout control of A .annularis
M iniasi a ith affactiva control of 
A ,annularis by aaans of house­
spraying or anti-la rval aeasures
♦ (♦♦♦MHaiiaal i f  A.ainiaus returns)
♦♦ Moderate aithout control of
M l m u t n u . I »  a iu  • f lt c t iv «  
control of A .f lu v la t i l is  
by aeans of house-spraying.
♦ ♦♦ Loa to aoderate aithout control of
A.aaculatus and especially 
A .f lu v ia t i l i s . Lou uith e ffective  
endophilic anopheline control by 
aeans of house-spraying.
♦ a Loa to ooderate aithout control of
MlyyliUlU "Q ••ptcUlly
A.aacu latus.H iniaal a ith e ffective  
control of A .flu v . uhere nec­
essary by aeans of house-spraying, 
p lus aeasures to reduce A.aac. 
vecto ria l capacity by aeans of 
house-spraying, :ooprophylaiis or 
loeering output froa breeding- 
s it e s .
Footnote: t i t  should be noted that the level of a a la r ia  r is k  aay r is e  as a result of unusual 
d iaato log ical conditions, environeental factors and in f lu i  in  parasite ca rr ie rs .
Source: Hhite (1982)
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Estimating deaths prevented by the programme is even more speculative. 
In Nepal, the case fatality rate (CFR) pre-control Is thought to have 
been around 1%. Since then, both public and private sources of 
treatment have proliferated so 0.5* Is used here as a low estimate. To 
allow for the likelihood of deaths arising from Increased chloroqulne 
resistance, 2« is used as an upper estimate. In 1984, no deaths were 
said to have resulted from malaria so this CFR is applied to the 
unadjusted numbers of cases.
Estimates of cases and deaths prevented represent the level at which 
cases would eventually stabilize without the programme. The time 
profile of the Increase of cases and deaths is thus not addressed in 
these calculations since it would add unnecessary sophistication to what 
are fairly crude calculations.
Only the effects of the control programme on malaria have been 
considered here. Other benefits Include its effects on the control of 
other vector-borne diseases such as Japanese B encephalitis and 
filariaris, and the reduction of nuisance Insects such as bed bugs.
7.2 Resource use consequences of malaria control: consequences for 
government resources
If the malaria control programme were to cease, a proportion of the 
malaria patients would seek treatment at government facilities. 
Estimating the total cost of treatment requires assumptions on the 
proportion of patients that would seek treatment and the cost of 
treatment.
In the absence of any better basis for estimation, it is assumed that 
the proportion of cases seeking treatment would be the same as the 
present proportion of cases detected through PCD mechanisms. The cost 
of outpatient treatment Is taken to be the mean of the cost per 
suspected case of detection and presumptive treatment In Saptari and 
Parsa (see Tables 6.6 and 6.7), namely Rs 13. It is further assumed 
that a proportion of cases equivalent to four times the number of deaths 
would be admitted to hospital, at a cost per person of Rs 300 
(approximate cost, taken from Phillips 1985). These assumptions produce 
a cost for the government of treating the cases that would present In
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7.3 Resource use consequences of malaria control: consequences for 
household expenditure
Current situation
In Chapter 6, data on household expenditure on treatment by case 
detection method was reported. It appeared that despite the universal 
availability of free malaria treatment services, a considerable 
proportion of malaria patients chose to visit and pay for other sources 
of treatment. This pattern of behaviour Is of considerable importance 
when considering the likely implications of cessation of control. The 
use and cost of these services Is therefore considered here before 
making the assumptions necessary for the cost-effectiveness analysis. 
Information on these topics from the household survey relates to two 
small and relatively Isolated areas whereas data from the patient survey 
covers a large number of cases in 6 districts of diverse 
characteristics. Therefore the latter data is of greatest use in 
considering the patterns and determinants of use of sources of treatment 
and so is discussed here.
Table 7.2 shows the number of visits made by each patient to sources of 
help before receiving presumptive treatment. The proportion making no 
visits ranged from 23* in Bara to 53* in Dang. One visit was made by 
between 32* in Morang and Bhojpur and 67* in Bara. Relatively few 
patients made more than one visit except in Morang and Bhojpur. 
Patients with P. falciparum infections were more likely to make any 
visit, and more likely to make more than one visit, than P.vivax cases.
Information was also collected on the source of help. The proportion of 
all patients who visited a hospital ranged from 1* in Sarlahl to 13* in 
Morang. Fewer visited a health post. Virtually no-one said they visited 
a community health leader or a community health worker (presumably 
because they were largely absent in the districts studied), or an 
ayurvedic practitioner. A considerable proportion, ranging from Just 
under 20* of all patients in Dang and Bhojpur through approximately 30* 
in Rupandehi, Sarlahi and Morang to 47* in Bara, visited a private
the absence of malaria control, which can be viewed as the savings for
the government created by malaria control.
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Table 7.2: Number of visits per case to sources of help prior to 
presumptive treatment: patient survey
Nissing:0
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practitioner. Drug sellers were also frequently visited: 13% of cases in 
Dang visited a drug seller, between 20 and 30% in Bhojpur, Bara and 
Sarlahi, and around 40% in Rupandehi and Morang. Finally, visits to a 
faith healer showed considerable variation, from a low of 2% in 
Rupandehi, 4% in Bara and 6% in Sarlahi, to 13% in Dang, 15% in Morang 
and 31% in Bhojpur. Figure 7.1 shows how total visits were distributed 
between sources of help in each district. Use of malaria services is 
not shown here because the question asked about visits made before 
receiving presumptive treatment.
Table 7.3 shows the distribution of the total amount spent by each 
patient by district. A considerable proportion spent nothing: 24% in 
Bara, around 30% in Rupandehi and Morang, around 40% in Sarlahi and 
Bhojpur and 53% in Dang. Of those who spent something, the majority 
stated that they spent under 30 rupees but a small proportion quoted 
considerable sums, some so high that their accuracy seems questionable 
(for instance Rs 1200 spent by one case in Dang on sacrifice and 
worship) . Because of the skewed distribution, geometric as well as 
arithmetic means were calculated. Average expenditure was as follows:
Total expenditure per case
District Median
(Ra)
Arithmetic
(Rs)
Standard
Deviation
n Geometric
mean
(R«>
Dang 0.0 42.3 116.3 363 4.7
Rupandehi 10.0 31.6 73.5 2030 7.5
Sarlahi 4.0 29.0 94.9 168 5.1
Morang 25.0 82.7 146.1 358 14.3
Bhojpur 10.0 69.7 159.0 153 9.3
Bara 20.0 69.9 110.1 51 14.8
All survey 10.0 41.0 98.7 3123 7.7
districts
The geometric means show that differences between the districts still 
persist even when the effect of the skewed distribution is reduced by 
log transformation.
The greater the number of days off work, the more was spent on 
treatment. Mean expenditure is shown below for Rupandehi, categorized
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Figure 7.1: Distribution of total visits between sources of help, by
district
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Table 7.3: Distribution of patient expenditure on treatment, by
district: patient survey
l i a t r i c t To tal
Dan, Rupandehi S a ri ah l H oran , B ho jpur Bara
T o ta l e x p e n d itu re  on 
i l l n e s s
No e x p e n d itu re 194 650 68 117 63 12 1104
co lua n  pe rc en t 53 .4 1 32 .01 40.51 32 .71 41 .21 23 .51 35.41
Rps 1-9 16 336 28 25 10 9 424
c o lu s n  pe rc en t 4 .41 16.61 16.71 7.01 6 .51 17.61 13.61
Rps 10-19 33 264 16 25 12 4 354
co luo n  p e rc e n t 9 .1 1 13.01 9.51 7.01 7 .81 7.81 11.31
Rps 20-29 17 192 14 27 6 5 261
co luo n  pe rc en t 4 .71 9.51 8.31 7.51 3 .91 9.81 8.41
Rps 30-39 16 125 a 17 8 1 175
c o lu a n  p e rc e n t 4 .4 1 6.21 4.81 4.71 5 .21 2 .01 3.61
Rps 40-49 B 88 8 17 5 2 128
c o lu a n  pe rc en t 2 .2 1 4.31 4.81 4.71 3 .31 3 .91 4.11
Rps 50-99 36 221 18 38 21 4 338
co lu o n  pe rc en t 9 .9 1 10.91 10.71 10 .61 13 .71 7 .01 10.81
Rps 100-199 21 100 5 47 12 6 191
co lua n  pe rc en t 5 .8 1 4.91 3.01 13.11 7.81 11.81 6.11
Rps 200-299 10 25 1 16 6 4 62
co lu o n  pe rc en t 2 .B 1 1.21 .61 4 .51 3.91 7.81 2.01
Rps 300 and ove r 12 29 2 29 10 4 86
co lu a n  pe rc en t 3 .3 1 1.41 1.21 8 .11 6 .51 7 .81 2.81
T o ta l 363 2030 168 358 153 51 3123
co lu a n  pe rc en t 100.01 100.01 100.01 100.01 100.01 100.01 100.01
H is s in g :130
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by number of days not worked. The geometric mean chows a smoother and 
lees exaggerated but nonetheless similar pattern.
t ie  a n  e x p e n d i t u r e  b y  d a y i  n o t  w o r k e d  (R u p a n d c h l)
Days not 
worked
Arithmetic
( R * )
Standard
Deviation
n Geometric
mean
( R « )
0 9.8 25.7 53 1.3
1-4 17.0 31.5 335 4.3
5-9 21.3 41.9 638 5.6
10-14 32.3 58.7 321 9.3
15-19 67.8 148.3 114 14.3
20-24 62.8 106.5 54 21.3
25-29 56.7 48.9 13 34.9
30+ 64.3 85.4 33 25.7
Similar Information for the other districts showed that high mean 
total expenditure was associated with cases who had 15 or more days 
off work. High expenditure per patient also seemed to be associated 
with classification, with imported cases spending more than indigenous 
cases.
Expenditure on drugs and laboratory examinations took up the largest 
share of total expenditure, with a mean expenditure per patient of Rs 
16.9 in Dang, Rs 22.2 in Rupandehl, Rs 13.4 in Sarlahl, Rs 60.3 In 
Morang, Rs 34.0 In Bhojpur and Rps 40.9 In Bara. Expenditure on 
sacrifice and worship was relatively high in Bhojpur (mean of Rs 
23.5), Bara (mean of Rs 10.4) and Dang (Rs 17.9) but not in other 
districts. While considerable sums were spent by a few individuals on 
fees, special foods and travel to obtain care, mean expenditure per 
patient on these items was low in all districts. Figure 7.2 
illustrates how mean total expenditure was divided between the various 
types of expenditure in each district.
In conclusion, despite the comprehensive malaria service presently 
offered in the districts studied, a substantial proportion of malaria 
patients sought help from some other source of care, whether to obtain 
a type of care not available from the malaria service (for instance 
the services of faith-healers), to supplement the care offered by the 
malaria service, or in ignorance of the existence of the malaria
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service. As a consequence, substantial suns of money wera spent: a 
total of around Rs 128,000 by tha 3123 Individuals In tha survey for 
whom this Information was available. Recourse to these other sources 
of treatment seemed to be particularly associated with lengthy periods 
of disability, though it Is unclear whether this was because patients 
delayed obtaining treatment from the malaria service because they were 
treated (ineffectively) elsewhere, or whether it was the long period 
of Illness that led them to consult private sources of treatment. 
Imported cases were also more likely to purchase care, possibly 
because they had to seek treatment when away from home, or they may 
have had greater access to cash to pay for treatment than Indigenous 
cases.
Assumptions for the cost-effectiveness analysis
It can therefore safely be concluded that the Increased number of 
malaria cases resulting from the cessation of control Is likely to 
lead to substantial private expenditure on treatment. It Is assumed 
for the moment that mean private expenditure per case on treatment 
will remain at the same level. This will be an underestimate If 
patients make more use of private facilities as may happen, for 
example, if public facilities become overburdened by malaria cases.
7.4 Resource use consequences of malaria control: consequences for 
lost work time
Current situation
In Chapter 6, days of work and school lost were discussed In relation 
to case detection method. Here, a fuller presentation of that data is 
given in order to Investigate in more detail the Influences on days of 
work and school lost. This will enable a more informed Judgement to 
be made on how days of work and school lost might be affected by the 
cessation of malaria control.
For those who stated they normally worked, Table 7.4 shows days not 
worked by district. The variation between districts is considerable 
and 3 districts In particular stand out. Sarlahl and Bhojpur both have 
a relatively high proportion of cases (around 30%) who lost no days.
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Table 7.4: Number of days not worked by district
D istric t Total
Dan, Rupandehi Sarlahi Horan, Bhojpur Bara
Days not worked due 
to il ln e ss  
0 days 26 54 42 62 40 6 230
colusn percent B.3Z 3.41 2?.21 22. ?1 30.31 14.01 ? .3 l
1-4 days 33 338 33 45 21 1 471
coluan percent 10-5Z 21.51 22.? l 16.61 15. ?1 2.31 1?.01
5-? days 75 642 28 51 33 10 83?
coluan percent 24.01 40. ?1 1?.41 18.81 25.01 23.31 33. ?1
10-14 days 73 323 26 28 11 12 473
coluan percent 23.31 20.61 18.11 10.31 8.31 27. ? l 1?.U
15-1? days 46 114 8 25 13 4 210
coluan percent 14.71 7.31 5.61 ?.21 ?.81 ?.31 8.51
20-24 days 2? 54 3 11 7 0 104
coluan percent ? . 31 3.41 2.11 4.11 5.31 0.01 4.21
25-2? days 12 13 2 5 1 2 35
coluan percent 3.81 .81 1.41 1.81 .81 4.71 1.41
30 days and over 1? 33 2 44 6 8 112
coluan percent 6.11 2.11 1.41 16.21 4.51 18.61 4.51
Total 313 1571 144 271 132 43 2474
coluan percent 100.01 100.01 100.01 100.01 100.01 100.01 100.01
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Morang also had a relatively high proportion who lose no days (23%) 
but also had 16% who lost over 30 days. The averages ir* as follows:
Pay« of nark lait
District Mode Median
(days)
Mean
(days)
Standard
deviation
% losing 
no days
n
Dang 10.0 10.0 12.1 9.6 8.3 313
Rupandehl 5.0 7.0 8.3 6.6 3.4 1571
Sarlahl 0.0 4.0 6.1 7.6 29.2 144
Morang 0.0 7.0 14.5 22.9 22.9 271
BhoJ pur 0 .0 5.0 7.6 9.6 30.3 132
Bara 10.0 10.0 13.4 10.9 1A.0 43
All survey 
districts
5.0 7.0 9.4 10.6 9.3 2474
The mean days lost Is thus 9.4 (range by district 6.1 - 14.5).
Mean days lost was calculated for a variety of sub-groups of the 
survey population. This approach was preferred to multiple regression 
because of concerns over data quality and the high correlation between 
a number of the Independent variables. Where appropriate, geometric 
means are given In addition to arithmetic means because of the skewed 
distribution of days of work lost. Since cases f r o m  Rupandehl 
predominate In the sample, the means for Rupandehl are reported here. 
In general, despite the variation In mean days l o s t  between the 
districts, the means for the population sub-groups behave consistently 
across the districts. A comment Is made below only when this Is not 
so.
Age: Mean days lost varied little with age, except t o  rise amongst 
those aged 65 years and over.
Sex: Mean days lost was virtually Identical for males and females, 
being 8.3 for males (SD 6.8) and 8.5 for females (SD 6.1) In 
Rupandehl.
Visits per patient and total expenditure per patient: As might be
expected, mean days lost Increased as visits per patient and total 
expenditure per patient Increased. For example, mean days lost was
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6.8 (SD 4.7) in Rupandehl for those cases who spent nothing, and 9.2 
(SD 7.2) for those who spent Rps 1 and over. An even sharper 
difference was evident in Morang, where the figures were 5.5 (SD 8.1) 
and 18.1 (SD 25.7). Equivalent geometric means for Morang were 2.45 
and 8.02.
Source of slide: As shown in Chapter 6, mean days lost showed little 
variation by source of slide.
Species and classification: In Rupandehi, mean days lost for P.vlvax 
cases was 7.9 days (SD 6.1) and for P . falciparum. 10.9 days (SD 8.1). 
After log transformation, this difference was found to be significant 
(P < 0.001). This pattern was mirrored in the other districts, with 
the exception of Sarlahl. Indigenous P . vlvax cases in Rupandehl had a 
mean days lost of 7.9 (SD 5.8) and imported A P.vlvax of 8.3 (SD 7.7). 
Similar figures for P.falciparum were 11.9 days, SD 8.6 (indigenous) 
and 9.6 days, SD 7.0 (imported A). This pattern was not repeated in 
all districts. In Morang, mean days lose by indigenous P.vlvax was 8.5 
(SD 13.2) and by imported A P.vivax 15.3 (SD 26.2). In the case of 
P .falcloarum. both Morang and Dang show a reverse pattern to 
Rupandehi, though few cases are involved.
Number of days from start of fever to slide collection: As might be 
expected, mean days of work lost increased as the number of days 
between the start of the fever and slide collection (i.e. presumptive 
treatment) increased. In Rupandehl the figures were as follows:
Mean day a  work l o s t  by day» f ro m  a t a r t  g f fav a r to  g ild s  
c o lle c tio n  (R upandehl)
Days from start Arithmetic Standard n Geometric
of fever to mean days deviation mean days
slide collection lost lost
0 - 2 5.3 4.2 215 4.0
3 - 5 6.2 4.0 573 5.3
6 - 8 8.2 5.3 361 7.2
9 - 11 9.9 4.1 164 9.1
12+ 15.4 10.0 245 12.6
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A similar pattern was apparent for mean days lost by the number of 
days between the start of the fever and radical treatment.
Number of days from slide collection to radical treatment: Mean days 
lost Increased as the number of days between slide collection and 
radical treatment Increased, though within a more restricted range 
than the figures above. For a time lag of 7 days and less, mean days 
lost In Rupandehl was 7.4 (SD 5.7), for 8 - 14 days, 9.3 (SD 7.4), for 
15-30 days, 9.8 (SD 6.7) and for over 30 days, 10.1 (SD 7.1).
Presence of previous fever: In Rupandehl, mean days lost for those who 
had not had a previous fever was 8.3 (SD 6.1) and for those with a 
previous fever, 8.8 (SD 7.8). In Morang these figures were 6.9 (SD 
7.6) and 16.7 (SD 25.2). The more detailed Information below on days 
lost by number of days between the previous and current fever shows a 
clear pattern.
Meen s»ayg pf work lost by days between current fever and previous 
fever (Rupandehi and Morang)
Days from 
previous 
to current 
fever
Mean
lost
Rupandehl 
day 8 Standard 
deviation
n
Morang
Mean days Standard 
lost deviation
n
< 8 weeks 10.2 7.6 103 12.9 13.8 57
8-24 weeks 8.0 6.8 166 20.1 24.1 68
24-52 weeks 9.0 10.7 91 22.4 36.9 54
> 1 year 8.0 5.6 64 7.7 13.4 27
Attention was drawn earlier to the unusually large proportion of 
Morang cases who lost over 30 days' work. The above figures support 
earlier comments on possible confusion between previous and current 
episodes. Mean days lost In Morang Is much closer to the experience of 
other districts for those cases w ho have not had a previous fever or 
where the fever was more than one year earlier. Thus It seems that 
some of the longer periods of days lost may result from individuals 
who either have had a new Infection soon after a previous infection, 
or a relapse. In some cases, days lost may not therefore relate only 
to the current episode of fever.
For all those who stated they normally attended school, Table 7.5
2 2 6
T a b le  7 . S :  N u a b s r  o f  d a y a  o f  s c h o o l  l o s t  b y  d i s t r i c t
> is tr ic t Tatal
Dang Rupandehi Sarlahi Horang Bhojpur Bara
Days of school lost 
due to il ln e ss  
0 days 4 11 1 4 0 0 25
coluan percent 7 .3 1 3.01 14.71 21.41 0.01 0.01 7.41
1-4 days 4 33 2 7 2 0 48
coluan percent 7 .3 1 15.11 33.31 14.71 33.31 0.01 14.41
5-f days 13 104 3 4 1 1 128
coluan percent 23 .61 47.71 50.01 14.31 14.71 100.01 39.01
10-14 days IT 45 0 5 2 0 71
coluan percent 34 .51 20.41 0.01 11.91 33.31 0.01 21.41
»5-19 days 4 10 0 5 0 0 21
coluan percent 10.71 4.41 0.01 11.91 0.01 0.01 4.41
20-24 days 5 10 0 1 0 0 14
coluan percent T . 11 4.41 0.01 2.41 0.01 0.01 4.91
25-24 days 1 1 0 3 1 0 4
coluan percent 1 .B1 .51 0.01 7.11 14.71 0.01 1.81
30 days and over 3 4 0 4 0 0 13
coluan percent S . 51 1.81 0.01 14.31 0.01 0.01 4.01
Total 55 218 4 42 4 1 328
coluan percent 100.01 100.01 100.01 100.01 100.01 100.01 100.01
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■hows days of school lost. The distribution shows a not dissimilar 
pattern to days of work lost, though the small numbers make 
conclusions more difficult. Morang In particular again showed a 
relatively high proportion with no days lost and with more than 30 
days lost. The averages by district were as follows:
gays of gch99l l o s t
District Mode Median Mean Standard % losing n
(days) (days) (days) deviation no days
Dang 10.0 10.0 11.6 7.9 7.3 55
Rupandehl 5.0 7.0 8.3 6.6 5.0 218
Sarlahl 0 .0 4.5 4.2 3.2 16.7 6
Morang 0 .0 7.0 14.5 24.5 21.4 42BhoJ pur 3.0 7.5 9.7 8.4 0.0 6
Bara 7.0 7.0 7.0 0 .0 0 .0 1
All survey
districts 10.0 7.0 9.6 11.0 7.6 328
These averages are close to those for days of work lost. with a
similar pattern of variation between the districts. Sarlahl, for
example, is again the lowest, Dang Is one of the highest, and Morang
again has the most extreme distribution
Mean days of school lost was analysed by the samei categories ,as days
of work lost. Results are again reported here for Rupandehl, the 
numbers for the other districts usually being too small to permit 
conclusions to be drawn.
Age and sex: Mean days of school lost varied little by age or sex.
Visits per case and total expenditure per case: No relationship was
apparent between mean days of school lost and number of visits for 
treatment or expenditure on treatment.
Source o f  slide: Mean days of school lost showed slightly more 
variation b y  source of slide than mean days of work lost. If all PCD 
categories are grouped together, the mean days of school lost Is 9.2 
(SD 5.7) for ACD and 8.0 (SD 6.8) for PCD.
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Species end classification: In Rupandehi, mean days of school lost for 
P . vlvax cases was 8.0 (SD 6.6) and for P. falciparum. 10.8 (SD 6.9) 
(this difference was tested using a log transformation but was not 
significant). Mean days of school lost were similar for indigenous 
(7.9 days) and Imported P.vlvax (8.7 days) In Rupandehi. The numbers 
of Imported P. falciparum cases were too small for conclusions to be 
drawn for Rupandehi. For the sample as a whole, mean days of school 
lost for indigenous P. falciparum was 12.8 (SD 8.8) and for Imported A 
P . falciparum. 8.6 (SD 6.7).
Number of days from start of fever to slide collection: Mean days of 
school lost tended to increase as the number of days between the start 
of the fever and slide collection Increased. In Rupandehi, the results 
were as follows:
Mean days g f  school l o s t  by days from s t a r t  of ¿ever to  g lid e
collection (Rupandehl)
Days from 
start of fever 
to slide 
collection
Arithmetic
lost
Standard
deviation
n Geometric 
mean days 
lost
0-2 6.7 5.1 32 5.3
3-5 5.4 2.4 59 4.9
6-8 7.8 7.9 66 6.2
9-11 9.8 1.7 20 9.7
12+ 14.4 7.6 39 11.8
A  similar pattern was apparent for mean days lost by the number of 
days between the start of the fever and radical treatment, though with 
a wider range of mean days lost. For a time lag of 0-7 days, mean days 
lost in Rupandehi was 6.2 (SD 7.3), and for a time-lag of over 30 
days, 17.1 (SD 7.3).
Number of days from slide collection to radical treatment: Mean days 
of school lost in Rupandehi increased as the time-lag between slide 
collection and radical treatment increased. For a time lag of 0-7 
days, mean days of school lost was 7.2 (SD 6.5), for 8-14 days, 9.7 
(SD 6.5) and for 15-30 days. 11.2 (SD 6.8).
Presence of previous fever: In Rupandehi, mean days of school lost for 
chose who had not had a previous fever was 8.4 (SD 6.8) and for those
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with a previous fever, 9.0 (SD 6.8). Other districts showed a greater 
difference. In Morang, for example, the means were 9.2 (SD 11.0) for 
those without a previous fever and 16.7 (SD 28.1) for those with a 
previous fever.
What can be concluded from this data on days of work and school lost? 
Information obtained In the patient survey on number of days of work 
lost was expected to be approximate. Indeed, the distribution of days 
of work lost was extremely wide, with a small minority of patients 
reporting very large numbers of days (maximum days reported were 48 In 
Dang, 90 In Rupandehl, 60 In Sarlahl, 180 In Norang, 60 In Bhojpur and 
45 In Bara) .
However on the whole, mean days not worked varied In the expected 
directions when analysed above for various sub-groups of patients and 
behaved consistently across the districts. Moreover, while the mean 
days not worked of 9.4 days appears high. It Is not Inconsistent with 
the mean days from start of fever to presumptive treatment of 7.6 
days. Information on days lost appears therefore good enough for 
general conclusions to be drawn, even If there are some Inaccuracies.
Two factors appear to Influence strongly mean days of work lost. 
Firstly, on average P. falciparum cases lost 40% more days than P . vlvax 
cases. Secondly, the longer the periods between the start of the 
fever and presumptive and radical treatments, the more days of work 
were lost. The relationship between days of work lost and the 
classification ot the patient Is less clear. In Rupandehl, Imported 
P.falciparum cases lost on average fewer days than Indigenous 
P.ffllclPfllTMB. but the figures were very similar for P.vlvax. It might 
be suggested that imported P.falc)p»rn« Infections are less severe 
because these Individuals are more likely to have had malaria before, 
but It is not clear why this argument does not apply also to P.vlvax 
Infections.
Days of work lost varied considerably between the districts, for 
reasons that are In general unclear. However, Dang had both a longer - 
than-average mean days of work lost and a mean time-lag from start of 
fever to slide collection that was the longest of all the NMEO 
districts. Thus delay In receiving treatment may help to account for
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the higher mean day* of work lost. This explanation may also hold for 
Bara though the number of cases Is too small to draw firm conclusions. 
The only other district that varied markedly from the survey mean was 
Morang. Here the mean days of work lost seems to have been biased by 
confusion between current and previous episodes.
Days of school lost showed a very similar pattern to days of work 
lost, with a virtually Identical mean and standard deviation. Days 
lost by species and time-lag between start of the fever and treatment 
also behaved In a similar fashion. P .falciparum cases on average 
experienced a mean number of days of school lost which exceeded 
P.vlvax cases by 35%.
The above analysis Is more difficult to do using the data from the 
household survey because some of the sample numbers In the population 
sub-groups are small. For example, too few P .falciparum cases 
occurred In Dhanusa to analyse days not worked by species. In Nawal 
Parasl, however, mean days not worked per person Infected were 8.9 (SD 
6.4) for P.vlvax cases and 11.5 (SD 9.7) for P. falciparum cases, or 
about 30% more, thus confirming the conclusion from the patient survey 
(though the difference here was not significant).
The Implications of these findings are that household resource costs 
stemming from the period of disability caused by malaria will Increase 
If the proportion of P.falciparum Infections Increases and If case 
detection Is less rapid. The first of these eventualities Is already 
occurring and this trend is likely to strengthen as chloroquine 
resistant strains of malaria become more established In Nepal. The 
likelihood of the second eventuality depends on the extent to which 
Nepal can maintain its current, relatively efficient case detection 
mechanisms. Given the greater time-lag between infection and treatment 
that seems to occur In integrated districts, increased Integration may 
well lead to greater household resource costs. So may cessation of 
formal malaria control activities.
Assumptions for the cost-effectiveness analysis
In order to calculate the value of the lost work time which would 
result from the cessation of malaria control, It Is necessary to make
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assumptions on the proportion of malaria patients engaged In economic 
activity, the mean days lost per case and their value. Given the
uncertainties surrounding the assumptions, It was decided to err on 
the side of caution. In low receptive areas. It Is assumed that the 
great majority of cases would continue to occur In the working 
population, so the current proportions of patients engaged In economic 
activity In Morang, 11am and Rupandehl are used (79%, 86% and 82%).
In moderately receptive areas, since the probability of children being 
Infected Is greater, it Is assumed that 70% of cases would be engaged 
In economic activity with the low case estimate, and 50% with the high 
case estimate.
It Is further assumed for the moment that the current pattern of days 
of lost work per case would continue. This Implies that the 
withdrawal of malaria-specific case detection and treatment services 
would not increase the delay before treatment and thus Increase days 
of Illness and days of work lost per case. This assumption Is later 
relaxed.
At present, the pattern of transmission is scattered, with few 
households experiencing more than one case at a time or In a short 
period of time because of rapid case detection and treatment. This 
situation would be likely to change In the absence of a control 
programme and cases could cluster in households, producing an effect 
that would be greater than the sum of days lost multiplied by the 
current mean dally loss since the capacity of the household to cover 
for Illness would be reduced, and this would be most likely to occur 
at times of peak labour demand because of the coincidence of periods 
of intensive agricultural activity and peak malaria transmission. Lost 
days are therefore valued at Rs 8 per worker, double the value 
estimated in Chapter 6, to allow for the likely clustering of cases 
in households. No adjustment is made for seasonal unemployment since 
the peak of malaria transmission coincides with busy periods in the 
agricultural cycle, but Rs 8 is multiplied by the conversion factor of 
0.9, giving Rs 7.2, to convert it to an economic price.
As the analysis of data from the patient survey suggests, the 
resulting value of total days lost will be an underestimate if the 
species mix changes since P. falciparum cases appear to lose more
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days of work Chan P. vlvax cases. It will also be an underestimate 
If Increased chloroqulne resistance results In lengthier periods of 
Illness or more severe Illness, and If the withdrawal of control 
activities lengthens the period between the onset of the fever and 
treatment.
Deaths from malaria give rise to a loss of the earnings the Individual 
would otherwise have earned over his or her remaining lifetime. In 
order to calculate these losses, assumptions are required on the 
average age of death, years of life remaining at that age, annual 
earnings and on a discount rate. At an API of 250 per 1000, the high 
estimate for moderately receptive areas, the first attack of malaria, 
that most likely to be fatal, will occur by the age of 4 and at an API 
of 62, the lower estimate for moderately receptive areas, by the age 
of 16 years. Therefore It Is assumed that the mean age of death will 
fall In the age groups 1-4 and 15-19 for the low and high case 
estimates for moderately receptive areas. For low receptive areas, 
the low estimate Is based on the current situation where the first 
attack occurs In teenagers and young adults. So 25-29 Is taken to be 
the age group containing the mean age of death for the low case 
estimate, and 20-24 for the high estimate. Life tables (Central 
Bureau of Statistics 1977) were used to estimate years of life 
remaining at these ages.
The permanent removal of a household member from the workforce Is 
likely to have more severe consequences on household labour supply and 
productivity than the temporary removal due to a short period of 
Illness. It Is therefore assumed that the dead household member would 
have been fully employed for 7 months of the year (the period of peak 
labour demand) and partially employed for the remainder of the year. 
The value of a day of full employment Is taken to be Rs 15 (the wage 
for agricultural labour) and Its value at slack periods of the year 
40% of that, namely Rs 6. The weighted average is thus Rs 11.25 and 
Is multiplied by 312 working days In the year and by the conversion 
factor of 0.9 to give annual earnings of Rs 3200. A discount rate of 
12% Is used. It Is assumed, somewhat arbitrarily, that a child 
becomes productive at the age of 15. Because of the sweeping 
assumptions necessary to estimate the value of lost work days. It was
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noC thought to bo worthwhile to introduce auch refinements as 
adjusting values for age or sex differences in productivity.
7.5 Changes in the quality of life
If the cessation of malaria control were to lead to a high incidence 
of malaria and, with increased chloroqulne resistance, to an increased 
risk of death, the quality of life of the population of the Teral 
would suffer. There is no obvious way of placing a value on this 
consequence but an approximation can be made to a quality of life 
measure by translating the numbers of cases and deaths into 'healthy 
days of life'. This has the advantage that it incorporates both cases 
and deaths in one measure, but the disadvantages that days of illness 
and days of death are treated as equivalent and that only individuals 
who are actually infected are counted.
It can be argued that society is not indifferent as to when days of 
healthy life are saved - sooner rather than later. Thus the measure 
'discounted days of healthy life gained' has also been calculated, 
with days discounted at 12% per annua.
Barnua (1987) argues for calculating also the measure 'discounted 
productive years of life lost' , including only years of life lost in 
productive ages and weighting the years for variations in productivity 
over a person's life-time. Since the production consequences are 
taken into account separately here (as a resource saving consequence) 
this measure is not used.
7.6 Cost of control
The estimates of the cost of control are based on cost figures 
presented earlier for Horang, Rupandehi and Ilam. Saptarl and Parsa 
have been omitted because cost data is Incomplete with respect to 
overhead costs and private costs. Since surveillance costs are 
largely fixed with respect :o the level of activity, they have been 
distributed between low and moderate areas in proportion to the 
population distribution. In order to distribute the cost of spraying 
between these areas in Rupandehi, insecticide costs have been 
calculated directly since data are kept separately for low and
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moderate areas. Other spraying costs have been distributed In 
proportion to the distribution of sprayman days.
7.7 Cost-effectiveness estimates
Table 7.6 presents the results of the cost-effectiveness calculations. 
Information on private costs and days of work lost was not available 
for I lam so information from the patient survey for an adjacent hill 
district, Bhojpur, was used.
The first four cost-effectiveness ratios (C I, C II, C III and C IV) 
illustrate the resources required to prevent cases and deaths but 
cannot on their own imply anything about the relative value of 
preventing malaria - this requires a comparison with similar ratios 
from other health programmes to see whether the cost per case, death 
and healthy day of life gained from malaria control is more or less 
than that from other health programmes. These figures have not been 
located for Nepal, but a comparison is made with ratios from other 
countries in Chapter 8 below. It is useful to note here, however, the 
difference in the ratios between low and moderately receptive areas, 
and between the Terai and Hill. Relatively greater value (in terms of 
cases and deaths prevented) is obtained in moderately receptive areas 
and in the Terai since the cost of control is not proportional to the 
risk of malaria - In particular, the surveillance network is more 
expensive in the Hills and spraying is expensive in low receptive 
areas where A. annularis is the vector.
The cost-effectiveness ratio C V suggests that present government 
control costs are not matched by savings in government treatment costs 
that would be incurred in the absence of control except with the high 
case estimate and high case fatality rate in moderately receptive 
areas in the Terai. This suggests that malaria control cannot be 
justified, as might be expected, by savings in government treatment 
costs alone.
If, however, private treatment costs are added to government treatment 
costs, net savings result (ratio C VI) at a level of cases between the 
low and high estimates. Inclusion of the value of lost work days 
makes a dramatic difference (ratio C VII). Net savings result even
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Table 7.6: Cost-effectiveness calculation*
L o i receptive Rod. receptive Lo i receptive  Rod. receptive Loo receptive Rod. receptive
Fopila tioa 389,023 115.317 62,717 22.961 231,667 159,326
I
A. COST or RALA1IA C0ITI0L (to
m 231 651 351 591
To IRBO
1,213,132 360,655 620.397 225,599 963,675 663,190
-sp ray ia f coot 0 666,516 0 0 1,328,968 308,706
- t o t i l  c u t 1,213,832 805,169 620,397 225,599 2,292,623 971,896
To kousekolds
- t r u t n a t  ( I ) *5,882 13,906 3,662 2,163 62,618 26,868
- lo s t  to rk  days (b) 2*.083 7,299 1,296 776 36,621 21,929
- to ta l c u t 69,965 21,205 6,936 2,962 77,039 68,797
Total c u t  
1. CONSEQUENCES 
I .C u u
1,283,797 826,376 623,332 221,561 2,369,662 1,020,691
Cases o ithoo t c o itro l
-lo o  estiaate  (c) 3,890 6,935 628 1.371 2,315 9,560
-k i|k  r i t i n t e  (d) 13,361 28,897 1,711 5.760 9.239 39,132
Cases 1910 586 177 33 ) ) 1.613 695
Cases preveoted
- lo i  e s t in te 3,306 6,758 373 1,365 902 8,665
- k ifk  e s t ile te  
I I .  Dcatbs
16,977 28,720 1,636 5,707 7,666 38,937
Deatks o i tb o i t  cootrol
- lo *  e s t in te  cases,.SI CFI 19 33 2 7 12
- lo i  u t i u t e  cases,21 CFI 78 139 9 28 66 191
-k i( k  e s t in te  cases,.51 CFI 78 166 9 29 66 199
- k ifk  u t i n t e  cases,21 CFI 311 578 36 US 115 797
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Table 7.6: continued
<................ Roreof...............> <---------------- I l u ---------------> <---------- lopeidebi.............>
Lot receptive Rod. receptive Lo* receptive Rod. receptive Lo* receptive Rod. receptive
I I I .  le e ltk y  dips of l i fe
S e v iif i  io kee ltky d ip t ef l i f e  (* )
-Io» e i t i u t e  cete*,.SS CP1 289,329 616,922 29,313 113,303 151,109 787,210
- lo *  e s t iu te  ceses, 21 CFI 1,013,995 2,172,706 109,031 922,553 581,915 2,933,092
- k ifk  e s t iu te  ceses,.SS CF1 1,267,916 2,892,319 121,157 525,269 690,312 3,667,027
-high estiso te  ceses,21 CF1 9,920,170 10,119,965 979,860 1,970,951 2,565.109 13,691,591
Sevinfs in discoonted keeltky 
- Io *  e s t iu te  ceses,.SS CFI
deys e f l i f e  ( ! )  
106,131 201,780 9,237 30,836 92,123 219,975
- le *  e s t iu te  ceses,2S CFI 280,810 513,136 28,996 92,686 196,090 699,151
- k ifk  estioete ceses,.SS CFI 950,035 859,150 38,202 130,326 203,675 926,521
- k ifk  e s t iu te  ceses,21 CFI 1,198,692 2.167,290 115,031 391, in 619,399 2,736,569
I f .  Sevinfs i i  resources ( I t )  
Govereieet tre ito e n t ( f)
- lo *  e s t ile te  ceses,.51 CFI 39,732 75,920 3,599 11,838 19,652 116,559
- lo *  e s t iu te  ceses,2t CFI 106,255 199,013 10,861 35,396 59,233 280,022
-k ifh  e s t iu te  ceses,.51 CFI 168,232 317,228 19,665 99,636 108,973 505,992
-k ifk  e s t iu te  ceses,2S CFI 939,329 811,362 93,932 197,799 267,297 1,117,060
Privet« tre e tie o t (e)
-lo »  e s t iu te  ceses,.5S CFI 259,759 530,960 29,295 105,693 70,890 680,731
-lo »  e s t iu te  ceses,21 CFI 259,759 530,960 29,295 105,693 70,890 680,731
- k ifk  e s t iu te  ceses,.51 CFI 1,176,662 2,256,367 130,191 998,390 616,396 3,059,096
- k ifk  e s t iu te  ceses,U  CFI 1,176,662 2,256,367 130,191 998.390 616,396 3,059,096
Lost »orkdeys (k)
-lo »  e s t iu te  ceses,.51 CFI 783,083 1,903.792 73,689 232,255 397,869 1,616,670
- lo *  e s t iu te  ceses,21 CFI 2.319,277 9,133,999 292,093 779,502 1,258,929 5,379,313
-k ifk  e s t iu te  ceses,.51 CFI 3,276,829 3,672,207 302,999 587,817 1,599,202 9,158,751
- k ifk  e s t iu te  ceses.21 CFI 9,901,607 10,191,313 976,137 1,882,118 5,293,919 13,199,738
Totel s e v iifs
-lo» e s t iu te  ceses,.51 CFI 1,082,569 2,010,171 106,522 399,736 938,361 2.913,955
- lo *  e s t iu te  ceses,21 CFI 2.680,286 9,858,966 282,298 915,591 1,388,996 6,390,066
-k ifk  e s t iu te  ceses,.51 CFI 9.621.723 6,295,801 997,305 1,065,89) 2,329,571 7.723.739
-k ifk  e s t iu te  ceses,21 CFI 11,012,593 13,259,093 1,150.210 2,979,002 6,127,111 17,390,899
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T a b l e  7 . 6 :  c o n t i n u e d  I
< ............... Horeig- -----------> ( . ------------- H a , - - ---------- > ( ............. lupendeki ---------- > m
Lot receptive  Rod. receptive Loi receptive Hod. receptive U »  receptive  Hod. receptive n
C. COST-EFFBCTIIEIESS IATI0S ( I t )
I .  Cost per cete prevented ( i )
- lo v  e s t in t i  cites 388 122 1,141 170 2,628 118 1
-k ig k  e s t in te  c ite t 86 29 257 40 302 26 I
I I .  Cost per deitk prevented ( j )
- lo »  e s t in te  enees,.51 CFI 66,001 23,831 198,814 33,181 204,734 21,354 1
-Io »  e s t in te  ceses,21 CFI 16,500 5,958 49,703 8,295 51,104 5.339 I
-high e s t in te  cases,.51 CFI 16,500 5.719 49,703 7,963 51,184 5,125 I
-high e s t ile te  cises.21 CF1 4,125 1.4)0 12,424 1,991 12,796 1.201 I
I I I .  Cost per diy of healthy l i f e  gained (k)
- lo »  e s t in te  cases,.51 CFI 4.44 1.34 14.48 2.02 15.68 1.30 I
-lo »  e s t in te  cases,21 CFI 1.27 0.38 3.90 0.54 4.07 0.35 1
-k ig k  e s t in te  cites,.5X  CFI 1.01 0.29 3.32 0.44 3.43 0.28 1
-k ig k  e s t in te  ceses,2t CFI 0.29 0.08 0.90 0.12 0.92 0.07 1
I ! .  Cost per discounted d iy  of b e iltk y  l i f e  giined (1)
- lo v  e s t in te  c ises,.51 CFI 12.09 4.10 46.05 7.41 56.25 4.75 I
- Io »  e s t in te  cises.21 CFI 4.57 1.11 14.95 2.47 16.22 1.50 1
-k ig k  e s t in te  cises,.S I CFI 2.15 0.97 11.13 1.75 11.63 1.10 I
-k ig k  e s t in te  ceses,21 CFI 1.12 0.30 3.70 0.58 3.13 0.37 1
1. l e t  sevings in goveronent c u r i t i  ve and preventive costs (a)
- lo »  e s t in te  ceses,.51 CFI (1,174,100) (729,749) (416,852) (213,741) (2,272,771) (855.340) 1
- lo »  e s t in te  ceses,2 t CFI (1.107,577) (411,157) (409,5 36) (190.203) (2,233.190) (691.872) I
-k ig k  e s t in te  ceses,.SX CFI (1,045,600) (487,942) (405,731) (175,964) (2,103,450) (465,952) I
-k ig k  e s t in te  ceses,2X CFI (779,508) 4,193 (376,465) (77,805) (2,025,126) 215,166 1
I I .  le t  sevings in to te l cure tive end preventive costs ( i )
- lo *  e s t in te  cases,.51 CFI (960,228) (212,495) (391,200) (110,303) (2.244,349) (201.477)
- lo v  e s t in te  coses,21 CFI (893,705) (94,103) (383,803) (86.745) (2.204,748) (38.009)
k igk e s t iu te  coses,.51 CPS 85,180 1,754,520 (279,232) 270,241 (1,609,472) 2,566,226
-k ig k  e s t in te  coses,21 CFI 351,272 2.240,654 (249,965) 348,400 (1.451.149) 3,247,345
I I I .  Totel net sevings (o)
- lo »  e s t in te  coses,.51 CFI (201,228) 1,183,797 (318,810) 121,175 (1.9)1,101) 1,393,264 '
• lo»  e s t iu te  coses,21 CFI 1,396,490 4,032,092 (143,004) 686,980 (980,466) 5,319,375
-k ig k  e s t in te  coses,.51 CFI 3,337,926 5,419.427 21,973 857.282 (44,091) 6,703,048
-k ig k  e s t iu te  coses,21 CFI 9,721,796 12,4)2,648 724,070 2,250,441 3,757,649 16,370,153
f i l l ,  l e t  sevings per cose prevented (p )
- lo »  e s t in te  ceses,.51 CF1 (60.86) 175.16 (855.02) 90.12 (2,141.49) 160.80
- lo »  e s t in te  ceses,21 CFI 422.38 596.62 (313.74) 510.90 (1,007.39) 613.92
-k ig k  e s t in te  ceses,.51 CFI 222.87 188.70 13.26 150.21 (5.72) 172.15
-k ig k  e s t iu te  ceses,21 CFI 649.59 432.90 437.60 394.31 470.94 420.43
I I .  l e t  sevings per deeth prevented (q )
- lo »  e s t in te  ceses,.51 CFI (10 . 345) 34,139 (149,022) 17,591 (166,858) 29,149
-lo »  e s t iu te  ceses,21 CFI 17,949 29,070 (14.721) 24,9)3 (21,179) 27,822
-k ig k  e s t iu te  ceses,.51 CFI 42,901 37,509 2,568 29,869 (970) 33,657
-k ig k  e s t in te  ceses,21 CFI 31,260 21,512 21,177 19,602 20,293 20,549
2 3 8
Table 7.6: continued: Notes
(«) Based os lean priva te  expenditnre t f  l i  12.7 (R oro ig), I t  69.7 ( I U i ) ,  Is  31.6 (topaedehi) a u lt ip lie d  by c t iv e r s it i  
factor of 0.93.
(b) Based ob proportioa o f cues fo rk ing  sad lo s t work days o f 791 and 16.3 (Rorang), 161 aod 7.6 ( I l a i ) ,  121 aod 6.3 
(lapandehi) s u lt ip l ie d  by aeao d a ily  loss o f Is  6 aod coaversioa fa c to r o f 0.9.
(c) Assuaiog API o f 10 is  lo t  aid 60 i i  loderate re c e p tiv ity  areas.
(d) A sso iiig  API o f 62 i i  lo t  aid 230 i i  aoderate re c e p tiv ity  areas.
(e) Attuning death to occor io age-groups 1-6 a id  13-19 fo r  high aid lo t  case e s tiia te s  fo r loderate areas, 
aid 20-26 aid 23-29 fo r  lo t  receptive oreas.
( f )  D iscou t rate o f 121.
( | )  Assoiiog proportions seekiog t r e a t ie i t  of 631 (R oraig), 261 ( I l ia ) ,  511 (Itpaodebi), aid t r e a t ie i t  cost 
of b  13 fo r  cases aod b  300 fo r f o i r  t i le s  the tu b e r  of deaths i i l t i p l i e d  by cooversio i fa c tor o f 0.95.
(k) Loss fo r cases based oo proportion of cases to rk io g  as i i  (b) fo r  lo t  receptive areas aod 701 fo r lo t  e s t in te  aod 
501 fo r high e s t in te ,  u d e n te  receptive areas t i ie s  loss per day o f b  I .  aid loss fo r deaths based 01 average da ily  
«age tkrooghoot year of b  11.25 t i n s  conversion fa c to r of 0.9 aid days to rked per year o f 312.
Lifetime earnings based 01 (e) above aid d is c o u te d  a t 121.
( i )  Total cost of c o i t ro l  d ivided by cases preve ited .
( j)  Total cost o f c o i t ro l  divided by deaths preveited.
(k) Total cost o f con tro l d ivided by days of hea lthy l i f e  gained.
( l )  Total cast o f con trol divided by days of healthy l i f e  gained d iscou ted  a t 121.
(1) Goveruent t r e a t ie i t  costs v itho n t con tro l l in o s  governnent cost o f con tro l.
(1) Total t re a tn a t  costs v itko o t con trol l in is  to ta l  c ira t iv e  and p re ve itive  cost of control.
(0) Total resonree costs v it h o it  con trol i i i u  to ta l  cost of c o l t r a i .
(p) Total resoarce costs l i tk o n t  c o ltra i t i n s  to ta l  cost o f con tro l, divided by cases prevented.
(q) Total resoarce costs o ithon t con trol l i n s  to ta l  cost o f c o n tro l, divided by deaths prevented.
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assuming low Incidence except with the low case fatality rate in low 
receptive areas and with either fatality rate in the expensive areas 
of the low receptive Terai where malathlon is sprayed (Rupandehi) and 
the low receptive hill (Ilaa) . This result Indicates that in narrow 
terms, considering only the resources used in malaria control and the 
resources that malaria control creates in terms of avoided treatment 
costs and productivity losses, malaria control can be justified. 
However, the ratio omits the value of preventing illness and saving 
life per se. It thus under-estimates the value of malaria control and 
does not provide an answer to the question of whether one should 
invest in malaria control as opposed to some other service.
The final two cost-effectiveness ratios, C VIII and C IX, divide net 
savings by cases and deaths, producing a net saving per case and per 
death. These figures suggest considerable potential benefits to 
individuals from preventing malaria.
Given the large number of assumptions necessary to produce the cost- 
effectiveness ratios, it is clearly important to test the sensitivity 
of the conclusions to variations in key assumptions. Table 7.6 itself 
incorporates some sensitivity analysis by using low and high case 
estimates and case fatality rates. In addition, the effects of 
changing the following assumptions were tested:
halving the value of a day of work lost and of the annual loss 
due to death;
doubling the cost of private treatment; assuming all cases 
receive government outpatient treatment; and doubling the 
government inpatient cost;
- doubling days of work lost per case;
discount rates of 5% and 8%.
The effects of changing assumptions were as follows.
Cases prevented: The cost-effectiveness ratios are highly sensitive to 
assumptions on the number of cases prevented, as indicated by the 
range in cost per case prevented (C I).
Case fatality rate: Varying the case fatality rate has a large effect 
on the indicators healthy days of life and lost workdays. For
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example, 'savings In healthy days of life' (B III) are almost 
quadrupled by changing the case fatality rate from 0.5% to 2%, and 
lost work days trebled. Since lost work days are by far the greatest 
component In 'savings In resources' (B IV), 'total net saving' (C VII) 
and 'net savings per case and death' (C VIII and C IX) are very 
sensitive to variations in the case fatality rate.
Value of days of work lost: Halving the value of days of work lost
has relatively little effect. Only one of the values In 'total net 
savings' (C VII) is switched from positive to negative (low receptive 
area of Ilam, high case estimate and low case fatality rate). 'Net 
savings per case and death prevented' are roughly halved but again, 
only one value switches from positive to negative.
Treatment costs: Assuming 100% seek government outpatient treatment 
and the cost of government inpatient treatment is doubled has the 
effect of approximately doubling savings in government treatment 
costs. This is sufficient, however, only to switch one value in C V, 
'net savings in government treatment costs' , from negative to positive 
(moderately receptive area of Ilam, high case estimate and high case 
fatality rate). In conjunction with the doubling of private treatment 
costs, the effect is to switch the values of C VI, 'net savings in 
total treatment cost', from negative to positive for all moderately 
receptive areas and. low case estimates. Thus net savings occur 
whatever the case estimate and case fatality rate in moderately 
receptive areas but not for low receptive areas of Rupandehi or Ilam 
where control is costly, or the low receptive area of Morang and the 
low case estimate.
Vork days lost per case: Doubling the work days lost per case has 
little effect because total work days lost are dominated by those 
resulting from death. In the ratio C VII, 'total net savings', only 
two values switch from negative to positive.
Discount rate: A reduction in the discount rate to 5% increases
savings in discounted healthy days of life and in the value of lost 
work days by about 50%, thus affecting both the ratio C IV, 'cost per 
discounted day of healthy life gained', and C VII, 'total net savings' 
and consequently C VIII and C IX. The cost per discounted day of
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healthy life gained la thus considerably lower, and all values of 
'total net savings' (C VII) becaae positive except the low receptive 
area of Ilam and Rupandehl with a low case estimate and low case 
fatality rate. With a discount rate of 8%, these areas with a low 
case estimate and high case fatality rate are also negative.
In conclusion, the sensitivity analysis indicates that the most 
important assumptions are those relating to the incidence of malaria 
in the absence of malaria control and the case fatality rate. Any 
cost-effec.tlveness ratio that includes a variable that depends on the 
days of life saved by preventing deaths (eg days of healthy life 
gained, lost work days saved) is dominated by the assumptions on 
deaths. Thus the assumptions on the period of incapacity of each case 
or its value are of little Importance. Even halving the estimated 
value of the annual loss due to death has little effect.
The cost of malaria control is such that even if all cases received 
treatment at government expense, only in the moderately receptive 
areas with a high case estimate and high case fatality rate would 
treatment costs exceed the current costs of control. Superficially 
this might indicate that a curative rather than preventive strategy 
was worthwhile. However the ratio 'net savings in government 
treatment costs' (C V) Ignores firstly the sizeable sums that 
individuals may spend on treatment, and secondly the cost to 
individuals in the form of lost production.
In terms of the economic analysis the results of the sensitivity 
analysis are reasonably reassuring: the exact values of the economic 
parameters (number of days lost per case, value of days lost per case 
and per death, value of treatment cost) are of less importance than 
the epidemiological parameters. Of all the economic parameters, that 
whose value appears to be the most Important is the discount rate, 
though it affects only some of the cost-effectiveness ratios.
7.8 Summary
This chapter has provided the assumptions which, when matched with the 
cost analysis, enabled an assessment of the desirability of malaria 
control to be done. The framework of Figure 4.1 was used to assess
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the consequences of malaria control, namely cases and deaths averted, 
savings in resource use and changes in the quality of life.
The number of cases in the absence of malaria control was difficult to 
assess and was speculatively put at minimum and maximum APIs of 10 and 
40 for low receptive areas and 60 and 250 for moderately receptive 
areas. The case fatality rate was put at 0.5% and 2%.
Consequences for government resources stem from treatment demands for 
cases that would arise in the absence of malaria control. It was 
assumed that the proportion of cases seeking government treatment 
would be the same as the present proportion of cases detected through 
PCD mechanisms; that the cost of outpatient treatment was Rs 13; that 
inpatient cases would equal four times the number of deaths; and that 
the cost of inpatient treatment was Rs 300.
Consequences for individuals stem from the costs of private treatment 
and of days of work lost that would arise in the absence of malaria 
control. Data from the patient survey was used to examine the 
Influences on private expenditure and days of work and school lost in 
order to assist speculation on how these might change if the malaria 
control programme were to cease. The most Important findings on 
private expenditure were that a substantial proportion of malaria 
cases currently sought help from non malaria service sources of care 
and spent substantial sums of money. Use of these other sources of 
treatment was particularly associated with lengthy periods of 
disability and with Imported cases.
In the case of days of work and school lost, it was found that there 
was a strong association with the species of parasite, P. falciparum 
cases losing significantly more days of work than P. vlvax cases, and 
that the longer the periods between the start of the fever and 
presumptive and radical treatments, the more days of work and school 
were lost.
The assumptions made for the cost effectiveness analysis were that 
mean private expenditure per patient would remain at the current 
level; that the current proportions of patients engaged in economic 
activity would persist in low receptive areas but would be reduced to
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70% and 50% In moderately receptive areas, low case estimate and high 
case estimate respectively, due to the Increased numbers of children 
Infected; that the current pattern of days of lost work per case would 
continue; and that the value of each day lost would be Rs 7.20, double 
the current value, due to multiple cases within households which would 
limit their capacity to cope with the workload of sick members.
The value of the loss of production due to deaths was estimated by 
making assumptions on the average age at death for each API level and 
using life tables to estimate years of life remaining at those ages. 
Based on assumptions on the value of a day of full employment and on 
labour demands through the year, the value of a year's work was put at 
Rs 3200. It was assumed that a child became productlven at age 15, 
and the value of years of life lost was discounted at 12%.
Changes In the quality of life that would result from the cessation of 
malaria control could not be valued, but a proxy quality of life 
measure was used in the form of the indicators, 'healthy days of life 
lost' and 'discounted healthy days of life lost'.
Estimates of the cost of control were based on the cost analysis In 
Chapter 6 for Morang, Rupandehi and Ilam. Costs were distributed 
between low and moderately receptive areas of each district.
Nine cost-effectiveness ratios were calculated: 
cost per case prevented; 
cost per death prevented; 
cost per day of healthy life gained; 
cost per discounted day of healthy life gained; 
net savings in government curative and preventive costs; 
net savings In total curative and preventive costs; 
total net savings (Including value of days of work lost); 
net savings per case prevented;
- net savings per death prevented.
The first four could not on their own Imply anything about the 
relative value of preventing malaria since they required a comparison 
with similar ratios from other programmes. Present government control 
costs were not fully matched by savings in government treatment costs
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except with the high case estimate In moderately receptive areas In 
the Terai . If private treatment costs were added, net savings 
resulted at a level of cases between the low and high estimates. 
Inclusion of the value of lost work days resulted In net savings in 
virtually all areas.
The relevance of these various cost-effectiveness ratios to policy­
makers was discussed. An extensive sensitivity analysis Indicated 
that the most Important assumptions were those relating to the 
incidence of malaria In the absence of malaria control and the case 
fatality rate. The exact values of the economic parameters were much 
less Important.
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DISCUSSION
8.1 Research objectives and methods
Chapter 1 listed the following aims of this research study:
1. to explore the relevance of recent developments in the methodology 
of cost-effectiveness analysis to disease control programmes in 
developing countries and specifically to malaria control in Nepal;
2. to apply cost-effectiveness analysis to the malaria control 
programme in Nepal in terms both of (a) the cost-effectiveness of 
various malaria control strategies and (b) the cost-effectiveness 
of the malaria control programme as a whole, in order to refine a 
methodology capable of more general application to disease control 
programmes in developing countries;
3. to assess whether policy-relevant conclusions can be drawn from 
the application of cost-effectiveness analysis to the malaria 
control programme in Nepal.
The following chapter takes up point number 3, so this chapter 
concentrates on whether the research has been able to achieve alms one 
and two.
The recent developments in the methodology of cost-effectiveness 
analysis have been found to be applicable to malaria control, though no 
attempt has been made to apply cost-utility analysis through use of an 
output measure such as quality adjusted life years. The methodology of 
the main components of the evaluative framework are considered in turn 
below.
Cost analysis
The cost analysis proved quite feasible, though was much assisted by the 
programme budgeting system used by a number of NMEO regions and 
districts. Accurate costing would have been far more difficult in the 
absence of such a system. The Joint nature of costs in integrated
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districts was the main costing problem encountered, to which there was 
no easy solution.
Effectiveness analysis
The greatest methodological problem was posed not by the cost analysis 
but by the absence of good evidence on the effectiveness of alternative 
malaria control strategies or of the programme as a whole. Since It was 
beyond the scope of the research to mount a trial of alternative 
strategies, programme data and the views of experts as expressed in the 
External Reviews had to be relied on for evidence of effectiveness. Two 
main strategies were used to cope with the consequential poor evidence 
on effectiveness. For the comparison of alternative ways to achieve a 
programme objective (eg vector control, or case detection and treatment) 
measures of intermediate output were used, such as houses sprayed or 
cases detected. This approach is valid where this measure is common 
to the alternatives being compared and there is good reason to believe 
that it is a reliable proxy for a final output measure. For example in 
the case of spraying. It is known that both DDT and malathlon are 
effective in killing susceptible and exophillc mosquitoes if properly 
applied; thus the measure 'houses sprayed' is a reasonable proxy 
indicator of output for the purpose of comparing insecticides so long 
as allowance is made for the differing periods of time over which they 
are effective.
For the analysis of the desirability of malaria control, the approach 
adopted to cope with the shortcomings of the effectiveness data was to 
estimate minimum and maximum levels of cases in the absence of control, 
in the expectation that the true value lay somewhere between these. This 
was admittedly guesswork, but it made it possible to explore the extent 
to which conclusions on cost-effectiveness were likely to be sensitive 
to the precise assumptions adopted on the likely level of malaria in the 
absence of control.
A final short-coming of the effectiveness analysis is that the effect of 
malaria control activities on diseases other than malaria has been 
Ignored. These other diseases include viral encephalitis, leishmaniasis 
and fllariasls. Although they do exist in Nepal, malaria presents the 
most serious problem and is taken to be the main raison d'etre of the
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control programme. Given the uncertainties over its effect on malaria, 
there seems to be little point in speculating on its effect on other 
diseases, about which even less is known.
Resource saving consequences
The cost-effectiveness analysis was able to estimate the value of the 
resource saving consequences included in the evaluative framework, 
namely savings in public and private treatment costs and savings in lost 
work time. The inclusion of both of these items can be controversial. 
In the context of a developed country, where all who need treatment are 
likely to obtain it, few question the relevance of averted treatment 
costs to a cost-effectiveness analysis. In a developing country, 
however, treatment may be confined to particular diseases, population 
groups or geographical areas. The inclusion of treatment savings can 
thus bias analyses or programme choice in favour of particular 
programmes or particular geographical areas.
In the comparisons undertaken within the context of this analysis, this 
type of bias was not a problem. For example, no cost-effectiveness 
ratios were available for other health programmes in Nepal to which 
malaria control might be compared, and no conclusions were drawn on the 
geographical scope of the malaria control programme that would be 
affected by differences in private treatment practices between areas. 
Indeed, inclusion of averted treatment costs is of value in seeing 
whether these alone are sufficient to offset the cost of control 
activities. Finally, given that alternative malaria control strategies 
and alternative case detection and treatment strategies have different 
consequences for the number and duration of cases of malaria, it is 
important to take into account their differing consequences in terms of 
treatment costs.
Controversy over the inclusion of savings in lost work time as a 
consequence has two sources: concern that it biases investment decisions 
in favour of programmes that improve the health of the workforce as 
opposed to children or the elderly; and concern that extremely crude 
measures are used to value days of work lost. The analysis here copes 
with these concerns in several ways. Firstly, a very broad definition of 
work was used in the surveys, encompassing not merely paid employment
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buC also unpaid work within and outslda tha household, including 
childcare, housework and food preparation. Moreover, no arbitrary 
definition of the workforce was used: malaria cases were asked whether 
they considered themselves to work, according to the definition of work 
outlined above. Account was therefore taken of the work contribution of 
both children and the elderly. Secondly, the household survey was 
designed to explore the mechanisms within the household which determined 
whether the illness of a family member was translated into a loss of 
Income or production. The resulting estimates of loss were much lower 
than if estimates had been based on the number of days of disability 
multiplied by a dally wage.
Finally, while it is recognised that households and society value the 
extension of life and improvement in quality of life as benefits in 
their own right and not merely as means to Improvement in economic 
circumstances, in a poor subsistence economy, people themselves place a 
high priority on Improving their economic circumstances. It was clear 
from discussions with villagers on the consequences of malaria that 
concerns about inability to work and earn a living were not concerns 
Imposed by the preconceptions and framework of the research but 
reflected real local concerns.
Two resource-saving consequences occasionally Included in cost-benefit 
analyses of malaria control programmes have been Ignored in this 
analysis. They are the averted funeral expenses which result from saving 
lives (included by Rao and Bhombore 1956) and the value of the calories 
that an episode of fever consumes (Included by Barnum 1978, Wright 1977 
and Ramaiah 1980). The first has been excluded here because malaria 
control merely postpones death, the second because the empirical basis 
for estimating a value appears to be very shaky.
Quality of U f a
Since an assessment of the utility of malaria prevention to individuals 
in terms of the improvement in the quality of life was not possible 
within the scope of the fieldwork, the second-best solution adopted here 
was to use the measure 'healthy days of life lost' as a proxy and as a 
convenient way of amalgamating both cases and deaths in one measure. It 
is recognised, however, that such a measure Incorporates assumptions on
250
the relative weight to be given to days of Illness versus days of death 
and to different age-groups. Indeed, the cost-effectiveness 
calculations showed clearly the extent to which the measure favours 
programmes which prevent deaths rather than episodes of Illness.
Putting costs and consequences together
In putting costs and consequences together, a variety of ratios were 
calculated, ranging from a simple control cost per case averted to net 
savings per case averted. This approach both facilitates a discussion of 
the relevance of different measures to different sorts of decisions and 
different decision-makers and assists comparisons with other cost- 
effectiveness studies which on the whole calculate a less comprehensive 
range of costs and effects.
In valuing costs and consequences, the decision was taken to adopt 
economic pricing, adjusting for the extent to which prices diverged from 
the true social opportunity cost of goods and services, but not social 
pricing on the grounds that this had not been used In economic 
appraisals In Nepal, for instance In those conducted by the World Bank, 
and that there was virtue In consistency of practice. Similarly the 
approach to economic pricing and discounting used drew on the practice 
of the World Bank and Asian Development Bank in Nepal.
The analytical framework
The final issue that needs to be tackled in considering the 
appropriateness of the cost-effectiveness methodology in evaluating 
malaria control in Nepal is the relevance of the analytical framework. 
Cost-effectiveness analysis, like cost-benefit analysis, is rooted in 
partial equilibrium theory. Mishan (1982) warns his readers as follows:
"Let me remind the reader again that the context of a cost- 
benefit analysis is that of partial equilibrium analysis, one in 
which we concentrate on the valuation of several items on the 
assumption that the effects of consequent changes in the prices of 
all but the most closely related goods or bads may be neglected as 
we vary the amounts or introduce any one of these several items".
In the case of the evaluation of the costs and benefits of endemic 
disease control projects, there seems to be general agreement that a
251
macro focus Is appropriate. This has been argued by Barlow (1967) with 
reference to malaria control In Sri Lanka, by Newman (1965) for malaria 
In Sri Lanka and Guyana and by Welsbrod, Andreano, Baldwin, Epstein and 
Kelley (1973) for schistosomiasis In St Lucia. Newman, for example, 
argues that:
"In both Ceylon (Sri Lanka) and British Guiana (Guyana), the 
removal of malaria here Is estimated to have resulted In an 
acceleration of the crude rate of natural Increase by 0.7% per 
year. When one disease assumes such a major role, Its 
eradication can no longer be treated as a marginal change. The 
whole of the demographic systems and hence the whole of the 
social and economic systems, were previously geared to a heavy 
loss of life in order to come to terms of equilibrium with the
disease. Its eradication thus Implies that we must analyse 
whole new systems; In economic terms, we must then deal with 
general equilibrium analysis and not ... partial equilibrium 
analysis .... which Is quite valid for relatively minor 
diseases."
Weisbrod et al (1973) comment, however, that:
"the consequences of structural change are very difficult to deal 
with empirically, given the current state of knowledge. General 
equilibrium theory in the social sciences exists at a level of 
abstraction which as yet has relatively little operational value".
Barlow, despite epidemiological and economic data that were relatively 
good for a developing country, still had to make many assumptions on the 
initial effects of malaria control and on relationships between 
variables In his model, and some of his assumptions were severely 
criticized.
This methodological issue Is not a major problem for that part of the 
cost-effectiveness analysis that Is concerned with the evaluation of 
alternative malaria control strategies, since achievement of a certain 
level of malaria control Is taken as given. It Is a problem, however, In 
assessing the desirability of malaria control per se ■ The methodology 
employed in Chapter 7 assumed that the consequences of complete loss of 
control would be of the same nature as those from a much smaller number 
of cases, namely health consequences, resource costs stemming from 
treatment costs and loss of work time, and reduction in the quality of 
life. This approach, however, Ignores two possible further consequences 
of loss of control, namely abandonment of land by farmers and the 
Interaction of this effect and that of loss of work time with a number
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o f  o c h e r  e c o n o a i c  v a r i a b l e s  Co a n  e x C e n t  C h a C  h a s  r a m i f i c a C i o n s  
C h ro u g h o u C  Che econom y.
The consequences of abandonmenc of land would be Che loss of Che 
marginal produce of farm land and seeders in malarious areas, neC of 
any gain in Che marginal produce from Che new acCiviCies of migranCs and 
any gain in ouCpuC from new uses Co which Che abandoned land mlghc be 
puC, for example foresC produces if forescry were Co be developed.
If iC is choughc ChaC loss of conCrol of malaria is likely Co have 
widespread ramif IcaCions ChroughouC Che economy of Nepal, chen a macro 
analyCical framework would be appropriace Co evaluaCe Chis situation. 
The ideal analytical approach would be Co simulate Che economy of Nepal, 
using a macro-economic model of the main relationships such as that 
devised by Barlow (1967) (see Annex 1) . The main changes induced by 
loss of control would be fed into the model (any change in fertility and 
mortality races, change in quantity and quality of labour inputs, change 
in consumption and savings rates, change in availability and qualicy of 
land) in order to see their collective effect on per capita income over 
time. The information required on the immediate effects of loss of 
control would be largely the same as in the micro model, but the 
relevant variables would be allowed to interact with other economic 
variables in the model to determine in the long run the Impact of non- 
marginal changes in labour supply, land and possibly population numbers 
on per capita income.
Very little guidance is available in the literature on what might be the 
consequences of complete loss of control. The references cited above 
were all examining the consequences of moving from a position of no 
control to one of control or eradication, at a time when the countries 
concerned were far less developed than they are now. No study seems to 
have considered in detail the economic consequences of loss of control 
in the 1980s. The cost-benefit analyses of malaria control reviewed in 
Chapter 2 all confined themselves to loss of work time and treatment 
costs, ignoring any other possible consequences.
It is thus possible only to speculate on the consequences of loss of 
control in Nepal. Since the 1950s, much of the Terai has been opened up 
to external Influences, with a considerable growth in agriculture,
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commerce and minor Industry. Improvements In communications have made 
previously isolated areas accessible. If malaria incidence were to rise 
considerably, the population now has access to sources of treatment, 
both government and private, and the level of awareness of malaria seems 
quite high. There is therefore no longer the same fear of malaria that 
was reported to be a reason for the under-population of the Terai in the 
1950s. Thus there seems to be little reason to suppose that the return 
of malaria would lead to the widescale abandonment of the settlements 
that have taken place in recent years.
This view is supported by the absence of alternative means of livelihood 
for the settlers. Cultivable land is in extremely short supply in Nepal, 
with what land there is remaining to be exploited being in the malarious 
parts of the Terai. Moreover, in terms of the more intensive 
exploitation of existing agricultural land, again the potential lies 
primarily in the Terai where average holdings are much larger than in 
the Hills but average farm output is little greater (Mills 1988) . 
Employment opportunities are relatively limited, whether in rural or 
urban areas.
A final reason for assuming that a resurgence of malaria would not force 
farmers off the land is that it is difficult to envisage that the 
government could stand by and allow an epidemic of malaria to continue 
without mobilizing at least treatment, if not control activities. 
Similarly, if malaria began to affect the viability of industrial and 
commercial enterprises, employers would presumably see it to be in their 
interest to provide treatment. This speculation supports the 
assumption, made earlier, that loss of control would not significantly 
increase the period between onset of the fever and treatment.
If abandonment of land is not likely and treatment services are 
mobilized during epidemics for priority groups, then there is less 
reason to suppose that the resurgence of malaria would have wide-ranging 
economic effects. Those most vulnerable to malaria, small-scale 
subsistence farmers, produce little for sale and thus a fall in their 
production and consumption is unlikely to have any major effects on 
marketed agricultural production or agricultural exports.
These points lead to the conclusion that loss of control of malaria
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would bo unlikely Co lead Co major consequences chac ere noC taken Into 
account in the cost-effectiveness framework used here.
8.2 Validity of data
The validity of the data used in the cost-effectiveness analysis is 
considered here under three headings: the programme cost data, the 
effectiveness data, and the evidence on household resource costs.
Programme cost data
The main shortcomings of the data on the costs of the malaria control 
activities of the NMEO and ICHSDP can be summarized as follows:
- a comprehensive analysis of costs in all districts was possible 
for only NMEO districts, and only for recurrent not capital costs. 
In addition, sinca many districts did not report expenditure 
according to a programme budget format, it was not possible to do 
any detailed analysis of costs by programme or activity for all 
districts;
- because of resource limitations, the detailed analysis required 
for the cost-effectiveness study could only be done for three NMEO 
districts and two ICHSDP districts. While this was adequate to 
draw overall conclusions, it has left unanswered some detailed 
questions on why costs and cost-effectiveness vary between 
districts. In particular, a more extensive analysis of the costs 
of integrated districts would have been desirable given the speed 
with which the government is now pursuing integration;
however, costs of Integrated districts were much more difficult to 
analyse because of the Joint nature of activities in Integrated 
districts and the multiple sources of funding and multiple budgets 
for malaria control. Far more estimation procedures had to be used 
than in NMEO districts. Moreover, the accounting system at ICHSDP 
headquarters was so complex that it was impossible to disentangle 
headquarters costs associated with malaria control from those 
associated with other programmes;
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- the costa of drugs end Insecticides were estimated on the basis of 
quantities used rather than quantities supplied, thus excluding 
the costs resulting from wastage. Although enquiries were made In 
the study districts about supplies, stock levels and wastage. It 
proved very difficult to put any figures on these. Underestimation 
of the cost of drugs will have very little effect on costs since 
drug costs are an Insignificant proportion of total costs. The 
same Is not true of Insecticides, but spraying Is anyway the most 
expensive malaria control strategy so underestimation would not 
affect study conclusions. The only area In which It might be 
Important Is In the comparison of Insecticides, because the 
different bulk of different Insecticides (particularly Fleam as 
opposed to malathlon) leads to different distribution practices 
which may well result In less wastage and loss of Fleam as opposed 
to malathlon. This advantage of Fleam was taken account of in the 
analysis In a qualitative rather than quantitative way;
the analysis has made no allowance for the movement of malaria 
patients between districts, for Instance In calculating district 
per capita costs. It Is unlikely that this will have Introduced 
any major distortions In the cost or cost-effectiveness analysis;
- Joint costs presented a problem In the calculation of malaria 
control costs in ICHSDP districts and case detection and treatment 
costs by different approaches in NMEO districts. However, the 
great majority of costs are salary costs, which are the easiest to 
allocate out to different activities. It is therefore anticipated 
that the costs reported are of the correct order of magnitude. If 
not precisely accurate.
Effectiveness data
In the comparison of alternative approaches to vector control and 
alternative case detection and treatment methods, considerable use was 
made of Indicators of intermediate output, particularly population 
covered, population and houses sprayed, slides taken, and cases detected 
and treated. It Is therefore Important to consider the reliability of 
this programme data.
256
Presumably for historical reasons, because In the early years of the 
control programme a detailed survey of houses and people was required, 
the NMEO has always kept Its own population statistics. These are 
regularly updated through the means of the house-to-house visits of 
malaria field workers. These population statistics are generally 
believed In Nepal to be more accurate than estimates based on the 
dlcennlal population census and Indeed are frequently used by socio­
economic surveys to provide a sampling frame.
The quality of programme data Is regularly checked by the Internal and 
external evaluation teams. In general, for the period covered by the 
analysis here, the NMEO programme data was said to be reliable (though 
problems have more recently been experienced In those districts where 
cases have risen considerably). During the field work for this study, It 
was apparent that district officers had a regular programme of 
supervision of field workers. Similarly, slide collection seemed to be 
reasonably well done and cross-checking procedures were adhered to. The 
same was not true, however, for ICHSDP districts. Little supervision 
seemed to take place of community health worker activities and large 
backlogs of slides built up In district laboratories at the height of 
the transmission season. Statistics on such aspects of programme 
performance as the time-lag In providing radical treatment and the 
cross-checking of slides are Incomplete for ICHSDP districts.
Programme data leaves unanswered the major question of the extent to 
which either the NMEO or ICHSDP are detecting all the cases of malaria 
that arise. Annual blood examination rates (ABER) in the study districts 
In 1984 were as follows:
NMEO districts Morang 13. 19%
Rupandehi 17. 96%
111am 23. 92%
ICHSDP districts Saptari 4.96%
Parsa 7. 74%
Assuming these are representative In til 1 space, which seems a 
reasonable assumption In NMEO districts given the regular routine of 
house-to-house visits, the high ABER of NMEO districts suggests that a
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high proportion of case* should b® detected. The same Is not true, 
however, of ICHSDP districts. There are thus good grounds for suspecting 
that the ICHSDP districts detect a smaller proportion of cases than NMEO 
districts.
Details of each malaria case, as revealed by the investigation and 
completion of the SF5 form, are likely to be less reliable than the 
simple count of cases or report of species type. This comment 
particularly applies to the classification of cases as Indigenous, 
imported or relapse since this classification depends on obtaining a 
reliable account of the patient's movements. This he may be unwilling to 
give If It Involved movement across the Indian border or illicit trading 
activities. Information on relapses and the presence or absence of a 
previous fever appears to be particularly unreliable.
Household resource costs
Information on household resource costs (private expenditure and losses 
resulting from the period of disability caused by malaria) were obtained 
from the patient and household surveys. The validity of the data from 
these surveys is therefore considered in turn.
Patient survey. When the survey was designed. It was appreciated that a 
number of features were likely to affecc the accuracy of the data 
collected. Nonetheless, the survey was set up since it was the only 
feasible way of collecting the information from a range of districts. 
However Its results need to be Interpreted in the light of the following 
features.
Firstly, malaria workers were used to fill in the data collection form 
(termed the ESM1 form). This Is likely to have had both advantages and 
disadvantages. Advantages Include their generally good relationship 
with the community and their personal knowledge of Its members. 
Disadvantages may be that respondents were hesitant about revealing 
their use of other sources of medical assistance, and/or magnified their 
reports of expenditure, possibly In the hope of reimbursement. 
Secondly, difficulties of communication and transport limited the 
guidance that could be given on the use of the ESM1 form. All efforts 
were made to simplify the form and print self-explanatory guidance on
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it, but Che quality of the data la likely to have depended on the 
enthusiasm and motivation of district and unit malaria officers.
Thirdly It was recognised that the difficulties of wording the question 
on 'work lost', despite the care taken In translating and piloting the 
form, were likely to lead to differences In Interpretation of the 
question. It did, however, appear from discussions In the districts and 
informal discussions with villagers that the definition of 'work' used 
by the form was one familiar to local communities.
Fourthly, It was anticipated that there were likely to be problems of 
recall since there could be a significant time lapse between the period 
of incapacity (primarily occurring prior to presumptive treatment) and 
the investigation of the case. This problem applied to information from 
both this form and the SF5 form, the report of the investigation of each 
malaria case which was also analysed. Table 8.1 shows the time-lapse 
between start of the fever and completion of the ESM1 form by district. 
The mean by district varied between 21 days (Rupandehl) and 71 days 
(Bara).
Finally, the NMEO's long experience of use of the SF5 form indicated a 
number of other factors affecting data quality. Dates (for instance of 
previous fevers, start of current fever) were known to be difficult to 
obtain and unreliable. Ages might be approximate rather than accurate. 
A reported 'previous fever' might not be malaria. And perhaps most 
important, depending on the purpose of their Journey, people might be 
unwilling to disclose travel to India, making classification of the case 
as Indigenous or Imported difficult.
It Is useful to comment here on the use of the ESM1 form in each 
district, using information gained from field visits to four of the six 
districts and discussions with the five district malaria officers and 
one district health officer.
Dang: No particular problems were reported. However communication 
problems are likely to have made supervision more difficult in Dang than 
in other districts In the survey.
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Table 8.1: Numbar of days between start of current fever and completion 
of the ESM1 form.
D is tric t Total
Dang Rupandehi Sarlahi ■ora.' Bhojpur lara
Tiao-lag start of 
cu rr .fev .to  data 
c o ll .
<1 Meek 3 233 2 5 12 0 255
coluan percent 1.41 12.91 1.51 1.71 9 .01 0.02 9 .8 1
1 -2  Meeks 14 401 14 20 13 0 444
coluan percent 4 .41 22.31 12.32 4.91 9 .8 1 0.01 17.92
2 -3  Meeks 40 473 28 33 19 1 594
coluan percent 11.31 24.31 21.51 11.41 14.31 4.51 22 .91
3-4  ueeks 57 343 39 34 13 0 504
coluan percent 24 .01 20.21 30.01 11.71 9 .81 0.01 19.52
>4 Meeks 105 331 45 198 74 21 774
coluan percent 47.41 18.41 34.41 48.31 57 .11 95.51 29 .92
Total 219 mi 130 290 133 22 2595
coluan percent 100.01 100.02 100.02 100.01 100.01 100.01 100.01
Hissing:¿58
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Rupandehl: The dlstrlcC malaria officer reported that In checking some 
of the early forms some Inconsistencies had been found. The forms were 
sent back for checking and the unit offices visited to provide guidance. 
Subsequently no problems had arisen.
Sarlahl: Unit officers had received little guidance and early ESM1 forms 
were not attached to their matching SFS form. Some confusion had arisen 
over the question on 'work' , for instance with number of days not worked 
being completed for patients who did not normally work. The district 
malaria officer and two of the unit officers were briefed on the proper 
completion of the forms. An attempt to locate SF5 forms to match the 
ESM1 forms failed and the forms analysed for Sarlahi date from the 
period after the visit, the early ESM1 forms being rejected.
Norang: The district malaria officer reported a tendancy to exaggerate 
expenditure on treatment. His unit staff enquired how to fill in the 
form if they suspected exaggeration and were told to fill in the figure 
given.
Bhojpur: No particular problems with the form were reported. However, 
because the forms for Bhojpur disappeared in transit and re-supply took 
time, NMEO HQ instructed the district malaria officer to complete ESM1 
forms for the cases that would have been interviewed if the forms had 
arrived on time. This accounts for the high proportion of cases in 
Bhojpur where ESM1 form completion occurred more than four weeks after 
the start of the current fever (see Table 8.1).
Bara: ESM1 forms were received late in Bara (October 1984). Shortage of 
laboratory technicians meant that a considerable back-log of slides had 
built up over the peak period of malaria transmission (approximately 
June to September). The time-lag from slide collection to radical 
treatment was thus generally longer than in the other districts, and 
also the time-lag between start of the fever and SFS and ESM1 form 
completion (Table 8.1). The ESM1 forms received lacked matching SF5 
forms: these were obtained but only approximately half the ESM1 forms 
could be matched. For the remainder, SF5 information was coded as 
'missing'.
It had been intended to interview all cases occurring in the districts
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over a 12 month period. Because of a variety of problems to do with the 
supply and use of forms, this was not achieved. The proportion of 
district cases picked up by the survey can be roughly assessed by 
comparing the district cases reported by month with the cases in the 
survey. The proportion of district cases In the survey was very high In 
Rupandehi for 6 months, and around 80% In Horang for 5 months. Bhojpur 
achieved high coverage but with a considerable lag. Coverage In Dang, 
Sarlahi and Bara was poor.
In conclusion, it appears from scrutiny and analysis of the data that 
the information on the days of disability caused by malaria is 
reasonably reliable, though there probably is some confusion between 
current and past episodes of malaria, particularly in Morang. 
Expenditures on treatment, however, are likely to be exaggerated. This 
is primarily likely to stem from the information given by respondents, 
though may also reflect a bias In the cases picked up by the survey If 
the more remote cases, which would be those less likely to have access 
to private sources of treatment, were missed In the districts where 
coverage of the cases occurring In the months of the survey was poor. 
The existence of some level of private expenditure Is, however, clear 
given the extent of the use of private sources of treatment. Around 50% 
of cases reported visiting a source of help other than the malaria 
service one or more times. Visits are more likely to be under-reported 
Chan over-reported, since patients may be unwilling to report visits to 
the malaria workers who collected the information, and the period asked 
about related to the time before presumptive treatment whereas 
expenditure refers to that period plus the period between presumptive 
and radical treatment.
The likely exaggeration of amounts spent does not completely invalidate 
the data collected. The level of expenditure is correlated with factors 
that might be expected to influence it, as discussed in detail in 
Chapter 7. The balance of the evidence suggests that substantial 
private resources are being used to obtain treatment for malaria, even 
if the exact magnitude of the expenditure is not known.
Ho u s e h o l d  survey. Since the household survey was carried out by 
independent and trained interviewers, it was possible to include
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procedures and checks Co help ensure Che validlcy of Che daCa collected 
In ways ChaC were noC possible in Che paCienC survey. In parClcular:
- Interviewers were used who were familiar with Che survey area and
able Co speak Che local languages;
for each paCienC Interviewed, a neighbourhood control was located 
and Interviewed by the same Interviewer;
one of the criteria for selection of the survey areas was that a 
laboratory should be available in the unit office, so that the 
delay between a slide being taken and the case being diagnosed 
might be minimized, thus reducing also the delay between the onset 
of the Illness and the Interview and thus the recall period 
required of respondents;
every effort was made to Interview the malaria patient within one 
week of the case being diagnosed;
a percentage of Interviews were repeated by a different 
Interviewer;
completed questionnaires were checked In the field and In 
Kathmandu for completeness and Internal consistency;
the data were coded and put onto a computer In Kathmandu and 
limited checking done. They were then exhaustively checked and 
edited In London. Queries were sent to Nepal and answers received.
The errors identified during the checking process In London included 
variables coded as 'no' when 'not applicable' was appropriate; errors in 
summing variables to create a total; and data entry errors (for example 
characters misplaced). Some variables, particularly age but also dates 
(for example of illness and treatment), were recorded more than once, 
for Instance in both the patient and the household questionnaire and by 
the independent Interviewer In the patient questionnaire and by the 
malaria assistant In the SF5 form. The values of such variables were 
compared and not surprisingly, inconsistencies were found. For instance
263
In the design of the survey. It was recognized that It was difficult to 
predict the likely number of cases and that this might present problems 
for Interviewers if many cases occurred at the same time and for survey 
numbers if few cases occurred. The latter possibility was allowed for by 
identifying an adjacent area that could be Included if cases were few in 
the main study area. In Nawal Parasl, it was necessary to Include this 
adjac ent area. In contrast, in Dhanusa so many cases occurred that the 
survey team could not interview them all within a reasonable time of the 
diagnosis. All cases who could not be interviewed within 14 days of 
diagnosis were dropped from the survey, but when the interviewers had 
time, these cases were visited and a household interview completed in 
order to check whether any bias might have been introduced into the 
analysis by their omission.
Comparison of the missed households with the survey households showed 
that slightly more of the former had agriculture as their main 
occupation and slightly fewer wage labour; slightly fewer had no land 
and those with land had slightly more land and higher grain production. 
These differences were not sufficient to alter the conclusions drawn 
from the evidence on the survey households. It seems likely that the 
missed households were more remote , and thus more dependent on 
agriculture simply because access to employment was limited where they 
lived.
SF5 forms for the missed cases were also analysed. There were no 
differences between survey and missed cases in how they were detected or 
in the species of parasite. Slightly more of the missed cases were 
indigenous and on average they were detected and treated slightly more 
slowly than the mean for cases.
8.3 Findings of the cost-effectiveness analysis: choice of strategies 
Ways of organizing an activity
The analysis in Chapter 6 compared the relative costs of NMEO and ICHSDP 
districts. It appeared that:
some respondents fell into one 5 year age-group according to one
response and into an adjacent one according to another response.
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the ICHSDP districts of Saptsrl and Parsa had a markedly lower
cost per capita for surveillance than the three NMEO districts;
costs per slide and per case were much closer to those of the
NMEO;
spraying costs were relatively similar.
Firmer conclusions on comparative costs are not possible without 
information from a wider range of districts. However the differing 
behaviour of costs as activities increase in the two types of district 
can be used to draw tentative conclusions. In ICHSDP districts, costs 
respond immediately to an increase in cases since time is diverted 
from other activities. In NMEO districts, the surveillance
infrastructure is expensive in terms of cost per case when Incidence 
is low and falls rapidly as cases rise. Thus NMEO districts with 
relatively few cases (eg Morang) are likely to be considerably more 
expensive than ICHSDP districts, whereas NMEO districts with higher 
APIs (eg Rupandehl) are likely to have similar or lower unit costs.
The cost behaviour of the two organisational patterns is thus likely 
to depend crucially on the level of cases . Their relative
effectiveness is much more difficult to establish. There are grounds 
for suspecting that ICHSDP districts detect a relatively smaller 
proportion of total cases than NMEO districts. If this lower level of 
detection results in Increased transmission, then ICHSDP districts may 
compare unfavourably with NMEO districts on the basis of a measure 
such as cost per case prevented. However it is difficult to draw any 
firm conclusions until better evidence is available on the true 
incidence of malaria in NMEO and ICHSDP districts.
Programme data indicate that in general, malaria control activities 
are carried out much less rigorously in ICHSDP districts than NMEO 
districts. ABERs are generally much lower, 6.3% in integrated 
districts in 1984 as opposed to 17.0% in NMEO districts. Only 27% of 
cases in integrated districts were given radical treatment within 7 
days of diagnosis and 55% after 14 days in 1984 compared with 42% and 
29% in all NMEO districts. 75% of cases detected in integrated
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district* were given radical treatment, leaving 25% receiving only 
presumptive treatment, compared to 92% and 8% In NMEO districts.
It Is difficult to Incorporate these aspect* of performance in the 
cost-effectiveness analysis without knowing how they affected malaria 
transmission In Integrated districts. It Is clear, however, that the 
relatively low unit cost of malaria control activities In Integrated 
districts results not only from possibly greater efficiency In the use 
of resources (eg less surplus capacity) but also from a less Intensive 
application of malaria control activities.
Means of case detection and treatment
Table 8.2 summarizes the relative cost (to the NMEO) and contribution 
of the main case detection methods. It brings out clearly the 
Important contribution now made by passive methods. ACD still 
collects the majority of slides and thus usually has the lowest cost 
per slide (though PCD (MC) in Rupandehi Is lower). However PCD (V) 
and PCD (MC) , as might be expected, have a much higher slide 
positivity rate and lower costs per case detected and treated. The 
pattern In all three districts is consistent: ACD Incurs the highest 
cost per case, with PCD (V) cheaper, and PCD (MC) cheapest. In terms 
of the share they absorb of total case-detect Ion costs and the return 
in terms of cases detected, the pattern is consistent across all three 
districts that ACD absorbs a considerably higher share of total case 
detection costs than its share of total cases. In contrast, the 
shares of PCD (V) In Morang and I lam and of PCD (MC) are Morang are
similar. In Rupandehi, the shares of cases detected by PCD (V) and
PCD (MC) are more than double their share of case detection costs.
The addition of private costs (of treatment and loss of work time)
does not alter these conclusions on the relative costs of the
mechanisms. However, it Is Important to note that there were few 
differences In days of work lost by case detection mechanism. Given 
the association between days of work lost and time-lag between start 
of the fever and presumptive treatment, this lack of difference is 
likely to reflect the fact that this time-lag did not differ greatly 
between case detection mechanisms: Indeed if anything, PCD mechanisms
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Tabla 8.2: Th« relativ« contribution and coat for th« NMEO of
different cate detection method«.
Case detection Morang Rupandehi H a s
AÇP/APÇD/Fgllgw:uc
- % of total slides 87% 85% 84%
- % of total cases 56% 42% 65%
- % of total case- 78% 77% 76%
detection costs (b)
- NMEO cost per slide (c) Rs 10.32 Rs 8.44 Rs 16.76
- NMEO cost per case (d) Rs 2059 Rs 791 Rs 6316
PCD O l
- % of total slides 5% 11% 15%
- % of total cases 19% 33% 24%
- % of total case- 18% 16% 24%
detection costs (b)
- NMEO cost per slide (c) Rs 43.15 Rs 13.49 Rs 29.80
- NMEO cost per case (d) Rs 1518 Rs 336 Rs 5523
PCD (MC)
- % of total slides 4% 2% •
- % of total cases 2% 19% -
- % of total case- 2% 5% -
detection costs (b)
- NMEO cost per slide (c) Rs 4.67 Rs 21.45 -
- NMEO cost per case (d) Rs 1048 Rs 98 '
(a) District-level programme costs only, excluding administration
and regional and national programme costs.
(b) Total costs of ACD/APCD/Follow-up, PCD(V), PCD(MC), PCD(M),PCD 
(H), excluding radical treatment.
(c) Cost of case detection divided by number of slides.
(d) Cost of case detection and radical treatment divided by number 
of cases.
2 6 7
(•specially the malaria clinic) provided presumptive treatment more 
rapidly than ACD.
M e a n s  o f  v e c t o r  c o n t r o l
The cost of alternative insecticides was explored in Chapter 6. In 
terms of the 1984 coat per capita per cycle or cost per house sprayed 
per cycle, DDT was half the cost of malathlon and this difference la 
much accentuated when the duration of the effect is taken into 
account. Fleam was considerably mora expensive than malathlon. 
However, from the NMEO's perspective (paying local costs only), Fican 
had lower operational costs than malathlon and was easy to use in the 
field because of its lightness. No comparison was possible of spraying 
with other means of vector control since these have not been used 
routinely.
V e c t o r  c o n t r o l  v e r s u s  c a s e  d e t e c t i o n  a n d  t r e a t m e n t
This is the most difficult choice to evaluate, since it is essential 
to have information on the effectiveness of the two approaches, which 
is largely lacking for Nepal. Moreover, the issue is not either/or, 
but rather what nix of vector control and case detection and treatment 
is most efficient.
The annual cost per capita of case detection and treatment wa s  
estimated to be Rs 2.88 in Morang and Rs 3.76 in Rupandehi (Table 
6.5). In contrast, the annual cost per capita of spraying was Rs
11.05 and Rs 10.03 (one cycle of DDT in Morang and Rupandehi) and Rs 
31.40 (two cycles of malathion in Rupandehi) (Table 6.2).
This difference in the cost of the two approaches, especially when the 
number of cycles of spraying required is taken into account, suggests 
that considerable intensification of case detection and treatment 
would be possible before costs would exceed those of spraying. Thus 
altering the mix of activities in favour of Increased case detection 
and treatment could be worthwhile if it could be achieved without 
significantly increasing malaria transmission.
It is realistic, however, to recognise that the main source of finance
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for Che two approaches is different. From Che NMEO's point of view, 
Che local (non* insecticide) cost of spraying (around Rs 2.20 per 
capita per cycle at district level) is actually lower chan the cost of 
case detection and treatment (Rs 2.40 - Rs 3.10 per capita per year in 
the Teral) if only one cycle of spraying is required, and not greatly 
more expensive if two cycles are required.
8.4 Findings of the cost-effectiveness analysis: malaria control 
versus other health programmes
Efficiency considerations
Table 7.6 estimated that the cost per case prevented was Rs 26 to Rs 
170 in moderate receptive areas, and Rs 86 to Rs 2,628 in low 
receptive areas. In terms of cost per death prevented, it was Rs 
1,281 to Rs 33,181 (moderate receptive areas) and Rs 4,125 to Rs 
204,734 (low receptive areas). Net savings in total curative and 
preventive costs occurred at a level between the low and high case 
estimates in all areas except in the expensive, low receptive areas of 
Rupandehi and I lam. Net savings in total costs occurred for both case 
estimates in moderate receptive areas.
Unfortunately, the cost-effectiveness estimates for malaria cannot be 
adequately compared with other health programmes in Nepal since only 
one study has produced a comparable ratio: that of $371 and $695 by 
Barnum and Yaukey (1979) shown in Table 2.3. Comparisons have 
therefore to be sought with programmes in other countries. In terms of 
deaths prevented, Table 2.3 presented an analysis of the cost per 
death prevented through different health interventions in a variety of 
countries. The estimates range from under $100 for immunization to 
several thousand dollars for hospital treatment and malaria 
eradication.
The Nepal results on cost per death prevented translate to a minimum 
of $78 (Rs 1,281 for high case estimate and 2% CFR) and a maximum of 
$12,438 (Rs 204,734 for low case estimate and 0.5% CFR). Taking the 
maximum for moderate receptive areas, thus excluding low receptive 
areas particularly for Rupandehi which is very expensive relative to 
the malaria risk, gives a maximum figure of $2,016 (Rs 33,181). This
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range of estimate* for Nepal compares not unfavourably with the 
figures In Table 2.3 given that the major health consequence of 
malaria In Nepal Is morbidity rather than mortality.
A recent paper (Prost and Prescott 1984) calculated cost-effectiveness 
ratios per year and discounted year of healthy life added for 
onchocerciasis control In West Africa and measles Immunization In 
Ivory Coast and Zambia. A further study (Evans and Murray 1987) 
challenged many of their assumptions and reworked their figures. The 
results from these two studies can be compared with similar figures 
for Nepal by updating the Prost and Prescott figures from 1977 to 1984 
dollars (on the basis of Barlow and Grobar 1986), converting the Nepal 
estimates from days to years and using the NMEO cost as the numerator. 
The Prost and Prescott and Evans and Murray papers also calculated 
'cost per discounted productive year of healthy life added', Including 
only productive years (considered to be the years between the ages of 
IS and 60). A similar figure has been calculated for Nepal by 
applying the assumptions on proportion of cases engaged In economic 
activity and ages at death used to estimate lost work days. The 
resulting figures are shown below.
Study Cost per 
year of 
healthy 
life added
Cost per 
discounted 
year of 
healthy life 
added
Cost per dis­
counted pro­
ductive year 
of healthy 
life added
Onchocerciasis control
•Prost and Prescott $32 $240 $240
-Evans and Murray $273 $2119 $4852
Measles immunization
• Zambia $19 $89 $354
• Ivory Coast $16 $78 $304
Malaria control, Nepal $2-$336 $8-$1207 $14-$1247
The comparison of the Nepal results with the Prost and Prescott 
figures and with the Immunisation results Is highly sensitive to the 
expected level of deaths without control, for the Nepal estimates fall 
either side of these estimates for the other programmes. However, It 
Is clear that malaria control Is well worthwhile In areas where there 
Is a considerable risk of resurgence and where the cessation of 
malaria control would result In considerable numbers of cases and
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deaths. If the Evans and Murray figures are a aore accurate
reflection of the cost-effectiveness of the onchocerciasis control 
programme, then the Nepal malaria programme Is considerably more cost- 
effective .
Finally, the Nepal results can be compared with the cost-effectiveness 
ratios shown In Annex 5, Tables A 5 .2, A5.3 and A5.5. Since these
costs are generally government programme costs, excluding 
consideration of direct and indirect benefits, similar cost- 
effectiveness ratios have been calculated for Nepal, namely:
NMEO cost per capita $0.19 - $0.60
NMEO cost per case prevented $1.52 - $154.66 
NMEO cost per death prevented $74 - $12,034
The Nepal costs per capita are v e r y  much at the lower end of the 
ranges shown in Table A 5 .2 for parasitic diseases. The minimum 
estimate of the Nepal cost per case prevented compares very favourably 
with many of the estimates for parasitic diseases in Table A 5 .3, 
though the maximum estimate exceeds most of them. It Is of interest 
to note that the range of the Nepal cost per death averted is not 
dissimilar from the range shown In Table A5.5 for oral rehydration 
projects. These comparisons Indicate that malaria control In Nepal Is 
no less cost-effective than many other health Interventions and when 
compared with many parasitic disease control programmes appears quite 
attractive.
Equity considerations
The relative attractiveness of malaria control can additionally be 
assessed by supplementing the evidence on cost-effectiveness with a 
discussion on which population groups benefit from malaria control. 
This discussion adds to the study the dimension of equity which has so 
far been ignored. Data from the patient survey of malaria provides 
evidence on the age of malaria patients, and from the household survey 
on their socio-economic status.
Although Information on the age and sex of malaria patients is 
routinely collected, It Is not analysed. Figure 8.1 shows the age-
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Figure 8.1: Age - distr Ibut Ion of malerla cases and of Che
population, by district: patient survey
A g e  d i s t r i b u t i o n  o f  d i s t r i c t  p o p u l a t i o n
Bar*
t7~71 Census population **" ** [\\l ¿ur^ey populaUon
A g e  d i s t r i b u t i o n  o f  d i s t r i c t  p o p u l a t i o n
census
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Figure 8.1: Age - distribution of malaria caaes and of the census
population, by district (continued) .
A g e  d i s t r i b u t i o n  o f  d i s t r i c t  p o p u l a t i o n
A g e  d i s t r i b u t i o n  o f  d i s t r i c t  p o p u l a t i o n
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cemuiFigure 8.1: Age - dlstr Ibut Ion of malaria cases and of the
population, by district (continued).
A g e  d i s t r i b u t i o n  o f  d i s t r i c t  p o p u l a t i o n
A g e  d i s t r i b u t i o n  o f  d i s t r i c t  p o p u l a t i o n
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distribution of cases In each district as analysed by the patient 
survey and compares this with the age-dlstrlbutlon of each district 
population taken from the 1981 census. In general, the proportion of 
cases amongst small children was considerably lower than their 
proportion In the total population. This position was reversed for 
teenagers and adults up to the age of 40.
The age-dlstrlbutlon of cases showed some variation between districts. 
In Bhojpur and Morang, the highest proportion of cases (nearly 25%) 
occurred In the 20-24 age-group whereas In Dang cases were 
concentrated in the 10-14 age group. Rupandehi and Sarlahi showed a 
less sharp peak, but cases were concentrated amongst young adults. The 
average age of cases by district was as follows:
Average age of malaria cases
District Mode Median Mean Standard n
(yrs) (yrs) (yrs) Deviation
Dang 11.0 16.0 21.2 14.5 367
Rupandehi 30.0 22.0 23.7 14.0 2060
Sarlahi 30.0 26.0 26.7 13.3 169
Morang 20.0 22.0 23.7 12.8 447
Bhoj pur 22.0 23.0 25.2 12.0 157
Bara 30.0 29.0 29.1 14.6 28
All survey 30.0 22.0 23.7 13.8 3228
districts
Since approx B » e of malaria in Nepal in 1984 were
classified as 'Imported A' (l.e. Imported from India), it might be 
expected that the characteristics of migrants, in particular their age 
and sex, would affect the age and sex distribution of cases. In Figure 
8.2, the proportion of indigenous and of imported cases by age-group 
has been expressed as a ratio of the proportion of each age-group in 
the district population. The resulting ratio fluctuates around 1 
(where the proportion of cases in the age-group equals the age-group's 
share of the total population) . The figure shows that the proportion 
of young adults amongst Imported cases considerably exceeds their 
proportion amongst indigenous cases or the whole district population.
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Table 8.3 shows the sex distribution of total cases by age-group. The 
most marked feature is a preponderance of males in the 20-24 age- 
group. If cases are distinguished by their classification (Table 8.4), 
then imported cases are seen to be predominantly male.
An important Influence on the age and sex distribution of cases 
therefore appears to be the relative significance of imported cases in 
each district. Imported cases are predominantly young adult men, and 
the variation in the age-distribution of cases between districts is 
thus associated with the pattern of migration and the risk of being 
infected by malaria in India. Indigenous cases are more evenly 
distributed across age-groups, though with some concentration also 
amongst young adult males which may possibly be related to their 
occupations and the likelihood of their spending time outside the 
village and being exposed to a greater risk of infection.
The age - distribution in Dang peaked earlier than in the other 
districts, with a concentration of cases in the 10-14 age group and a 
median age of 16 years in contrast to a median of 22-29 years in the 
other districts. The great majority of these cases were indigenous. 
In 1984, Dang experienced a considerable increase in malaria 
transmission, and it appears from the information here that teenagers 
were particularly at risk. This may therefore be an Indicator of the 
consequences on different age-groups of a resurgence of malaria 
transmission.
This information on age and sex distribution of cases leads to the 
conclusion that unlike many priority health programmes in developing 
countries, malaria control in Nepal at present benefits not so much 
children as the male (and to a slightly lesser extent female) working 
population. To some extent this reflects the proportion of imported 
cases in the districts sampled, but even indigenous cases showed a 
preponderance of adult males. Malaria control thus has some Importance 
in terms of assisting households to earn their living without the 
disruption caused by adult illness. Clearly, if malaria control were 
to cease and cases rose considerably as a result, the age distribution 
would change with a greater proportion of children being affected.
In the patient survey, it was not possible to enquire about the socio-
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Tabi« 8.3: Sax distribution of total casas by aga-group:
patlant aurraj
ftp tffS )
0-4 yr* 5-8 y r* 10-14 yr* 15-19 yr* 20-24 yr* 25-29 yr* 30-34 yr* 35-39 yr*
Sei(*f5)
Rale 64 203 246 264 382 283 217 152
roe percent 3.1Z 9.71 11.81 12.61 18.31 13.61 10.41 7.31
coluan percent 51.61 55.81 57.61 64.51 74.81 71.51 70.21 65.01
Feeale 60 161 181 145 129 113 92 82
roa percent 5.31 14.11 15.91 12.71 11.31 9.91 8.11 7.21
coluan percent 48.41 44.21 42.41 35.51 25.21 28.51 29.81 35.01
Total 124 364 427 409 511 396 309 234
roa percent 3.81 11.31 13.21 12.71 15.81 12.31 9.61 7.21
coluan percent 100.01 100.01 100.01 100.01 100.01 100.01 100.01 100.01
AfeltfS) Total
40-44 yr* 45-49 y r* 50-54 yr* 55-59 yr* 60-64 yr* 65 yrt 
and over
Sei(sfS)
Hale 109 61 49 24 19 15 2088
roa percent 5.21 2.91 2.31 1.11 .91 .71 100.01
coluan percent 65.71 57.51 66.21 63.21 51.41 45.51 64.71
Feaale 57 45 25 14 18 18 1140
roa percent 5.01 3.91 2.21 1.21 1.61 1.61 100.01
coluan percent 34.31 42.51 33.81 36.81 48.61 54.51 35.31
Total 166 106 74 38 37 33 3228
roa percent 5.11 3.31 2.31 1.21 1.11 1.01 100.01
100.01 100.01 100.01 100.01 100.01 100.01 100.01
H issin g:25
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Table 8.A: Sex distribution of total cases by classification:
patient survey
C lassification of case Total
Indigenou
s
laported
A
laported
other
Relapse Untraced
Sex(sfS)
Hale 1286 640 44 113 0 2083
roe percent 61.71 30.71 2.11 5.41 0.01 100.01
coluan percent 57.71 81.61 69.81 79.01 0.01 64.71
Feaalt 943 144 19 30 1 1137
row percent 82.91 12.71 1.71 2.61 .11 100.01
coluan percent 42.31 18.41 30.21 21.01 100.01 35.31
Total 2229 784 63 143 1 3220
roa percent 69.21 24.31 2.01 4.41 .01 100.01
coluan percent 100.01 100.01 100.01 100.01 100.01 100.01
H iss in g :33
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economic statue of malaria patients. This information was collected in 
the household survey and can be compared with similar Information for 
the controls. In Dhanusa, own agriculture was the main occupation for 
66% of malaria patients and the secondary occupation for 6%, and for 
69% and 8% of controls. Wage labour was the main occupation of 27% and 
secondary occupation of 38% of patients, the proportions for controls 
being 19% and 26%. In the rural subsistence economy of Nepal, those 
with land are generally better off than those without land, with those 
dependent on wage labour generally being the worst off. The above 
information thus suggests that those who get malaria tend to be the 
poorer members of communities.
This impression Is supported by evidence on the value of household 
assets and crop production. In Dhanusa, controls tended to have a more 
valuable house than malaria patients. The mean land area cultivated 
per household owning land was 1.52 hectares (SD 1.30) for patients and 
1.91 hectares (SD 1.95) for controls. Average paddy production per 
household producing paddy was 611 kg (SD 725) for patients and 879 (SD 
1170) for controls. Average maize production was 682 kg (SD 689) for 
patients and 891 kg (SD 1133) for controls.
In Nawal Parasl, however, a slightly different picture Is apparent. In 
terms of occupation, patients, as In Dhanusa, are slightly less likely 
to farm on their own account and more likely to be wage labourers than 
controls. However, the mean house value, mean cultivated land per 
household owning land, and mean paddy and wheat production are all 
slightly less for controls than for patients. In contrast the median 
for all these indicators is greater for controls than for patients. 
It may be that the patient means are inflated by a few more wealthy 
individuals who got malaria.
The data is therefore Insufficient to draw firm conclusions on the 
socio-economic status of patients, but suggest that they may be the 
less well off.
8.5 The cost-effectiveness of the Nepal malaria control programme in 
comparison to malaria control programmes In other countries
As discussed in Chapter 2, section 2.4, there have unfortunately been
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few detailed studies of the cost-effectiveness of malaria control. 
Table 2.6 summarized the results of those studies that have produced 
cost-effectiveness ratios expressed in the form annual cost per person 
protected, cost per case prevented, or cost per death averted. To 
these results can now be added similar ratios for Nepal.
From Table 7.6, the following ratios can be calculated in US$ 1984. 
The costs in the first cost column are NMEO costs per capita of the 
relevant population: for case detection and treatment and combined 
methods, this means the population of each area in Table 7.6 and for 
spraying, the population sprayed (the population shown in Table 6.2 
for DDT spraying but half the population for the malathion area 
because two cycles were sprayed) . The cost per capita of combined 
methods is not the sum of the other two because the population 
denominator used is that for the whole area, only part of which was 
sprayed.
Bgpfll cost-sffgctlycncgg estimates (S 1384)
Control 
me thod
Annual cost 
per person 
protected ($)
Cost per case 
prevented
($)
Cost per 
death
averted ($)
Case detection and 0.19 to 2.40 to 119 to
treatment only 0.60 68.50 11,938
Residual 0.61 to Not Not
spraying only 1.91 available available
Combined 0.37 to 1.52 to 74 to
methods (where used) 0.60 154.46 12,034
The above figures and those in Table 2.6 should be compared 
cautiously since the source documents often provide Inadequate 
information for judging the quality of the cost and effectiveness 
estimates. In particular, the cost estimates in Table 2.6 are liable 
to be Incomplete, for Instance omitting capital costs and 
administrative overheads, and are taken from very different types of 
programme, analysed at different stages in their evolution. Despite 
these cautionary words, some useful comparisons can be made from the 
broad orders of magnitude of the figures in Table 2.6 and those from 
Nepal. Comparing cost per capita, the Nepal programme is very 
economical. It is also surprisingly close to the recent estimates
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for Thailand of $0.16 and $0.61 for combined methods. In terms of 
cost per case prevented it also comes out reasonably well, especially 
considering that the upper estimate is very much a maximum figure for 
Nepal, but Is still less costly than the Garki study, for example, 
though this was a research project Implemented In an area of much 
higher endemlclty. Thus as a malaria control programme, the Nepal 
programme appears to be relatively efficiently run.
8.6 Summary
This chapter has discussed in turn the research objectives and 
methods, the validity of the data and the findings of the cost- 
effectiveness analysis.
The research found that the recent developments in the methodology of 
cost-effectiveness analysis were applicable to malaria control. The 
greatest methodological problem was posed not by the cost analysis 
but by the absence of good evidence on the effectiveness of 
alternative malaria control strategies or of the programme as a 
whole. The value of the resource saving consequences included in the 
evaluative framework could be estimated with the help of survey data 
and their inclusion was justified. In the absence of an assessment 
of the utility of malaria control to individuals, the measure 
'healthy days of life lost' was used as a proxy though the analysis 
highlighted the extent to which it favoured programmes which prevent 
deaths rather than episodes of illness.
The relevance of the evaluative framework to malaria control in Nepal 
was examined. Cost-effectiveness analysis, like cost-benefit 
analysis, is rooted in partial equilibrium theory. For example the 
methodology employed in assessing the desirability of malaria control 
assumed that the consequences of complete loss of control would be of 
the same nature as those from a much smaller number of cases, namely 
health consequences, resource costs and quality of life effects. 
However, it is generally agreed that a macro focus is appropriate to 
the evaluation of the costs and benefits of endemic disease control 
projects. In particular, two further consequences of control were 
ignored: abandonment of land by farmers and the Interaction of this 
effect and that of loss of work time with a number of other economic
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variables Co an extent that had ranifloatIons throughout the economy. 
These issues were discussed and it was concluded that the loss of 
control of malaria would be unlikely to lead to major consequences 
that were not taken into account in the cost-effectiveness framework.
The validity of the data was considered at length. The limitations 
of the cost data Included the small sample of districts, the 
difficulties of analysing the costs of integrated districts, and 
problems of joint costs. The effectiveness data displayed greater 
shortcomings, necessitating considerable reliance on indicators of 
intermediate output. Their accuracy was therefore assessed. The 
validity of the data from the patient and household surveys was 
discussed and their strengths and weaknesses pointed out.
Finally, the findings of the cost-effectiveness analysis were 
discussed. The cost behaviour of NMEO and ICHSDP districts was 
compared and it was concluded that their relative costliness would 
depend to a considerable extent on the level of cases. Little 
information was available on their relative effectiveness though 
programme data indicated that malaria control activities were carried 
out much less intensively in ICHSDP than in NMEO districts. The 
relatively low unit costs in ICHSDP districts thus resulted not only 
from possibly greater efficiency in the use of resources but also 
from a lower level of activity.
The relative cost to the NMEO and contribution in terms of proportion 
of cases detected was discussed for the main case detection methods. 
In general, ACD absorbed a considerably higher share of total case 
detection costs than its share of total cases. PCD methods detected 
cases at relatively low cost and if anything slightly more speedily 
than ACD.
Vector control costs differed considerably depending on the 
insecticide used, DDT being considerably cheaper than malathion. 
Vector control costs were considerably more expensive than case 
detection and treatment costs, suggesting that altering the mix of 
activities in favour of Increased case detection and treatment could 
be worthwhile if it could be achieved without significantly 
Increasing malaria transmission.
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The cost-effectiveness ratios calculated to assess the desirability 
of malaria control were summarized. They could not be adequately 
compared with similar ratios from other health programmes In Nepal 
because only one could be located. Therefore they were compared with 
Information on the cost of death prevented through different health 
Interventions in a variety of countries. Given that the main health 
consequence of malaria is morbidity not mortality, the Nepal 
programme appeared reasonably cost-effective. The results from the 
Nepal analysis were also compared with cost-effectiveness ratios from 
programmes for onchocerciasis control and measles immunization. The 
comparison was highly sensitive to the expected level of malaria 
deaths without control, but the malaria control programme appeared to 
be well worthwhile in areas where there was a considerable risk of 
resurgence. Similarly a comparison with data on parasitic disease 
control projects suggested the Nepalese programme was relatively 
attractive.
The relative attractiveness of malaria control was additionally 
assessed by reviewing evidence on which population groups were 
currently benefiting. It was concluded that the majority of cases 
were young adult men and therefore that unlike many priority health 
programmes in developing countries, malaria control at present 
benefited not so much children as the male (and to a slightly lesser 
extent female) working population. Data on the socio-economic status 
of patients was insufficient to draw firm conclusions, but suggested 
that they may be the less well off members of communities. Therefore 
the malaria control programme might have important equity effects.
The chapter ended with a comparison of the Nepal costs per capita, 
case and death prevented with similar data from malaria control 
programmes in other countries. In general, the Nepal programme 
appeared relatively efficient in this comparison.
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POLICY IMPLICATIONS FOR NEPAL9.
The information produced by the cost-effectiveness analysis provides the 
basis for considering possible changes to malaria control strategies in 
Nepal. It Is important to stress, however, that it is not possible to 
include all factors relevant to the choice of strategy i n  a cost- 
effectiveness analysis, so the analysis contributes to, rather than 
determines decisions. Moreover, while the cost data is reasonably 
accurate, there are many uncertainties surrounding the effectiveness of 
both existing and alternative control measures. This, therefore, affects 
the confidence with which policy changes can be recommended. Policy 
changes are considered below firstly for vector control methods, 
secondly for case detection and treatment strategies and finally for the 
organisation of malaria control.
9.1. Vector control methods
A variety of vector control methods are possible, including
- spraying with residual insecticides;
- focal spraying;
- larviclding;
biological control such as larvivorous fish;
- environmental management and modification;
measures to prevent or reduce contact between the vector and an 
individual, such as impregnated bed nets, screening and the use of 
mosquito coils.
These are examined in turn below.
Residual spraying
The only Insecticides used in routine spraying operations in the years 
immediately before and including 1984 were DDT and Malathion. In 
addition, the analysis was able to assess the costs of Fleam, sprayed 
for the first time in 1985, because of a further study in which the 
author had been involved. Various trials have taken place assessing 
insecticide consumption for a limited range of other insecticides,
285
namely fenltrothion 40WP, lambdacyhalothrin 10WP (a pyrathrold) and 
plrlmlphoa-methyl 50EC In addition to bendlocarb 80WP (Fleam). 
Comparing the cost of these Insecticides without data from their large- 
scale use Is extremely difficult because price can vary depending on the 
purchaser, country of use, size of the potential market, and the age of 
the product. Moreover, little Is known of the operational costs of some 
of these Insecticides, and for some there Is uncertainty about the 
optimal dosages for Nepal.
Table 9.1 therefore shows a rough comparison In terms of the Insecticide 
cost alone of four Insecticides, selected because they have been or may 
be used In Nepal, If only on a small scale. Prices for plrlmlphos* 
methyl and bendlocarb are actual 1987 prices, while the others are 
quotations from the manufacturer. Fenltrothlon appears to be the least 
expensive of the four, followed by lambdacyhalothrin and bendiocarb. The 
relative attractiveness of bendlocarb vis-a-vis plrlmlphos-methyl 
depends on whether 1 or 2 gm/m^ of the latter Is required. Further 
investigation is needed of operational costs to see whether these would 
effect the attractiveness of the insecticides to donors and recipients. 
Fenitrothlon and plrlmlphos-methyl are bulky relative to bendlocarb, but 
the pyrethroids such as lambdacyhalothrln are similar to bendlocarb In 
terms of lightness and ease of use and thus are likely to have similar 
operational costs. If trials prove that their persistence Is such that 
only one cycle Is required, they are likely to have a significant cost 
advantage. Moreover their prices are likely to fall In the future.
Ultimately, however, choice of Insecticide Is determined firstly by who 
Is the donor, and secondly by which of the Insecticides are manufactured 
by firms of the donor's nationality. Where the donor has a choice of 
insecticide, cost-effectiveness considerations are likely to enter into 
Its decision on which insecticide to donate, but the donor may also wish 
to spread its favours amongst competing firms. These donor 
considerations are reflected In the recent pattern of Insecticide 
donations to Nepal. DDT is clearly the most cost-effective Insecticide 
everywhere In Nepal except where A. annularis Is the main vector. Yet 
since Nepal's main donors to the malaria control programme no longer 
manufacture DDT, Nepal has had great difficulty In obtaining additional 
supplies. In its place, Britain has donated British products, Initially 
Fleam and subsequently Actellic (plrlmlphos - methyl), which are
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Tabla 9.1s Comparlaon of tha 19*7 coat par paraon par annua of four 
residual lnaectlcldes
Insecticide
and
Dosage
Cost of 
product 
C1F Nepal
<R »>  ( • )
Quantity 
per person 
per cycle
(b)
Cost per
cycle
( R a )
Cost per
annua
( R a )
< c >
Fenltrothlon 
40WP (1 g»/»2>
81.05/kg .239 kg 19.37 38.74
Lambdacyhalo- 
thrln 10WP 
<0.025 gm/m2>
1350.89A g .020 kg 27.02 27.02/
54.04
Pirimiphos- 
aethyl SOEC 
-1 ga/a2
-2 ga/a2
170.89/L 
170.89/L
.163 L 
.326 L
27.86
55.71
55.72
111.42
Bendlocarb 
80WP <0.4 gm/»2)
984.46Ag .041 kg 40.36 80.72
(a) Prices for fenltrothlon and laabdacyhalothrIn are based on 
quotations for the price of the active Ingredient. Prices of 
the other Insecticides are actual 1987 prices.
(b) Data froa trials In Nepal.
(c) Assuming either one or two cycles for laabdacyhalothr In and two 
for the other Insecticides.
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considerably aore expensive than DDT. Fenltrothion has not been an 
option so far for the malaria control programme since It Is a Japanese 
product, and therefore donated only by Japan which has not until very 
recently been Interested In assisting the control programme.
From Nepal's perspective, at present financing only local costs, the 
costs of applying the various Insecticides are far more Important than 
the Insecticide cost. The newer, lighter Insecticides such as bendlocarb 
and lambdacyhalothrln have both cost and operational advantages over 
bulkier Insecticides such as malathlon and fenl troth Ion. As yet, 
however, only the costs of bendlocarb have been Investigated so no 
conclusions are possible on which of the newer Insecticides Is most 
cost-effective from Nepal's perspective.
The more expensive the Insecticide, the greater Is the share of 
Insecticide In the total cost of spraying and thus the greater the 
effect on costs If reduction In consumption is possible, either by 
reduced dosages or aore selective spraying. More selective coverage was 
suggested by the external assessment team In 1984 (HMG/WHO/USAID/ODA 
1984). Making the plausible assumption that more selective spraying 
will reduce variable costs but not fixed costs, then approximately 75% 
of total spraying costs (In DDT areas) and over 80% (In malathion areas) 
would be Influenced by selective spraying. Thus In contrast to case 
detection methods, where a high level of fixed costs means reduction in 
activity may have little effect on total expenditure, more selective 
spraying will have a fairly immediate effect on costs. This result was 
Indeed shown by a trial using fenltrothion in Indonesia which compared 
the effects of 2 cycles of full coverage at 2gm/m2 plus one of selective 
coverage with 3 cycles of selective coverage. The latter reduced 
Insecticide costs by 69% and operational costs by 52%, and reduced 
malaria rates and vector populations to very low levels though was less 
rapidly effective than full coverage (Gandahusada et al 1984). More 
Investigation Is required In Nepal of vector behaviour so that aore 
informed decisions can be taken on whether spraying can be confined to 
certain areas of houses and outbuildings.
Focal spraying
Given the shortage of Insecticide In Nepal, Increasing emphasis Is being
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placed on focal spraying, thac Is spraying particular villages when 
cases reach a certain level.
The cost of focal spraying will depend on how It Is organized and how 
much la required. If spraymen are recruited when needed, unit costs are 
likely to be similar to residual spraying though total costs would be 
lower If focal spraying permits less extensive spraying. If a team Is 
recruited and employed throughout the main transmission period, unit 
costs will depend on whether the team can be kept active or Is 
unemployed for part of the time.
Other -vector control methods
Unfortunately, only patchy Information Is available on the costs and 
effectiveness of the other methods of vector control in Nepal. 
Larvicidlng has been tried, but the cost and effort of achieving control 
of A . annularis with larvicides was considered to be uneconomical and the 
approach was discontinued (White 1982) . No cost information was 
located.
In 1985 a small experiment In larvicidlng was started, using locally 
made up larvlclde consisting of 74% Mobil waste, 25% kerosene oil and 1% 
detergent. The Mobil and detergent were waste products from local 
Industry and were obtained free of charge. The kerosene oil cost Rps 6 
per litre. At the time of this study, the experiment was still In Its 
very early stages and Issues such as the manpower required and frequency 
of application had not been decided, so cost estimates were not 
possible.
Studies have been conducted for some time on the potential for use of 
biological methods of vector control, especially larvivorous fish. At 
the time of the field research for this study, local larvivorous fish 
had been identified but no information was available from field trials. 
Since then, a trial has been conducted but was unsuccessful due to heavy 
flooding (HMG/WHO/USAID/ODA/JICA 1988). No cost data Is available but It 
Is unlikely that larvivorous fish would be an expensive option, though 
their effectiveness and potential coverage are uncertain. The 1988 
External Review cited above commented that "these applications
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(Including use of larvivorous fish) are only suitable for very special 
conditions".
Small experiments have been tried with vector control through 
environmental management, using means such as pond and ditch cleaning. 
The situation analysis report In 1977 noted that a small experiment with 
cleaning pools did not change the malaria pattern. The 1988 External 
Review reports the results of a study of simple environmental management 
measures (draining small seepages, making sluice gates for Intermittent 
flushing, clearing vegetation from ponds and shore-line clearing) 
applied In moderate receptive areas of Dhanusa district. The work over 
the transmission season required 14,428 man-hours, of which 14% were 
provided free by communities. Free labour was difficult to obtain in the 
two months when farmers were busiest and for cleaning streams that lay 
between villages. The larval density of all anophelines fell but adult 
densities remained high In this area compared with sprayed areas and 
malaria cases continued to arise In significant numbers. The Review 
concludes that the area selected for environmental management was 
unsuitable and that In an area where active transmission Is taking 
place, reduction of vector density by environmental management measures 
alone will often not be sufficient to reduce vectorial capacity.
Little cost data Is available from any of the environmental management 
trials. The situation analysis report for 1984 reports a cost per 
capita for environmental management of Rs 1.23 for the 1982 transmission 
season. The per capita cost of the labour for the recent study reported 
above is Rs 0.90, assuming an 8 hour working day and a wage of Rs 10 
(the 1984 rate for spraymen). The budget for a planned, externally 
funded research project suggests a per capita cost (1985 prices) of 
around Rs 1.40 (labour, equipment and community education materials 
only, excluding supervision) In the first year, and Rs 0.90 In years 2 
and 3 when maintenance only would be required and community Involvement 
would supplement hired labour. It therefore appears that simple 
environmental management measures would cost in the region of Rs 1 to 2 
per capita (c. 1984). Such costs compare very favourably with the costs 
of spraying. If areas can be identified where this type of 
environmental management Is effective In reducing vector densities and 
malaria transmission, It is likely to be a cost-effective means of 
vector control.
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Control of transmission has been a particular problem in the foothills 
fringing the Terai. In 1985, experiments started with using small dams 
with sluices which could be opened every few days to flush larvae from 
streams. A trial began in 1987 but unusually heavy rainfall destroyed 
those dams made of local materials and provided lessons in dam design 
(Draper and Webber 1987). Further results have not yet been reported.
Personal protection methods have not been much explored in Nepal, though 
a study of impregnated bed nets is now being planned (Draper and Webber 
1987). Published reports suggest that the cost of treating bed nets 
with insecticide (permethrin) is around $1.25 for an application rate of 
0.5 g per sq.m (Schreck and Self 1985). The net Itself is estimated to 
cost $15 in Nepal based on imported nylon. Under-fives (15* of the 
population) will not require a net since they share that of their 
mother, so the cost per capita is approximately Rs 225. Assuming the 
life of the net is 6 years, the approximate annual cost (12% discount 
rate) is Rs 55 per person protected, a relatively high per capita cost 
in relation to other control methods. Even if the net were to cost only 
$2 (the price in Thailand), the per capita cost (Rs 11) would still be 
relatively high.
No evidence is available of the cost or effectiveness of personal 
protection methods such as screening and colls.
An important consideration in evaluating the cost-effectiveness of 
personal protection methods will be 'who pays'. Where individuals are 
expected to purchase items, their cost needs to be evaluated in relation 
to personal disposable income, and the willingness of individuals to 
spend their income on these methods.
7.2. Case detection and treatment methods
A number of options face Nepal in moving to a more efficient and 
economical system of case detection and treatment. The following list 
of options is not meant to be exhaustive, but shows options being 
considered or introduced in other countries, or mentioned in various 
Situation Analysis or External Review reports. Some have already been 
tried out in Nepal.
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The options are:
- remove ACD altogether 
remove ACD In certain areas
- fortnightly ACD visits
- eliminate follow-up of cases 
expand the numbers of PCD (MC)
• change radical treatment procedures
- decentralize malaria laboratories.
These options are evaluated In turn below.
Remove active case detection
Active case detection is still an Important means of case detection In 
Nepal and absorbs a considerable share of total resources. However, the 
lower the case incidence and the greater the development of PCD 
mechanisms, the lower Is the yield of ACD. Yet by the nature of Its 
work, ACD has high fixed costs and cannot significantly reduce Its level 
of activity to match the lower level of cases detected. Thus the lower 
the Incidence of malaria, the more expensive ACD becomes in terms of 
slides collected and cases detected.
ACD has been described as 'having no place in long term malaria control' 
(WHO 1984). At the time the fieldwork for this study was being done, 
the NMEO was firmly committed to ACD. Since then, however, the 1986 
External Situation Analysis Team has recommended its discontinuation 
(HMG/WHO/USAID/ODA 1986), the 1987 Internal Assessment has termed it 
'uneconomical' (NMEO 1987) and the 1988 External Assessment Team has 
urged the implementation of the 1986 recommendation because of the low 
cost-effectiveness of ACD and the dangers of inadequately sterilized 
pricking needles (HMG/WHO/USAID/ODA/JICA 1988). However, the objective 
of ACD is not merely case detection, but also monitoring of the malaria 
situation. This is particularly crucial in Nepal given the rise in 
Incidence in 1984 and 1985 and the threat of increased chloroqulne 
resistance. If ACD were to be removed, some other method would need to 
be developed for detecting changes in the malaria situation and planning 
preventive action.
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If Che drastic action were to be envisaged of stopping ACD altogether 
and relying on PCD methods. It Is Important to establish whether overall 
savings could be achieved even with the necessary considerable expansion 
of the PCD network. Of the various PCD methods at present In use, PCD 
(H) Is constrained by the availability of health units and there has 
always been some question over the commitment of general purpose health 
units to the Intensive screening of fever cases for malaria. PCD(M) Is 
tied to the location of malaria unit offices, determined by management 
considerations. Those PCD mechanisms with the greatest potential for 
rapid expansion are therefore PCD (V) and PCD (MC) . PCD (MC) is 
unlikely to be economic at low levels of incidence outside urban centres 
and is analysed below for potential for expansion In its own right 
rather than as a replacement for ACD, so the discussion here 
concentrates on the cost of expanding PCD (V).
Removal of ACD would require firstly an Increase In activity of existing 
volunteers and secondly the recruitment and support of new volunteers. 
The first will reduce the unit costs of volunteers since the costs of 
supporting volunteers depend largely on the number of volunteers rather 
than on their level of activity. Thus support cost would be spread over 
a larger number of slides taken and cases detected If the level of 
activity increases. The second Is unlikely to increase unit costs 
unless It is anticipated that the costs of supporting a volunteer will 
Increase significantly as the volunteer network expands. This may be 
the case In remote areas, but In these areas ACD is also expensive. 
Thus there Is no reason to suppose that the expansion of PCD (V) will 
result In unit costs above those of ACD.
A more important consideration is likely to be whether the PCD network 
as a whole can achieve the same level of case detection as achieved at 
present with a mix of ACD and PCD. This can only be ascertained by 
experiments with removing ACD, on the lines already being tried by the 
NMEO. The opinion of the 1987 Internal Assessment was that "If there Is 
no ACD mechanism, most of the cases detected by the ACD source would go 
to other sources" (NMEO 1987). However, particular attention would need 
to be paid to whether women and children would be adequately represented 
In the workload of passive mechanisms. A study In Thailand (Ettling, 
Thlmasarn, Krachalklin amd Bualombai 1989) found that women and children 
were under-represented In malaria clinics when their workload was
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compared Co Che age and aex dlsCrlbuClon of malaria prevalence In Cha 
communlCy as established by a serological survey. The laCCar 
information Is noC available for Nepal, buC Che age and sex dlsCrlbuCion 
of cases does differ beCween case deCecCion mechanisms. For insCance, 
data from Che paclenc survey for Rupandehi showed that 23% of ACD cases 
were under 10 years but only 13% of all PCD cases and 10% of PCD (V) 
cases; and 47% of ACD cases were female compared Co 35% for all PCD 
cases and 38% for PCD (V) . If ACD were Co be abandoned, ways would need 
Co be found of ensuring adequate coverage of mothers and children, for 
instance by making the volunteer network sufficiently accessible and 
attractive.
Existing costs can be used to make a rough estimate of the resource 
implications of removing ACD and expanding PCD (V). In 1984, the cost 
of supporting a volunteer (district-level costs only and excluding 
parasitology and radical treatment) is estimated to be Rs 1476 in 
Morang, Rs 674 in Rupandehi and Rs 1215 in I lam. Assuming a target of 
one volunteer per 2000 people and unchanged support costs per volunteer, 
the cost implications can be calculated as shown in Table 9.2 and 
compared with the present cost of ACD (case detection costs only) . The 
figures suggest that the replacement of ACD by strengthened PCD (V) 
would indeed result in savings.
The difference in the support costs between Horang and Rupandehi 
suggests that the cost estimate may not be completely accurate. 
Moreover, the NME0 is conscious that it at present lacks the funds to 
provide adequate supervision and supplies to volunteers. However the 
difference between the cost of a complete PCD (V) network and ACD is so 
great that the cost of supporting volunteers could be considerably 
higher without exceeding the current cost of ACD. Allowance also needs 
to be made for the cost of replacing the monitoring role of ACD, but 
this is unlikely to be expensive if sampling methods are used.
Any policy that relies extensively on volunteers must consider the 
economic implications for volunteers. Evidence suggests that the 
current economic implications are not great (see Chapter 6) . The 
implications of increasing the workload can be examined by assuming that 
the increased number of volunteers would handle all the cases currently 
detected by ACD (ie through ACD, APCD and Follow-up) and would maintain
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Table 9.2: The cost 
PCD <»)<*>
implications of removing ACD and expanding
Morang Rupandehi H a m
Cost of supporting a 
volunteer (Rs)
1,476 674 1215
No of volunteers 
required
252 195 33
Total support 
cost (Rs)
371,952 131,430 40,095
Currant cost of 
ACD (Rs)
658,710 474,478 262,060
Costs are based on economic prices , and thus are not the same as
budgeted expenditure.
(k) Costs are those of supervision, supplies and slide collection. 
Based on one per 2000 population.
Case detection only.
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th«lr existing slide positivity rate. In Morang, for Instance, this 
would mean a workload of 569 cases and 15,222 slides, or on average 60 
slides per volunteer In contract to the current figure of 35, and In 
Rupandehl, 1671 cases, 20,245 slides, and on average 104 per volunteer 
In contrast to 57 at present. If It Is assumed that these are spread 
over the period April to October, this Implies 9 a month per volunteer 
(Morang) and 15 a month (Rupandehl). This does not appear to be a 
significantly high time commitment for a volunteer.
Elimination of ACD would also lead to savings In parasitology costs. 
Annual blood examination rates are extremely high at present In many 
districts (for Instance around 25* In Ilam) with a low return In terms 
of cases detected. While parasitology Is relatively cheap (Rs 1.54 per 
slide In Ilam) a reduction In the number of slides, if It was sufficient 
to permit manpower to be redeployed, would produce savings that could be 
used more effectively elsewhere. For example, the reduced number of 
slides In Morang, assuming for purposes of Illustration that PCD (V) 
detected all the ACD cases at the PCD (V) slide positivity rate and only 
district-level parasitology costs were saved (ie assuming parasitology 
overhead costs remain unchanged, a conservative assumption since, for 
example, regional cross-checking costs would presumably be reduced), 
would produce a saving of Rs 47,000 or 68« of the locally-funded 
recurrent costs of the parasitology programme. In Rupandehl, the saving 
would be Rs 100,000, or 67%. While the parasitology programme takes up 
only 6-10* of locally-funded district expenditure, such savings could 
none-the-less be valuable.
Selective reduction of ACD
Even If ACD be retained, it can be questioned whether it is appropriate 
for all areas of Nepal. The ACD network will always be more expensive 
In hill districts than In the Teral, since the terrain Is difficult, 
populations scattered, salaries and allowances higher and Incidence In 
general lower. In Ilam, 84* of the cost of ACD Is accounted for by the 
»«lories of MFWs and the other main cost Item (DA/TA) takes up 12*. The 
NMEO has considered reducing the frequency of house-to-house visits from 
once-a-month to once every two months In order to reduce costs. This 
would considerably reduce salary costs and DA/TA per house visited 
though probably not halve them because MFWs would have to cover a much
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greater area. However, the yield in cases is likely to be considerably 
lower, because some potential patients would resort to self treatment or 
PCD mechanisms. A more worthwhile policy change would be to experiment 
with eliminating ACD in hill districts where the risk of Increased local 
transmission is much less than in the Teral. In its place, more 
emphasis could be placed on the promotion of PCD (V), who would probably 
detect more cases and experience rapidly decreasing costs per slide and 
per case as their workload rises. It may well be at present that 
maintaining both ACD and PCD (V) networks, each involving high fixed 
costs, results in much higher total costs per slide and per case 
detected than if one of the networks were removed.
The above suggestion is put forward to reduce the cost of case-detection 
and treatment where malaria incidence is low. In 1987 the NMEO 
implemented an alternative approach to ACD in Kanchanpur district in the 
Far-West in order to cope with a large number of cases in difficult 
terrain. House-to-house visits by malaria field workers were stopped for 
three months and Instead, the workers manned malaria "depots", 
stationary outreach stations to which fever cases could come for 
diagnosis and treatment. The morning was spent seeing patients, and the 
afternoon in outreach health education activities. No cost data are 
available on this experiment. It would presumably lead to some savings 
in DA/TA and in parasitology costs, and would mean that more cases would 
be detected by MFWs and with a shorter time-lag between infection and 
treatment. To some extent, though, it may simply have redistributed 
cases between case detection mechanisms.
The implementation of this approach is presumably not dependent on the 
existence of ACD since workers could be trained and depots established 
rapidly if an unexpected rise in cases occurs. It offers a less 
expensive alternative to the malaria clinic (since a mlcroscopist is not 
stationed at the depot) and is thus likely to be cost-effective at a 
lower API than that required for the clinic (see below). It is not, 
however, likely to be a cost-effective solution where incidence is low 
since the high fixed cost characteristics of ACD are largely unchanged 
(workers are still employed full-time).
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Elimination of Follow-up
The 1986 External Situation Analysis Team suggested that follow-up of 
P .vivax cases should cease because of the high workload, and that 
follow-up of P. falciparum cases should be intensified. This suggestion 
was made in conjunction with a recommendation that MFWs should be 
transfered from ACD to other duties (supervision of volunteers, 
motivation and mobilization of communities in treatment and control 
activities). Clearly, elimination of follow-up for P.vivax only makes 
economic sense if house-to-house visits for active case detection are 
stopped: otherwise the taking of an additional slide can be done at 
minimal marginal cost.
Fortnightly ACD
Fortnightly rather than monthly ACD has been suggested by various 
reports and tried as a means of reducing incidence when the API is 
increasing or has Increased. The cost of ACD is Influenced by the 
population density and the distance to be covered. MFWs usually live in 
their locality so doubling the number of visits is likely to result in 
some saving in travel time, though it is still likely that almost double 
the number of MFWs will be needed, thus doubling costs.
This is unlikely to be worthwhile unless incidence is high and PCD 
mechanisms do not detect significant numbers of cases. However, if 
fortnightly ACD can be seen as an alternative to spraying, then it may 
be economic. For Instance, if it is assumed that it doubles the 
district-level cost of case detection and that cases are twice what they 
would have been with spraying, the additional cost of the Increased case 
detection and treatment activities would be around Rs 2.AO per capita 
per annum (Morang) and Rs 3.10 (Rupandehi) compared to the cost per 
capita per cycle of introducing spraying of Rs 8.69 (for DDT) in Morang 
and Rs 13.35 (for malathion) in Rupandehi (figures from Tables 6.2 and 
6.A). Thus fortnightly surveillance could potentially be quite a cost- 
effective measure if it reduces the need for spraying. This remains 
true even if allowance is made for the increased private expenditure and 
loss of work days resulting from the Increased cases (for instance a 
doubling of the API from 3 to 6 would result in Increased private costs 
in Morang of Rs 0.12 per capita and in Rupandehi of Rs 0.05 per capita).
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Expansion of PCD (MC)
In the earlier analyses, malaria clinics have emerged as a particularly 
low cost method of case detection and treatment. It Is therefore useful 
to explore In what circumstance they are likely to be appropriate. A 
malaria clinic will appear low cost only where It has a sufficiently 
large catchment population with a sufficient number of cases. For 
Instance, If a cost per case for case detection and radical treatment of 
Rs 500 Is regarded as an acceptable maximum, a malaria clinic such as 
that in Morang, costing Rs 14,615 per year, needs to detect 30 cases per 
year to achieve this unit cost. At an API of 2, this requires a 
catchment population of 15,000 in the vicinity of the clinic or with 
reasonable access to it.
At this level, there may well be some spare capacity In the clinic. In 
Morang 0.45% of malaria clinic slides were positive, and detecting 30 
cases would thus require 6700 slides, or 24 per working day. An 
experienced laboratory technician is expected to examine 60 per day. 
The laboratory technician in the malaria clinic also has to take slides, 
give presumptive and radical treatment and do an epidemiological 
investigation. If even so, he has some spare time, a larger population 
or more cases could be served at decreasing average cost. If the slide 
positivity rate was as high as In the Rupandehi malaria clinics (22%) , 
30 cases would require only 136 slides, or less than one per day. At 
this level of slides, there would be considerable spare capacity, and a 
much larger population could be served at decreasing average cost.
The increased use of malaria clinics thus depends on Identifying areas 
with a sufficiently large catchment population and sufficiently high 
Incidence of malaria. Minimum levels are probably a catchment 
population of 15,000 and an API of 2. The higher the API, the lower can 
be the catchment population.
Changing radical treatment procedures
Two options to decrease the cost of radical treatment are already being 
tried out and are under review by the NME0: reducing the treatment of 
P.vivax cases from five days to one or two days, and using MFWs to do
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radical treatment:. A third option which la beginning to be discussed Is 
using volunteers Co do radical treatment, and a fourth option has been 
proposed by External Reviews, giving lunediate radical treatment Instead 
of presumptive treatment.
Since malaria workers are required to give a five day treatment 
personally, thus requiring them to visit five times or stay for five 
days, reduction In treatment length has considerable potential for 
reducing coats. However, It needs to be set against the cost of any 
increase In cases arising from a higher relapse rate. Costs will result 
firstly from detection and treatment of relapaed cases, secondly from 
detection and treatment of cases that result from Increased transmission 
and thirdly from private expenditure on treatment and loss of work time 
of the relapsed and additional cases.
Although the NMEO has been studying the difference In relapse rates 
between one and five day treatment, no clear conclusions have yet 
emerged. Since reduction in the length of radical treatment appears to 
have such a clear potential for savings, It is Important for the NMEO to 
establish whether relapses and increased transmission could offset the 
reduction In workload.
As long as the ACD system Is retained, using MFUs to do radical 
treatment seems t© be a sensible extension of the role of a single 
purpose worker since It Is likely that tha additional work can be taken 
on at a low additional cost. Similarly, using volunteers to give 
radical treatment will be a low cost option. An additional visit might 
be required to notify the volunteer of a case though this could be done 
through the usual courier system. The major problem would seem to be 
ensuring the volunteer gives appropriate treatment when cases are very 
infrequent. Simple treatment guides or pictures could overcome this 
problem. While a volunteer might be reluctant to undertake this work. 
It may also Increase his satisfaction and feeling of Involvement. Since 
the volunteer's catchment area is usually very local, five day treatment 
could be given with limited effort, and the volunteer could also be used 
to take follow-up slides If this Is considered worthwhile.
While the costs of the volunteer's time may be low, the earlier analysis 
shows that the costs to the NMEO of supporting the volunteer (especially
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visits b y  a supervisor and courier) are significant. Since the 
supervisory visits are already being made, extra help connected with new 
duties of radical treatment could be done at the small extra cost of a 
longer stay, not a new visit.
Both the 1986 and 1988 External Evaluation Teams recommended that 
presumptive treatment should be discontinued and replaced by S day 
treatment of chloroquine and primaquine for any patient suspected of 
having malaria appearing at a PCD mechanism. The details of treatment 
practices are not specified: for example whether the 5 day treatment 
would be handed to the patient at one time and whether a blood slide 
would be taken. Reading between the lines, it seems most likely that one 
contact per patient Is intended, and taking a blood slide only If the 
patient has failed to respond to an earlier treatment (or if the case is 
particularly severe or particularly likely to be P.falciparum).
Drugs are an extremely small percentage of total case detection and 
treatment costs. At Rs 0.59 per person given presumptive treatment and 
Rs 1.48 per case for radical treatment, they can be compared to a cost 
per case of detection and radical treatment of between Rs 200 and Rs 
1518 (minimum and maximum costs for PCD (V) , PCD (M) and PCD (MC) In 
Morang and Rupandehi). In 1984, 6% of all PCD (V) slides were positive 
and 14% of all PCD (M) slides. Therefore for every 100 people attending 
PCD (V) , under the traditional system total drug costs would amount to 
Rs 71.42 (100 given presumptive treatment and 6 given radical treatment) 
and If immediate radical treatment were given, Rs 148. Expressed as a 
drug cost per true case of malaria, the cost would rise from Rs 11.90 to 
Rs 24.67. A similar calculation for PCD (M) gives drug costs per 100 
people of Rs 88 and Rs 148, and an increase In drug costs per case from 
Rs 6.29 to Rs 10.57.
If the Immediate radical treatment were given at one time, the increased 
drug cost would easily be offset by savings In the time required to 
contact those found to be positive. Moreover, If no slide was taken, 
savings per 100 suspected cases of at least Rs 97 (Morang) and Rs 195 
(Rupandehi) would arise, which would more than offset the increased drug 
costs. From the cost point of view, therefore, immediate radical 
treatment appears worthwhile.
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The 1986 External Situation Analysis Team gave the main reason for 
discontinuing presumptive treatment that it may be responsible for 
selecting chloroqulne-resistant strains of P. falcfp»*-»»» especially when 
the time-lag between presumptive and radical treatment is quite long 
(HMG/WHO/USAID/ODA 1986). The 1988 Team added that it suspected from the 
increased proportion of relapses amongst P.vlvax cases that incomplete 
courses of radical treatment were common (HMG/WHO/USAID/ODA/JICA 1988). 
These arguments suggest that decreased cost may be accompanied by 
increased effectiveness in terms of more rapid cure and a reduction in 
the speed of the spread of chloroqulne resistance. Moreover, the 
availability of immediate radical treatment may increase the 
attractiveness of PCD posts and increase the proportion of total cases 
that arise in the community that are treated. However, there are also 
dangers associated with the use of primaquine in population groups with 
a high frequency of Glucose-6 - Phosphate Dehydrogenase deficiency.
Decentralize malaria laboratories
In 1984, most laboratory work was centralized in district laboratories. 
However, the NMEO was considering decentralization, providing one 
laboratory for every 2 unit offices. It is relatively straight-forward 
to establish the population and level of activity that would make a unit 
laboratory economic. For example, a population of 100,000 and an ABER 
of 15% would give rise to IS,000 elides per year or S3 elides per day If 
a laboratory technician works 280 days a year. Thus one laboratory 
between two unit offices would appear economic and could produce savings 
taking into account the reduced travel required for couriers and the 
more speedy notification and treatment of cases. However, if ACD were 
discontinued and/or if routine slide-taking were stopped, decentralized 
laboratories are unlikely to be economic unless the task of mlcroscopist 
can be combined with other activities.
9.3 Organization of malaria control
One of the most important policy issues that Nepal has been facing for 
some years is the issue of the desirability of the integration of 
malaria control activities with general health service activities, and 
the speed with which integration should be pursued. Integration is 
unlikely to change markedly the costs of spraying since the two patterns
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of organization usa similar approachas (unlass It Is argued that 
Integrated districts are likely to have less effective case detection 
and treatment systems and thus may need to rely to a greater extent on 
spraying for the control of malaria). Indeed the analysis In Chapter 6 
suggested that the cost of spraying was not dissimilar between NMEO and 
ICHSDP districts.
However, case detection and treatment costs appear to be considerably 
cheaper In Integrated districts. Table 6.4 calculated the following 
district-level per capita costs:
NMEO districts Morang Rs 2.40
Rupandehl Rs 3.10
H a m  Rs 8.35
ICHSDP districts Saptarl Rs 0.75
Parsa Rs 0.92
It would be misleading, however, to use these figures as the basis, 
without adjustment, for calculating the savings that might arise from 
Integrating all districts. As discussed In Chapters 6 and 8, the total 
costs of case detection and treatment In an Integrated malaria control 
service are likely to be very sensitive to the level of malaria, unlike 
NMEO costa. Both Saptarl and Parse detect and treat fewer malaria cases 
in relation to population than the NMEO districts, their respective APIs 
being 0.7 and 1.05 in contrast to 1.51 in Morang, 5.91 In Rupandehl and
1.08 In Ilam. Without a more extensive sample of NMEO and ICHSDP 
districts. It Is difficult to anticipate how ICHSDP costs would respond 
In districts with higher APIs. If a linear relationship is assumed 
between per capita cost and API In ICHSDP districts, projecting the 
likely cost of an Integrated service In Morang on the basis of the 
Saptari and Parsa APIs and per capita costs gives a per capita cost of 
approximately Rs 1.14. This suggests that costs of case detection and 
treatment In an integrated district are roughly half those of an NMEO 
district at an API of around 1.5.
It would be unwise, however, to assume that this relationship held over 
the whole range of APIs that might arise. Moreover, It would be 
realistic to expect: there to be some limit to the extent to which
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resources could be switched to malaria control to cope with a rise in 
cases in integrated districts. It would be plausible to assume that up 
to a certain point, the integrated service could cope with a rise in 
cases but that eventually the number of untreated cases and delay in 
treatment would be such that an epidemic could occur, necessitating 
emergency and expensive measures.
A crucial issue, therefore, in any discussion of integration policy, is 
the extent to which the case detection and treatment activities of 
integrated districts are adequate to prevent a major rise In 
transmission. It is of note that despita regular warnings by Internal 
and external evaluation teams that case detection and treatment 
activities in Integrated districts were very poor, and that many cases 
of malaria were likely to have been missed or given radical treatment 
very late, there has not been, in those districts Integrated up to 1984, 
any signs of a major Increase in malaria. NMEO staff attribute this to 
the low receptivity of these districts. Since they are very similar to 
adjacent NMEO districts which report rather higher APIs, this suggests 
an element of overkill in NMEO malaria control strategies for these 
areas and the scope for a more economical programme.
However, the increase in cases that occurred in 1985 and 1986, 
particularly in NMEO districts in the Mld-Uest and Far-Uest, warns that 
not all districts may be equally suitable for Integration. This 
hypothesis may soon be tested since in July 1987, a high level decision 
was taken to integrate all vertical programmes, Including malaria. In 
1987 all NMEO districts in the East Region were Integrated and all 
Regional offices, and the district offices in the other regions were 
expected to be integrated in the near future. The precise pattern of 
integration is as yet, however, unclear, and there is some suggestion 
that some single purpose workers may be retained at district level.
9.4 Summary
This chapter has speculated on the likely costs and effectiveness of 
changes to current malaria control strategies in Nepal. Policy changes 
were considered firstly for vector control methods, secondly for case 
detection and treatment methods and thirdly for the organisation of 
malaria control.
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Alternative vector control m e t h o d s  analysed were alternative 
insecticides, more selective spraying, focal spraying, larviciding, use 
of larvivorous fish, environmental management and Impregnated bed-nets.
All other insecticides would be in total more expensive than those 
currently in use, but some of the new insecticides, for example 
lambdacyhalothrin, might be significantly cheaper to apply. The more 
expensive the insecticide, the greater was the share of insecticide in 
the total cost of spraying and thus the greater the effect on costs from 
more selective spraying. More research was required on the extent to 
which more selective spraying was possible in Nepal. The cost of focal 
spraying would depend on how it was organised.
Virtually no cost or effectiveness data were available on larviciding or 
the use of larvivorous fish. Scanty data on the cost of simple 
environmental management measures suggested a cost in 1984 of between Rs 
1 and Rs 2 per capita, and trials suggested that areas for environmental 
management needed to be carefully chosen. It was concluded that if 
areas could be identified where simple environmental management measures 
were effective in reducing vector densities and malaria transmission, 
then they were likely to be a cost-effective means of vector control.
Estimates of the cost of personal protection methods such as Impregnated 
bed-nets suggested that they were relatively expensive per person 
protected.
Case detection and treatment options analysed were removal of ACD, 
removal of ACD in certain areas, fortnightly ACD visits, elimination of 
follow-up, expansion of malaria clinics, changes in radical treatment 
procedures and decentralization of malaria laboratories.
The cost consequences of removal of ACD and expansion of PCD (V) were 
assessed. It was clear that replacement of ACD by strengthened PCD (V) 
would result in savings. Moreover, the implied workload for volunteers 
did not seem to be unreasonable. However, women and children currently 
made up a greater proportion of ACD than PCD cases suggesting that if 
ACD were to be abandoned, the volunteer network would need to be made 
sufficiently accessible and attractive to women. Even if ACD were to be
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retained as a strategy. It was suggested that It need not be used In the 
Hills where It was particularly costly and where the risk of Increased 
local transmission was much less than In the Teral. Elimination of 
follow-up would only make economic sense If house-to-house visits were 
stopped: otherwise the taking of an additional slide could be done at 
minimal marginal cost.
Fortnightly ACD did not appear to be worthwhile In the presence of PCD 
mechanisms unless It could be seen as an alternative to spraying. If so, 
the additional cost of more frequent house-to-house visits would be only 
around Rs 3 per capita compared to a cost per capita per cycle of 
spraying of at least Rs 9.
The circumstances under which malaria clinics were likely to be cost* 
effective were explored. It was concluded that a catchment population 
of 15,000 and an API of 2 were minimum requirements. The higher the 
API, the lower could be the catchment population.
Changes In radical treatment procedures assessed Included reducing the 
treatment of P . vivax from five days to one or two days, which would be 
attractive so long as the savings would not be offset by relapses and 
increased transmission; using MFWs and/or volunteers to do radical 
treatment, which would be attractive since It should be possible for 
MFUs and volunteers to take on the work at relatively low marginal cost; 
and discontinuing presumptive treatment In favour of immediate 5 day 
treatment of chloroqulne and primaquine for any suspected case. The cost 
implications of this last option were assessed and It was concluded that 
the increased drug cost would easily be offset by savings In malaria 
worker time and parasitology costs. The decentralization of malaria 
laboratories appeared economic as long as ACD was retained.
Finally, the advantages and disadvantages of Increased integration were 
assessed. In the districts evaluated, case detection and treatment 
costs were considerably lower in ICHSDP than In NMEO districts. However, 
the APIs In the ICHSDP districts were also considerable lower. On the 
assumption of a linear relationship between per capita cost and API In 
ICHSDP districts. It was estimated that costs of case detection and 
treatment in an Integrated district were roughly half those of an NMEO 
district at an API of around 1.5. However, the extent to which
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integrated service* could cope with a rapid Increase in transmission was 
questioned. It was noted that despite concerns that control activities 
in Integrated districts were poor, there had been no sign of a major 
increase in malaria despite many years of integration. This suggested 
an element of overkill in NMEO control measures in similar areas, but 
this conclusion could not be extrapolated to other areas with greater 
risk of Increased transmission such as Mid-West and Far-West districts.
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10. CONCLUSIONS
10.1 Theoretical aspects of the methodology of cost-effectiveness 
analysis of disease control programmes In developing countries
This study has shown the relevance of cost-effectiveness analysis to 
decision making on disease control programmes In developing countries. 
In particular, It has shown that the current 'state of the art' In cost- 
effectiveness analysis of health programmes In developed countries Is 
relevant and can be applied In developing countries.
Disease control programmes, and In particular malaria control, present 
choices to decision makers which encompass many of the choices reviewed 
In Chapter 2. For example, they Involve choices of sector, strategy, 
place of Intervention, time of intervention and target group. In some 
ways they present more of a challenge to the analyst than many of the 
topics chosen to be the subject of cost-effectiveness analyses in 
developed countries because they represent public health, community-wide 
interventions rather than curative interventions targeted at individuals 
which tend to be easier to evaluate.
The micro analytical framework of economic evaluation has been argued to 
be relevant In the Nepalese context. On largely practical grounds, 
cost-effectiveness rather than cost-utility analysis was employed to 
evaluate the malaria control programme. However, this decision can also 
be justified on theoretical grounds. In terms of the criteria listed by 
Torrance (1985) for determining when cost-utility rather than cost- 
effectiveness analysis Is desirable (see Chapter 2, section 2.1), In 
malaria control:
quality of life is not the only Important outcome: malaria for 
most people is a relatively short, acute illness with no lasting 
effects ;
- although malaria causes both morbidity and mortality, these
effects can be combined in a common unit of outcome such as 
healthy days of life lost without using utility weights; 
no study of a developing country health programme has used cost- 
utility analysis: thus there are no studies to which the Nepal 
results could be compared;
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- Che quality of Che effecClveneas data la poor: Che uae of utility
weighta would only add further assumptions and uncertalntiea.
On theoretical grounds, In order to achieve conalatency with economic 
evaluation methodology In other aectora, It la lsq>ortant to uae ahadow 
pricing in economic evaluatlona of health programmes In developing 
countriea. In the Nepal atudy, the effect of ahadow pricing waa 
relatively alight but thla doea not deatroy the argumenta for ahadow 
pricing.
In general, the coat-effectlveneaa literature undereatlmatee the 
dlfflcultlea of formulating the meaaurea of health effecta required for 
economic evaluation and dlacoverlng the relatlonehlp between programme 
activitiea and health outcome. In the caae of malaria, none of the 
conventional meaaurea of health effect are very aatlafactory except for 
the purpoae of Internal assesament of programme efficiency. In terma of 
comparlaona with other health programmes which have been the subject of 
economic evaluations (eg immunization, dlarrhoeal disease control) 
malaria is primarily a cause of morbidity rather than mortality, the 
episode of Illness la relatively brief, If often acute, and In Nepal, 
adults are affected as much or more so than children. Thus If the 
measures 'cases and deaths prevented' are used to compare the cost- 
effectiveness of malaria control with other health programmes, they 
disguise the different nature of the health effects resulting from the 
various programmes. Moreover, while the measure 'healthy days of life 
lost' overcomes to some extent the problems caused by the differing 
impact of different health programmes on Illness and death, It biases 
programme choice towards health programmes which prevent child deaths, 
and away from programmes such as malaria which also benefit adults and 
primarily prevent Illness rather than death.
The difficulties of assessing the relationship between inputs and 
outputs are a consequence not only of the data collection problems In 
developing countries but also of the nature of disease control 
programmes. In the case of the Nepal malaria programme, these 
difficulties were accentuated because malaria incidence In most areas 
was low, making design of any field trial of control strategies 
difficult.
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In general, these problems of assessing effectiveness are underestimated 
by economists engaged In cost-effectiveness analysis. Yet evaluation 
conclusions are often more sensitive to the values of the effectiveness 
data than the cost data.
One of the major features of the evaluation framework now used In cost- 
effectiveness studies In developed countries Is the inclusion of 
resource - saving consequences. As discussed in Chapter 8, these can be 
an important consequence of health programmes and they need therefore to 
be considered in developing country studies. For example in the malaria 
control programme in Nepal, the means of case detection and treatment 
and Its level of performance affected the period of illness of a malaria 
patient. The longer the delay between infection and slide collection, 
and slide collection and radical treatment, the more days of work were 
lost. Similarly, the longer the period of illness, the more private 
resources were spent on treatment.
These findings underline the importance of taking a social perspective, 
Including not only government costs and consequences but also those 
falling on households, which have rarely been considered in the cost- 
effectiveness literature on health programmes in developing countries. 
However, if study results are to influence government decision makers, 
the study must also include an assessment of costs and consequences from 
the government* s perspective and consider whether there is any conflict 
between government and social perspectives and between government and 
donor perspectives.
10.2 Methods of applying cost-effectiveness analysis to disease control 
programmes in developing countries
The research reported here illustrates both the scope for, and 
difficulties of applying cost-effectiveness analysis to disease control 
programmes in developing countries. The research was perhaps fortunate 
in encountering an information system that made analysis of programme 
costs relatively straightforward. However, in most countries and 
programmes, cost data tend to be the most readily available of all types 
of data, simply because they are required for accounting purposes. In 
contrast, until recently health programmes have often not been required 
to prove that they are effective in terms of indicators of change in
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The research also illustrates the difficulties associated with 
evaluating a preventive, as opposed to a curative, programme. In a 
curative programme, the number of Individuals affected with a particular 
condition Is known, and also the proportion cured, though there may be 
some uncertainty over the extent to which individuals have benefited 
from treatment or the period for which the Improvement will last. In a 
preventive programme the number of Individuals affected is hypothetical: 
it Is the number who would. In the absence of the programme, be 
Infected. Assessing this number requires baseline Information, either 
from the period before the programme was Introduced or from areas where 
the programme has not been Implemented. Both of these approaches have 
their difficulties, particularly In the case of malaria where the pre­
programme situation may be long ago and non programme areas may not be 
comparable to programme areas.
Given the uncertainties over the effectiveness of a preventive programme 
such as malaria control, Incremental analysis is particularly difficult 
to do. For example, In the case of the Nepal analysis this requires 
assessing the incremental effect of a change In strategy on malaria 
incidence. Many factors other than the strategy itself - for example 
the weather, temporary migration patterns, the Indian malaria situation 
- affect the annual Incidence of malaria, making it difficult to isolate 
the effect of the change In strategy.
While the Nepal research demonstrates the Importance of a social 
perspective in cost-effectiveness analysis It also demonstrates the 
difficulties of obtaining the required Information on private costs and 
consequences. Some form of survey is required, and questions can be 
difficult to formulate. In the case of private expenditure on medical 
care, there Is the problem of recall period and of assessing the 
reliability of responses when enquiries are being made about only one 
category of household expenditure (making It impossible to check the 
magnitude of all reported expenditure against Income).
In the case of assessing time lost due to the disease, there is the 
problem firstly of assessing whether the time lost by the sick person Is
health: hence the difficulties of obtaining the Information required on
effectiveness from the Nepalese malaria programme.
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compensated for by an Increased time Input by other household members, 
and secondly of placing a value on any time loss. The Nepal analysis 
suggests that assuming that all the period of disablement of the 111 
person Is lost to the household, and that this period should be valued 
at the local wage, will overestimate the actual cost of illness to the 
household.
Indeed, the Nepal research in general emphasizes the importance of 
Including consideration of the role of the household In any cost- 
effectiveness analysis of disease control. The household uses its 
resources to cope with illness, it finances preventive activities, it 
influences the effectiveness of government preventive activities (for 
Instance by whether or not houses are replastered after spraying) and it 
affects the cost-effectiveness of case detection and treatment 
activities by its decisions on the use of services.
Despite the difficulties the research encountered In the application of 
cost-effectiveness analysis, the research also underlines the Importance 
of this type of evaluation. Malaria control is probably the largest 
single programme of the Ministry of Health in terms of resources used; 
it is in regular contact with about 9m of Nepal's 17m population, and it 
faces important choices to do with strategy and target population as the 
quantity of insecticide available to it is reduced, as it re-orientates 
Itself from aiming at eradication to control, and as the nature of the 
malaria problem changes with population movements, environmental change, 
and development of parasite resistance to insecticides and drugs. Cost- 
effectiveness analysis can help malaria control programmes improve their 
efficiency by asking pertinent questions and bringing home the resource 
implications, for both the government and households, of alternative 
strategies and matching these with their likely effectiveness.
10.3 The potential for increasing the cost-effectiveness of the malaria 
control programme in Nepal
Chapter 4, section 4.2, discussed the various choices faced in making 
decisions on a malaria control programme. In particular, it classified 
these choices by the level of objective:
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Laval 1: cholca of malaria control varsua othar health programmes 
Laval 2: cholca of vactor control versus casa detection and treatment 
Level 3: choice of means of case detection and treatment 
: cholca of means of vactor control 
Level 4: choice of ways of organizing an activity.
The conclusions here are thus discussed In terms of these levels, taking 
them In reverse order. Finally, conclusions are drawn on the relative 
costliness of malaria control In Nepal as compared to malaria control 
programmes In other countries.
Choice of ways of organizing an activity
Chapter 9 suggested a number of ways of Increasing the efficiency of 
particular malaria control activities:
- Increased use of MFWs for radical treatment;
- use of volunteers for radical treatment;
- one or two day radical treatment;
- Immediate radical treatment;
- decentralization of laboratories;
Integration of malaria control activities.
The first should lead to a more economical use of staff so long as the 
ACD network remains In existence . The second depends on whether 
volunteers can be trained and would be willing to take on extra duties. 
If so. this Is likely to be cost-saving. One day treatment could lead 
to a considerable time-saving for unit staff but better Information is 
necessary on relapse rates. Immediate radical treatment would also save 
costs: drug costs would increase but they would be more than offset by 
savings in the time required to trace confirmed cases and give radical 
treatment and In parasitology costs. Decentralization of laboratories Is 
clearly worthwhile as long as the number of slides collected Is 
sufficient to keep a laboratory technician fully occupied.
No clear cut conclusions were possible on the cost-effectiveness of an 
Integrated pattern of organization without better Information on the 
true incidence of malaria In NMEO and ICHSDP districts. The analysis 
suggested that integration might be economical at low levels of malaria, 
but that Its costs would approach those of the NMEO as cases increased.
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It also seems that despite a lower level of performance than the NMEO, 
Its activities In districts Integrated up to 1984 were sufficient to 
contain malaria at a low level. However Its ability to contain malaria 
In districts of higher receptivity has not been tested, nor Its costs In 
circumstances of relatively high transmission.
Choice of means of case detection and treatment and means of vector 
control
Case detection and treatment. The analysis in Chapter 6 suggested that 
the proliferation of case detection methods Is resulting In relatively 
high unit costs for each method. Chapter 9 therefore evaluated the 
costs of stopping ACD, either throughout Nepal or In Hill areas, and 
expanding the volunteer network. Financially this would bring 
advantages, but information Is required on whether case detection would 
fall to unacceptable levels In the absence of ACD.
Other options considered Included expanding malaria clinics since they 
are an economical means of case-detection and treatment in areas of 
concentration of population and cases. Malaria depots seem likely to be 
a cost-effective means of case detection and treatment at lower APIs 
than malaria clinics, though at low levels of incidence they will be 
expensive because a high proportion of their costs are fixed. Firmer 
conclusions on malaria depots are not possible because their costs have 
not been studied.
Vector control. Conclusions on the merits of different insecticides are 
relatively straightforward. DDT Is the most economical Insecticide In 
terms of total costs, followed by malathlon. Of the newer generations 
of Insecticide, those which are low In volume and weight such as Flcan 
have distinct operational advantages In Nepal. The more expensive the 
insecticide used, the more worthwhile become strategies to limit the 
quantities used. These include selective coverage and focal spraying. 
More Information is required on their effects.
Very limited information is available on the costs and effectiveness of 
environmental management and modification, though trials are now 
underway which should produce better information. What evidence there 
is suggests that environmental management is likely to be a cost-
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The value of personal protection has been little explored. However the 
risk of malaria Is at present relatively low and personal protection 
measures are directed at the entire population (and may require 
expenditure by everyone) . Thus the cost is likely to be high relative 
to the reduction in risk, though protective measures do protect also 
against diseases other than malaria.
Choice of vector control versus case detection and treatment
Clear-cut conclusions on the relative cost-effectiveness of vector 
control and case detection and treatment and the optimum mix of the two 
strategies is impossible in the absence of reasonable information on 
their effectiveness. Given the high cost of spraying (largely stemming 
from the insecticide cost), there is considerable potential for 
intensifying case detection and treatment activities before they exceed 
the cost of spraying, and this will be cost-effective if it reduces the 
amount of spraying required. However, as long as insecticide is 
available to Nepal at the cost of applying it alone, the cost advantage 
from the government's point of view of case detection and treatment 
strategies is considerably reduced, though not eliminated.
A considerable reduction in spraying has occurred in recent years and 
there are now attempts to assess its effect on transmission (Draper and 
Webber 1987) . Hopefully this will enable a better evaluation of the 
cost-effectiveness of spraying and the circumstances under which 
spraying is worthwhile.
Further evaluation is also required of the optimal mix of strategies. 
For instance a combination of case detection and treatment and focal 
spraying is now being considered as a means of reducing insecticide 
requirements (Draper and Webber 1987). In the light of the spread of 
chloroqulne resistance, it is clearly important that a capacity be 
retained for mounting spraying campaigns rapidly.
effective means of vector control In the Outer Teral wherever small-
scale, labour Intensive methods can be used and are effective.
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Chole* of malaria control versus other health prograi
The evidence presented In Chapter 8 suggests that while the cost per 
case and death prevented by the Nepal malaria control programme la not 
as low as that of some other preventive programmes, notably those such 
as immunization targeted at young children, It nonetheless represents a 
worthwhile health service activity. However the analysis underlines the 
importance of stratifying geographical areas in terms of their malaria 
risk and determining the most cost-effective strategies for each area. 
The tendency has been to apply a particular strategy - for Instance ACD 
- throughout the malarious area, at a cost which may not be Justified by 
the results in terms of reduction in malaria risk in certain areas. The 
calculation of the cost-effectiveness ratios in Table 7.6 Indicates that 
the cost-effectiveness of malaria control Is highly sensitive to the 
numbers of cases and deaths prevented since a large proportion of the 
costs, especially of case detection and treatment, are fixed. Thus In 
high risk areas, malaria control appears to be highly cost-effective and 
in low risk areas, less so.
A further important consideration Is the age-group protected from 
illness by malaria control. In contrast to those health programmes most 
commonly Identified as cost-effective, namely those which Improve the 
health of children, the malaria control programme in Nepal at present 
mainly treats older children and adults. It therefore represents an 
important means of Improving adult health. In terms of the cases It 
prevents, It does protect children but also protects adults.
While quantitative comparisons of cost-effectiveness are not possible 
with other health programmes in Nepal, the discussion In Chapter 8 of 
the Nepal results relative to the results of analyses of malaria control 
programmes In other countries suggests that the Nepal programme la both 
economical and relatively efficient. It is therefore likely to represent 
a more efficient use of resources than many other existing health 
service activities in Nepal, notably curative services.
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1 1 . IMPLICATIONS FOR FURTHER RESEARCH
11.1 The methodology of cost-effectiveness analysis
There are two main priorities in developing the methodology of cost- 
effectiveness analysis in the developing country context. The first is 
to improve the measures of effectiveness used. In particular, a health 
index needs to be developed which is relevant to the diseases of 
developing countries. This could be built on the 'healthy days of life' 
measure, but should improve on the subjective assessment in that measure 
of the degree of disability Imposed by different diseases. An 
assessment is required of what dimensions of health should be reflected 
in the index (eg physical, social, emotional functioning) in terms of 
the value placed on health by individuals. Then different levels of 
ill-health need to be ranked relative to each other. Finally, different 
diseases need to be scored in terms of the degree to which they impair 
health.
As a parallel effort, the relevance of the measure 'quality adjusted 
life years' to developing countries should be explored. In particular 
research should investigate whether the questionnaires used to elicit 
utility weights in developed countries are relevant to, and usable in, 
the developing country context, and whether they can be suitably 
adapted.
The second methodological research priority is to improve the methods 
available to investigate the consequences of illness for households. 
There are virtually no studies available to guide researchers wishing to 
Include these consequences in their cost-effectiveness studies. The 
most problematic area is that of time loss due to Illness and improved 
methods are required to study the extent of such time loss within 
households and the extent to which intra-household mechanisms operate to 
minimize the loss. These methods will need to be adapted to the nature 
of the disease (eg chronic versus acute) and its prevalence (common or 
rare). Research is also required on the best means for valuing time 
loss.
More studies have looked at private expenditure on treatment than at 
time losses, but there is still inadequate exploration of the methods
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appropriate for enquiring about private expenditure where this Is done 
In Isolation rather than as part of a household Income and expenditure 
survey.
11.2 The application of cost-effectiveness analysis to disease control 
programmes
The top priority in research on the application of cost-effectiveness 
analysis to disease control programmes Is simply to do more studies. 
Individual studies are rarely self-sufficient In the sense that policy 
conclusions can be drawn entirely on the results of that study alone. 
Comparisons usually have to be made with other studies from the same 
country or other countries In order to illuminate certain policy Issues. 
Yet as shown by the study reported here, even for as prominent a disease 
as malaria, there are very few studies either of its overall cost- 
effectiveness or of the cost-effectiveness of particular malaria control 
strategies. The implications of the research results reported here are 
that different malaria control strategies can have very different cost 
and effectiveness implications. Thus national and international 
decision makers have much to gain from a larger stock of cost- 
effectiveness studies.
One important way of doing more cost-effectiveness studies is to ensure 
that a cost analysis is attached to any research on the effectiveness of 
alternative malaria control strategies. Similarly, project or programme 
evaluations should always have a cost component.
An important element of further application of cost-effectiveness 
analysis to disease control programmes should be to include 
consideration of the reasons for variations in the costs and 
effectiveness of control strategies between different geographical areas 
and control programmes. Little exploration of this topic was possible 
in this study because of the scarcity of other studies which report 
similar cost-effectiveness ratios. However, as the number of studies 
grows, more extensive discussions will be possible of the sources of 
cost and effectiveness variations.
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11.3 Malaria control in Nepal
The research on the cost-effectiveness of malaria control in Nepal 
reported here leads to three main areas for research which would permit 
the conclusions of the study to be strengthened and Increase knowledge 
of how the malaria control programme might be made more efficient.
The first area is to expand the research on the effectiveness of 
alternative vector control methods, particularly spraying of residual 
Insecticides and environmental management. The questions to be answered 
are what effect does spraying have on malaria transmission in particular 
locations; are there ways of economizing on the spray coverage required, 
for instance by selective coverage or focal spraying; what forms of 
environmental management are cost-effective; in what parts of Nepal are 
they applicable and is there a mix of vector control strategies that 
would be more cost-effective than one strategy applied in isolation.
It is particularly Important that environmental management be fully 
evaluated. Cost Information should be collected as part of this 
evaluation, distinguishing costs borne by the NMEO and by communities. 
In addition, since the costs of this control approach will be compared 
with approaches that involve continuing expenditure alone (eg spraying), 
information should be collected on the length of life and maintenance 
requirements of environmental management measures such as dams.
The second area is to improve understanding of what determines the use 
of services by a person who develops a fever. What influences their 
choice of public or private services, and their use of active or passive 
methods of case detection? Greater understanding in this area would, 
for example, enable a better assessment of the scope for exploiting use 
of private sources of treatment for malaria, and of the scope for 
dropping one or more of the existing case detection methods and 
expanding others.
The third area is to investigate the effectiveness of alternative 
organizational patterns of case detection and treatment, particularly 
the advantages of a single purpose as opposed to a multi-purpose worker. 
Conclusions on the relative cost-effectiveness of the ICHSDP and NMEO 
are at present difficult to make because it is unclear what proportion
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of total cases each approach detects, and whether the likely lower level 
of detection and slower detection In Integrated districts matters In 
terms of Its effect on the level of malaria transmission.
>
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ANNEX 1
THE RELATIONSHIP BETWEEN MALARIA. MALARIA CONTROL 
AND ECONOMIC DEVELOPMENT
Malaria control affects per capita Income through Influencing population 
size and the supply of land, labour and capital. The mechanisms through 
which these effects occur and the empirical evidence are reviewed below.
1. Population growth
"Any economic study of the effects of a public health 
Intervention Is totally dependent on demographic 
projections, since economic growth must be understood In 
relation to population size." (Brown 1986).
Unfortunately, disentangling the effects of malaria control on 
population size and separating It from other influences on population 
growth is extremely difficult.
The most straightforward effect of malaria control on population size 
Is the reduction of mortality directly due to malaria. However the 
magnitude of this effect and the age at which death is prevented 
depends crucially on the degree of endemlclty of malaria. This Is 
classified by WHO as:
Hypoendemlc: spleen rate In children (2-9 years) not exceeding
1 0*;
Mesoendemlc: spleen rate in children (2-9 years) between 11% and
50%;
Hyperendemic: spleen rate in children (2-9 years) constantly over
50%; spleen rates In adults also high (over 25%); 
Holoendemic: spleen rates In children (2-9 years) constantly over
75%, but spleen rates in adults low (Bruce-Chwatt 
1980).
In hypoendemlc and mesoendemlc malaria, only a small proportion of the 
population are Infected and thus deaths are likely to b e  
correspondingly low, except that occasional epidemics may cause 
substantial deaths at all age groups. After epidemics, population 
birth and death rates are said to return quickly to normal (Slnton 
1935). In hyperendemic malaria, mortality Is most likely to occur In 
children up to the age of 5 years (Bruce-Chwatt 1980). However, since 
transmission Is Intense but seasonal, acquired immunity Is 
insufficient to prevent the effects of malaria on all age groups, and 
there Is some mortality In adults. In holoendemic malaria, there Is 
perennial Intense transmission resulting In a considerable degree of 
immunity In all age-groups, but particularly In adults. Children are 
initially protected by passive immunity transmitted via the placenta, 
and then gradually develop acquired Immunity. There Is some 
considerable mortality due to malaria in children, but on the whole 
the indigenous adult population Is little affected, though Immigrants 
are at high risk.
Malaria Is believed to contribute substantially to deaths from other 
causes. For example Giglioll (1972) studied the pattern of mortality 
before and after the eradication of hyperendemic malaria In Guyana,
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over a 30 year period. The fall in Mortality specifically related to 
malaria was considerably less than the decline In general mortality. 
From an examination of causes of death and possible other explanations 
for the decline In general mortality, he concluded that malaria 
eradication was the prime factor. An earlier study of the Guyana 
data, using statistical methods of analysis, concluded that the 
spraying campaign reduced the crude death rate by 3.7 per 1000 (Newman 
1965).
Other studies have come to similar conclusions on the Indirect 
contribution of malaria to mortality. Payne et al (1976) observed a 
reduction In general mortality from 23.9 to 13.5 deaths per 1000 
population and In Infant mortality from 157 to 93 per 1000 live births 
following malaria control In a study In Kenya. A contrasting opinion, 
however, comes from the Garkl project In Northern Nigeria (Mollneaux 
and Gramiccia 1980). In treated villages, the fall In infant 
mortality and child (1-4 years) mortality was proportionately much 
smaller than the corresponding fall In malaria risk. They suggest 
that malaria Is a common precipitating cause of death and that control 
removes the cause, but that in a large proportion of cases, death Is 
delayed very little, possibly because these children have a high risk 
of dying from other precipitating causes or an underlying cause. They 
speculate that if chronic malaria affects adversely the general 
underlying condition, death rates may decrease further in the later 
stages of control.
A recent survey of studies of holoendemic malaria In Africa has 
concluded that the evidence suggests that holoendemic malaria caused 
an Infant mortality rate of around 100 per 1000, this being the order 
of magnitude of the fall In Infant mortality following control efforts 
(Bradley 1987). This conclusion draws on evidence from early studies; 
more recent studies Imply a much lower infant mortality rate due to 
malaria possibly, Bradley speculates, because o f  extensive 
chemotherapy even in the absence of organized control programmes.
Malaria affects not only mortality but also fertility, by causing 
miscarriages. Malaria control thus has a direct influence on birth 
rates and alao an Indirect effect through reducing mortality and thus 
Increasing the population size and the number of potential mothers. 
For example, Bruce-Chwatt (1980) comments that epidemic malaria Is an 
important cause of abortions, miscarriages and neonatal deaths; and 
that the effects of endemic malaria on the 'reproductive wastage' In 
indigenous populations In highly malarious regions vary Inversely with 
the degree of tolerance of the disease possessed by the community. 
Newman (1965) estimated that the campaign against hyperendemic malaria 
In Guyana raised the crude birth rate by 3.1 per 1000.
Much of the controversy to do with the economic effects of malaria 
control has concentrated on Its impact on population growth. Many 
analyses have been done with data from Sri Lanka (for example. Gray 
1974, Newman 1965, Frederlksen 1960) and population growth has also 
been emphasized by economists as an effect of malaria control In 
Mauritius (Meade 1961) and India (Cohn 1973). Reviews of malaria 
control In Nepal have also commented on this effect.
In Sri Lanka, the general mortality rate declined from the 1920s, 
though neither gradually or continuously, and population increased. 
Changes In mortality can be viewed In two ways: as a continuous
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regression line with deviations for higher death rates In the late 
1930s and early 1940s, or as two distinct lines separated by a rapid 
fall In the crude death rate from 20.2 to 14.6 per 1000 which occurred 
In the first year of the antl-malarla campaign (Brown 1986). Since 
district-level data Is available, analyses have tried to explain the 
observed decline In mortality and Increase In population by 
correlating changes In crude mortality rates by district with 
Indicators of malaria prevalence. Newman's conclusion was that 
malaria control contributed to 48% of the post-war fall In mortality 
(Newman 1965); Gray that It contributed about 23% (Gray 1974) . This 
amounts to a fall In the crude death rate due to malaria control of
1.9 to 4.2 per 1000. Newman also argued that malaria control resulted 
In a rise In the crude birth rate, concluding that malaria accounted 
for 60% of the population growth that had occurred since the War.
While the exact contribution of malaria control to population growth 
In Sri Lanka remains controversial, It Is clear that malaria control 
was more Important than other explanations Investigated such as 
Improved health services, better nutrition and general economic 
development. The method of analysis adopted owed much to the 
availability of reasonable crude birth and death rates by district. 
Assessments In other Aslan countries have had to do without such data 
and In consequence their analyses have been less sophisticated and 
conclusions more tentative.
For example, Cohn (1973) reviewed the data for India. Crude death 
rates had fallen from around 27.4 per 1000 In the 1940s to around 16- 
18 per 1000 In the late 1960s. Contributing factors were likely to be 
the control of communicable diseases (smallpox, cholera, tuberculosis, 
malaria), Improved water supply and environmental sanitation, 
Increased availability of antibiotics, expanded health services, fewer 
famines because of grain Imports and an Improved distribution system, 
and a government more responsive to distress. On the basis of an 
estimate of malaria deaths pre-eradication, Cohn concluded that the 
antl-malarla campaign was the major factor In the acceleration of 
population growth after 1951.
2 . Supply of land
It Is frequently argued that malaria control can promote economic 
development by Increasing the availability of natural resources such 
as land, thus enabling an expansion of output by providing a greater 
return to labour and capital than that obtainable elsewhere. Numerous 
examples are quoted In the malaria literature of countries where 
malaria control has permitted new land to be cultivated. For example 
In Indonesia, In one area In Java where rice cultivation had been 
abandoned apparently due to malaria, It Is said that DDT spraying at a 
cost of $12,000 permitted rice to be grown of the value of $740,000 
(Ketterer 1953).
However, there are a number of problems with the valuation of benefits 
stemming from the Increased supply of land. Firstly, as Barlow (1967) 
and Cohn (1973) emphasize, few studies (witness the one quoted above) 
take account of the opportunity costs of land development. Malaria 
control is a necessary but not sufficient condition for land 
reclamation, since Investment is required in land clearance, road 
construction, lrr lgat Ion, farm equipment, housing etc. These 
resources could have been used elsewhere and thus the new land is
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obtained at the prlca of a reduction in output elsewhere. The 
resources oust therefore be valued according to their srast productive 
alternative use. Secondly, crop production requires corresponding 
Inputs of labour, seeds etc and thus tha gross value of the crop 
overstates the gain. For example, unless the labour used In crop 
production was previously unenployed, its cost needs to be allowed for 
In terms of output forgone elsewhere by Its use In the new area. 
Finally, It Is not Inevitably true that the new land gained provides a 
greater return to labour and capital than that available elsewhere (la 
is more fertile): this needs to be demonstrated.
One of the few more rigorous studies to take Into account the effect 
of malaria control on the supply of land la that by Barlow (1967, 
1968) in Sri Lanka. Pre malaria control, 62% of the population was 
concentrated In the small and essentially non-malarlous Uet Zone and 
malaria control permlttad the spatial re-allocation of population. 
Barlow argues that If, as seemed likely, the marginal product of land 
In the malarious districts before control was higher than the marginal 
product of land elsewhere, control contributed to the expansion of 
output by leading to the relocation of labour and capital In districts 
where the marginal product of land was relatively high.
Barlow's Investigation of the value of malaria control Is based on a 
simulation model of the economy Incorporating a Cobb-Douglas 
production function relating output to the quantity and quality of 
labour and capital. Since land la not a specific argument In the 
production function, the increased supply of land Is viewed as 
permitting an Improvement In allocative efficiency and Is included In 
the form of one of the indexes of the quality of the capital stock. 
However the value of the Index was guessed at, since Barlow had 
Information only on the shift of the labour force between non- 
malarious and malarious areas and not on their relative fertility.
9. Supply of labour
Changes In the supply of labour as a result of malaria control can 
take the form of:
- reduction in deaths producing an increase in time available for 
productive activities;
reduction In disability (time off work) also increasing the time 
available for productive activities;
- reduction In debility increasing the productive capacity of 
workers.
These changes are relevant whether the work in question Is Inside or 
outside the home, and whether workers are wage-earners or work on 
their own account. They are also relevant to children in the form of 
benefits from Increased attendance at school and improved school 
performance.
Problems in assessing these changes in the supply of labour relate 
both to measurement and valuation. Measurement Involves assessing the 
mortality, morbidity and debility caused by malaria. Mortality was 
discussed above. Morbidity assessment shares many of the same 
problems: the duration and frequency of malaria morbidity In an 
individual will depend on malaria endemlcity, vector and parasite 
species, and the sex and age of the individual. For example in 
hypoendemlc and mesoendemlc areas, the number of individuals falling 
111 will be relatively few. If the parasite species Is P. falciparum
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Illness may be relatively severe; if P . vlvax relatively mild but If 
untreated, relapses may cause debility.
In hyperendemic and holoendemlc areas, the degree of Immunity will 
determine the morbidity of the working population. The extent of 
morbidity In a highly endemic area was the subject of considerable 
controversy in the early 1950s. For example Wilson et al (1950) 
argued that:
"In the tropical zone, where transmission is both more 
constant and more Intense, malaria carries an even greater 
hazard to Immigrant groups and Individuals; but at the 
same time It may show such slight manifestations among the 
Indigenous adults that at first glance malaria might 
appear to be absent".
This view, however, was disputed by Macdonald and Visvanathan 
(Macdonald 1951, Visvanathan 1951). Viswanathan, for example, argued 
that the relative freedom from malaria of the Indigenous population 
stood out only In contrast to the far worse experience of the 
Immigrant: malaria was an appreciable public health problem even 
amongst indigenous adults In the worst malarious tracts In India.
Quantitative evidence Is scarce. Slnton (1935) reviewed the evidence 
from India on days of work lost. Estimates ranged upwards from 2 days 
per person per annum but their significance is unclear because no 
information was given of the endemic ity of malaria in the various 
areas and most patients received some form of treatment. A study in 
West Africans reported that adults living in an area of high 
endemiclty and mainly P .falciparum infections still had clinical 
attacks though morbidity was relatively slight - attacks of 1 to 10 
days duration, mean of 4.2 days of illness and 3 days off work, and an 
average of 1.5 attacks per person per year (Miller 1958). Another 
study, of a very small sample, also in West Africa, found that malaria 
caused on average only one day of sickness per adult per year 
(Colbourne 1955). No direct quantitative evidence appears to be 
available on the debility caused by continued attacks of malaria.
Two major difficulties arise in valuing changes in the supply of 
labour. Firstly, it is unclear what effect Improved health will have 
on actual production. The latter will depend partly on the factors 
that govern the individual's allocation of time between leisure 
activities and activities that raise Income. It will also partly 
depend on whether opportunities exist for additional work time to be 
productively employed, that is on the existence of unemployment and 
underemployment. Whether these exist, and if they do whether they 
should be taken into account, have been the subject of much 
controversy (Goode 1970, Mushkln 1962, Schultz 1962, Stevens 1977), 
mainly turning on whether unemployment and underemployment can be 
considered as temporary problems, susceptible to government monetary 
and fiscal policy, or rather as structural phenomena. In the context 
of underdeveloped economies, it Is generally accepted that the 
likelihood of unemployment and underemployment should be allowed for 
in any assessment of the value of Increased labour supply.
Secondly, a value has to be found for the marginal product of 
additional work time. This has tended to be approximated by measures 
of the average product of labour such as the average agricultural wage 
or even the minimum agricultural wage (Prescott 1979a). Neither of
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these may bear m uch relationship to Marginal product, not least 
because additional workers nay require the exploitation of relatively 
unfavourable production situations. However, the observed average 
product may understate the marginal product of healthy workers If the 
average product reflects the productivity of an '111' work force. 
Alternatively, additional labour units nay be valued by an amount 
equal to the total product per worker, though this assumes that 
production Is attributable to labour rather than to all factors of 
production.
A number of studies have looked In detail at the effects of 111 health 
on the production and earnings of Individuals and families. One 
methodological approach Is a cross-sectional analysis correlating 
Indicators of 111-health with Indicators of productivity at the level 
of the Individual (this method was adopted by Uelsbrod et al (1973) to 
look at the effects of parasitic disease In St. Lucia). A major 
drawback to this approach Is that unhealthy workers may reduce the 
returns to other Inputs In the same enterprise - for Instance to 
capital and other workers - so the earnings differential between the 
healthy and the sick may not be an adequate measure of the likely 
benefit of Improved health (Stevens 1977). A more appropriate 
observation unit would be the production activity as a whole (l.e. the 
economic enterprise or household). A further problem with the cross- 
sectional approach, however. Is that the effects of Ill-health can 
only be discovered If the majority of workers are healthy, and not If 
more-or-less everyone Is sick to some degree (Kamarck 1975).
A second methodological approach Is longitudinal, comparing the output 
and earnings of Individuals or families before and after disease 
control. Some studies combine this with a cross-sectional approach by 
Incorporating a control group (for example a group of villages not 
included in malaria control activities). This approach found that 
annual expenditure on hired labour and land left uncultivated was 
significantly lower post-spray than pre-spray In a group of villages 
In India, presumably because of the increased availability of family 
labour time (Bhosbore et al 1952). A similar combined longitudinal 
and cross-sectional approach was adopted by Conly In Paraguay (Conly 
1975) though here the effect of control activities was not the prime 
focus of the study. Instead, a variation In the Incidence of malaria 
from one year to the next provided the opportunity to study the extent 
to which malaria accounted for observed variations In economic 
Indicators. Data were collected on illnesses (both malaria and other 
illnesses), population movements, farm-work (time spent, types of 
work, source of labour), harvest quantities and changes In the number 
of animals and poultry, other kinds of work and purchases and debts. 
Farms were classified by the severity of the malaria they experienced 
(the group most severely affected experiencing an average of two 
episodes per person per year), and economic Indicators compared for 
each group between the malaria-free year and the malaria-epidemic year 
and between groups for both years. Malaria was found to have slowed 
down the land-clearing programme and to have reduced the amount of 
land brought under crops. Preferential attention was given to cash 
crops, Increased use was made of extra family members and many tasks 
were delayed. The reduced availability of labour due to suilarla thus 
appears to have affected not only the performance of daily production 
tasks but also the choice of crop and resources devoted to investment 
activities.
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A number of macro level studies have estimated an annual national 
economic loss or output forgone by assuming that Individuals who are 
111 suffer a certain percentage loss In working capacity (Prescott 
1979b) . This Is multiplied by the total number of Individuals who 
would be Infected In the absence of control and valued by some measure 
of the productivity of labour. It Is then assumed that disease 
control would result In a gain equal to the value of this loss. This 
method can be criticised on a number of counts:
levels of malaria without control are usually calculated on the 
assumption that they would have remained as In the year before 
control started - though this Is not necessarily true; 
since good malaria morbidity and mortality data are rarely 
available, various assumptions have also to be made on the 
effect of the control programme on malaria;
the figure for the percentage loss In working capacity often has 
little basis In reality;
assessing the value of this loss runs Into the problems 
discussed above to do with unemployment and the value of a 
worker's marginal product.
Nonetheless, because of Its simplicity, this approach has often been 
used to estimate both the retrospective and prospective gains from 
malaria control (Cumper 1979, Kuhner 1971). For example, Kuhner 
calculated the loss In agricultural gross domestic product by 
multiplying the assumed labour coefficient In the agricultural GDP 
(i.e. the contribution of labour to output) by the manpower lost due 
to malaria deaths and cases (assuming sixty cases per death and 15 
days lost per year per case) and by the average output per worker. 
Unemployment was known to be negligible and underemployment assumed to 
be non-existent.
An alternative macro approach to estimating the effects of improved 
health on output was suggested by Malenbaum (1970). He applied step­
wise regression analysis to an Input-output model with output In 
agriculture as the dependent variable, and as independent variables, 
various indicators of agricultural Inputs (e.g. labour, fertilizer), 
health status (e.g. infant mortality rate, malaria mortality), and 
labour quality (literacy rates etc). The model was run with both 
International and national data (for instance for provinces in 
Thailand) . The formulation of the model has been severely criticised 
(Goode 1970, Beenstock 1980, Wells and Klees 1980) and its explanatory 
power was not very high. A particular problem concerns the direction 
of causality: from Increased output to improved health or from 
improved health to Increased output.
4 . Supply of capital
The significance of the supply of capital stems from Its effect on 
future Income. Other things being equal, the higher the rate of 
capital formation, the higher will be the growth of per capita income 
In the future.
The effect of malaria control on the supply of capital rests on 
speculation rather than any empirical evidence. In his model, Barlow 
assumed that the larger population resulting from malaria control 
would have higher consumption requirements and thus would reduce the 
rate of private saving from a given aggregate level of disposable 
income (Barlow 1967). Moreover, savings would be more likely to be
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devoted to housing - assumed to be Investment with relatively low 
returns - though reduction In the funds households required for 
treating malaria would Increase the Income available for savings.
In the public sector, Barlow distinguishes 'productive' physical 
capital, such as dams and roads, from public consumption such as 
police stations and schools. He assumed that an Increased population 
requires a proportionate Increase In public consumption expenditure, 
at the expense of public Investment, though admits that many 
consumption expenditures such as education may create a more 
productive labour force. This effect Is Ignored by Barlow and others, 
on the grounds that there Is a substantial lag before It Is 
experienced and that In the absence of malaria control, funds could be 
Invested with an immediate pay off. Cohn (1973) makes similar points 
in relation to malaria control in India, placing particular emphasis 
on the effect of malaria control on changing the age structure of the 
population (since children are most affected by malaria in highly 
endemic areas) and thus increasing dependency ratios. He argues that 
this Increases marginal consumption, depresses marginal savings and 
Investment rates, and alters the pattern of Investment towards less 
directly productive forms such as housing, schools and medical care.
Barlow's assumptions on private and public saving mean that the 
greater the population size as the effects of malaria control accrue 
through time, the lower is the share of income saved and thus the 
lower Is output per capita. These assumptions have been challenged. 
Borts (1967), for example, commenting on Barlow's model, thinks It 
unlikely that household savings behaviour will remain unchanged if the 
productivity of capital rises as a result of malaria control (for 
example, because new land Is more productive). More generally, models 
such as Barlow's can be criticised for over-emphasizing the role of 
capital formation In economic growth (Cassen 1981).
5. Malaria control and economic development
Two rather different conclusions on the Implications of malaria 
control for economic development emerge from this brief review. The 
conclusions from micro-level studies tend to be optimistic: malaria 
affects labour productivity and thus Its control will produce economic 
benefits. However, such studies assume a partial equilibrium 
framework: that is they look only at marginal changes in labour 
supply, neglecting the possibilities of non-marginal changes and of 
their effects on other economic variables. In particular, the 
population growth consequence of malaria control is Ignored. In 
contrast, the macro-level studies - primarily those by Barlow (1967) 
and Cohn (1973) - have focused particularly on the population growth 
consequence, making assumptions of its effect on consumption, savings, 
investment and output growth that lead to pessimistic conclusions.
In the case of malaria control, a partial equilibrium framework will 
be inappropriate If non-marginal changes In a variety of economic 
variables are likely consequences and malaria control will have 
ramifications throughout the economy. Barlow's model, for example, 
included a large number of variables - a simplified version of the 
relationships between variables in the model is shown In Figure 1. A 
vital question is the extent to which a conflict exists, as Barlow's 
model implies, between reduction in malaria and Increased per capita 
output. In a pessimistic scenario, malaria control results In
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Figure 1: A simplified model for evaluating the impact of malaria
eradication on per capita Income
Source: Barlow and Davies (1974)
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Figur« 1: A simplified model for eveluetlng the impset of malaria
eradication on per capita Income
Source: Barlow and Davies (1974)
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population growth which Increases labour aupply relative to other 
factors of production and produces declining returns. Per capita 
income thus falls.
In a more optimistic scenario, malaria control (alone or in 
conjunction with other health improvements) , despite population 
growth, produces greater labour efficiency, greater returns to other 
factors of production and other favourable by-products. Stevens 
(1977), for example, criticizes existing studies for focussing on the 
short-run as opposed to the long-run where Improved health may 
encourage organizational and technological change. In a society where 
ill health is the norm, organizational modes and technologies are 
likely to have been adapted to prevailing constraints - for example, a 
shortage of labour at harvest time. An increase in labour may have 
little short-term effect on output, but in the long-term Improved 
health will encourage change in the whole productive environment. It 
may also in the long term lead to decreased fertility. Moreover, 
population growth is not inevitably inimical to economic development 
(Cassen 1981).
Which of these scenarios applies in a particular context is a matter 
for empirical investigation. It is appropriate to conclude, however, 
on a cautionary note. The review of the relationship between malaria, 
population mortality and fertility rates, and the supply of land, 
labour and capital warns against any simplistic generalizations of the 
economic effects of malaria control. Empirical findings have been too 
readily translated from one setting to another, or assumptions made 
which have little basis in reality. In the case of malaria. It is 
particularly Important that any d i s cussion of its economic 
consequences should pay attention to the characteristics of malaria in 
the areas being studied: in particular to the degree of endemlcity, 
level of tolerance of malaria in the community and species of vector 
and parasite.
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ANNEX 2
COSTING METHODOLOGY
1. Introduction
The cost analysis was divided Into two parts. In the first part NMEO 
expenditure was analysed by region and district and related to the 
population covered and number of cases. Because of lack of suitable 
Information In an appropriate form, this analysis could only look at 
total expenditure not expenditure by activity such as spraying and 
surveillance, only at recurrent not at capital costs, and could only be 
done for NMEO and not for ICHSDP districts. Therefore the second part 
of the analysis selected five districts, three NMEO and two ICHSDP, and 
analyzed the costs of malaria control In much greater detail. Total 
costs were calculated and allocated to operational activities in order 
to produce unit costs for malaria control activities.
The year 1984 rather than a financial year was chosen as the base for 
the analysis because the calendar year encompasses the main transmission 
season which is split into two by the financial year. For instance the 
first and second spraying rounds take place in different financial 
years.
2. Availability of financial Information
The costing approach adopted was strongly Influenced by the availability 
of financial information. This differed between the NMEO and ICHSDP, 
necessitating a different approach in each organization.
2.1 NMEO
In general, the availability of financial Information In the NMEO Is 
very good. Budgets are held by the NMEO headquarters (NHQ) , by each
Region and by each district. Districts are responsible for the great 
majority of the resources used In the districts, the exceptions being 
Insecticide, drugs and laboratory equipment and chemicals which are 
recorded In NHQ accounts and supplied to districts without charge.
Over the last few years, the NMEO has been gradually Implementing a 
programme budgeting system. Budgets have been allocated by programme 
for several years, but the reporting of expenditure by programme has 
been required only from 2041/2 (1984/85). However, two Regions and a 
number of districts have for several years been recording expenditure by 
programme and presenting this in their Annual Reports. The programme 
structure is shown in Table A2.1. This structure much facilitated the 
economic analysis.
Within each programme, budgets and expenditure are recorded by the 
budget code structure used within the government. The codes are shown 
In Table A2.2, together with an explanation of the expenditure Included 
under each code.
The Nepali financial year runs from July 16 to July 15. Remarkably, 
financial accounts are available a month or two after the end of the 
financial year. In addition, since malaria statistics are recorded for
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Tabi« A2.1: Programma budget categoria«
PROGRAMME ACTIVITIES INCLUDED
Surveillance Operation* of unit offices, border check 
posts, supervision by surveillance staff 
in district offices, regions, NHQ
Paraaltology All laboratories
Health education Supplies for volunteers, supervision and 
support to volunteers and community 
motivation by districts, regions, NHQ
Spraying Spraying operations, supervision and 
support by districts, regions, NHQ
Administration and Administrative support at district.
miscellaneous region, NHQ
Entomology Entomological activities at regions and 
NHQ
Research and
Training Training centre, Hetauda.
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Tabi* hi.1\ Budget codea
BUDGET
CODE
DESCRIPTION MAIN ITEMS PURCHASED
1 Salaries Permanent & Temporary staff
2 Allowances Staff allowances
3 DA, TA Dally & travel allowances paid to staff 
travelling on duty
4.1 Services Electricity, telephones etc
4.2 Other services e.g. porters, printing
5 Rent Rent of offices
6 Repair,
maintenance
Of vehicles, equipment etc.
7.1 Office goods Stationery
7.2 Newspapers Newspapers, magazines
7.3.1 Fuel for 
vehicles
Fuel for passenger vehicles
7.3.2 Fuel for other 
purposes
Fuel for lorries, lamps etc.
7.4 Clothes, fodder For spraymen, animals
7.5 Supplies Forms etc
8.1 Encouragement
prizes
8.3 Drugs, lab Chloroquine, lab supplies.
supplies insecticides
9 Contingencies Conferences, functions etc.
10.1 Furniture Purchase of furniture
10.2 Vehicles Purchase of vehicles
10.3 Machinery,
equipment
Purchase of machinery, equipment
12.1 Building Repair, maintenance of buildings
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Che years of the Gregorian calendar, moat districts report 'expenditure 
to Paush' , i.e. from the start of the financial year to December, making 
it possible to convert expenditure from financial years to calendar 
years. For these reasons, It was possible In the cost analysis to take 
1984 as the year for the analysis.
External assistance is Included in approved budget figures, with the 
exception of WHO assistance and unforeseen donations. Amounts actually 
disbursed are Included in expenditure figures.
In the case of insecticides and drugs, actual expenditure may give a 
misleading picture of resource use in any given year since stocks may be 
run down or increased. In addition, it is difficult to apportion a 
national sum for these items to districts. For these reasons, 
expenditure on insecticides and drugs was excluded from NHQ expenditure. 
It was then added into district expenditure by applying unit prices to 
the drugs required for district malaria cases and to the quantity of 
insecticide used.
2.2 ICHSDP
Unlike the NMEO, the ICHSDP performs many functions and does not have a 
comprehensive programme budgeting system. Financial information could 
therefore not readily be obtained from accounts, but had to be estimated 
by field visits to districts.
At national level, the ICHSDP headquarters is funded partly by 
government funds and partly by various projects which are externally 
financed. It was not possible to obtain an estimate of the resources 
absorbed by malaria control.
At district level, malaria control is one of the functions of the 
district health office. The district health office and the health posts 
in the district are financed from two budgets, the regular budget which 
pays all staff salaries and some overhead expenses, and the development 
budget. Malaria has its own budget within the development budget, 
financing largely supplies (forms etc.) and some supervision costs. Two 
other budgets within the development budget, for supervision and for 
transport, may also be used for supervising malaria control activities, 
and the development budget for administration finances an accountant for 
the development budgets.
Expenditure on malaria control in integrated districts may thus be 
financed from five sources: the regular budget, and the development 
budgets for malaria, supervision, transport and administration. In 
addition, drugs, insecticides and laboratory supplies are provided free 
by the ICHSDP headquarters. Those supplies which originate from 
external assistance are recorded under NMEO expenditure. Accounts are 
maintained by financial and not by calendar year.
3. Prices: recurrent items
Prices were required for the main inputs into the programme. A 
particular problem was presented by pricing drugs and insecticides 
because some supplies currently used had been purchased several years 
before and for some of these their prices could not be traced. WHO 
estimates of prices for the main anti-malarial supplies were available
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for 1981/82 and 1984/85. Therefore these were used when actual prices 
were not known.
A major question concerns whether the original price paid or the price 
of replacement supplies should be taken. To evaluate the actual 
expenditure burden of the programme, historic prices are required. 
However, particularly In the comparison of alternative strategies, the 
supplies for the various strategies need to be costed consistently. In 
prices of a common year. Here, therefore, replacement prices are 
relevant.
In the sections below two prices are therefore calculated. The historic 
price Is the actual price paid, or an estimate of It, for supplies used 
In 1984. The replacement price Is an estimate of the value of the Item 
In 1984. The replacement price Is required particularly for the 
economic analysis. The appropriate value for traded commodities such as 
supplies Is the 'border price', that Is the 1984 c.i.f. (carriage, 
insurance, freight) price to the Nepal border (see section 6.4 for a 
discussion of pricing principles In the economic analysis). Taxes such 
as customs duties should be excluded from the border price and internal 
transport costs calculated separately. Taxes can here safely be Ignored 
since donated supplies pay no duty and the prices calculated here have 
no tax Included. Freight costs to Nepal could not be calculated 
precisely In this study, and charges are based on a recent study of the 
comparative costs of Insecticides for malaria control (M Phillips, A 
Mills, The operational costs of insecticide spraying for malaria 
control. A case study of Nepal. EPC, LSHTM May 1987). Distribution 
from the main godowns to districts is paid for from Regional budgets and 
is thus accounted for separately.
3.1 Anti-malarial drugs
Chloroquine: Chloroquine (150mg base) Is purchased annually In Nepal 
from the Royal Drugs Company at a price of Rs 195/1000. This Is 
therefore the historic price, and also the replacement price for locally 
purchased chloroquine. If, however, supplies were purchased
Internationally, the estimated price from WHO is $6.40/1000, plus 25% 
allowance for freight gives a border price of $8/1000 or Rs 131.68.
Primaquine: The most recent supply of primaquine (15mg base) was from
WHO in 1982, at a price of Norwegian Kroner 16/1000. This translates to 
Rs 33.09/1000 and adding 25% for freight gives Rs 41.36/1000. The 
1984/85 WHO estimated price Is $3.80/1000, plus 25% for freight gives a 
border price of $4.75/1000 or Rs 78.19.
Sulphadoxine and pyrimethamine: No Information was found In Nepal on the 
price of sulphadoxine and pyrimethamine used In 1984, and It appears to 
have been supplied pre-1982. The 1981/82 WHO estimated price was 
$80/1000 and this, plus 25% freight. Is used as the historic price, 
giving Rs 1234/1000 using a 1981 exchange rate. The dollar price of the 
drug has remained relatively constant, the WHO estimated price for 
1984/85 being $79.50. The border price Is thus $79.50 plus 25% freight 
or Rs 1635.71/1000. The higher border price In 1984 despite a constant 
dollar price reflects the devaluation of the Nepali rupee against the 
dollar.
Treatment costs can now be calculated. The NMEO estimates drug 
requirements on the basis of the following average drug usage patterns:
355
Presumptive treatment: 3 tabs chloroqulne (ISO mg base)
Radical treatment. Imported P. falciparum: 2 tabs sulphadoxlne 
and pyrimethamine plus 3 tabs primaquine (15mg base)
Radical treatment, all others: 6 tabs chloroqulne (150 mg base) 
plus 4 tabs primaquine (ISmg base).
This gives the following treatment costs:
Presumptive treatment:
historic prices Rs 0.59 per person
border prices (Imported chloroqulne) Rs 0.40 per person 
border prices (local chloroqulne) Rs 0.59 per person
Radical treatment. Imported P. falciparum: 
historic prices Rs 2.59 per case 
border prices Rs 3.51 per case
Radical treatment, all others:
historic prices Rs 1.34 per case
border prices (Imported chloroqulne) Rs 1.10 per case 
border prices (local chloroqulne) Rs 1.48 per case
3.2 Insecticides
DDT: The DDT used in Nepal In 1983 and 1984 was a number of years old 
and Its price and year of origin could not be traced. WHO estimated 
prices for DDT (75% w.d.p.) were $1500/metrlc ton In 1981/82 and $1400- 
$1700/metric ton In 1984/85. A 1985 consignment from WHO to Nepal cost 
$1950/metric ton. $1500/metrlc ton is thus taken as the historic price 
and $1755 as the border price ($1950 deflated by 10% to give a 1984 
price).
The likely 1984 freight cost proved difficult to estimate. The freight 
cost of the 1985 consignment was therefore taken ($410/metrlc ton) and 
deflated by 10% to give a 1984 price of $369/metrlc ton. The 1984
border price was thus estimated at $2124/metrlc ton or Rs 34.96/kg.
The historic freight cost was calculated by discounting the 1985 freight 
charge by 10% per annum back to 1980, giving $0.24/kg. The total 
historic price Is thus $1.74Ag or Rs 20.88 at 1980 exchange rates.
Malathlon: In 1983, USAID supplied 2 shipments, each of 300 tons, at a 
cost of $1850/metrlc ton to Calcutta or Rs 26.92/kg- Freight to Nepal 
was estimated by USAID to be $233/metrlc ton or Rs 3.39/kg- Malathlon 
sprayed In 1983 and 1984 Is likely to have been mainly the 1983 stock. 
A historic price of Rs 30.31/kg Is therefore taken.
The border price Is calculated on the basis of the WHO estimated 1984/85 
price of $1800/metrlc ton. Actual freight costs are available for a 
1985 USAID consignment, of $379/metrlc ton. This Is deflated by 10% to 
give a 1984 price of $341. The 1984 border price Is thus $2141/metrlc 
ton, or Rs 35.24/kg-
Fleam: In 1985, 33.2 metric tons of Fleam was supplied at $30/kg f.o.b. 
Due to shortage of time, air freight was used at a cost of $2.26/kg. 
resulting In a total price of $32.26/kg or Rs 600.36. If surface
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freight had bean used, the price would have been $1.09/kg, giving e 
total 1985 price of $31.09 or Rs 578.58/kg.
This Insecticide Is not Included In analyses of 1984 expenditure 
patterns. However, Its price Is required In the comparison of 
alternative strategies, and for this has been translated to 1984 prices. 
It Is assumed that the dollar price of the Insecticide would have been 
the same, and the freight charge 10% less, giving $30.99/kg at surface 
freight rates or Rs 501.10 at 1984 exchange rates.
3.3 Salaries
Estimating the salaries of different grades of personnel proved a 
considerable problem In this analysis because government staff received 
a considerable Increase In July 1984. District accounts for 2040/1 were 
thus based on the old salary scales, and for 2041/2 on the new salary 
scales. Moreover Information on staff by grade and salary was readily 
available for the new salary scales but not for the old which had a 
complex pattern of allowances.
The new salaries represented an approximate 35% Increase, though 
salaries appeared to Increase more than this because the previously 
large allowances were largely eliminated and salaries Increased to 
compensate. 1984 expenditure thus comprised 6 months of the new salary 
scales, and 6 months of the old scales approximately 35% lower. This Is 
equivalent to an Increase In 1984 of 17.5% (half of 35%). The new salary 
scales are thus multiplied by 117.5/135 to obtain an estimate of the 
actual salary payment to a particular officer In 1984. Employee 
contributions to the provident fund are included In this figure. An 
additional 10% of the monthly salary for 12 months has been added for 
the government's contribution to the provident fund, in order to obtain 
the total costs of employment.
4. Prices: capital Items including equipment
An exhaustive listing of all capital assets was neither possible nor 
worthwhile. The major Items were therefore taken, namely buildings, 
vehicles, microscopes and sprayers. These, with the exception of 
buildings (see below) were priced at their replacement value. They were 
then annuitized, taking into account their replacement price, length of 
life and a  rate of interest to reflect the opportunity cost of the 
capital tied up in them. A rate of Interest of 12% was used.
A listing of replacement and annual costs for the capital Items is shown 
In Table A2.3.
Buildings: no estimate needed to be made of the cost of buildings 
because virtually all NMEO buildings are rented and an appropriate sum 
Included In the accounts. In ICHSDP districts, buildings are generally 
government-owned and a rent was estimated based on locally prevailing 
prices.
Vehicles: Information was available In Nepal only for a newly purchased 
long-wheel-base Landrover. Estimates of similar costs for short-wheel­
base and pick-up Landrovers were obtained from the Landrover company In 
the UK, and for Mitsubishi, Hlno and Mazda vehicles from WHO. Length of 
life was taken as 10 years, based on advice in Nepal and the condition 
of the existing fleet.
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Tabi* A2.9: Coat of capital ltaaa
ITEM REPLACEMENT LIFE ANNUAL ANNUAL
COST COST COST
($1984) (yra) ($1984) (Rs 1984)
Vahldes:
Landrover LWB 11,800 10 2,089 34,377
Landrover SUB 10,300 10 1,823 30,007
Landrover Pick-up 9,200 10 1,628 26,802
Mitsubishi 4WD 9,700 10 1,717 28,259
Hiro 2 ton 8,000 10 1,416 23,306
Mazda 3 ton 10,500 10 1,858 30,589
Motorblke 1,000 417 6,858
Blcycle (Rs) 750 3 - 313
Microscopes :
Oil Immersion 500 15 73 1,209
Entomological 800 15 117 1,934
Dissecting 600 15 88 1,450
Research 2,500 10 442 7,283
Spraying:
Sprayers 100 5 28 457
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Motorbikes were valued st the WHO supply price to Nepal, with s length 
of life of 3 years. Bicycles were costed st local prices, also with a 
life of 3 years.
Microscopes: Two microscopes had been supplied by WHO in 1983, at a 
price (excluding freight) of $210 and $344. Based on these and on WHO 
Geneva purchase prices, the prices in Table A2.3 were estimated. Length 
of life, based on current experience in Nepal, was estimated at IS 
years.
Sprayers: Sprayers were supplied by USAID in 1982 at a price of $68 plus 
$13 freight each. Applying a price Increase of 10» per year gives a 
1984 replacement price of around $100 each. Life was estimated at S 
years. For convenience, the cost of replacement nozzles, an expendible 
item, is noted here. They were costed at $3 each and three per sprayer 
per round.
5. Analysis of NMEO district recurrent expenditure
The object of the analysis was to calculate total recurrent expenditure 
at district level, consisting of
- actual district expenditure
- an estimate of the cost of drugs used
- an estimate of the cost of insecticide used
- a share of regional expenditure
- a share of NHQ and RTC expenditure.
Information on NHQ, RTC, Region and district expenditure was available 
for FY 2039/40, FY 2040/1 and FY 2041/2 up to Paush. An analysis of a 
sample of districts indicated that on average, 46% of the expenditure of 
a financial year was spent in the first half, and 54% in the second 
half. 1983 and 1984 expenditure was thus calculated in the following 
way:
1983 - <2039/40 x 0.54) ♦ (2040/1 x 0.46)
1984 - <2040/1 x 0.54) ♦ (2041/2 to Paush)
To 1983 and 1984 district expenditure was added the cost of drugs and of 
insecticides costed at historic prices. Total slides were multiplied by 
the cost of presumptive treatment and total cases by the appropriate 
radical treatment cost. Outside boundary cases were Included in total 
cases. Kilograms of insecticide used in each year were multiplied by 
the appropriate historic insecticide price.
While this method accurately identifies the minimum historic cost of 
drugs and insecticide, it is likely to be an underestimate to the extent 
that wastage or losses of supplies occurred.
In order to obtain a complete view of the cost of the various district 
activities, it is necessary to apportion to them an appropriate share of 
regional and national expenditure. The basic principle should be that 
expenditure is apportioned in relation to the call a particular district 
makes on regional and national resources. The demands a district makes 
will clearly depend on a number of factors, including the size of its 
population, the number of cases, population sprayed etc. Since
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programme budget figures are available. It Is logical to consider each 
programme separately since, for example, the resources devoted by 
Regions to spraying will be d ram on only by districts where spraying 
takes place.
Table A2.4 shows how national and regional expenditure was apportioned 
to districts. The regional and national 'malaria Index' was calculated 
In order to adopt a method of apportionment that reflected both the size 
of the district population and the number of cases. It Is assumed that 
surveillance, parasitology and research and training resources, and also 
NHQ entomology are devoted to districts In relation to the malaria 
Index, reflecting the magnitude of the suilarla problem In each district. 
Health education activities are aimed at the general population and thus 
are distributed in proportion to population. Spraying resources are 
distributed In proportion to the population sprayed, as Is regional 
entomology expenditure on the assumption that it is used primarily to 
monitor the effects of spraying. Finally, the larger a district's 
expenditure, the more claim It Is likely to make on regional and 
national administrative resources. Thus the administration programme Is 
distributed In proportion to total district recurrent expenditure.
NHQ expenditure was available only by code not by programme. Programme 
budgets were available for 2040/1 and 2041/2 and the average 
distribution by programme over these two years was used to break down 
total NHQ expenditure by programme. To this was added WHO assistance, 
allocated to administration (long-term and short term staff) and 
training (fellowships). Since the WHO contribution supports also ICHSDP 
malaria activities, only 68% (the NMEO’s share of total protected 
population) of the WHO support to administration was Included. The full 
amount for training and research was retained, and also USAID assistance 
to training since these support the role of the NMEO as a centre of 
expertise. Expenditure recorded in NHQ accounts on drugs and 
Insecticides was excluded since these were separately estimated at 
district level. RTC expenditure was allocated to the research and 
training programme.
In both the East and West Regions, actual programme expenditure was 
known. In the Centre and Mid West Regions, the 2041/2 programme budget 
was used to apportion total expenditure between programmes.
6. Analysis of the costs of selected districts
In the second part of the cost analysis, five districts were selected 
for detailed study. The general approach to the analysis was first to 
account for all inputs used In each district. Including externally 
donated items and regional and NHQ overheads; secondly, to allocate all 
Inputs to operational activities, thirdly to convert the financial 
prices used to 'economic prices' (see below) and finally to divide the 
financial and economic costs of each activity by measures of output, to 
produce unit costs.
6.1 Choice of districts
The choice of districts for detailed analysis was partly determined by 
the earlier random selection of districts for the patient survey, and 
partly by convenience and feasibility. Selecting the districts of the 
patient survey provided the advantage that results from the analysis 
could be Incorporated in the cost-effectiveness work. Morang and
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Tabi*  A2.4: Apportionment of NHQ, RTC and ragionai expenditure to 
distrlcta
DISTRIBUTED TO DISTRICTS IN RELATION TOi
Share of National or Share of Share of
aalarious regional total sprayed total ex-
population sa la ria population in penditure
in country/ index country/region in country/
re g io n"’ . . . region'4’
EXPENDITURE ON:
Surveillance
- NHQ i
- Ragion i
Parilitology
- NHQ l
-  Region x
Health Education
- NHQ i
- Ragion i
Spray»ng
- NHQ l
- Ragion a
M aini stration
- NHQ i
- Ragion i
Entoaology
- NHQ t
- Ragion i
Ratearci), training
- NHQ l
- RTC a
'  D is t r ic t  aalarious population divided by national NHEO /regional aalarious population.
’ 1/2 (d is t r ic t  aalarious population divided by national NHEO /regional aalarious population) 
♦1/2 (d is t r ic t  cases divided by national NHEO /regional cases).
* D is t ric t  sprayed population divided by national NHEO /regional sprayed population.
’  D is t r ic t  expenditure divided by national NHEO /regional expenditure.
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Rupandehl war* Chua chosen and In addition are reasonably representative 
Teral districts. They are also both the location of their respective 
Regional offices, enabling the necessary Regional cost data to be 
collected without additional travel costs. In addition, Morang provided 
the opportunity to study adjacent districts, thus economizing on 
transport costs. From Morang, the ICHSDP district Saptarl could 
conveniently be visited, and also what was considered to be a fairly 
typical hill district, Bhojpur, which had also been Included In the 
patient survey. Unfortunately no seats could be obtained on the flight 
to Bhojpur and Instead a visit by road was planned to Ham, a hill 
district on the edge of the Teral, and Panchtar, another hill district. 
Due to the state of the road to Panchtar, the vehicle failed to reach It 
and thus only data on Ilam could be obtained. In order to analyze a 
second ICHSDP district, Parse was selected since access was easy from 
Katmandu.
The cost analysis Is thus done on five districts:
Morang, a NMEO district In the Eastern Teral and tha base of the East 
Regional Office;
Rupandehl, a NMEO district In the Western Teral and the base of the West 
Regional Office;
Ilam, a NMEO hill district In the Eastern Hills;
Saptarl, a ICHSDP district in the Sagamatha zone, in the Eastern 
development region, integrated in 1975;
Parse, a ICHSDP district in the Narayanl zone, in the Central 
development region, also Integrated In 1975.
This group of districts represents a compromise between the Ideal and 
the practical. It does represent a reasonably typical range of 
districts, with two major omissions. Firstly, there Is no mld-West 
district, due to difficulties of access and time constraints. Moreover 
no mid-West district, unlike those districts chosen here, reported 
expenditure by programme. Thus the cost analysis would have been more 
difficult and much more speculative.
Secondly, no recently Integrated district was selected. This omission 
was made on the advice of national officials, who felt that the upheaval 
of Integration would make cost analysis very difficult.
6.2 Collection of information
Before the visit to each district, as much Information as possible on 
expenditure and control activities was gathered In Katmandu from the 
districts' Annual Reports. During the district visits, this Information 
was checked. In particular, the programme expenditure was thoroughly 
clarified, in order to Identify how strictly programme classification 
was adhered to, and whether expenditure belonging to one programme was 
in fact charged against another.
While NMEO programme categories provided a general framework for the 
analysis, some apportionment was necessary, for instance to separate 
case detection from treatment costs. Ideally, district and unit staff 
would have been asked to keep a diary of their activities, in order to
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assess the proportion of their time devoted to different activities. 
This was not possible, and due to the seasonal nature of control 
activities, would have needed to be done for a whole year to provide 
useful information. Instead, the views of malaria staff on their time 
allocation were relied on, supplemented where possible by records of 
field visits. Several unit offices were visited in each district, to 
interview unit staff on their activities.
Apportionment of time was a much more severe problem in ICHSDP 
districts, where most staff perform a number of functions. Here again, 
the views of staff had to be relied on, and information was obtained 
from district health office staff and also from visits to several health 
posts in each integrated district. An additional reason for not 
attempting any more detailed study of time allocation patterns in ICHSDP 
districts was that these districts were already being intensively 
Investigated by various evaluation studies.
The accumulated cost data was entered into a Lotus 123 spread sheet for 
analysis.
6.3 Cost analysis methodology
The methodology adopted in the cost analysis is briefly described below, 
first for NMEO districts, then the two NMEO regions, the NMEO 
headquarters, and finally ICHSDP districts. Where local circumstances 
meant a different approach had to be adopted in a particular district, 
this is mentioned. Otherwise the approach described was applied to all 
the districts considered in the section.
6.3.1 NMEO districts (Morang, Ilam, Rupandehl)
The first step in the cost analysis was to take actual expenditure by 
programme and code for 2040/1, 2040/1 to Paush, and 2041/2 to Paush.
From this, 1984 expenditure could be estimated by taking the second half 
of 2040/1 expenditure and adding it to the first half of 2041/2 
expenditure. In Rupandehi, expenditure by programme was available for 
2039/40 but not for 2040/1. Therefore 2040/1 programme expenditure was 
estimated by:
(a) allocating expenditure under a particular code to a programme 
where this was known to be the sole user of that code;
(b) allocating salary and TA/DA expenditure to spraying by using 
the 2039/40 expenditure as a base and adjusting it for a 
decrease in the population sprayed in 2040/1;
(c) allocating remaining expenditure to programmes in relation to the 
2039/40 distribution.
The average of expenditure 2040/1 to Paush for all codes was then used 
in calculating 1984 expenditure.
In Ilam, expenditure 2040/1 to Paush was available only for all 
programmes. The average across all codes was therefore applied to 
2040/1 programme expenditure to obtain 1984 expenditure, with the 
exception of spraying. No spraying took place in 1984, the spraying 
budget in 2040/1 being used for the Autumn 1983 round. Therefore no 
spraying expenditure was allocated to 1984.
The second step in the cost analysis was to adjust 1984 expenditure for
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misallocations between programmes and omitted Items. Some of these
adjustments varied between districts depending on how district staff
actually spent their time. The main adjustments were:
(a) Total salary expenditure was Increased to Include the government 
contribution to the provident fund, not Included In NMEO accounts.
(b) The salary of the district malaria officer is charged to the 
surveillance programme although he Is Involved In other 
programmes. Given the DMO's district-wide responsibilities, It 
would seem logical to charge his salary to administration. The 
DMO's salary and an appropriate sum for DA/TA was thus subtracted 
from the surveillance programme and added to the administration 
programme.
(c) The spraying programme contains salary expenditure only for 
temporary staff. An estimate was made of the time of district and 
unit staff spent on spraying, and the appropriate salary cost 
subtracted from the programme paying their salary and added to the 
spraying programme.
(d) In recent years, an additional malaria field worker (MFW) has been 
added to unit offices to support malaria volunteers and undertake 
health education activities. He Is paid, however, from the 
surveillance programme. In Morang and Ilam, the salary of an 
appropriate number of MFW plus DA/TA was transferred to the health 
education programme. In Rupandehl It was considered that only 
half the time of this MFW was spent on health education, the rest 
being used for radical treatment. Thus only half the MFW's 
salary, plus DA/TA, was transferred.
(e) Surveillance aids are used to collect slides from malaria 
volunteers but are paid under the surveillance programme. An 
appropriate sum was transferred to the health education programme 
by dividing expenditure on aids by the number of 'points' visited 
(MFWs, health posts, volunteers) to obtain a cost per point. In 
this calculation, volunteers were given half the weight of the 
others since slides tended to be collected less frequently and the 
MFW for health education also collected volunteer slides. The 
cost per point was then multiplied by the number of volunteers to 
determine the sum to be transferred.
(f) In all districts. It was considered that funds for minor supplies
were very short, particularly In the health education budget, and 
that the surveillance budget was on occasion used for volunteer 
supplies. However, the surveillance budget for supplies seemed 
too small to permit much re-allocation and so the recorded amounts 
were left unchanged. In Ilam, however, no expenditure was 
recorded for supplies for parasitology (codes 7.1 and 7.5) or for 
supplies and contingencies for health education (codes 7.1, 7.5
and 9). This appeared to be an accounting misallocation since 
these programmes and codes had sums entered for 2039/40 In Ilam 
and in other districts, and the sums In these codes In the 
administration budget for Ilam were unusually large. Therefore 
the administration budget for 1984 was left with the sums In codes 
7.1, 7.5 and 9 spent In 2039/40, and the balance was distributed 
to the parasitology and health education programmes.
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(g) Drug, insecticide and laboratory supplies costs were added in to 
the appropriate programmes by multiplying slides and cases by the 
presumptive and radical treatment costs; kilos of Insecticide used 
by its cost; and transferring the district's share of laboratory 
supplies from NHQ expenditure to district expenditure.
(h) The annual e q uivalent cost was added for sprayers and 
microscopes. In the case of sprayers, districts had inherited 
more sprayers than they were currently using. Only the cost of 
sprayers actually used, plus one spare per three teams, was 
Included. The cost of nozzles was estimated on the basis of three 
nozzles per round.
The third step in the cost analysis was to add to district expenditure 
an appropriate share of NHQ, RTC and regional expenditure. The method 
used is described in subsequent sections.
The fourth step was to distribute the administration programme to the 
other programmes, in order that all costs should be distributed out to 
operational activities. The criteria adopted for distribution was total 
(recurrent and capital) programme expenditure. Each operational 
programme thus received a share of the administration programme in 
proportion to its own total expenditure divided by total operational 
programme expenditure.
Finally, expenditure in the surveillance programme was distributed 
between the various types of case detection and radical treatment, and 
in the parasitology programme between the district laboratory and 
malaria clinic. This distribution is approximate since many costs are 
shared, but is necessary to gain an idea of the relative cost of ACD and 
PCD mechanisms. PCD (V) is already costed under the health education 
programme. Thus the activities to be costed here are ACD, PCD (M), PCD 
(MC) , PCD (H) and radical treatment and investigation.
PCD (M) , case detection by the unit office , can be regarded as an 
incidental and virtually costless addition to its normal activities. 
Therefore no attempt was made to attribute a proportion of unit office 
salaries to PCD (M).
PCD (H), case detection by a hospital or health post, can likewise be 
considered a minor additional workload, whose cost is borne by a non- 
NMEO budget. No attempt was made to calculate the cost incurred by the 
hospital or health post in NMEO districts. However the NMEO cost of 
supporting PCD (H) - time of surveillance aids, supplies, drugs,
supervision - was estimated.
The method of cost distribution adopted was as follows. Firstly, 
salaries were distributed. From the total surveillance salary 
expenditure, the cost of MFWs at unit offices was allocated to ACD, the 
exception being Rupandehi, where district officers considered that on 
average 1.5 MFW per unit were used for radical treatment (half of the 
health education MFW and the reserve MFW). Therefore in Rupandehi, one 
less MFW per unit was allocated to ACD. Surveillance aid expenditure 
was distributed according to the method described earlier, based on the 
number of points visited. District office salaries in the surveillance 
budget (usually a malaria inspector and recorders) were allocated to 
'supervision* and to malaria clinics, where appropriate. Remaining 
salary expenditure was allocated to radical treatment.
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Secondly, TA/DA expenditure wee distributed, allocating the estimated 
cost of TA/DA for MFUs to ACD, for supervisory work by the district 
office to supervision, and the remainder to radical treatment.
Codes 4.2, 7.1, 7.3.2 and 7.5.1 were distributed, arbitrarily, 50% to
radical treatment and the remainder to slide detection in proportion to 
the slides collected by each mechanism. The cost of drugs for 
presumptive treatment was distributed according to the slides collected 
by each mechanism, and drugs for radical treatment were allocated to 
radical treatment.
Finally, supervision costs were distributed 50% to radical treatment and 
50% to case detection, and then to each case detection method In 
proportion to the slides each collected.
To complete the costing of PCD (MC), the appropriate laboratory staff 
were subtracted from the parasitology programme, and other codes 
distributed In proportion to slides examined.
Since salaries make up the great majority of expenditure, they are the 
most important element to distribute correctly. In the above analysis, 
it has been assumed that the cost of all MFWs In unit offices (except in 
Rupandehi) belong to ACD, and the malaria assistant and Inspector at the 
unit office to radical treatment and Investigation. This Is to some 
extent a simplification. When the pressure of cases Is high, MFWs may 
be used for radical treatment. In I lam and Morang It appeared that the 
great majority of cases were treated by the MA or MI. In Rupandehi, 
however, the district office stated that MFWs were used to treat all 
P.vlvax cases, and all but the first day of treatment for indigenous 
P . falciparum. If possible this was done by the MFW on his normal 
rounds, but more usually by the reserve MFW or by MFWs on completion of 
their monthly schedule of visits. Some allowance has been made for this 
In the costings, though possibly an Insufficient allowance.
A further simplification is to assume that the MA and MI cost belongs 
solely to radical treatment and Investigation. This ignores their role 
In supervising case detection mechanisms. To some extent any 
mlsallocatlon here will offset any mlsallocation of MFW time.
6.3.2 NMEO Regions (East and West)
Analysis of Regional expenditure proceeded according to the same method 
and sequence of steps described above for the districts. The major re­
allocations of expenditure required between programmes were as follows:
(a) An estimate was made of the proportion of regional staff time 
devoted to spraying and the cost transferred from the appropriate 
programme to the spraying programme.
(b) In the East, a large sun under code 7.3.2, used largely to pay for 
fuel for insecticide dumping, was recorded in the administration 
programme. This was transferred to the spraying programme.
In discussions with the Regions, it appeared that the Regional truck was 
used primarily for insecticide dumping, and in addition that the 
Landrover pick-ups were similarly occupied for three to four months of 
the year. Therefore the whole capital cost of the truck, and an
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appropriate portion of the capital cost of the pick-ups, was added to 
the spraying programme. The remaining pick-up cost and the cost of the 
regional SWB Landrover was shared between programmes In proportion to 
their expenditure on fuel for passenger vehicles (code 7.3.1.).
The share of regional expenditure belonging to the districts studied was 
calculated as follows. Surveillance and parasitology expenditure were 
distributed by multiplying them by the regional malaria index (see Table 
A2.4), which gave Morang 26%, H a m  3% and Rupandehi 30% of regional 
expenditure on these programmes. Health education was distributed
according to the district's share of total regional malarious 
population, and spraying and entomology according to the district's 
share of regional population sprayed. Finally, the administration
programme was distributed in proportion to the district's share of total 
recurrent regional expenditure (Including the cost of drugs and 
insecticides).
6.3.3 NMEO Headquarters and Regional Training Centre
Again, analysis of NHQ expenditure proceeded in a similar way to that of 
regions and districts. Programme expenditure was not available, and was 
estimated by applying the distribution of budget codes by programme in 
the 2040/1 budget to 1984 expenditure. Drug and insecticide expenditure 
was excluded. The capital cost of passenger vehicles was distributed In 
proportion to programme expenditure on code 7.3.1., and of lorries In 
proportion to the expenditure of the spraying and administration 
programmes on code 7.3.2.
WHO expenditure was divided between administration and research and 
training since no clear basis was apparent for distributing expenditure 
to other programmes. WHO activities to support malaria control assist 
not only the NMEO but also the ICHSDP. Therefore the NMEO's share of 
WHO expenditure allocated to the administration programme was calculated 
according to the NMEO's share of the total malarious population (68%).
NHQ expenditure was distributed to districts In the way described above 
for regions. The national malaria Index (see Table A2.4) was used to 
distribute surveillance, parasitology, research and training, entomology 
and WHO administration expenditure, giving 6% to Horang, 1% to Ilam and 
8% to Rupandehi. Each district's share of total population sprayed and 
total malarious population was used to distribute the spraying and 
health education programmes respectively. Finally the administration 
programme was distributed In proportion to total district expenditure.
This method will over-estimate the share of NHQ and RTC expenditure 
belonging to the districts to the extent that the NHQ and RTC support 
also malaria control activities In ICHSDP districts. Since the majority 
of NHQ and RTC activity is centred on NMEO districts, and only a small 
proportion of NHQ and RTC expenditure Is attributed to any one district, 
any misallocation here would not have much effect on total district 
expenditure.
6.3.4 ICHSDP districts (Saptari and Parsa)
The objective of the cost analysis In ICHSDP districts was first to 
estimate the share of total expenditure absorbed by malaria control, and 
then to divide this share between different malaria programmes.
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No Information was aval labio In Saptarl and Parsa on oxpondlturo for 
2041/2. Therefore 2040/1 expendlturo was used, and Increased to an 
approximate 1984 level by Increasing total salary and allowance 
expenditure by 17.5% (half of the 35% Increase In 2041/2).
The share of the regular budget attributable to malaria control was 
estimated In the following way, based on the advice of the district 
health officer and health post staff. In the district health office an 
allowance for rent and the annuitized capital coat of vehicles and 
microscopes was added In. Then a proportion of the time of the district 
health officer was apportioned to malaria, based on the advice of the 
DHO (25% In Saptarl and 21% In Parsa) and all of the time of the 
district malaria assistant and laboratory technicians. The proportion 
of salary expenditure attributable to malaria was then used to share out 
expenditure under the other codes of the district health office regular 
budget, except the microscope cost which was allocated totally to 
malaria.
Laboratory supplies and equipment were supplied free from ICHSDP 
headquarters. Since ICHSDP HQ expenditure could not be estimated, an 
allowance needed to be added In to make ICHSDP distrlcta comparable to 
NMEO districts. The NMEO spends approximately Rs 100,000 per year on 
laboratory supplies, and takes 1,269,000 slides, giving a cost of 
Rs 79/1000 slides. This unit cost was applied to ICHSDP slide numbers 
to estimate the cost of laboratory supplies, and added to the malaria 
share of district health office expenditure.
Malaria expenditure at district health office level was then divided 
between parasitology (staff and supply costs of the laboratory), 
spraying (the time of staff spent supervising spraying), surveillance 
other staff time) and administration (malaria's share of general 
office overheads).
Allocation to malaria control was more difficult at health post level. 
In sharing out salaries, radically different results are obtained 
depending on whether the actual time Involved In malaria Is estimated, 
or a proportion of total time. In the first method, malaria Is viewed 
as an addition to the normal work of staff, and only the Incremental 
time attributable to malaria Is Included. In the second method, malaria 
1* attributed a full share of staff time, including that not spent In 
direct patient care. To Illustrate this point, village health worker 
(VHW) time on malaria could be estimated on the basis of 10 minutes per 
slide. Multiplying by the 17,354 slides from ACD and APCD In Saptarl 
gives a total of 413 days for malaria. However, the time could also be 
estimated on the basis of the number of activities done by VHWS. These 
amount approximately to eight (malaria, TB. leprosy, EPI, under fives, 
maternal care, family planning, health education). Attributing one 
eighth of VHW time to malaria gives 2520 days for malaria (6 VHWS per 
health post for 12 health posts, working on average 280 days per year). 
Since one aim of this study Is to compare NMEO and ICHSDP costs, it Is 
appropriate that malaria should be regarded as a main and not an 
additional activity. Therefore one eight of the time of VHWS Is 
attributed to malaria.
At health post level, however, the situation Is rather more complex, and 
estimates must be regarded as very approximate. In Saptari, health post 
reported that 50% of the time of the health-post-In charge, and 
50% of the time of one auxiliary health worker, were spent on malaria.
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This was difficult to believe. Therefore their activities were taken 
and the time spent on each estimated. No spraying had been done In 1984 
In Saptarl, but In Parsa the time of health post staff spent supervising 
spraying was estimated. Time spent on radical treatment and 
Investigation was estimated on the basis of assumptions, checked with 
health post staff, that the health post - in-charge treated three quarters 
of the cases and the AHW one quarter, and that of the cases requiring 5 
day treatment, three quarters required 5 full days to visit and treat 
and one quarter 5 half days. Slide collection by health post staff was 
assumed to be additional to their normal clinic work, and 10 minutes per 
slide was allowed for slide collection. Finally, an allowance was made 
for the time spent by peons on collecting slides from VHWs and 
delivering them to the laboratory.
Expenditure in the non-salary codes of the regular budget for health 
posts was then distributed in proportion to the malaria share of salary 
expenditure.
Those parts of the development budgets drawn on by malaria control fall 
under the malaria, supervision, transport and administration development 
budgets. The malaria budget for Parsa for 2040/1 was increased to an 
approximate 1984 level by allowing for the Increased level of spraying 
In 1984, and divided between spraying and surveillance according to the 
use made of the various codes of the malaria budget. The cost of drugs 
and insecticides used was added. A share of the supervision, transport 
and administration development budgets was attributed to malaria control 
by distributing code 3 (TA/DA) In proportion to health post time spent 
on malaria, and other codes In proportion to district health office time 
on malaria. Malaria control's share of the administration development 
budget was recorded under the administration programme, and the 
remainder under surveillance.
District staff in both districts were adamant that no malaria patients 
were admitted to hospital, and this was supported by an interview with 
the civil surgeon In Blrganj (Parsa). No In-patient cost was therefore 
allocated to malaria In either ICHSDP or NMEO districts.
The end result of these calculations was expenditure on malaria 
separated into programmes for surveillance, parasitology, spraying and 
administration, and for each programme, the amount contributed by the 
district health office regular budget, the health post regular budget, 
the malaria development budget, and other development budgets. Finally, 
the administration programme was distributed to other programmes In 
proportion to their total expenditure.
6.3.5 ICHSDP Headquarters and Zonal offices.
In the time available, It was not possible to make an estimate of the 
proportion of ICHSDP headquarters and zonal expenditures devoted to 
malaria. Staff support at headquarters consisted of a deputy director 
with responsibilities for dlarrhoeal diseases, EPI and other 
communicable diseases In addition to malaria, and two support staff. 
Other costs could not be estimated. Thus comparisons between ICHSDP and 
NMEO services can be made only at district level, ignoring the overhead 
costs of supporting the district level.
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6.4 Economic analysis methodology
The appropriate concept for valuing resources In an economic analysis Is 
that of social opportunity cost - the value to society of a particular 
resource In Its next best alternative use, or what has to be given up by 
using the resource In its current activity. In a highly developed 
market economy, the relative prices of goods and services normally 
provide a reasonable approximation to the relative costs to the economy 
of producing them and to their value In the next best alternative use. 
This may not be the case in developing countries where, for example, 
additional workers may be taken from a pool of unemployed workers and 
thus their opportunity cost - l.e. output forgone - will be less than 
the wage paid to employ them.
Financial prices may thus be adjusted In an economic analysis to produce 
'accounting prices' that reflect social opportunity cost. The approach 
adopted here is that recommended in the Ministry of Overseas 
Development's 'A Guide to the Economic Appraisal of Projects in 
Developing Countries' (HMSO 1977). Traded goods and services are valued 
at world (border) prices, that is the price prevailing on the world 
market, and the prices of non-traded goods and services adjusted so that 
all goods and services are valued in terms of a common yardstick. 
Prices can be further adjusted through use of a savings premium to 
favour those programmes which encourage saving rather than consumption 
In economies where the availability of savings is considered a 
constraint to the achievement of government objectives. Finally, prices 
can also be adjusted through use of a consumption weight to favour 
programmes which redistribute income in ways considered desirable. 
Accounting prices which reflect social opportunity cost are often called 
'efficiency prices', and those which reflect savings or income 
distribution objectives, 'social prices'.
The main focus of the economic study of malaria Is to evaluate the 
economic effects of malaria on individuals and the economy, and a 
detailed Investigation was not possible of the precise accounting prices 
appropriate for Nepal. It Is In any case desirable that different 
evaluations use a consistent set of accounting prices. Therefore recent 
World Bank and ODA reports for Nepal were studied, and the following 
principles adopted.
Accounting prices
Accounting prices were calculated as described below for traded and non- 
traded goods. No study was found which used a savings premium or 
consumption weight, and there did not seem to be strong grounds for 
choosing any particular weights. Therefore no adjustments were made to 
efficiency prices.
It can be debated whether the opportunity cost of donated Items should 
be given a positive value, on the grounds that their use In the 
programme may not be at the expense of any other local Investment. This 
argument is not accepted here, since many donors earmark Investment sums 
for a country and then decide how to distribute them, so investment not 
made in malaria is likely to be made In some other local programme.
Traded goods
The major traded items used in malaria control are drugs, insecticides,
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and capital equipment. These were valued at world prices which were In 
general taken to be the estimated WHO price, plus carriage, Insurance 
and freight to the Nepal border.
The only problem arises over chloroqulne. Its world price Is
considerably below the price of locally produced chloroqulne, but It 
would not be supplied from abroad since WHO supplies only Items not 
available In Nepal, and the government would presumably not purchase 
from foreign sources. Following the ODA guidelines, chloroqulne Is 
therefore treated as non-traded.
Non-traded goods
It was not possible to value non-traded goods by the desirable method of 
separating the Inputs used to make the goods Into labour, traded goods 
and non-traded goods. The short-cut of a conversion factor was used, 
adjusted to take account of the estimated foreign exchange component of 
each non-traded good.
It seems to be generally agreed that the level of distortion of prices 
In the Nepalese economy Is not very great, and a standard conversion 
factor (SCF) of 0.9 has been used recently by the World Bank (Babal 
Irrigation Project, Staff Appraisal Report, Jan. 1984) and In an ODA - 
funded feasibility study (Tumllngtar Irrigation Project, HMG, Nepal June 
1984). This figure Is therefore used here, adjusted as noted below. 
Since the cost analysis has been made by budget code, It Is convenient 
to list conversion factors by code.
Labour: In Nepal, unskilled labour Is usually valued at some
proportion of the average dally wage, on the grounds that It Is under­
employed for a substantial proportion of the year. In malaria control, 
unskilled labour Is used for spraying. However districts appear to have 
considerable difficulty In recruiting spraymen at the wage of Rs 10 per 
day, saying that the wage Is not high enough to attract labour. This 
suggests that the marginal productivity of labour In Its next best 
alternative use is not less than Rs 10, perhaps because spraymen are 
required at relatively busy times of the year (May-June and August- 
September). Thus no adjustment is made to the unskilled wage, and it Is 
multiplied by the SCF of 0.9. Skilled labour is treated In a similar 
fashion.
DA/TA (code 3): The majority of DA/TA goes on per diem payments, a 
minority being transport costs. A conversion factor of 0.92 Is 
therefore applied.
Services (code 4.1): Financial prices are multiplied by a conversion 
factor of 0.95.
Porterage, printing (code 4.2): Other studies report that porters are 
fully employed through the year. Printing costs will include a foreign 
exchange component so a conversion factor of 0.92 is applied.
Rent (code 5), repairs and maintenance (code 6), office goods (code
7.1) , newspapers (code 7.2), supplies (code 7.5.1), furniture (code
10.1) , buildings (code 12.1): Foreign exchange costs are likely to be 
small so 0.92 Is used.
Fuel (codes 7.3.1, 7.3.2): The price of fuel will reflect Its Import
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price end local transport costa, which will have a very high foreign 
exchange conponent. Thus 0.98 Is used.
Medical equipment (7.5.2), locally purchased drugs and supplies (8.3), 
machinery, equipment (10.3): These have a high foreign exchange 
component: 0.98 Is used.
Contingencies (code 9): This code appears to fund the local costs of 
meetings so 0.90 Is used.
Items In other codes and donor-funded Items (donated drugs and 
Insecticides, capital goods) are traded goods and are valued at border 
prices. The only exceptions are WHO local costs which will give rise to 
a higher foreign exchange component then local administration expenses 
and are thus given a conversion factor of 0.92.
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ANNEX 3
ESM1 AND SF5 FORMS
(ENGLISH TRANSLATION)
ECONOMIC STUDY OF MALARIA
ESM 1
District Unit/Health post Locality/Vek
Village Patient's name Age/Sex
Instructions:u i a i i L i i u o .
Fill in this form when you fill in the SF5 form. Read the 
questions to the patient exactly as they are written. If the patient is a 
small child, ask a relative to reply for the child.
Do you normally work?
YES NO (go to Qu.2)
(a) During the present fever did you work ?
YES (go to Qu.2) NO
(b) How many days could you not work at all?
......................... days
Do you normally go to school?
YES NO (go to Qu.J)
(a) During the present fever did you go to school?
YES (go to Qu.3) NO
(b) How many days of school did you miss?
.......................... days
Before blood was taken did you seek help for the present fever from any place 
or person?
YES NO (go to Qu.A)
(a) Where did you go? 
-hospital 
-health post
-community health leader 
-community health worker 
-private practitioner
-drug seller 
-ayurvedic dispensary 
-faith healer 
-other (specify)
Before radical treatment was given, did you spend any money to get help or 
treatment for the present fever?
YES
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NO (end of interview)
(a) How much did you spend?
f ees rps_ 
Medicines, laboratory examinations, injections rps” 
Special foods rps” 
Sacrifice, worship rps 
Travel expenses rps” 
Other (specify) rps”
TOTAL rps
Copies
Health post/district malaria office 
NMEO/ICHSDP HQ, KATHMANDU.
Signature of investigator_
Post_______________________
Data_______________________
Checked in district_______
Post_______________________
Date_______________________
How to fill in form ESM 1.
1. Only information on the present fever should be recorded, not information on 
previous attacks of malaria.
2. In Question 1, "work" is defined to include all types of work such as house­
hold work (cooking, cleaning, child care etc), agricultural work, trading etc.
3. In Question 3, note that the question asks about action taken by the patient 
before the blood slide was made.
A. In Question A, note that the question asks about any expenditure before radical 
treatment was given.
5. Two copies of the form should be made. Each copy should be attached to a copy 
of the completed SF5 form for the same patient. One set should be filed in 
the district malaria office/health post and the other sent to the NMEO/ICHSDP 
headquarters in Kathmandu.
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In fon—  tjqo on -SF5.
Primary Investigation of M»l«t« Patient.
Oistricfc
Unit
Locality No.
Village
No. of houses in village 
Population in village 
Patient name 
Age
Sex
Name of house owner
House number
Date of investigation
Condition of slides
Slide No.
Source (ACD.PCD,etc)
Date of collection
Date of laboratory receipt
Date of examination
Result (density) and species
Oate of dispatch of result to unit
Date of reception of result in unit
Description of fever
No. of days of fever before slide collection 
Date started
Any people in the house or nearby have fever? 
Was treatment given when slide taken 
If so, how many tablets?
If not, why not?
Has patient had thia type of fever before?
If so when, where.
Any drugs given?
Any collection of slides?
If so when, where, by whom?
Treatment given or not. If not why not?
Movement of patient
Have you been away from your home for last 2 months? 
Description of journey, dates.
Ditto for last 2 years.
After this fever have you travelled?
Where?
When?
If patient has left, where has he gone?
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Local description
Housing conditions - windows etc.
Any ponds, rivers etc near house?
OPT spray
Has the house/village been sprayed?
Has the house been re-plastered?
Present condition of the walls - is there a spray mark?
Classification of patient 
Indigenous/imported A/relapse /untraced
Medical treatment
Date started drug treatment
Date of completion
How many mgs chloroquin?
'• ” " primaquin?
Remedial measures (optional)
Collection of slides - start date, completion date.
Number of people
No. of people with fever
Consumption of chloroquin
Total slides collected
No. of slides from fever cases
No. of slides from non-fever cases
Total positives
No. PV
No. PF
No. mixed
Focal spray (optional)
Date of completion
Houses and structures sprayed
Population protected
Entomological study (optional)
Date started 
Date completed 
Results
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Mass Blood Survey (optional)
Date started
Date completed
No. of slides in sample
No. PF/PV/mixed
Suggestions from District
copies to: NHQ
Region
District
etc.
Investigator ......
Date...............
Signature..........
Checked in District
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ANNEX 4
HOUSEHOLD SURVEY QUESTIONNAIRES
ECONOMIC 3TUDT OP MALARIA IH NEPAL ODA/TO* ERA
1964
HOUSEHOLD INTERVIEW QUESTIONNAI RE
Household No* /  /  /  /  /  
Checked by In terv iew er /  /
Household Type
P a tie n t
Control
a
a
Be-oh00k ( D is t r ic t ) Name Date
Ro-ohook (Kathmandu) Mamo Date
Coded by Nano Dato
Ro-coded by Hamo Dato
1.1
1i2
1 .4
n é
1.8
1.10
Record o f Vi a i t«
INTRODUCTION 
Head o f  Household 
Nano o f  Rea pondent 
Mother Tongue 
House Number (NMBO) 
L o cality  Number 
Ohit O ffice
R elig ion  ___
V illage  ____
Ita it  Number 
D is t r ic t
V is itNisaber DatoTsar
o f  Visi 
Month
t
Day "
Interviewed Moved Temp . absent Refused Other(sp ec ify ) Name o fI n te rv i ­
ewer
1
2
3
4___
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INF0B1ATICW CW HOUSEHOLD HéMBEfi
I would like to know how many people live end oat together in this houso 
Please tell me the following information of the family members. 
(Instruction : Please start from the household head).
No. of Q. Number 2.1 2.2 T . j 2.4 2 .5 € 1 — » — " 2 :9  ~
members Name of fasiily Relation Age Sex Marital Has this Was this Is he /she able Has ho/ehemembers to the
household
head
Year Month 1-Malo 
2m  Female
status person been 
present con­
tinuously 
for tho 
past 6 
months ?
1 -  Yes
2 . No
person here 
for the 
last 30 Ays
1 . Yos
2 . No
to read and 
writo a simple 
letter ?
1 . yes
2 . No
over been 
to eohool ?
1 . Yes
2 . No
- r j
03
04...
05
06 1 "
07
Ofl
09 _____________|
10 .  — . . J
h — ... ------------------ ;
— — f ------------------ ------------- i
1
l M-----------
l- 1 2 --------- i------------------------ L ---------------______ _ _ J b  . 1 ___________ j __________
Instruction: Q.No.2.3: Those childron who are under 6 years »lease Q.Ho. 2.5 Q.Ho. 2.6 end 2.7
write the ntsnber of completed years end monthe and abovo 6 years I.Marnod Ignore short oven-night
write ago only. 2.Never married absonces.
3. Widow/Widower
4-Di vo rood
3-Separated
Wo . 2-9.1 2.9.2 TVS 2.11 | 2.11.1
leu of 
family 
o ambers
Up to what cIm b  
(this person) 
passed ?
la he/aho percsently 
studyin<: t
1 . Tea
2 . Ho
What la hia^ tor 
Min oocupation ?
Is he/ahe involved 
in any rocondary 
occupation ?
1 - Tea
2 . Ho
What is hia/ 
her secondary 
occupation ?
01
02
03
S4
oZ
-57----
00
65 '
■ 10
11
T2 H
~ ?J
14
• i f " *
Instruction Q. Ho. 2-9.1 Inetruction: P..I571710 and 2.11.1
Codo : 1-Up to claw 5
2. Cl m i  6-7
3. Clan 8-10
4- Fassed Intermediate level
5- P eased Beohlor lcvol
6- Paeeed Master degree or above
01-Own agriculture
02 .0ov t. or aomi-Covt. employment
03- Daployod by o thers in  tho F v t. firm  on sa la ry  baeio
04-  S o lf  employod in  P v t. s e c to r , e .g . buainoee/contraot
05- Toaehor/lawyer/foginoer/fooctor or other professional
06- 0wn cotta«« industry 
0?-Va«e labour
08- Skilled labour (earponter etc.)
09- M ilita ry  A o lic e
10- Domestic work
11- Can1t work/doos not do any work 
(Chronically ill, disabled, elderly ohiId).
99-Cither (spicily) ________________________
2 .1 2  P lo u o  d e sc r ib e  how h e /a h e  spon t h is /h e r  time y esterd ay  botweon when ho/she c o t up and whan h a /ah a  want to bed.
(In a tru o tio n  : f t j n 't  aak to  ai\y ch ild  who doea n o t g o  to  aohool o r  do any work o r  to  tho  person whose a c t iv i t i e s  wore recorded in  th e  p a t ie n t /  c o n tro l in te rv ie w ).
- 4 -
382
0 . 2 . 1 2 .1 2 . 12 .2
No. o f  fam ily
Were the a c t iv i t i e s  you d id  
y es te rd ay  and the time you e^en t ty p ic a l  fo r  th is  time
( i f  no) Why no t ?
01
02
03
04
05
06
07
08 ~
09
¡Ó
11
12
13
14
15
Q.No. 2 . 12 .
Codo 01 / /  F estiva l
02 / / R elig ious duties
03 / / Child b ir th
04 / / Out—o f—v i l la g e  v is it in g
05  / / Karriago coromony
06 / / I l ln e s s
07 / / School holiday
08 /  /  Markot day
09 / / Slack period fo r  own work
10 / / Looking fo r  paid work but not a va ilab le  e tc .
99 / / Other (s p e c i fy )  __________________________
383
(instruction : Do not ul the Malaria Patient and Control Poreon)
«•*» i 2.13 2.13.1 ’ 2.13.2 2.13.3 2.13.4
Numbor
of
family
mombors
Sine* the last 
visit, has any 
one not bon 
conpletaly wall? 
1-Yee(continue) 
2.Mo
If y#s, for 
how many 
days was ho
eha not 
completely 
Mil t
During this period,was 
he/she totally disab - 
' lod/unablo to work/ 
unable to carry out 
his^ ior normal ictivi- 
tioa ?
I.Toe; 2»No (Co to Q. 
Ho. 2.14)
(Por child, ask whotha 
hs/sho was not playing 
or not as active is 
usual)
I f yos for 
how many 
Jay;T*
What illness did he/fchd
had ?
Cods:1.fevor
2.respiratory 
problems
3 -  eye infection I
4- bad diarrhoea !
5 -  skin disease j
6- lnjurles and 
wounds
9-othor (specify)
-01___ •
02
03
¿4
— S- — • ___ — . — ... ... —
-or'-1 —
' 58
.1° -
. . ... . ”
... - -
11
12
~T}~
14 ...... . — ....
Vi- ‘ i _
0. Ho 2.14 2.14.1 2.14.2 2.15 2.16
of
family
mombor
Since i\y last visit, 
wore there any days 
when ho/she could not 
carry out his^ ier 
normal activities or 
work for reasons 
othtr than lllnoss ? 
1. Yes ; 2. No
[f yos, what were the 
reasons he/sho could not 
work/carry out his/^ tor 
normal activities ?
Cods
1.Festival 
¿.Religious duties 
3*Child birth 
4.0ut-of-village 
visiting
5J<arriago ceremony 
9.0thar (specify)
How many days 
ho/sho could 
not do werk 
normal activi­
ties ?
Vhero did he/sho 
normally sloep 
within last 30 
days ?
Code
l.lnsido the roon 
2.0utside the 
room(Varanda) 
3-Opon epacc 
9*0thsr(specify)_
Did he/she use j 
mosquito nets at 
the sleeping
time ?
Code t 1 . Yes
2 a No.
.
01 -52 H
~53---
04" '
y06
07
58---
-B5---
11
5---
3
4
. ._ ______
Instruction : q • »»• *•’«
Do not ask for the malaria patient or control pc re on.
3« Which are th e  most busy m onths durin g  th e  year fo r y o u r  household ? ( In s tru c t io n :  Nepali m onths to  be recorded).
- 8 -
3 .1  Which aro the le a s t  busy m onths during  the y ea r fo r  y o u r household ? 
( in s t ru c t io n  : The in te rv ie w e r  f i r s t l y  observes and f i l l  in  the
4 .  What type o f  dw elling house i s  t h i s  ?
1 f  /  Room o r  f l a t  in  a  l a r g e r  s tru o tu rc  chared by one o r moreo th e r fa m ilie s .
2 /  /  S ing le  family h o u se .
9 /  /  O ther (sp eo ify ) ___
4.1 What types o f  m a te ria ls  a r e  m ostly  used in  the w alls  ?
4 .2  What type o f  roofing  m a te r i a l s  a re  mostly used in  th e  s t ru c tu re  ?
follow ing in fo rm a tio n . I f  the in te rv ie w e r i s  not able to  r e c o rd  the inform ation then on ly  ask come o f  th e  q u e s t io n s  to  the respondent o f  household.)
4*3 What is the type of flooring of structure ?
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94 .4  *r« th e  door* and windows screened a«al n s t  in se c ts  ?
4
Door* and windows N either Doors only Windows only
4.5 Would you f iv e  the p re s e n t  monetary value o f  your d w elling  house ? 
R s .
5 . Does your family own any o th e r  dw elling besides t h i s  one e i th e r  here in  th i s  v illa g e  o r  some where e ls e  ?
1 f~ 7  Tes 2 /  7  Mo
5.1 What would be the m onetary value o f  those d w e llin g /s  ?
R s ,
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6. LAKO HOLDIHC
"Could you pitaae toll no how much land you and your fuily aeabers own, how auch you have rented 
out and how Much you have rented in during the put 12  non the ?"
(Instruction : Pleue aak this question in the way you think best. Remuber to probe for land 
registered in the names of other aembere of the faaily besides household heed. Aleo find out if 
any fully member hu land in another Panohayat or in the Terai or Hills and Include this also. 
Oet information on total land rented in by various aesibors of tho fully on either tenancy 
(Mohiyani), share basis (Adhiyaa) or fixed amount basis (Koot).
(Bigha)
Type of Land Holding Cultivated Land 
Irrigated |lh-Irrifatod 
Area (Area
Pal low Area Total Remarks 1
t A. Registered in fuily member*' 
names (onward) i
! » run tjHt »ohiaat. -___ 1
1
_ . -4. .Total j ■ i
C. Chm land cultivated by the 
fuily (A - B ) !
It. Otter'■
land Adhiyaa/fcoot/ 
1 rented in Pixed Act. 1 r i
i_____________ T“ *1 ...... j
E. Total land cultivated by tho 
fteili (0>t) .
1
7 .
(Interviewer: Pleaee refer to queetion 6 and aee how iiuch land la cultivated by thia family .)
Earlier I had aakad about how much land you and your family owned and cu ltiva ted . I shall now 
aak you about the d ifferen t crop cultivated and produced betweet. Baisakh 2040 and Baiaakh 2041.
Name of Crop ----- tSSPIand
cultivated
(QV)
Productio
"OSTIina“
rented
out
(* v )
Received From 
Where land! Total 
ronted in j (Qty. in 
I Unit ) 
(Qty) j ( 2*3+4)
Production Sold 
(In unit)
Remarks|
!1
1 2 3 4 ; 5» 2+3*4 6
CercaiCrop
1. Paddy 1
2.  Mai tè""1 -  |3. Wheat
1 - !
Caah
Crop
b I
2.
1 -______ r : .....2_______________
12
8 .  Would you k indly  t o l l  me tho number o f  liv esto ck  you a r e  keeping ?
Types o f  Livestock dumber o f Livestock Estimated P r ic e  ( a l l )( b* .)
Buffalo
Milch B uffalo
Adult ho-buffalo
Cow
N ilch Cow
OX
Goat
Koree/nulo
Pi*
Other (Specify)
Total
9 . During the l a s t  y ea r  (Baisakh 2040 to  Baioakh 2041, B .S . ) ,  has any one in  t h i s  household eamod income from d if f e r e n t  a c t iv i t i e s  o th e r  than s e l l in g  food g ra in  and cash  crop ?
1 /~~7 Tes 2 f — J  No
9 .1  From what types o f  a c t i v i t i e s  d id you earn ?
1 / ~ 7  S e ll in g  liv e s to c k2 /  /  S e ll in g  m ilk o r  c l e a r i i  od b u tte r3 /  /  Wage labour
4 I  /  S alary  -  G ovt., Semi—Govt, o r p rivate in s t i t u t io n5 B usiness/C ontract
6 /  /  Cottage in d u s try  (o w n )7 7~~7 Pension9 /  /  Other (sp e c ify )  ___
10 . Have you employed any temporary wage labours* w ith in  th e  la s t  14 days ?
1 /  /  Yes 2 /  7  Ko
10.1 What was the to ta l  number o f  work days done by these wage labourers w ith in  the la s t  14 days ?
_________  work d ays.
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(To  be f i l l e d  in  by in terv iew er a fte r  in terv iew  ia  completed).
R e lia b i l i ty  o f  responaee
eAll T o llableMeetly r e lia b leDecree o f  o o -op era tionevery good Good
e P a r t i a l l y  r e lia b le  O ire lia b lo
eNot so  goodNot good a t  a l lDid the person in terv iew ed  understand the q u e s tio n s  ?
B
No d i f f ic u l ty  L i t t l e  d i f f i c u l t y B Much d i f f i c u l t y  C reat d i f f i c u l t y
Other comments, e s p e c ia l ly  any p a r tic u la r  responses you fee l were u n re lia b le  .
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ECONOMIC STUDI OF MALARIA IN NEPAL ODA/NEW ERA
198k
QUESTIONNAIRE : INTERVIEW NO. 1
Household Number /  "/ T T T 7 P atien tControlChecked by In terv iew er /"
Name DateName DateName Cate
Re-coded by Name Date
Nnme o f  P a tie n t Ca«te‘ Name o f  Control Caste
Age  __________________  Sex _R eligion __________ Mother IbungeAge _____________ _____ Sex _R eligion Mother"Tounge'
Name o f  Respondent ( i f  p a t ie n t/c o n tro l  ie  a ch ild )  R e la tio n sh ip  to  p a t ie n t/c o n tro l  ________________ _
House Number (NMHO)lo c a l i t y  Number _____________________U nit O ff ic e  ~_______________ _____ _Date o f  In terv iew  : _______(Year)
V illage __Unit NumberI i s t r i c t
______  (Montai TdayT
F i l l  t h i s  in  only  fo r  th e  P a t ie n t , not fo r  the Control Record of V is its
V is i t Date
Year
o f  V is it  Month" ¡Day Interview ed
Moved
away
Tempab s­
e n t
Refu­sed Other(Spe­c ify )
Name o f  In terv iew er
1 !
2 _______!___
-------- 1------------ !— —
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How long have you liv e d  continuously in  th is  d is t r ic t  7
1 r V  Less th an  a  year
2 /  7  1 - 2  y e a rs3 7  /  3 -  *» y e a rsV 7~~7  5 - 9  y e a rs
5 /  /  10 y e a rs  and over
6 A ll y ou r l i f e
Please d esc rib e  how you spent your time yesterday  between when 
you go t up and when you went to  bed ,
( In s tru c t io n :  I f  th e  p a tien t/co n tro l i s  a ch ild  o f  9 years o r  under who d oes no t work/go to school, ask  h i s /h e r  mother to  t e l l  yon abou t h e r  a c t iv i t i e s ) .
P a t ie n t /c o n tr o l  /  7  Mother
In s tru c tio n : In te rv iew er should c a lc u la te  1-13 by a c t iv i t i e s  a f te r  f i l l i n g  th e  d if f e r e n t  tasks which were done by p a t ie n t /c o n tr o l /  
Mother y es te rd ay .
No. o f hours
' Hunting & g a th e r in g  _
7 Fetching fu e l ___
'  M anufacturing _______r Food p ro cessin g  ____
7 C o n s trcu tio n  ________
7 Domestic works ______
7 Child ca re  ___7_____
7 Trading
7 A g ric u ltu ra l wage labour 
r N o n -ag ricu ltu ra l work
fo r  wages/salary __________
13 / /  E d u c a t io n _________________
T otal _____________
3 . So you spent _______  hours yesterday working (and a t  s c h o o l) . Onaverage d id you spend about same hours working (and a t  sch o o l) on each 
o f the l a s t  7 days ?
1 r . y Yes
2
3 y - j
No days worked ( 0o to  Q.No.1*). No w ork/school a l l  7 days but C an 't say  (Go to Q. Ho.*).«* Z 7 7
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What was the maximum and the minimum number o f  hours per day you worked (and spent a t  school) in  the l a s t  7 days, and fo r  how many 
d^ys d id  you work th e se  hour 7
Maximum______________ hours per day ______________  No. o f  daysKinimura ______________ hours per day ______________  No. o f  days
•vOi-o you paid fo r d o in g  th J l  work y e s te rd a y  ( s e l l in g  gc >ds and 
wage labour) 7
1 /  7  Yes 2 /  /  No (Go to  Q. No. 4)
Mode o f  payment ?
Code : 1 = Cosh (P iece  ra te )
2 = Cash (tim e ra te )
3 = Exchange Labour
't .  In  k ind  /  /
5 = Cash and kind (p ie c e  r a t e )
6 = Cash and kind (tim e  r a t e )
7 = S a le  b f  goods
How much did you earn  7
as ._______________  (both cash and k ind )
Within the la s t  30 days, were there days when you were not 
completely w e ll (as l: to p a tien t/ con tro l) 7
1 L _1  Yes 2 | I No «3o to Q* No. 15)
What i l ln e s s  did you have 7
NaL.e o f  i l ln e s s  ________________o ta r t in g  « ite  _________________
Did you have any o th e r  i lln e s s  7 
1 r  I Yes 2 f  | No
’*hct i l ln e s s  did you have 7
Hane o f  i l l n e s s _____________________ s ta r t in g  date
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- * ♦ -
( In s tru c t ion  : I f  the paticnt/control has had more than one 
typo o f  i l ln e s s ,  ask questions 5-11* f i r s t  fo r  the more recent 
i l ln e s s .  Then repeat the questions fo r the e a r l ie r  i l ln e s s  in 
the sep ara te  forms).
Do you f e e l  com pletely w e ll now 7
1 Yes 2 Z Z 7  No (Oo to  q. Ho. 6 )
On what day d id  you f i r s t  f e e l  completely w e ll 7 
da te
to ta l  days o f  illn ea s .
(In s tru c t io n  : I f  the patient/contro l is  9 years and under who 
works o r  goes to  school and over 9 years, continue the interview 
with q.No . 6 .  I f  the patien t/contro l i s  9 years and under and 
does not do any work o r  does not go to  school go to 0» No. 8 ) .
When you were i l l  with ( i l ln e s s ) ,  were there any
days w ith in  the la s t  JO days when you were t o t a l ly  d isabled/ 
unable to  work/unablo to carry out your normal a c t iv it ie s  
because o f  i l ln e s s  7
1 / C 7  2 / 7  No (Oo to  Q .No. 7)
FY>r how many days 7
_ _ _ _ _ _ _ _ _  days.
How d id  you spent your time during these days 7
1 / ~ ~ 7  Resting
2 f  /  S leep ing
9 /  ~7  Other (S p e c ify ) ____________
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6 .3  Vhat a c t iv i t i e s  were you prevented by your i l ln e s s  I r a n  d o in g  onthese days ?
Wo. of days / s t i v i t y
__________   01 /  /  Animal husbandry_ _ _ _ _ _ _ _ _  02 /  /  A g r ic u ltu re
___________  03 7 /  H untin g & g a th e rin g___________  O'* /  /  f e tc h in g  fuel
___________  05 /  /  M anufacturing___________  06 7 7 Fbod p ro cess in g_ _ _ _ _ _ _ _ _  07 /  7 C o n s tru c tio n
___ _ °® 7 7 C beiestic  works___________  09 7 7  C hild  ca re___________  10 7 7  T rad in g___________ 11 7  /  A g r ic u ltu ra l  wage
_ _ _ _ _ _ _  la b o u r__________ 12 / ~  /  H o n -a g r ic u ltu ra l_ _ _ _ _ _ _  work wages/
____________ __  s a l a r y_____________13 /  /  E d u ca tio n
7 .  On some days o f  your i l l n e s s  w ith in  the la s t  30 days were you
p o rtly  d isab led /unab le  to work/unable to carry out your norm al 
a c t iv i t i e s  ?
1 0 7 7  *•* 2 / ~ 7  Wo (Oo to Q.Ho. 10 )
7 .1  For how many days were you p a r t ly  disabled ?
__ days.
7 .2  Could you work your usual number o f  hour ?
1 0 7  ™  «*> to  Q*No. 7 .'*)
2 ¿21/
7 .3  On average , how many hours a day could you work ?
__  hours per day .
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7.*» Could you work hard as usual 1
1 CHS yua 2 L J  N°
( i f  the answer to  both 7.2 and 7 .1* i s  ‘ 'y e s '1, check the answer 
to Q. No.7).
7 . 5  What a c t iv i t ie s  did you do on these d ays  when you were p artly
disabled ?
Av. hrs. per  day No o f  day,
Ol[___JAnimal husbandry
Q2| } Agricu ltu re
03l lHunting & gathering
Ou! I Fbtchi rut fu e l 
Q5l l Manufactu ring 
Pél Ifbod processing 
Q7| [Construction 
08f ~~|Domestic works 
09[ ]Child care
ip j grad ing
111___ (Agricu ltu ra l wage
labour
i z l iNo.n-agri.cultuLral 
work fo r  Wages/ 
salary
_ l j [ H l Bducation
Total hro. per d ay__________________(Go t o  Q. No. 10)
(Instru ction : I f  the patient/control i s  9 years and under
who docs not do any work or does not go  to  school ask the question
to his/her mother about his/her i l l n e s s ) .
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□□
□□
□
8. VSien the ch ild  ( P a t i s n t / c o n t r o l )  was i l l  w i t h ________ ( i l l n e s s )
were th e re  any days w ith in  the 1 , s t  30 days when hc/she was not 
playing o r  not as a c t i v e  os usual because o f  the i l ln e s s  7
i  □  j  □  Ho (Oo to  Q. No. 9)
8 .1  FOr how many days 7 .
9« Old any one in  the household have to spend ex tra  time w ith in
the li-st 30 dayo lo o k in g  a fte r  his/her during the i lln es s  7
’  □  i  I l No (Oo to  Q. No. 13)
tt»o was the main person  who lo  ked a fte r  him/her 7
Nam* -------------------------------- * € * _________________Relationship ___________
For how many days d id  the child  (p o tien t/ con tro l) need spec ia l care 
because o f  th is  i l l n e s s  ?
_ _ _ _ _ _ _  days.
D i' ............... ............ (Name o f  person provid ing care ) spend
nuch extra time each day looking a fte r  _______________ (p a tien t/
co n tro l)  7
Less than 2 hours 
2 -  ** hours 
*♦ -  6 hours 
6 - 8  hours 
A ll day
398
Was h o /s h e  able to  c a rry  o u t h is /h e r  normal a c t iv i t i e s  as well 
during th o se  days ?
1 a  Yes (Go to  Q. No.13)
What was h c /sh e  prevented from doing ?
Ay- h r», p e r  day No. of days
01| ' Animal husbandry
02| | A g ricu ltu re
03| [Hunting & gathering 
C*f Ire tch irm  fu e l 
0 ? f  [M anufacturing 
06f  jfbod processing 
07{^]C ons tru e  t  ion 
08( ]Domestic works
09|~ 1 C hild care
10d J T^adi,«
_____  1 2 [_ jN o n -ag ri c u ltu ra lwork fo r  wages/ s a la ry
_____ I3j | S iu ca tio n
9 .6  Did some one h e lp  to  do th i s  work ?
1 □  No (Go to Q.No. 9 .1 0 )
5 □  Don't know (Go to  Q. No.13)
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9* 6 . 1 Who helped you 7
F i r s t  Helper Second Helper H iird  Helper
1 |__ j  Household Heaber □Name
AS«R ela tio n sh ip
□Name ___
AgeR ela tio n sh ip
□
Name
A««- _____ __R ela tio n sh ip
2 | l H ired Labour □ □ □
3 j | Labour Exchango □ □ □
9 | | O th er (sp e c ify ) □ a □
9 . 7  What work d id  they do 7 
(C-xJe by a c t i v i t y ,  sp e c ify  ta s k )
□
___task □  ______ task □______ task
9 .8  How many h o u rs each
day on average  d id  they 
h e lp  7 _ _  h rs . _____ h rs . ___ h rs .
9 . 9  Fbr how many days did  
they h e lp  7 -------- days ____days
( In s tru c t io n  t I f  code 1 in  Q. No.9 .6 . 1  go to  No. 11 
I f  code 2 in  Q. No.9 .6 .1  go to  Q. No.12 
I f  code 3 t  9 in  Q. Ho.9 .6 .1  go to  Q. No.13
9 .1 0  C i  no) why n o t 7
tOoi”  t o  N o. 13)
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10
( I n s tr u c t io n  : I f  the p o tie n t/c o n tro l  i s  9 years and under who docs work and Roes to  sc  he >1 and over 9 years ask th e  following q u e s tio n s ) .
10. V.ithin th e  l a s t  3° days, did  any one have to spend to  do ex tra
work or spend t in e  looking a f te r  you because o f  you r i l l n e s s  ?
1 CD 2  CD No (Go ^  Q. No. 10. 5 3 CD Dorft know
\ C  (Qo to Q.No.13)
10 .1  Mio had to  do e x tra  work ?
F ir s t  Holper Second H elper Third Helper
1 Household Member □
Age
R elationship
aNana
•'«« ___\_____
R e la tio n sh ip
nName _ _ _ _  _
A g e _____
R elationship
2 H ired Labour □ □ □
3 Labour exchange □ □ □
9 O ther (S pecify)__ □ □ C
10.2 What work d id  they do ? 
(Code by a c t iv i t y ,  
sp ec ify  ta sk )
m
___ task
m
___ta s k
m
_____  task
10.3 How many hours each
day on average d id  they 
h e lp  ? ___ _ _  h rs . ___h r s . ___ _ h rs .
10.4 For how many days did 
they h e lp  ? ---------- « « M _ _ _ _ _ _  days _____ d«ys
In s tru c tio n  : I f  code 1 in  Q.No. 10.1 go to  Q.No. 11
I f  code 2 in  Q. No. 10.1 go to Q.No. 12I f  code 3 * 9  Q. No. 10.1 go to  Q.No. 13
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10.5 ( I*  >*° e x tr a  work done) why not ?
(Go to  Q. No.13)
( In s t r u c t io n  s I f  household members haloed to  do th e  work).
Did th e  e x tra  work cause any problem fo r  y>ur fam ily ? Did 
h o /a h e /th e y  Hava to s to p  doing o th e r  thing» in  o rd e r to do the
1 Q  y es 2  [ | No (Co t< Q. No. 13)
What th in g s  did they sto p  doing ? who c to  pel 7
Name__ _______
Mjl'.i o________
Name _ _______
( I n s tr u c t io n  : the work).
________ A ge_____R ela tio n sh ip  _____ Task
______ .tge _____ R e la tio n sh ip _____ Tbsk
_______ A ge_____ R e la t io n s h .p _____  Task
.'»sis th i s  question  i f  liil»ura-r. were h ired  to  do
12 .  Mow su-ch money did  you hsvo to pay him /ti.-r/lhea ?
Per day (Rs. ) _________  meals _ _ _ _ _ _ _  Ct'.er (sp e c ify )  _____
•to ta l p e r i o d _________to ta l  M ount p a i a ( R s .)
(Include in  k ind).
^3. W ithin th e  l a s t  30 days did the househol* lo s e  any cash income
because o f  th i s  i l l n e s s  (exclude expenditure on medical treatm ent 
and h ire d  labour) ?
2 j |  No (Go to  q .  No.lU)
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Why did the household lose income ard what was it s  value ?
Value
Rs.
Rs.
Has the i l ln e s s  caused you or your household any other problems ? 
(record in  words o f  pa ticn t/con tro l).
1*«.1 Do you think your i lln es s  would « f f e c t  any production ?
(In s tru ct ion  : Ask Q. No. 15 to  the p a tie rt/ con tro l i f  he/sho is 
over 9 years or 9 and under uhc does work and goes to  schoo l. 
In terv iew er should aek the pa t ien t/ co n tro l *s mother i f  the patient/ 
contro l is  a ch ild  o f 9 yen-s end uiuler who does not work or does 
not go to  school).
r  l Pstient/control I I Mothers
15. Within the la s t  30 days, wer- ther  days you could not carry  out
your normal a c t iv i t ie s  or work fo r  reasons o th er than i l ln e s s  ?
2. □ » ■ > Fbr p a t i e n t  cor 
For c o n tro l  i f  
Q. No. 25 
For c o n tro l  i f  ■ go to  Q. No. 29
itinue go to  Q. N0 .16 
has been i l l  go to
has not been i l l
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15-1 What wer« the reasons you could no t w ork/carry  out your
normal a c t iv i t i e s  7 What vere you prevented from doing 7
1 □  F e s tiv a l _______________
2 l J R eligious d u t ie s  ______
3 H D  Child b i r t h ____________
4 | j O u t-o f-v illag e  v i s i t in g
5 | ] KaLTriage ceremony ______
9 | l Other ( s p e c i f y ) ________
Prevented fromdoing A ctiv ity  Code
Task □
Task □
Task _ □
Task □
Task □
Task □
How many days in  a l l  d id  you take up 7
( For p a tie n t continue q. N0.16
I f  co n tro l has been i ) l  go to <5.  No.25 
I f  con tro l has not been i l l  go to  q. No.29 )
THIS SECTION SHOULD COMPLETED FOR THE PATIETT ONLY
16. Can you describo how d id  you feel in  the l a s t  30 days when you
had the fcvor 7 What symptoms d id  vou have 7 (Record in
Column - 1 ) .
16.-; How many days d id  each symptom l a s t  7 (Record in  Column -  2 ).
16.2 Did each symptom continue a l l  day 7 (Record i n  Column- 3).
Code : 1 -  Yes (Go to  0- No.17)
2 -  No
16.3 Which time during the day d id these symptoms s t a r t  7
(Record in Column -  4 ) .
Code* 1 ■  Morning 3 « Evening2 = afternoon A = Night
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16.*« On av erag e , fo r  how many hour* aach day d id  these symptoms
l a s t  ? ( Record in  Column -  5)«
Record Shoct fo r  «Question No, 16
0?de:
I « 0 L 0 N N S
1 2 3 4 5
Symptoms No. o f days la s ta d
. i l l  day When i t  s ta rte d Hours per day Remarks
1 (__J Fever
2 □  Sh ivering
3 I Headache
4 ! I P ains in lumbs back, J o in ts  o f  han d s/leg s
5 (__| Nausea
6 i I Vomiting
7 j  Jbundice
3 ! Diorr.ioca
9 ( _ J  Corns
10 j | V*sak
1 ', { 1  t l r a d
12  u l^ O id d y
99 ( jO therO p a c i fy )____
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15
17. How d id  you f e e l  a f t e r  th e  fever had gone 7
1 !— J  Fveling com pletely  w ell ]—>  (Go to Q. No. 18)
2  l l Fever not gone
3 C__| Feeling s 1 [  l Vfeok
2 F 1 Tired
3 1 |  Oiddy
17.1 How aeny days d id  i t  l a s t  7
I days.
XI days.
IXX deys.
18. Have you t re a te d  y o u rs e l f  a t  hone fo r  th is  i l ln e s s  in  the l a s t
30 days 7 ( to  not in c lu d e  here purchased m edicine, q. No. 19 ask 
abou t those).
1 f l Yea 2 \ ; No (Qo to V No. 19)
l8 -1  Uhst was the treatm ent 7
18 .2  Did i t  cost you any money 7
1 C D  2 i iNo (Go to  a- N o .l8 .4 )
1 8 .3  How much did you Spend 7
Rs._________________
18.«* How many days a f te r  the s t a r t  o f the i l l n e s a  d id  you
t r e a t  y o u rse lf  7 
A f t e r _______ days.
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Did you go to  sec  someone fo r  h e lp  to  get b e tte r in th e  l a s t  
30 days such a s  a d o c to r, 'w i th  h e a le r , malaria v o lu n te e r , 
e tc . ?
' O * z \  1 No (Oo to  q .  No.21)
Where/to whom d id  you go 7 
Code: 01 = H ospital
02 -  H ealth ftjs t
03 « V illag e  h ea lth  le a d e r  
O’* « V illag e  hea lth  worker 
05 e Ayurvedic d ispensary  
OS * M alaria  c l in ic
07 = M alaria  o ff ic e
08 = M alaria v o lun teers
09 -  F a i th  henler
10 = Drug s e l le r
11 a P r iv a te  d o c to r /p ra c t i t io n e r
12 = Other (specify ) ____
(Exclude v i s i t s  to the p a t ie n t  by a malar-;..
How long did  i t  take you to  go go there and come back 7 ( I f  i t  takes to g o  to  . . .  place lo ss  than 10 minutes or the place i s  in  the same v illag e , code a 0 
Did some-one go  w ith you ? Code: 1 'Yes-, 2-No (Co to 
No. 19. 5)
VJho went w ith  you 7 Code: Fbr household member w rite r e la t io n s h ip  and fo r o ther code «O’
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19.5 Did you have to pay any money fo r  h e lp / t r e a h e e n t  ?
1 r I 2 [ I ffe (Oo to q. No. 20)
19.6  How much d id  you pay ?
XV is it XXV is i t
I I I
V is it Renarks
1 |___| F s o /p re se n t
2 L ~  M edicines, labora to ryt o o t  in je c tio n , e tc .
3 |__J T ra v e l expenses (two
way fo r  p a tie n t and companion)
'• f~ 1 Spoc in i  food 
5 ! 1 S a c r i f ic e  and worship 
9 C D  O th e r  (Specify) _____
Rs.
T o ta l
How many daya a f te r  the s t a r t  o f  the i l l n e s s  d id  you f i r s t  seek
help  ?
__ ______  daya (Go to C. No. 22)
( I n a tr u c l lo n  s I f  no v i s i t  made ask  q. N o.21)
l.hy d id  you not seek help  to  ge t the i l l n e s s  tre a te d  ?
1 !___| Too expensive
2»{ I No n eed , not s e r io u s
3«C l]]^® o T sr
': .[H )H a l  a r i a  worker came to  house
5.1 I Don • t  know 
9 •___i O th e r  (Specify) ___
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»ithin the22. Have you '*>cn v i s i te d  a t  >0mo by a  m alaria  workers w
l a s t  30 days ? ( a l l  m a la ria  w orkers)
1  f~~] Yoo 2 | ! No (Go to  q. No.23)
22.1 On which day /s d id  h o /th ey  v i s i t  you ? ( I f  the p a t ie n t  could not 
rot,1 ember th e  a c tu a l  d a te  then th e  in te rv iew er check the m alaria 
s t o n c i l  and w rite  d a te  on t h i s  form ).
_________________ d a te
_ d a ta
__ date
( In s t r u c t io n  s Ask t h i s  q u e s t io n  i f  the p a tie n t d id  not go to m a la ria  c l i n i c / o f f i c e  or v o lu n tee r).
25 . Do you know whore you can 50 and g o t fre a  treatm ent when you
have fever ?
1 \ I Yes 2 C l  No (Go to  q. No.2*»)-----  XSma oT plactf
23.1 Why d id  you not go th e re  ?
1 |  l Too expensive to  t ra v e l  
,!° neo(,t no t  s e r io u s
3 l TH Tou f *r
4 l ! Foor sorview
3 r ! Waited fo r  m a la ria  w orkers to  c a l l  a t  home 
6  } ~) Don't know
9 |___iO ther (sp e c ify )  ____________
2'«. W ithin the l a s t  12 m onths, have you had a favor l ik e  th i s
b efo re  7
1 | ] Yes 2 [ 1 No (Go to  q. No.29)
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24.1 When was the f i r s t  time you had i t  7
d a te .
24.2 For how many d ays were you not completely t * l l  thon 7
___  days.
2 k .  3 Did you re c e iv e  any treatm ent 7
1 CTjYcs 2(H ]N o (Oo to  Q. No. 2 k .5)
2 k .k  Where d id  you g e t  treatm ent and what was the trea tm ent 7
__________________  place ______ treatm ent .
24.5 Did yoi: g e t  th e  fe v o r  again  between th a t  f i r s t  time and the
p resen t fe v e r  7
1 l ¡Yes 2 1___¡No (Oo to r* No.29)
2 k . 6 A ltogether now many tim es did you get tho fever w ith in  the l a s t
12 months 7
________________  times.
(Inc lu do  f i r s t  and l a s t  o n i^ d e ) .
2 k . 7 For approx im ate ly  how many days were you not completely w oll on
each occasion  ?
_________ _____  days. (Go to O. No.29)
X I n s t ru c tio n  : Q. 25 -  28 to be .-sked o f con tro l respondents o n ly )
25. When you were i l l  w i t h _______________ (mention a l l  i l l n e s s
i f  c o n tro l  has had more than one w ith in  th e  la s t  30 days) d id 
you t r e a t  y o u rs e l f  a t  home ? (Excludo purchased m edicin es).
1 [___ ; yes 2 j ¡No (Oo to  q . No.26)
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25.1 What was the treatm ent ?
25. 3 
25. **
Did i t  cost you any money ?
,  | - ] w  d  |wo (Co to  q. No-25-1*)
How much did i t  co s t you ?
Ho. o .« i  ( » <  a f te r  the . t o r t  o f  the l l l o o . .  *HC you t r e . t  
y o u rs e lf  7
A f t e r ______________ _ days.
Did you go to see some-one fo r h e lp  to  ge t b e t te r  in  the L a s t  30 
d a y s , such as a d o c to r, f a i th  h e a le r ,  m alaria  v o lun teer e t c .  7
1 _ j  yes 21 lNo (Go to  q. No.28)
U here /to  whoa did you go 7 
Code:
01 ■  H ospital02  * Health post03 * V illage hea lth  leader Oh -  V illage hea lth  worker0 5  = Ayurvedic dispensary0 6  = M alaria c l in ic07 = H-U.aria o ffico0 8  = Malaria volunteer09 -  Faith healer10 = Drug s e l le r11 = Priva te  d o c to r /p ra c tit io n e r
99 = Other (specify ) ____
how long did i t  take you to  c °  there and cone back 7 ( I f  i t  takes to go to . . .  p la c e  le ss  than 10 minutes 
o r  th e  place is  in  the same v il la g e , code -  O
IVisit
IIVisit IllVisit Remarks
i
I
! a
□ □
t i r s i TirsT
1 m Tnu.
1__________
5HS.
H 5 S -
411
V is it
I I
V is it
I I I
V is i t Remarks
26.3 Did somc-one go w ith  you ? 
Code: 1 = le s ;  2 = No
(Go to  O.
No.26.5)
□ □ □
26. k W-io wont with you ?
Code : For household member w rite  r e la tio n sh ip  and fo r  o th e r code 'O'
26.5 Did you have to pay any monoy fo r h « lp /tre a tm e n t ?1 CZ3 *OS 2 | Z jN o  (Go to  Tj. N o .2 7 ) .
26.6 How much did you pay ?
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How many day* a f te r  the s t a r t  o f  the i l l n e s s  d id  you f i r s t  seek 
help ?
____________ days (Go to rj. N p.29)
(In s tru c tio n  : I f  no v i s i t  made ask o. No.28)
Why d id  you not seek h e lp  fo r  th e  i l ln e s s  ?
1 j | ltoo co s tly
2 . 1 INo need, not serio u s
3« j ! Too fa r  
4. | ‘Don't know
9 i lo ther (sp ec ify ) _______________
(To ask both the p a tie n t and c o n tro l  respondents)
Has anyone in  the household ( a p a r t  from p a t ie n t/c o n tro l )  not 
been completely w ell w ith in  th e  l a s t  30 days 7 
1 | _ J  yes 2 l ._ J  No ( End )
W.-.o were they ?
1 .  Name o f  parson _______________ Age _____  R e la tio n sh ip  _____
2. Wane o f  p e rso n _________________Age______ R e la t io n s h ip ______
3. Name o f  p e rs o n __________________ /ig.*  R e la t io n s h ip _____
For how many days was/were h e /s h e /th e y  not com ple te ly  well ?
1. __ _ _ _ _ _ _ _  ¿ay**
2 .  ______________ days.
3 .  ______________ days.
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29.2 W & s/were/he/she/they to ta l ly  d isab led /una blc
to  carry  o u t b i s / h o r / t h o i r  normal a c t i v i t i e s
( For a  c h i ld , ask  w hether hs/shs was not play: 
a c tiv e  as u s u a l) .
1 O  Y* 3 2  |  |  No (EM)
29«3 For how many days ?
29.** Vdnt i l l n e s s  d id  h e /s h e / th e y  have ?
to  work/unablc 
during these days
Lng o r not as
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INTÜRV lEWKR ' S R ¿PO RT
(To bo f i l l e d  in  by in to rv io w cr a f te r  in te rv iew  i s  completed) 
R e l i a b i l i t y  o f  responses
Did th a  person interviewed und erstand the q u es tio n s  ?
O ther comments, esp ec ia lly  any p a r t ic u la r  resjtonses you fe e l  
were u n re l ia b le .
D escrib e  what the p a tie n /c o n tro l  was doing when you arriv ed  
a t  th e  house.
Where do you think the p a t ie n t/c o n tro l  person comes from ?
1.[ J H ills  2 Ll3Torai 3 iZHU India
4.Q__ I Don't know 9 | j e t h e r  (Specify) _ _ _ _ _ _ _ _ _ _ _ _
| ) P a r t i a l l y  re lia b le  
| | U nre liab le
Degree o f  co-operation
i i Very good
C D  °°°d
I I Not so  good 
| | Not good a t  a l l
j___ ) No d if f ic u l ty
[371 L i t t l e  d i f f i c u l t y
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ECONOMIC STUDY OP MALARIA IN NIP AL
oda/Hew era
1904
QUESTIONNAIRE : INTERVIEW NO. 2
Checked by In te rv iew er Re-check (D ie tr io t )  Re-check (Kathmandu Name DateDateCoded by 
Re-corded by NameName Date - Date
Houcehold Number /  / ~7 1 l P a tie n t /  /  Control j  fDr.to o f  In te rv iew  No. 1
House Number (NMEO)  _______  V illageL ocality  Number _________________' U iit ffuaiSSrUnit O ffice ________________ D is t r ic t
Dnte o f  In te rv iew  ( .y e a r ) ____________ __ ^month) ___________  (düy)
F i l l  t h i s  in  only fo r  th e  P a tie n t n o t fo r th e  Control Record o f  V is its
V isitNo. Date o f  V is it In terv iew ed Moved Temp.abs- Ho fu eed O ther epcci 
)—
Name o f  In terv iew erï r Month ttV
— — —_J _______________________ tr= ____________ _
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P le a se  d e sc r ib e  how you spent you r tim e y e s te rd a y  between when 
you s o t  up and when you wont to  bod ?
( I n s tr u c t io n :  I f  th e  p a t ie n t/c o n tro l  i s  a  c h i ld  o f  9 y ea rs  o runder who does n o t go to schoo l/w ork, ask  h is / to e r  mother to t e l l  you about h e r  a c t i v i t i e s ) .___________  --- ---*** —  ---- —  .~]0i  ' d if fe r e n t  ta s k s  which wore done by p a t ie n t /’78  con tro l y o s te rd a y .
acch o f  tho  l a s t  7 days ?
1 r ~ 7  Tes2 /  /  No d ays worked (Go to e;.Ko.3)
3 7  /  No w ork/aehool a l l  7 days b u t on some days
1 2__/  C an 't say  (Go to 2 .No.3)
2 .1  '/h a t i.-as th e  maximum and the minimum number o f  hours per day you worked (and s p e n t a t  rchool) in  th e  l a s t  ? d a y s , and fo r how many 
days d id  you work th ere  hours ?
f  /  P a t ie n t /c o n tro l /  /  Mother
TasIT *123 In s tru c tio n  : In te rv ie w e r should c a lc u la te  hours 1-13 by a c t i v i t i e s  a f t e r  f i l l in g  the
01-Anim-.l hu6b-sndry 02. A g ricu ltu re  03-Kuntin2 ~-nd g a th e r in g  
04^ Fetching fu o l 0 %Manu fac t  u r ing
06. Food proceosing07- C onstru c tion
08-  Domestic works09- Child ca re10- Trading
11-  A g ric u ltu re  wage lab o u r12- Hon-Agri. work fo r  wagee/ealai-y
13-  B ducition
Activity Ho. o f  hours
T o ta l
2 . 3o you spen t ___  hours yesterday  w orking (and a t ,  sch o o l).Cn av irago d id  you spend about ____  hours w orking (and a t  school) on
hours per day 
hours per day
No. o f  days No. o f  days
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you paid  fo r d .in *  th i s  work y . . t . r d „  ( . . H i , «  .„ o d . »od wo», labour) ?
1 ZZ7 Ye* 2 n No (Go to Q. No.3).
2 .2 .1  Mode o f  payment 
Code : 1 m Cash (p iece r a te )
2 .  Cash (tim e r a te )3 m Exchange labour ,4 -  In kind /  /
5 m Cash and kind ip ie c e  r a te )
6 m Cash and kind (tim e r a t e )7 -  Sale o f  goods
How much d id  you earn ?
N". ____ _ (both cash and k in d ) .
I f  the p a t ie n t/c o n tro l  has had more than one type o f  i l l n e s s  ask q u e s tio n 3.6 to  12 f i r s t  fo r th e  more re c e n t i l l n e s s .  Then repeat th e  q u e s tio n s  fo r  the e a r l i e r  i l l n e s s  in  the sep e ra te  forms.
S l??* ,rXT 1.**t  v iB it* “•*■ * th e re  d «y* “hen you were not completely w ell ? (Ask to  p a tie n t/c o n tro l)
1 1— t  Ye* 2 L S J  Nor*(- i f  c o n t ro l  i l l  befo re  f i r s t  interview  p leace  go to  Q.No.8-  i f  c o n t ro l  not i l l  before f i r s t  
in te rv iew  p lease  go to  Q.No.13
-  fo r p a t i e n t  go to  Q.No. 8 .
1 /  /  C ontinuation  o f  12 /  /  New i l ln e s s
3 .2  What i l l n e s s  wac th i s  ?
1 o f  an i l l n e s s  you had before or
(Co t o  0 .No.3.4 )
3 .3  What d a te  d id  the i l ln e s s  s t a r t  ?_________________ d a te .
3 .4  Did you hav* any o th e r i l l n e s s  ?
1 /  /  2 /  7  No
3 .5  What types o f  i l ln e s s  ?
Name o f  i l l n e s s  _____________  _ s t a r t i n g  da te
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Do you now fee l completely w e ll ?
1 /~~7 Tee ,/ 2 Ho
On what day did you f i r s t  fe e l  com pletely w e ll ?
date.
Ho. o f  days i l l ,
(In s tru c t ion : I f  the pate in t/contro l is  over 9 years o r  9 and under 
who goes to school/work continue th e  in terview  with Q .No.4. I f  the 
patient/control is  9 ¿roars and under end does not go to  school/work 
continue with Q.Ho.6)
When you were i l l  since my la s t v i s i t ,  were there any days when 
you were "io ta lly  disabled/unable to  work/unable to ca rry  out your 
normal a c t iv i t ie s  because o f  your i l ln e s s  ?
1 /  7 Tea 2 /~  7  *o (Co to  O..N0 . 5 )
Fbr how man:' days ?___ day-J.
How d id  you spend y o u r 'tir .e  durin g  th ese  days ?
1 /  /  nesting
2 /  /  Sleeping9 /  /  0 ;h e r  ( rp ec iiy )
What a c t iv it ie s  cero you prevented by your 
these days ?
i  lincee from doing on
Tack dv.hre. per day N o.of days A c tiv ity
01 Z / Animal husbandry
02 7 / Agricu lture
03 7 / Hunting and gathei
04 7 / Fetching fuel
05 7 / Manufacturing
/ Food processing
---------  ~ ; 7 _ — 07 7  OS 7  
09 7
/ Construction 
~ /  Domestic works 
7  Child care
—  — — 10 Z11 7
/ Trading 
/ A g r i .wage labour
~  ; ; T : -
—
12 [  / Notv-Ag. works for
wages/salary
13 / / Education
On some days o f  your i lln ec s  since my last 
disabied/unable to work/tvmblo to  c a rry  out 
1 / / !c *  2 / / He (Go to  Q.W0.8)
v i s i t  w<sre you partly 
»ratal a c t iv it ie s  ?
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For how many day* were you p a r tly  d isab led  ? day*.
Could you work your usual number o f  hours ?
1 /  /  Yea (Co to  Q.Mo. 5 .4 )
2 O J  *•
On average, how many hours a  day could you work ?_  hours per day .
Could >ou work as ha id  an usual ?
1 n  y  (<V, tv  ! - X o .  8 '  2 ! ~ J  »o
( i f  the enswer to  both  5-2 and 5*4 i s  "Yes", check the anewer to  Q.*o. *>).
tfhat a c t iv i t i e s  did  you do on theso  days when you were p a r t ly  d i s a b le d  ?
- 5 -
Task Av.hr s .p e r  day Ko. o f  diy s
• T o t a l  h e  a r e  p e r  d a y  
(Co to  ^ .IIo .8 )
A c tiv ity
0 l /  /  Animal husbandry02 /  /  A gricu lture03 /  /  H-inting and g a th e r in g
04 /  /  Fetching fuel
0V  7 M anufacturing06/  /  Food processing
0 7 / /  C onstruction0o /  /  Domestic works09/ 7  C hild care10 / /  Trading11/  /  A g ricu ltu re  wi^e la b o u r
12/ ~ /  t'on-Ag.work fo r  w a g e s /sa la ry13 / /  EH vc a t  ion
(Ask •'.¡•'o.C end 7 only i f  th e  p a tie n t ^control i s  9 years and und er whodcoc noi co to  schoo l/w ork).
‘/hon___________ (pc t i e n t  /c o n tro l)  was i l l  s in c e  n\y la s t  v i s i t ,wore a iy  days whan iie/ahc was not p lay in g  or not as a c t iv e• s usua*. bacr.rao o f the i l l n e s s  ?
1 /~~7 Yoo 2 f ~ i  Fo (Co to  Q.Mo. 7)For hew man;/ deys ?__ days.
Did ar-yono in  th e  household have to  f  pend e x t r a  time einco try l a s t  v i s i t  looltin.™ a f te r  him /her during th e  i l l n e s s  ? 
i J__ /Y es 2 /_ _ / Jo  (Oo to  Q.Ko. 1 1 )
■ fho was the- main person who locked a f te r  .iim /hor ?'la n e ___________ __ _________Ace_________ R e la t io n s h ip _______________
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2 For how many day» d i d ______ ___  ( p a ti  e n t /c o n tro l) need sp ec ia lcare  because o f  th e  i lln e s s_________________  d a y s .
3 Did _______________  (name o f  person providing ca re ) spend much ex tra  time
each day looking a f te r  (p a t ie n t/c o n tro l) ?eLess than 2  hours 2 -4  hours 4 -6  hours
6-8  hours 
A ll day
4 Was h e /sh e  a b le  to  carry out h is /h e r  
th ese  days ?
1 /  /  Yea (Co to  Q.Ho. 1l)
* T D  Wo
5 What was he /she  prevented from doing 
Task A v .h rs .p e r day Ko.of days
6 Did coaeon« h e lp  to  do th io  work ?
1 /  /  Yes 2/~~7  Ho (Co to  Q.Ho. 7.
normal a c t iv i t i e s  ac w ell dcring
A ctiv ity
01 /  /  Animal husbandry
02 /  /  A g ricu ltu re03 /  /  Hunting and gathering
0<, /  7  Patching fuel05 7  /  W anufacturinc 0-5 7  /  Fbod processing07 /  /  C onstruction08 7  7 Domestic work«
09 /  /  Chi Id ca re10 /  _/  Trading
'.1 7 /  A g ricu ltu ra l wage labour 
12 ' /  7  f.'on—Ag.work *^r wages/salary 
1 J 7  7  Education
1° )  3 i  /  P » » 't know
(Co to Q.Ho.ll)
421
7>6<1 Who hoi pod you ?
1 /  /  Household
F i r s t  he lper Second h e lp e r Third he lp er
K - .  ^
u
Name CJAge Relation- -  Ship Ago _ R ela tio n ­ship Aga R e la tio n -  shi-
2 /  /  Hirod Labour CJ C J CJ
3 /  /  I-abourexchange CJ C J CJ
?  Z__/  Other(sp e c ify ) CJ C2 CJ
What work d id they do ? /"~~J(code by a c t iv ity ,a p o c ify  tank) ____ task C J
7.8  How many hours oach day on average J id  they h e lp  ?
7 .9  For how many days d id  they d*v*h e lp  ?
( In s t ru c tio n  i f  code 1 in  7 . 6 . 1 , go to Q. Ko. 9 
"  *» 2 ~ in  fo  to q. No.. .  •> 3 A 9 in  7 . zc <j. He.
7.10 ( I f  no) why no t ?
10
11
( Oo to  Q.No. 1 l)
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( i f  tho p a t ie n t/c o n tro l  i s  over 9 y o a r r ,  9 years  and under who doea work and goes to  sohool ask tho  fo llo w ing  q u e s tio n s .)
8 .  Sinco ny la s t v i s i t ,  han ai\y one had to do extra work or spend time 
looking a fte r  you because o f  your i l ln o e s  ?
1 )  7  *os 2 I  7  1,0 (Co to  U .K o. 8 .5 )  3 / "7  Don't know X—  —  (Co  to QiHo. 1 l )
8 .1  Who had to do ex tra  work ?
- 8 -
— F ir s t  helper Second helper T h ird  h e lp e r
cj. CJ CJ
1 /  /  Household 
member
Fame i'ane NameAge R olation- ”  sh ip
Ago R elation­ship Age R ela tio n ­s h ip
2 /  /  Hired Labour c j CJ c j
3 J~" /  Labourexohar.ge c j CJ CJ
9 /  7  Other( specify  ) „ _ CJ CJ CJ
8 .2 What work did thny do ? /* / / / 
(code by a c t iv i ty .
sp ec ify  task) ____  task ____  task
C J
___  task
8.3 How many hours each d v
on average did they help ? ____  hrs _____ hrs hrs
8.4 For how many days
d id  they help ? days day* day.
Instru ction : I f  codo 1 in Q.No. 8.1 go  to  T. .Vo. 9 
, ,  , ,  2 , ,  ,* 8 .1  go  to  Q. Ho. 10 
,,  , ,  3&9 ,,  8.1 go  to  Q. Ho. 11
8.5 ( I f  no extra work done) why not ? (Go to  Q. No. 1 l)
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( I f  household members helped to  do the work)
Did the ex tra  work cause  nny problem fo r your fam ily  ?Did he/6 ho-they have to  s to p  do r»« o th e r th ine*  in  o rd e r to  '.o th e  work ?
1 /  /Y e a  2 /  '7  No (O ' to  1 i)
What th ings d id  they a to p  doing ? Who stopod ?
Name_____________ Ago ______  R e la tio n sh ip __________  Task ________
Name _____________  Age _____  R elationship  _________  Task ________
Name_____________ Age ______  re la t io n s h ip ___________Tas'< _________
( in s tr u c t io n  : Ask t h i s  qu estio n  i f  labourer worn h ired  to  th e  work)
How much money did you have to  pay h inder/¿horn  ?
Per day ( R e . ) ___________ m oale__________ o th e r  (o p cc ify ) _______ -
T o ta l period ___________ to ta l  ac.ount paid ( R r .)  _______
(in c lu d e  in  kind)
S ince my la o t v i s i t ,  hae th e  household lo s t  any cash  income because o f  t h i s  i l ln c e r  (exclude  expenditure on medical trea tm ent and h ired  labour) ?
1 /  7  2 !  7  No (Co io 'l .  No. 12)
Why d id  th e  household lo s e  income and »hat was i t s  value ?
Reason Valuu
____  f t ' . ____
Re. ___
Rn.
424
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lias tho  i l l n e s s  caused you o r  your household any o th e r problems sinoo 
my l a s t  v i s i t  ?(reco rd  in  words o f  p a t ie n t/c o n tro l)  .
Do you th in k  y ou r i l l n e s s  would a f f e c t  any production  ?
( I n s tr u c t io n  s i .  Ask th is  q u es tio n  i f  the p a tie n t/c o n tro l  i s  over 9y e a rs  o r 9 and under who does work and goes to  schoo l.
2 . In terv iew er should ask ;hc p a t ic n t/c o n tro l ' s mother i f  the p a tie n t/o o n tro l  is  9 and ur.dor and does not work o r  does not go to schoo l.
/  /  P a tic n t/c o n tro l  / _/  Mother
S ince my la s t  v i s i t ,  were th e re  days you could not carry  out Yournormal a c t i v i t i e s  o r  work fo r  reasons o ther than i l ln e s s  ?
1 / "  /  Y o a F or  pat*, »nt continue Q.No. 13.
2 /  7  ho -» ! 2nd th e  er.terviow, i f  p a tien t c o n tro l  has been well sincef i r s t  in terv iow .
I f  th e  p a tie n t has bom  i l l  n o  t o  Q.Po. 14-
I f  -the control has been i l l  c °  to  Q.Mo. 20.
What were th e  reasons you could not w ork/carry ou t your normal a c t i v i t i e s  ? What were you prevented from doing ?
Reasons Frevented from d c ’ .ng A ctiv ity  code
1 /  7  F e s tiv a l Task £ 7
2 f  7  R elig io u s iu t lc e Task CJ
■ \ / 7 7  CM Id  b i r th Task £ 7
4 /  /  Out o f  v i l la g e  v? s i t i n g
Task ___ CJ
5 /  7 M arriage ceremony Task ___ CJ
9  r ~ 7  O ther ( s p e c i fy ) ____ Task ___ CJ
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13*2 Ho w  c i any days in a l l  did you take up ?
____________  days
In stru ction  : a»d in terview  i f  patiant/control has been w e ll a in es  
f i r s t  in terv iew . I f  they have been i l l ,  fo r  p a t ie n t  
ge  to  Q. No. 14, fo r  con tro l 40 to Q. No. 20 ).
Tins SE0TIC8» SHOULD BE CPU? lATED FOR THE PATIgHT ONLY
14 Can you describe how did .you fe e l  when you were i l l  since my la s t  
v i s i t  ?
11
1 5. What "yraptome did you have (Record in column -  1 )
15.1 Hew many days did each symptom la s t  ? 
( Record in  column -  2 )
15.3 Did each eympton continue a l l  day ? 
(Record in  column -  3 )
Code 1 1 .  Tee ( Co to o . Ho. 1$)
2 -  No
15.3 Which time during the day d id these symptoms s ta r t  ?
(Record in  column -  4 )
Code 1 1 .  Morning 3 * Evening
2 -  Afternoon 4 .  N ight
15-4 On average, fo r  how many hours each day did these symptoms la s t  ? 
(Record in  column -  5 ).
426
12
Reoord S h o t  fo r Question No« 1 >
C O L  U ■  N S
Cod* j
1
By-Pt-
2
No. o f 
lasted
3
Allday
4
When i t  •  P arted
5
Hours
perday
Remarks
1 n Fever
2 /  7  Sh ivering
3 /  /  Headache
-
4 /  /  Pains in  l*nbs/^>ack jo in ts  o f  hands and !s«s |
5 /  /  Nausea I_____ |
6 /  j  Vomitinc
7 /  /  Joundice •
S /  /  Diorrhosa
9 I ~ 1  Coma
10 /  /  Noak
11 n Tired
12 n  Ciddy
99 / ~ 7  Other (sp ec ify )
L i
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17.1. Where/to whom did you go 7
Code :
01 -  H ospital
0 2  -  H ealth  post
03 -  V illa g e  health  le a d e r
04 = V illag e  health worker
05 -  Ayurvedic d isp en sary
06 .  ¡ t a la r ia  c lir .ic
07 -  M ala ria  o ffice
08 .  M ala r ia  volun teer
09 -  F a i th  healer
10 -  Drug s e l le r  
1 1 .  P r iv a te  d o c to r /p ra c t i t io n e r
99 .  O th er (epecify) _____
( Fxclude v i s i ts  to  the p a t ie n t  bv a m a la ria
I Z 3
1 7 .2  How lo n g  did i t  take you to 
»o t h e r e  and come back ? 
( I f ,  i t  takes to go to  . . .  p la c e  l e s s  then IO m in u te« / t h e  p la c e  i s  in the rane  
v i l l a g e .  Code .  0  )
E 3 \£Z7
4-17.3 Did someone go with you ?
Code : 1 .  Tes, 2 * Ho (Cc to | v l .ro . 17.5);
17.4 Vi ho w ent w ith you ?
Code : ?tor Lousohold 
Member wri.to re la t io n s h ip  
and f o r  o ther code "O".
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17«5 Did you have to pay any money fo r  ho lp /trea tm en t ? 
1 / 7 Tea 2 /  7 No (Oo to Q.No. |9 )
1 7.6 Kow m irh d id  you pay ?
IV isit I IV is it mV is it Remarks. . .
| 1 /  /  Fee/present ns.____
! 2 /  /  M edicines, laboratory  t e s t ,  in je c tio n , e tc .
3 /  /  Travel expenses(two way, for p a tie n t and companion)
4 /  /  S p ecia l food
5 /  /  S a c r i f ic e  .'nd worship
—
9 /~~7 Other (spacify ) ___
Total Rs.____
( In s tru c t io n :  I f  no v i s i t  made ask Q. No. 18).
18 .  Why did you n o t oeek h e ir  to  ¡jet the i l ln e s s  t re a te d  ? 
Too expensive 
No need, not serio us
N a la r ia  worker ceme to  house 
Don* t  know
Other (specify) ________
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19. Have you been v i s i te d  a t  homo by a m ala ria  worker s in ce  my la s t  v i s i t  ?
1 /  /  Yes 2 /  /  Wo (EnU o f  in terv iew )
19.1 On which d a y /a  did he /th ey  v i s i t  you ? ( I f  the p a tie n t could not 
remember the ac tu a l  d a te  then the in terv iew o r check tho m alaria  s t e n c i l  and w rite  d a te  on th i s  form ).
- 16 -
__________________ _ dato
_______ _ d***
(End o f  th e  p a tie n t in te rv iew ).
( I n s tr u c t io n  : Ask Q. iSo. 20 -  22 only  fo r  the c o n tro l and only i f  
the c o n tro l has been i l l  s in ce  th e  f i r s t  in te rv iew ).
20. When you wore i l l  s in ce  my l a s t  v i s i t ,  d id you t r e a t  y o u rso lf  a t  home ? (Exclude purchased m edicines).
1 /  7  Ye* 2 / ~ ~ 7  No (Co to  Q .  No. 21 )
20.1 What was th o  trea tm ent ?
20.2 Did i t  cos t you any money ?
1 JZJ Yes 2 /~~7 No (Co to  i. No. 21)
20.3 How much d id  you spond ?
(*••) ______
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2 1 . Did you go to  someone Tor help to get b e t to r  auch as a d o c to r, f a i t h  h o a lc r , m ala ria  vo lun teer e t c . ,  s in ce  my l a s t  v i s i t  ?
1 /  7 Yo* 2 /  7 »o (Co to  Q. No. 22)
2 1 .1  K hsro / to  whom d id  you go
Cods t ----1V isit. . . .  .
I IV is it I I IV isit Remarks
01 .  H ospital
02 .  H ealth  post
03 •  V illage  h e a lth  leader
04 -  V illag e  h e a lth  worker
05 -  Ayurvedic d ispensary
06 .  M alaria  c l in ic
07 -  > * la r la  o f f lc o  
OG m M alaria  v o lun teer
09 -  F a ith  h ea lo r
10 .  Drug c e l la r
11 ■  P r iv a te  d o c to r /p ra c t i t io n e r  
99 -  O ther (sp e c ify )
Z=7 n j C J j
21 .2  How long d id  i t  tak a  you to go th e re  and come back ?
( i f  i t  taken to go to — p lace  le s s  than 10 m inu tes/ 
th e  p lace  i s  in  the same v i l la g e  code "0 "
hr*
min
T F T
min
hr* i
2 1 .3  Did someone go w ith  you ?Code : 1 .Y os, 2.No(Co to  <1.
No.21.5)
j
|
21 .4  Who went w ith  you ?Code : For household member w rite  r e la t io n s h ip  and fo r  o th e r  code "0" .
i
1
................ i
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21.5 Did you have to p4y any money fo r  h e lp /tro a tm en t ? 
1 /  /  Yos 2 /  /  No (End tho in te rv iew )
21 .6  How much d id  you pay ?
I you n o t nook help  fo r  the illnes3 ?
Too co u stly
No need, not serio u s
Too fa r
Don' t  know
Other (sp e c ify )  _____________
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In te rv iew er*« Report
(To be f i l l e d  in  bjr in terview er a f t e r  in te rv iew  is  completed) 
R e l ia b i l i t y  o f  responses
/ 7  A ll r e lia b le  f ~  ~J P a r t ia l ly  r o lia b le
/  7  Mostly re lia b le  / 7  U ir e lia h le
Decree o f  Co-operation.
/  7  Very good / 7  Hot so good
/  /  Cood /  / Hot good at a l l
Did the person in terviewed understand the questions ? 
/  / f,o d i f f i c u l t y  /  7 Kuch d i f f i c u l t y
/  -/ L i t t le  d i f f ic u l t y  / 7  Creat d i f f i c u l t y
Othor comments, o apec ia lly  any r - r t i c u l » r  rosponscs you foo l were 
u n re liab le .
Describe what tho pationt/oontr- 1 was doing when you arrived  at the
Vhoro do you think tho patient/oontro l person comes from ?
1 £ 7  H i l l .  2  T o n i  3 £ y  I „ d i „
4 /  7  Oo0' 1 know 9 /  / Other (o p o c i fy )  ______________
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ANNEX 5
ADDITIONAL TABLES
Table A5.1 : Outline of proposed form for collecting information on costs 
and effectiveness of parasitic disease control projects
Table A5.2 : Cost-effectiveness ratios of parasitic disease control 
projects: annual costs per person protected (from Barlow and 
Grobar 1985)
Table A5.3: Cost-effectiveness ratios of parasitic disease control 
projects: cost per case-year prevented (from Barlow and 
Grobar 1985)
Table A5.4: Comparison of mollusciclde programme costs for ten 
schistosomiasis control projects (from Jobin 1979)
Table A5.5 Comparative cost-effectiveness of oral rehydration therapy 
based on diarrhoea - associated deaths (from Applied 
Communication Technology 1985)
Table A5.6 Comparative vaccination cost per fully vaccinated child 
(from Phillips, Feachem and Mills 1985)
Table A5.7: Analysis of NMEO district recurrent expenditure 1983
Table AS.8 : Analysis of NMEO district recurrent expenditure 1984
Table A5.9: NMEO expenditure by geographical area, 1983 and 1984
Table A5.10 : Distribution of NMEO recurrent expenditure by management 
level and type, 1983 and 1984
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T*bl* A5.1: Outline of proposed fora for collecting Information on cost 
and effectiveness of parasitic disease control projects
DESCRIPTION or PSOJtCT; a. Insecticidal spraying la Zoea X
gg'IS jrrKnmifss
1. Population of project iooa <*)
2. Prevalence rates (P)
Disease A 
Disease B 
Disease C. etc.
3. Case-fatality rates (P)
Disease A 
Disease ■
rreC by project agency
:urred by doeastlc private
. Incurred by a
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Table A5.2 : Cost-affectlveneai ratios of parasitic disease control
projects: annual costs per person protected (from Barlow and
Grobar 1985)
p*T psrson 
(1984 t)
Control s«thod
CountryDrut s
Vactor Water
supply
airless
crn>«ao«o*li<U 0.76 . « Subsaharaaafrica Molynaus (1983)
Schistosomi*«!«
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
3
3
3
7
•
9
U
12
12
16
18
: 
s 
•
No spaclfl •d
Tañíanla
Sudan
Puerto tico 
Ubarla 
Ubarla 
arac11 
Uababws 
St. Lucia 
St. Lucia 
St. Lucia 
tarpi 
St. Lucia 
Puerto Ileo 
Puerto Ileo
Libarla
Irai
Zaire 
Zaire 
Brasil 
Puerto tico 
St. Lucia 
St. Lucia 
ledra 
St. Lucia 
St. Lucia 
E*TPt 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
Brasil
lu issaU la  at a l. (1961) 
Rugae*Ills st «1. (1961) 
Prescott (19Í3)
Jobla (1979)
Saladlo at e l. (1963) 
Saladlo at e l. (1983)
Jobln (1579T
Evans (1983)
Jordan at e l. (1982 b)
Cook at e l.  (1977)
Jordan at al. (1962b) 
X.rotakl 4 Darla (1981) 
Jordan at e l. (1982b)
Jobln (15757
Negroo-aponts 4 Jobln (1979) 
Chu at a l. (1981)
Evens (1583)
Saladlo at al. (1983)
Jobln (15797“
Jobln (1979)
Polderaan (1964)
Pol da raen (1964)
Jobln (1979)
Jobln (1979)
Cook at a l. (1977)
Jordan at «1. (1982b) 
toldaraan (1984) 
trea ties at al. (1961) 
Jordan at a l. (1978)
Jo bln (197-9)
Jordan at a l. (1982a)
Jordan at a l. (1982a)
Jobln (19757 
Jordan at a l. (1982a)
Jordan at a l. (1982a)
Jobln (1579)
Duka 4 Moor« (1976)
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Table A5.3 Cost-effectiveness 
projects: cost per 
Grobar 1985)
ratios of parasitic disease control 
case-year prevented (from Barlow and
Coat par
prevented 
(1984 t ) «afarancaDrviga control
Water
aupply
SchlitoeoaInala
0 .14** 0 .3 4 *“ 0.34 
2.4» 2.32 4.13 S . 31 a . S3 a . 93
9.13***
9.29
11.14
11.97***
13.37
13.99
14.47
14.99
18.43 
20.81
24.23 
24.08 
24.10 
30.29
30.44 
33.81
34.42 
39.04 
40.34®* 
41.90 
47.49
30.42
52.12 
33.41 
37.40
38.48 
43.02
48.13
84.23 
No e ffec t 
No affaci
s
No
*
a paci f ad
Oppar Volta
Iraa
Iran
Philippines
Iran
China
St. Lucia
Zaire
Iran
Libarla
Zaira
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
Iran
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
Zaira 
St. Lucia 
St. Lucia 
St. Lucia 
Libarla 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
St. Lucia 
Sudan 
Libarla
Rugenallla at a l. (1964) 
Rugeaallle at a l. (1964) 
Drullha at a l. (1981) 
Roeenfldd at a l. (1977) 
Roaanflald et a l. (1977) 
Parooq (19417 
Roaanflald at a l. (1977) 
Wlauar (198T7 
Roaanflald (1979) 
Poldaruan (1984) 
Roaanflald at a l. (1977) 
Sai ad In et a l. (1983) 
Poldaruan (1984)
Poatar (1947)
Salala (1980)
Belale (1980)
Jordan (1977)
Belele (1980)
Freatica at a l. (1981) 
Baiala (1980)
Maaaoud at al. (1982) 
Balda (T?8ffT 
Balda (1980)
Belda (1980)
Roaanflald (1979)
Belele (1980)
Balda (1980)
Poldaruan (1984) 
Roaanflald (1979)
Belala (I960)
Baiale (1980)
Sai odia et a l. (1983) 
Belale (1?80)
Belele (1980)
Belele (1980)
Jordan (1977)
Jordan (1977)
Roaenfleld (1979)
Aula et a l. (1982) 
SaladTa 7t al. (1983)
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C1—7 Poerlo Rico Bread
Lacaity ViroM ratillas
Caayama Si . Lada 
Cal-4e4ac
Sie
Laweaca
Bala
Hwisaala TaqaartaS Raw'S*«»
Iran Taniaaia 
a Dri StHrwr Muaaevi
Narwal Narwal Nalwal
Narwal Irr^ atlwi «ri f^la. Nalwal Natural «rigatlen Inigerlaa Irrifatiee Irriaaliaa Naleral
Anneal rainfall (cm) 115 129 140 250 ISO 160 50 30 30 10
Controlled area (km*) MO 12 202 II to 20 M 52 20 10
Population >,400 17,100 42,000 6,00 i j n 200 1,500 17 00 1*000 4000
Annual volumt of mail 
habitat treated (m*) 65.000 19000 106.400 12 00 >0,00 39000 15,000 1.3 54,000 500000 2000
Habitat volume per surface 
area (m'/km*) 500 7J9 514 10,00 100 195 6,00 16,000 200 200
Population density (persons/km*) 64 140 227 333 54 10 600 330 12 43
Habitat volume per person (m*) 7J 5.2 2J 30 11.5 20 10 >0 21 46
MoDuscicide NaPCP NaPCP NaPCP Bayer NaPCP 
k Bayer
Cost period (years) 10 7 1 l.l 10 4 5 1 1 1
Currency Ü5.» U S* U S * US.* U S * l) S.% US.* Egyptian U S* Shillings
Total cost of program >65,600 W Jio ».299 $32,500 >316,600 >34000 >6,10 120,20 >17000 TS 30,000
Base year for coats 1960 1960 1955 1972 1972 1961 1961 1963 1922 1972
Annual coat is 1972 US dollars $13000 $17,000 $100 $25000 $32000 $100 $1300 $51.600 $17000 $4,171
Annual coat per 100 m* treated >20 >19 $19 $17 >40 $26 >10 >1.40 >3.40 $2.10
Annual coat per km* >10 >M9 >92 >1.20 >400 >50 >600 >1,130 >2 >41
Annual coot per person >IS0 >100 >0.43 >4 00 >240 >0 50 >0.20 >345 >0 94 >015
Program coat breakdown labor 6596 61% 5096 *096 5096 3696 596 *%
Mofktsddde 3% 6% U% 129$ 109$ 11% 4096 >5% 19% 25%
Transport and equipment 7% 169$ 59$ 15% 24% 21%
Supervision 11% 169$ 1«% 54%
Others i% li% >9% 69$ 59$ 10% 25%
Comparison 
of 
aollusclclde 
programme 
costs 
for 
schistosomiasis control projects 
(from Jobln 1979)
Project or site Country Cost per child Deaths averted per Cost per death averted
per year
(1985 t)
1000 children
Matlab Hospital Bangladesh 0.50 4.04 $124
Sukawati Indonesia 1.14 6.97 $163
Darmaraja Indonesia 1.50 8.46 $177
Mass Media The Gambia 1.56 6.94 $224
Bandung Indonesia 0.92 3.25 $283
Campurdarat Indonesia 1.38 4.73 $291
Salt/Sugar Home Egypt 4.76 8.20 $580
Oralyte Home Egypt 4.99 7.80 $639
Mass Media Honduras 4.14 5.16 $802
Salt/Sugar Pre. Egypt 9.99 7.00 $1427
Oralyte Comm. Egypt 5.56 2.00 $2780
Con 2-Awareness Egypt 4.24 0.40 $10600
■ s
Source: Applied Communications Technology (1985)
Commun Ica t Ion Technology 198S)
Country Vaccines Strategy Cost per CFV Coat per CFV
(reference) delivered (local currency ft date) (SUS 1982)
Brazil Pull EPI (i) Routine (static) 4671 cruzeiros (1982) 26.0
(Creese 1982) Full EPI (ii) Intensification (outreach) 1579 cruzeiros (1982) 8.8
(Creese 1984) Polio (iii) Campaign (mobile) 378 cruzeiros (1982) 2.1
Cameroon 
:Ahmed 1982)
Pull EPI Nixed (atatic/mobile) 2758 franca (1981) 9.5
Gambia Full EPI Mixed (static/aobile) 38 dalasi1 (1980/81) 19.2
(Robertson 
et si. 1982)
24 dalasi2 (1980/81) 12.0
Ghana Full EPI (i) Outreach 41 cedi (1979) 154.0
(Litvinov 
et al. 1979)
(li) Mobile 12 cedi (1979) 45.5
Indonesia 
(Creese 1981)
BCG, 2 DPT Nixed (static/aobile) 1412 rupiah (1979) 2.6
Ivory Coast Full EPI (1) Mobile unit - Abengourou 2628 francs (1980/81) 8.9
(Shepard 1982) (ii) Static centres - Abengourou 5432 francs (1980/81) 18.5
Kenya Full EPI Static 150 shillings (1981) 16.6
(Wang'ombe 1982)
Philifg>ines BCG, 2 DPT Outreach 30 pesos (1978) 6.2
(Creese 1978)
Thailand BOG, 2 DPT Mixed (static/eobile) 217 baht (1979) 13.2
(Creese 1980)
1. With expatriates
2. Without expatriates
Comparative 
vaccination 
cost 
par 
fully 
vaccina' 
(from Phillips, 
Paachaa and Mills 1985)
T a b i «  A 5 .7  : A n a ly s is  o f  NMEO d i s t r i c t  r e c u r r e n t  e x p e n d itu re  1983
B is tr ic t
P ip u ln t in  
e t  r i i k  
IN )
(1)
T i t i l
e n e i
1903
(2 )
t i l t . - l e n i  
expenditure
M
(3)
Ie lle  i f
in c e t te  i le  
ned ( l i )
(6)
Velie • (  
d r i f t  
■ted ( l i )
(5)
IIQ  eid ITC t i f i n e !  
expenditure expenditure 
( b )  ( l i )
(♦) (V)
T ite l d i i t .  
expenditure
( b )
( • )
Per cepite 
expenditure
( b )
(9)
R o r t if 4M ,0S2 710 1,161,624 344,321 50,004 255,301 141,764 1,960,021 4.05
S u u r i 314,SI) 453 162,694 244,291 33,221 176,553 102,670 1,419,436 4.51
Jkapa 449,177 513 1,301,300 432,771 77,592 256,413 141,941 2,224,011 4.95
I l  i l é ) ,277 75 521,126 61,129 13,033 69,034 31,2)4 716,556 11.32
Peickter 71,233 35) 610,105 0 14,742 97,313 55,905 771,1)4 9.95
Bbsj par 10,244 359 695,656 6,113 12,757 106,577 60,905 112,071 10.99
U d iip tr 120,269 111 956,176 242,417 22,659 131,574 74,110 1,427,704 11.17
Ik o tu f 69,203 15) 656,242 0 1,451 16,196 41,022 799,611 11.55
I n t e r i  r e f io i 1,4SI,969 2,167 6,771,921 1,331,126 232,466 1,179,100 671,322 10,207,635 6.15
teieckeep 14,144 94 624,515 0 9,152 12,722 41,143 751,232 1.94
S iid k i l i 127,351 269 1,045,611 123,234 11,671 145,112 72,1M 1,4M,211 11.04
la k a t t ir i 351,492 1,096 1,139,995 790, M2 51,200 255,699 131,095 2,361,051 6.61
Di i i i k i 423,621 2,125 1,3)2,195 2,749,940 63,027 363,115 115,5N 4,693,176 11.01
S ir l ik i 322,532 745 N I ,  194 560,659 57,509 207,429 107,374 1,194,164 5.17
Ck i t * n 213,775 464 1,007,699 250,005 40,119 116,M7 M.510 1,511,100 5.57
Iu r e 97,641 294 501,041 0 14,203 •7,035 43,336 652,622 6.61
C e it r i l  r i f i l i 1,698,270 5,007 6,619,334 4,473,900 255,211 1,327,179 677,162 13,354,256 7.16
lupndeki 373,919 1,112 1,249,056 711,123 31,922 273,502 113,311 2,455,921 6.57
C e rb i 219,194 653 1,MS,430 15,393 22,416 117,917 107,114 1,391,410 6.36
t i l H 1)1,141 464 754,574 0 16,134 121,627 72,427 972,462 7.00
t i p i  l u t t i 305,376 146 1,012,335 471.463 39,650 224,040 146,316 1,963,103 6.43
I m i  p e rn i 329,3)5 790 1,115,195 623,461 39,111 227,145 146,136 2,151,117 6.53
I n t e r i  r i f i l i 1.367,442 3,045 5,267,219 1,121,440 157,073 1,041,302 655,310 1.942,413 6.54
S irU e t 126,731 341 921,5M 192,601 11,150 140,674 19,469 1,362,401 10.75
Deif 277,600 372 1,255,621 275,331 22,473 203,111 1)1,562 1,111,112 6.10
I u t e ; 197,612 165 703,537 317,543 19,140 122,245 79,327 1,242,492 6.29
Bardiya 201,059 109 663,117 172,625 17,410 112,260 71,464 1,037,016 5.16
I l i  I I I i 241,124 5)2 901,428 505,150 21,309 111,667 132,151 1,749,413 7.03
lu c k i i p t r 199,526 434 1,023,692 666,751 11,047 110,401 121,222 2,010,113 10.07
Hid r e i t  r e f i n 1,251,429 1,953 5,475,972 2,130,001 117,299 941,135 625,903 9,290,311 7.42
TOTU ( i ) 5,974,110 13,045 24,141,515 9,763,474 762,526 4,480,116 2,637,397 41,795,029 6.99
( • )  lie !id e e  expenditure 01 t r e e t m t  i f  e n e i  i t  IIQ
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T a b le  A 5 .8• A n a ly s is  o f  NMEO d l s t r l c t  r a c u r r e n t  e x p e n d ltu ra  1984
M it r i c t
P op nla tiu  
a t rin k  
191k
(1)
Total
caset
19l(
(2)
D iit . - le te l  f a l l e  t f  
etpenditnre iasec tic id e  
(In ) u e d  (1s)
(J ) (0)
fa lle  af 
drngt 
ued ( ln )
(3)
•IQ  and ITC le g itM l 
e ip e a d itire  ezpenditure
( b )  ( b )
( * )  (»)
Tatal d in t .  
e ip e a d itire
( b )
(1 )
Per capita 
e ipeaditire
( b )
(»)
lorang 504.810 760 1,268,902 15 (,7 (( (8 ,OK 273,1(2 150,6(( 1,095,(07 3.76
Saosiri 320,(2) (62 916,850 122,0(1 31,328 185,065 99,336 1,355,(20 (.23
Jkapa 40.201 6(6 1,(27,(86 256,515 73,39( 280,529 1(8,879 2,1(6,803 (.72
11 «• 63,7(1 (8 57(,962 0 12,190 77,226 35,(06 70 0 .1(( 10.65
Pancbtar 77,127 357 833,539 0 1(,83( 117,762 61,321 1,027,(57 13.32
Bhojpar (1,393 (32 772,373 0 K.304 115,373 6),09( 965,1(3 11.06
Udiipur 123,132 ((1 1,108,(03 (3,(89 26,771 162,19( 82,702 1,(23,959 11.50
XbotSDg 85,238 175 725,067 0 8,269 100,530 (0,655 8(2,521 10.35
E ute rn  reg ion 1,721,772 3,(01 7,627,982 577,591 229,102 1,311,(20 690,(78 10,(36,973 6.06
taaeckaap (9,679 91 703,627 0 9,3(0 91,596 (0,0(9 (( ( .6 5 2 12.12
Sindkali 131,3(9 731 1,099,522 38,528 22,093 17(,06( 79,097 1.413.304 10.74
H ihottari 3(7.111 1,365 1,1(2,662 1,(62,888 (8,093 283,09( 135,028 3,072,566 0.37
Danuski (35,776 2,3(7 1,(77,282 2,(63,153 60,608 371,225 177,377 ( .9 (9 ,6 (6 11.36
Sarlaki 333,226 1,021 1,0(2,77) 672,858 50,907 226,(25 107,6(3 2,100,6(6 6.30
C k itn i 291,(29 977 1,137,677 1(7,152 ( 2 .20( 223,(66 105,063 1,655,562 5.68
lavre 99,660 3(2 625,020 0 15,58( 99,997 (5,6(9 786,250 7.89
Central reg ion 1,728,(30 7,001 7,228,56( 5 ,18(,579 2(9,669 1,(69,068 689,9(7 K.822,626 0.50
lupandeki 390.79) 2,308 1,(20,638 909,624 52,074 3)9,757 107,571 2,909.664 7.(5
Carkka 222,110 963 1,209,1(2 0 23.671 212,152 115,191 1,560,956 7.00
Palpa KO, (09 695 (31,(16 0 19,950 1((,702 70.196 1.074,265 7.6)
(a p ilv a ita 3K .I15 1,601 1,127,727 ((6,309 (6,207 259,2)6 1((,06S 2,023,5(3 6.(3
lia a lp a ra s i 3(0,(23 1,310 1,208,2(7 608,686 (3,295 259,927 1(3,651 2,263,006 6.64
fes tem  reg ion 1,(10,120 (.957 5,797,869 1,96(,619 105,190 t,2 15 ,(7 ( 660,673 9,(32,234 6.97
Sarkket 133,756 (76 928,682 0 17,079 161,351 71,779 1,178,891 (.60
Dang 2(3,9(9 1,(21 1,(62,218 0 20,650 270,636 126,137 1,887,6(1 6.60
linkey 205,(05 1,207 7(1,189 82,(59 25,636 172,952 89,223 1,111,(60 5.(0
Bardiya 209,(03 (55 723,316 (8,590 20,062 155,99( 79,933 1,027,895 (.90
K a ila li 260,791 1,606 912,527 176,(11 26,783 230,6)3 122,082 1,538,(36 5.90
lanckanpor 208,868 2,5(1 1,072,300 174.860 22,072 267,969 135,361 1,673,362 8.01
Kid t u t  reg ion 1,306,972 (.506 5,910,232 (02,320 1(1,002 1.259,536 62(,31S (.417 ,6(4 6.(4
n r u  (# ) 6,167,29( 26,030 26,56(,6(7 (.209,108 (05,(60 5.257,090 2,673,613 (3,509,927 7.05
(a) I ic  1 ades eipenditere o i tre ite e n t i f  cases < t IBQ
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Tabi* A5.9: NMEO expenditure by geographical area, 1983 and 1984
Total b i l l y  b i l l y  
e ip e id it ire  Ooter Tarai l iM r  Tarai
b i l l y
■ i l l
Tatal b i l l y  b i l l y  
e ip e id it ire  O tter Tara i lu e r  Terai
b i l l y
■ i l l
Roraag 1,960,031 1,960,021 1,895,487 1,895,417
S u t « r i 1,419,0« 1,419,41« 1.355,420 1,355,420
Jkopa 2,224,018 2,224,018 2,186,803 2,186,103
11 l u 716.556 716,556 700,184 700,184
P aichtar 778,114 778,114 1,027,457 1,027,457
B k.jp«r 882,078 882,078 965,143 965,141
Udaipor 1,427,704 1.427,704 1,423,959 1,423,959
U a ta ï f 799,618 799,618 882,521 882,521
la i te r o  refion 10,207,615 5,601,544 1,427,704 3,176,116 10,436,973 5,417,710 1,421,959 1,575,104
tu eck«« p 758,212 758,212 844,652 844,652
S ia d h il i 1,406,211 1,406,211 1,413,304 1,413,104
la k a t ta r i 2,168,051 2,368,051 3,072,566 3.072,566
Daawka 4,691,876 4,693,876 4,949,646 4,949,646
S arlak i 1,894,164 1,894,164 2,100,646 2,100,646
C kittaa 1,581,100 1,581,100 1,655,562 1,655,562
I«»ra 652,622 652,622 786,250 786,250
C eatra l ra f io t 11,154,256 8,956,091 2,917,111 1,410,154 14,122,626 10,122,158 3,068,866 1.610,902
lopaadeki 2,455,921 2,455,921 2,909,664 2,909,664
Corkka 1,198,410 1,398,410 1,560,956 1,560,956
Palpa 972.462 972,462 1,074,265 1,074,265
la p ilv a s tn 1,961,803 1,963,803 2,021.541 2.021.541
la ia lp a ra t : 2,151,817 2,151,817 2.263,806 2,261,106
S e tte r«  re f ia i 8.942,411 6,571,541 0 2,370,872 9,832,214 7,197,011 o 2,635,220
S irkket 1,162,401 1,162,401 1,178,891 1,178,891
Daif 1,888,882 1,888,882 1,887,641 1,887,641
Baakey 1,242,492 1,242,492 1,111,460 1,111,460
la rd iy a 1,017,016 1,017,016 1,027,895 1,027,195
b i l a l i 1.749,411 1,749,411 1,518,416 1,518,416
b a c k a ip n r 2,010,111 2,010,111 1,673,362 1,671,162
Rid « e t t  r e f i t i 9,290,118 6,039,015 1,251,282 0 8,417,684 5,351,152 1,066,512 0
TOTAL (a ) 41,795,029 27,170.211 7,666,299 6,958,519 43,509,927 26,108,733 7,559,157 7,641.817
D is t r i  betioa 100.01 65.0t 18.11 16.6t 100.01 64.61 17.41 18.01
(«) b e la d e t e ip e id itire  t i  tre a ta e it of c u ts  i t  HQ
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T a b le  AS.10 : D is t r ib u t io n  o f  NMEO r e c u r r e n t e x p e n d itu re  by management
level and typa, 1983 and 1984
I
Î
H
! !
é!
î
1 5 5 5 5 5 3 5 3
2 2 5 255222
5 2 2 555252
2 2 2 222252
S S S S s S S S s
555235555
5 2 5555553
2 3 35 35 22 5
255252225
2 5 5 5 3 3 2 2 5
I
ilniill*
2 5 2 3 5 2 3 5
5 2 3 2 2 5 2 2
5 5 3 3 3 5 2 3
2 2 2 2 3 5 2 2
35532535
5 3 5 5 2 2 3 5
2 5 2 5 5 2 5 2
3 5 2 3 3 5 5 2
2 2 2 2 2 2 2 2
5 3 3 3 5 5 3 3
iÜJIiii
322255  § 3 5 5 5 5 5  5 
522255  2 5 5 2 5 2 2  2 
355553  3 5 2 2 5 3 5  5 
2 2 2222  2 2 2 5 2 2 2  2 
333353 5553533 5 
333535  5 5 5 3 5 5 5  5 
522252  2 2 5 2 2 5 2  5 
325335  3 5 3 3 5 3 5  3 
222555  2 2 22 2 5 2  2
533555  3 5 33 5 5 5  5
J  tlui!- itimi 1
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ANNEX 6
GLOSSARY
ABER
Annual blood examination rata (the annual number of slides taken 
expressed as a proportion of the population)
ACD
Active case detection (cases detected by house-to-house visits by 
malaria field workers and village health workers)
AHV
Assistant health worker
Active ingredient (of an insecticide)
APCD
Activated passive case detection (cases detected by malaria field 
workers and village health workers outside their normal schedule of 
visits)
API
Annual parasite index (all cases detected expressed per 1000 population) 
CBA
Cost-benefit-analysis 
CEA
Cost-effectiveness analysis 
CUA
Cost-utility analysis 
DA/TA
Daily allowance and travel allowance (paid to workers on field trips)
EPI
Expanded Programme on Immunization 
ESM1 Form
The form used by the patient survey of malaria to enquire about sources 
of treatment, expenditure on treatment and days of work and school lost
HFA
Health for All 
Household Survey
A survey in two areas of 867 malaria cases and 867 controls and their 
households, enquiring about the consequences of an episode of malaria
ICHSDP
Integrated Community Health Services Development Project 
Imported A
Malaria cases thought to have been infected in India
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MBS
Mass blood survey 
MFV
Malaria field worker 
NHQ
National headquarters of the NMEO 
NMEO
Nepal malaria eradication organisation 
ORT
Oral rehydratlon therapy 
Patient survey
A survey using the ESM1 form of 32S3 malaria cases In 6 districts 
PCD
Passive case detection (cases detected by passive methods)
PCD <H)
Cases detected by health units 
PCD (M)
Cases detected by malaria offices 
PCD (MC)
Cases detected by malaria clinics 
PCD (V)
Cases detected by malaria volunteers 
PHC
Primary Health Care 
RTC
Regional training centre of the NMEO 
SF5 Form
The form used by malaria workers to record the characteristics of each 
malaria case
SPR
Slide positivity rate (percentage of slides found to be positive)
VHW
Village health worker
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